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Abstract 
Avian pathogenic Escherichia coli (APEC) is the causative agent of avian colibacillosis, a localised 
or systemic infection resulting in clinical diseases such as colisepticemia, chronic respiratory disease 
and swollen-head syndrome. Globally, avian colibacillosis is the leading cause of morbidity and 
mortality in poultry, and it has been associated with massive economic losses and welfare problems. 
This organism is of public health significance as APEC is communicable to humans. The diagnosis 
of avian colibacillosis relies on clinical signs, typical pathological lesions and culture of E. coli from 
affected tissue(s). Antimicrobial therapy is often used both for treatment and control. Previous 
overseas studies have characterised APEC and identified virulence genes (VGs) that can be used as 
molecular markers for the identification of APEC. Little is known about APEC in broiler  chickens in 
Australia.  
The aim of this thesis was to gain a better understanding of the epidemiology of APEC in Australian 
broiler flocks and how factors including presence of VGs and phylogenetic group can improve the 
identification of this pathotype in Australia. Firstly, three faecal DNA extraction methods were 
evaluated. Faeces were collected from healthy chickens and chickens with colibacillosis from 
commercial broiler farms in South East Queensland (SEQ). The extracted DNA was screened by a 
pentaplex-PCR for five APEC-associated VGs (iroN, iutA, iss, hlyF and ompT). DNA extracted from 
E. coli isolates cultured from the cloaca and organs of the birds were screened using the same PCR. 
Repeated bead beating plus column elution was the preferred DNA extraction method, as it yielded 
good PCR quality and adequate quantity DNA. However, identifying APEC by direct detection of 
the five VGs from the faecal material was not feasible as all of these genes were also detected in all 
of the birds. However, the VGs were more commonly detected in E. coli isolates cultured from birds 
with colibacillosis. 
A cross-sectional study was performed to estimate APEC farm-level prevalence in healthy broiler 
chickens in SEQ and to identify potential risk factors associated with the carriage of APEC. At the 
farm-level, all of the 40 farms sampled were positive for APEC, that is at least one bird per farm 
carried APEC, while the within-farm prevalence was 63% (95% Confidence Interval: 55.8, 70.2). 
Higher APEC within-farm bird-level prevalence was significantly associated with the usage of well 
water as a source of drinking water, failure to disinfect the water line after each flock, farm visitors 
not showering before entering the shed, distances greater than 20 metres between the car park and the 
poultry shed and the presence of wild birds within 50 metres of the shed. Chlorinating the drinking 
water combined with automatic water filtration reduced within-farm bird-level APEC prevalence. 
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Therefore, based on the results concluded from the multivariable model, improving biosecurity and 
water treatments might reduce APEC prevalence, decrease the risk of colibacillosis, reduce the use 
of antimicrobials, improve food safety and positively influence poultry and public health.  
The antimicrobial susceptibility profile, phylogenetic group, virulence and plasmid replicon (PR) 
profiles of 50 clinical E. coli (CEC) and 187 faecal E. coli (FEC) cultured from broiler chickens were 
compared. Isolates showed genetic diversity regardless of the E. coli isolates’ pathogenicity, 
suggesting that there exists a substantive reservoir of associated antimicrobial resistance, VGs and 
PRs among E. coli from chickens. Resistance to older as well as newer antimicrobial drugs was 
detected among clinical and faecal E. coli. Despite no history of use of extended-spectrum 
cephalosporins (ESCs) and/or fluoroquinolones (FQs) in the Australian broiler chicken industry, 
resistance to these antimicrobials of public health importance were detected in Australian chickens 
for the first time. Sequence type (ST) 354 was the most common ST associated with FQ resistance 
and this ST has previously been identified in FQ resistant E. coli from humans, other domestic 
animals and wild birds. We hypothesise the source of FQ and ESC resistant E. coli may be external 
to the production facility. The identification of FQ and ESC resistance and globally disseminated STs 
in broiler chickens suggests the need for further studies to identify how poultry is included within the 
broader epidemiology of resistance amongst extraintestinal pathogenic E. coli (ExPEC) and the 
potential significance to public health.  
Finally, a subset of 29 CEC and 59 FEC, representing 88 enterobacterial repetitive intergenic 
consensus clusters and the most resistant isolates, were selected to determine the distribution of 35 
ExPEC-associated VGs. The study detected 34 VGs, with prevalence ranging from 3.4% (focG) in 
FEC to 100% (astA) among CEC. All the tested isolates were positive for at least four VGs. This 
study identified a set of VGs: iroN; iss; iutA; tsh; fimC; papC; papEF; vat; hlyF; astA; ibeA; feoB; 
ireA; cvi/cvaC and ompT that were significantly more likely to be found in CEC isolates. Future 
investigations may be able to use these VGs to detect APEC in Australia assisting in the diagnosis, 
control and prevention of colibacillosis in poultry. 
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1 Chapter 1: Literature review 
 
Avian colibacillosis is considered one of the most common diseases that affect the poultry industry. 
It results in significant economic losses and welfare concerns worldwide (Dho-Moulin and 
Fairbrother, 1999; Ewers et al., 2004; Nolan et al., 2013). Economic losses are the result of the high 
costs associated with treatment and vaccination, decreases in growth rate and egg production, high 
mortality and carcass condemnation at the abattoir (Nolan et al., 2013).  
Avian pathogenic Escherichia coli (APEC), the causative agent of avian colibacillosis (Antão et al., 
2008; Dho-Moulin and Fairbrother, 1999; Ewers et al., 2004; Kabir, 2010; Nolan et al., 2013), is a 
subpathotype of extraintestinal pathogenic E. coli (ExPEC). It is considered a potential zoonotic agent 
(Johnson et al., 2008b; Nolan et al., 2013; Rodriguez-Siek et al., 2005a). APEC coexists in the gut 
microbiota of healthy chickens with avian faecal E. coli (AFEC) (Dho-Moulin and Fairbrother, 1999; 
Ewers et al., 2004; Kabir, 2010; Nolan et al., 2013). Clinical signs and pathology in the bird 
population, isolation of E. coli from a lesion or faeces, bacterial virulence genotype, phylogenetic 
group and serotype have been used by several studies to differentiate APEC from AFEC (Johnson et 
al., 2008b; Lynne et al., 2012; Pfaff-McDonough et al., 2000; Skyberg et al., 2003). 
Avian colibacillosis has been reported as common in all age groups of commercial broiler flocks 
(Nolan et al., 2013). Reported prevalence ranges between 30% in the United States of America (USA) 
(Johnson et al., 2008b) and 14% in Bangladesh (Badruzzaman et al., 2015). Currently, there is no 
Australian data in regards to the prevalence of avian colibacillosis in broiler flocks. 
The severity of colibacillosis in chickens depends on the pathogenicity of the APEC, the chicken’s 
immune status and the presence of predisposing risk factors, such as poor chicken welfare, 
immunosuppression and co-infections that can increase host susceptibility (Dho-Moulin and 
Fairbrother, 1999; Ewers et al., 2004; Guabiraba and Schouler, 2015; Nolan et al., 2013; 
Vandekerchove et al., 2004a). A number of overseas studies identified vectors humans (farm worker 
and visitors), wild birds and rodents, source and type of treatment(s) applied to the drinking water 
and unfavourable housing conditions as major risk factors associated with avian colibacillosis 
(Kemmett et al., 2013; Nolan et al., 2013; Vandekerchove et al., 2004a). Low levels of APEC on 
overseas poultry farms, is associated with strict farm biosecurity and management practices, such as 
control of vectors by minimising bird interaction with other animals and hygienic cleaning protocols 
(Nolan et al., 2013; Vandekerchove et al., 2004a; Zanella et al., 2000). However, little knowledge is 
available in regards to the potential predisposing risk factors (biosecurity and farm management 
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protocols and environmental factors) associated with APEC among commercial broiler chicken 
flocks in Australia. 
Avian colibacillosis is traditionally diagnosed by clinical signs, pathology and the culture of E. coli 
from the infected lesion(s) (Nolan et al., 2013). However, these traditional methods are nonspecific 
and time consuming in comparison with being able to identify APEC directly from sample(s) utilising 
molecular methods. Previous studies have used molecular techniques to identify pathogens and/or 
genes directly from samples. These methods have proven to be reliable, cost-effective, user friendly, 
sensitive and specific as well as providing a distinct advantage in regards to time saving over 
conventional culture methods (Blessmann et al., 2002; Eyigor and Carli, 2003; Garofalo et al., 2007; 
McOrist et al., 2002). 
Antimicrobial agents are widely used in the poultry industry for the treatment and control of avian 
colibacillosis (Morley et al., 2005). The extensive use of antimicrobial drugs among humans, 
companion and production animals has led to the emergence of antimicrobial resistant strains among 
commensal and pathogenic E. coli (Zhao et al., 2005). The risk of antimicrobial resistant bacteria is 
a major concern for public health and veterinary medicine (Barton et al., 2003). In Australia, there is 
limited knowledge of the antimicrobial susceptibility of APEC to guide veterinarians in developing 
successful prevention and treatment schemes. Numbers of overseas studies have reported 
geographical variations in the antimicrobial susceptibility of APEC (Alvarez-Fernandez et al., 2013; 
Dheilly et al., 2013; Sola-Gines et al., 2015). The geographical variation in susceptibility of APEC 
highlights the importance of regional knowledge to control, prevent and treat avian colibacillosis 
(Aarestrup, 2005).  
The current review will give an overview of the global poultry industry in general and the Australian 
industry, specifically. General information in regards to colibacillosis, such as clinical signs, 
diagnosis, treatment and the causative agent will be reviewed. Identification and molecular 
characterisation of APEC are also included in this literature review. Furthermore, potential risk 
factors and preventive and applied control measures associated with avian colibacillosis are explored. 
Antimicrobial agents of public health and veterinary importance in Australia and worldwide are 
discussed, along with antimicrobial resistance (AMR) detected in APEC in previous studies. Finally, 
this literature review covers the current knowledge in regards to the molecular characterisation of 
commensal and pathogenic E. coli in broiler chickens globally. 
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1.1 The poultry industry  
Globally, the poultry industry has experienced massive growth in response to consumer demand for 
poultry products over the past few decades (Mulder and Nan, 2011). The Food and Agriculture 
Organisation of the United Nations (FAO) has reported a three-fold increase in poultry meat 
production in comparison to total population growth over the last five decades (Thornton, 2010). 
Whilst the largest poultry production growth was experienced in countries such as India and Vietnam 
with 217% and 136% increases respectively, other countries such as North and Central America and 
Europe experienced a steady growth over the same period of time (Windhorst, 2006). 
The substantial technical and scientific growth in different aspects of the poultry industry in many 
countries has been accompanied by several challenges in regards to food safety, animal welfare, 
efficiency of flock production, housing environment and the management of current and emerging 
diseases (Gororo and Kashangura, 2016; Penz and Bruno, 2011; Scanes, 2007). Respiratory and 
enteric diseases are considered the major diseases facing the poultry industry globally and cause 
massive economic and production losses (Kabir, 2010; Nolan et al., 2013). These diseases are due to 
viruses, such as avian influenza (Bertran et al., 2016; El Houadfi et al., 2016), bacteria, such as  
E. coli (Nolan et al., 2013), Salmonella species (Kabir, 2010) and parasites, such as coccidia (Nolan 
et al., 2013). 
1.2 The Australian poultry industry 
In 2010, the Australian Bureau of Agricultural and Resource Economics and Sciences reported the 
growth of the Australian poultry industry was steady and mirrored the global trends (ABARES, 
2011). The volume of Australian poultry meat production was estimated to be three million birds in 
1951, compared with 600 million birds in 2013 (Australian Chicken Meat Federation, 2014). This 
expansion in production was due to a combination of competitive chicken pricing compared with 
other meat and an increase in the diversity of chicken products (ABARES, 2011). 
In Australia, the majority of poultry operations are intensively concentrated due to their close 
proximity to urban populations (Australian Chicken Meat Federation, 2014). The broiler industry is 
highly vertically integrated with large companies owning or controlling all of the supply and 
production aspects such as sources of birds, feed mills, farms, veterinary services as well as slaughter 
and processing facilities (Australian Chicken Meat Federation, 2014). Currently, there are seven large 
integrated companies in Australia which supply up to 95% of the total Australian chicken meat, while 
the remaining 5% is supplied by small privately owned farms (Australian Chicken Meat Federation, 
2014). Ingham Enterprises Pty Ltd and Baiada Poultry Pty Ltd are the two largest integrated meat 
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companies supplying 70% of the total domestic Australian poultry meat (Australian Chicken Meat 
Federation, 2014). Broilers are typically raised in tunnel ventilated sheds containing 10,000 – 20,000 
birds (Chinivasagam et al., 2009). A standardised management protocol in regards to farm 
management, drug administration and biosecurity protocols are followed on all of the chicken farms 
owned by the company due to the integrated system (ABARES, 2011).  
1.3 Avian colibacillosis  
Colibacillosis mainly affects birds four to eight weeks of age, though it can affect adults, as a primary 
or secondary pathogen (Cheville and Arp, 1978; Dhillon and Jack, 1996; Nolan et al., 2013; Rashid 
et al., 2013). The disease is a complex syndrome that can occur as a localised (subacute form) or 
systemic infection (acute form) (Nolan et al., 2013; Paixao et al., 2016). The disease can manifest 
itself in different forms, such as, yolk sac infections (omphalitis), respiratory tract infections (air 
sacculitis), swollen-head syndrome, septicaemia, polyserositis, coligranuloma, enteritis, coliform 
cellulitis, salpingitis, pericarditis and perihepatitis in chickens, turkeys and other commercial avian 
species (Dho-Moulin and Fairbrother, 1999; Moulin-Schouleur et al., 2006; Paixao et al., 2016).  
1.4 Economic significance of avian colibacillosis  
Avian colibacillosis is considered the most common type of bacterial infection affecting the poultry 
industry. Globally, E. coli infections are considered the number one cause of carcass condemnation 
at slaughterhouses (Jakob et al., 1998; Santos et al., 2014). For example, 45.2% of poultry carcass 
rejection in Brazil, one of the world's largest exporters of chicken meat, was due to APEC infections 
(Fallavena et al., 2000). Globally, 36% – 43% of the broiler carcasses disposed of at slaughter are 
due to lesions consistent with E. coli infections (Fallavena et al., 2000; Norton et al., 1997). A 
mortality rate of 3.3% was reported in birds due to colibacillosis in Bangladesh (Rashid et al., 2013) 
and mortality rates of up to 10% have been reported in Denmark and Italy (Stokholm et al., 2010; 
Zanella et al., 2000). The disease is responsible for 2% – 3% decreases in egg production and the 
costs associated with prevention/control, vaccination and treatment are substantial (Antão et al., 
2008; Ewers et al., 2004; Gross, 1957; Kabir, 2010; Nolan et al., 2013; Stokholm et al., 2010; Zanella 
et al., 2000). 
1.5 Clinical signs and the pathological lesions 
The severity of the disease depends on the presence of predisposing factors, the immune status of the 
bird, the pathogen’s route of entry, virulence of the E. coli strain and the duration of exposure (Cloud 
et al., 1985; Dziva and Stevens, 2008). The clinical signs associated with avian colibacillosis are 
nonspecific and vary with age, species, type of infection and whether it is localised or systemic (Kabir, 
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2010; Nolan et al., 2013). Affected birds demonstrate signs of respiratory distress, reduced appetite, 
poor growth, depression and fever, which may also be accompanied by a high mortality rate (Kabir, 
2010; Paixao et al., 2016). Characteristic fibrinous lesions, such as, airsacculitis, pericarditis, 
perihepatitis, peritonitis and salpingitis are commonly found during post-mortem examination of the 
internal organs (Nolan et al., 2013; Vandekerchove et al., 2004b) (see Figure 1-1). 
 
 
 
 
 
 
 
1.6 Diagnosis of avian colibacillosis 
Currently, the identification of avian colibacillosis is based on the traditional diagnostic methods 
composed of clinical signs, characteristic macroscopic lesions found during post-mortem 
examination (Nolan et al., 2013; Whiteman et al., 1979) and isolation and identification of E. coli 
from the affected lesion(s) of chickens (Kabir, 2010). E. coli is isolated using selective media such 
as MacConkey agar and/or eosin-methylene blue agar or other selective media (Quinn et al., 2011). 
The majority of E. coli can ferment lactose on MacConkey agar and eosin-methylene blue agar 
producing distinctive pink and blue black with or without a green metallic sheen colonies, 
respectively (Quinn et al., 2011). Further biochemical tests, such as indole, Voges Proskauer (VP), 
methyl red, citrate and/or commercial assays such as: MicrobactTM GNB 24E (Oxoid); API® 20E 
(bioMerieux) and matrix-assisted laser desorption/ionization time-of flight (MALDI-TOF) may be 
used to confirm the identification of E. coli isolates (Quinn et al., 2011). Culture methods are 
considered to be the gold-standard for isolation and identification of E. coli (Kabir, 2010; Nolan et 
al., 2013). Molecular methods can also be used following phenotypic identification of bacterial 
isolates using species-specific polymerase chain reactions (PCRs). Pathotypes of E. coli can be 
Figure 1.1: Macroscopic lesions characteristic of avian colibacillosis in broiler chickens. (A) 
Clear air sac of a healthy chicken from http://www.poultryhub.org/health/disease/types-of-
disease/colibacillosis; (B) Characteristic fibrinous lesions of airsacculitis, pericarditis and 
perihepatitis from necropsy at poultry farm in South East Queensland. 
 
 
 
(B) (A) 
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further identified based on the presence of virulence genes (VGs) (Ewers et al., 2005; Johnson et al., 
2008b).  
Culture methods however, are labour intensive and time consuming in comparison with molecular 
methods such as PCR, which can be used to detect the unique nucleic acids (either RNA or DNA) of 
pathogens (Ishmael and Stellato, 2008) directly from faecal samples (Blessmann et al., 2002; 
Garofalo et al., 2007). Pathogen specific PCR tests can be applied on extracted DNA from faecal 
samples to rule-in or-out targeted pathogens (Nechvatal et al., 2008). However, the direct application 
of molecular techniques to faecal samples has been hampered by the inability to extract PCR quality 
DNA that is free from PCR inhibitors, such as bile salts, haemoglobin, degradation products and 
complex polysaccharides (Abu Al-Soud and Radstrom, 1998; McOrist et al., 2002).  
Variation in the composition and consistency of faecal samples from different animal species affects 
the quality (purity) and the quantity (concentration) of the extracted DNA (McOrist et al., 2002) and 
therefore, the ability to successfully amplify DNA and detect pathogens (Hart et al., 2015). A number 
of studies have highlighted the need for careful consideration of DNA extraction methods from 
different animal species (Goldberg et al., 2016; Hart et al., 2015; Rapp, 2010). For example, DNA 
was successfully extracted from fish faecal samples using the isopropanol method, while the MoBio 
Power Fecal DNA kit (Qiagen Pty Ltd, Chadstone, Victoria, Australia) was needed to extract quality 
DNA from equine faecal samples (Hart et al., 2015).  
Generally, chicken faeces contain less moisture compared with other animal species (Akhtar et al., 
2013), which leads to difficulties in dissolving the faeces in a buffer (Barnard et al., 2011). Chickens 
may have additional inhibitors compared to other mammalian faeces as they excrete urinary waste in 
the faeces via a common cloaca (Chambers et al., 2001). Therefore, testing is required to detect the 
best method(s) for DNA extraction from faeces for chickens, rather than simply extrapolating from 
other species.  
There are several methods, such as physical, mechanical, chemical extraction and commercial kits, 
specifically designed for DNA extraction from faecal samples. DNA extraction methods must 
produce repeatable and accurate PCR results (McOrist et al., 2002; Yu and Morrison, 2004). 
However, the complex matrix of faecal samples make it a challenging job to choose the most suitable 
extraction protocol as some common methods, such as the cell lysis by boiling method, are incapable 
of removing faecal inhibitors (Rapp, 2010; Wilson, 1997).  
To evaluate the purity and the contamination level of DNA, the ratio of the absorbance at 260 and 
280 nm (A260/280) is used. Samples are considered relatively free from contamination if the ratio of 
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A260/280 is 1.80 – 2.00 (Desloire et al., 2006). Several studies have reported that QIAamp DNA 
Stool Mini Kit (Qiagen Pty Ltd) gave superior results (increased purity and DNA concentration and 
minimised the PCR inhibitors) compared with other commercial kits (FastDNA™ SPIN Kit (MP 
Biomedicals, Santa Ana, California, USA); NucleoSpin® (Macherey-Nagel, Germany) and Quantum 
Prep® AquaPure™ genomic DNA isolation kit (Bio-Rad Laboratories Pty Ltd, Gladesville, New 
South Wales, Australia) when extracting DNA from faecal samples of ruminants and humans 
(Desloire et al., 2006; McOrist et al., 2002; Nicklas and Buel, 2003; Verweij et al., 2004; Verweij et 
al., 2007).  
Yu and Morrison (2004) evaluated four different DNA extraction methods from faecal samples from 
cows. The methods tested were the QIAamp DNA Stool Mini Kit (Qiagen); the FastDNA™ SPIN 
Kit (MP Biomedicals); phenol-dependent bead-beating method (BB+P/C) (Whitford et al., 1998) and 
repeated bead beating plus column (RBB+C) which is a modified BB+P/C. The study reported that 
the RBB+C gave a 1.5 to 6-fold higher yield than the other methods evaluated, as well as, providing 
a higher quality of DNA, free from PCR inhibitors. 
Gioffre et al. (2004) reported that direct culture from the faeces of bovines gave the highest sensitivity 
when compared with the QIAamp DNA Stool Mini Kit (Qiagen) and the heat lysis method for the 
detection of E. coli. However, in agreement with Yu and Morrison (2004) they found that the QIAamp 
DNA Stool Mini Kit extraction method resulted in fewer PCR inhibitors compared to the heat lysis 
protocol. The commercial kit was able to rapidly detect VGs by PCR from bovine faecal samples. 
For human stool samples, the extraction using the QIAamp DNA Stool Mini Kit (Qiagen) yielded 
statistically greater PCR sensitivity in comparison to the Chelex methods (Cordova et al., 2010) 
Overall, molecular methods to detect pathogens or VGs directly from faeces have proven to be 
reliable, cost-effective, user friendly and accurate in other animal species, therefore, providing a 
distinct advantage over conventional methods (Blessmann et al., 2002; Eyigor and Carli, 2003; 
Garofalo et al., 2007; Gioffre et al., 2004; McOrist et al., 2002). However, currently, there is a lack 
of information pertaining to the quality and quantity of extracted DNA from chicken faecal samples 
using different DNA extraction methods (Barnard et al., 2011). 
1.7 Risk and predisposing factors associated with avian colibacillosis 
Predisposing factors for colibacillosis can be loosely categorised into three different categories, those 
related to the bird susceptibility, environment and agent (Barnes, 2013). The interaction between 
these factors determines if disease occurs in the chicken flocks (Barnes, 2013; Dho-Moulin and 
Fairbrother, 1999). 
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The breed of broiler chicken, as well as, the quality of the egg at the hatchery can play a crucial part 
in relation to the bird’s susceptibility to APEC infection (Barnes, 2013; Kabir, 2010). 
Immunocompromised and/or young birds are more prone to infection and disease in comparison with 
healthy older birds (Barnes, 2013; Dziva and Stevens, 2008; Kabir, 2010). Furthermore, primary 
respiratory infections due to other pathogens (e.g. viruses (Newcastle disease virus, infectious 
bronchitis virus, infectious laryngotracheitis (herpesvirus)) and bacteria (Mycoplasma gallisepticum, 
Pasteurella multocida) might increase the birds’ susceptibility to APEC infection (Dho-Moulin and 
Fairbrother 1999; Kabir, 2010).   
Generally, stress can increases the susceptibility of the birds to all diseases (Barnes, 2013; 
Vandekerchove et al., 2004) and colibacillosis in particular (Antao et al., 2008; Johnson et al., 2008). 
The occurrence of stress among the chickens could be induced by different infectious agents and/or 
inappropriate husbandry and management, such as inadequate feeding and poor climatological farm 
conditions (Barnes, 2013; Dziva and Stevens, 2008; Kabir, 2010). A previous study suggested that 
the presence of a systemic avian colibacillosis infection can indicate the presence of physiological 
stressors (Zanella et al., 2000). 
The fact that APEC is found in the gastrointestinal tract of healthy and unhealthy birds means it is 
commonly disseminated in faecal material (Circella et al., 2012; Johnson et al., 2008; McPeake et 
al., 2005; Rodriguez-Siek et al., 2005a), which means that APEC are widely distributed in the bird’s 
surrounding environment through faeces, litter, water, dust and feeders (Barnes, 2013; Dziva and 
Stevens, 2008). Furthermore, APEC can persist for a long period of time under dry conditions, 
meaning birds may be continually exposed to APEC leading to a higher risk of colibacillosis 
(Whiteman et al., 1979). Several studies have reported constant high levels of E. coli among litter in 
the chicken sheds (Macklin et al., 2006; Runge et al., 2007). The common practice in Australian 
poultry production, similar to American poultry production in regards to the litter, is to reuse the litter 
for several poultry production cycles (Macklin et al., 2006; Runge et al., 2007). Thirty percent of 
farms in study by Runge et al. (2007) reused their litter multiple times. Poultry bedding is considered 
as a rich source for pathogens originating from poultry faeces (Runge et al., 2007).  
Environmental pressures are positively correlated with increased susceptibility to APEC infection 
among broiler chickens (Kabir, 2010). These environmental pressures can lead to physical damage 
to the respiratory system due to previous respiratory infections, excessive ammonia levels and/or high 
faecal contaminated dust (Barnes, 2013; Kabir, 2010; Vandekerchove et al., 2004). High flock 
density, inadequate ventilation and poor litter quality in the broiler flock especially during winter 
with restricted ventilation are major environmental stressors (Barnes, 2013; Kabir, 2010; Leitner and 
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Heller, 1992). Proper ventilation is important to reduce the levels of E. coli on a farm. Wathes et al. 
(1986) found warm and dry temperatures of more than 30 °C increased the rapid death of aerosol  
E. coli (Wathes et al. 1986). Studies on Australian poultry farms have reported a seasonal pattern for 
E. coli survival, where survival rates increase in the colder months compared to summer months 
(Chinivasagam et al. 2009; Wathes, 1996). Another study by Chinivasagam et al. (2009) suggested 
that high temperatures and direct sunlight reduced the level of bacteria. 
One of the main sources of APEC infection in poultry flocks is the acquisition of infections from 
APEC contaminated aerosols. The majority of the Australian farms are mechanically ventilated and 
this is a major risk factor for colibacillosis and can also contribute to transmission of large volumes 
of contaminated air to the outside environment (Barnes, 2013; Davis and Morishita 2005; Ginns et 
al. 1998; Kabir 2010; Vaicionis, 2006).  
The normal intestinal flora of birds could be disturbed due to factors such as: general enteritis, 
antimicrobial administration, poor water quality and sudden feed changes (Barnes, 2013). This 
disturbance can lead to the introduction of APEC infection through the gastrointestinal route by 
contaminated water, feed and litter (Barnes, 2013). 
Impaired biosecurity protocols on farms which allow birds to contact wild birds, rodents, insects or 
any other wild animals are potential risk factors for APEC infections (Jiang et al. 2014; Wang et al. 
2013). Generally, the animals and insects act as vectors to introduce and/or spread the disease among 
flocks (Barnes, 2013; Vandekerchove et al. 2004a). It is not only the wild animal that can introduce 
colibacillosis, but infectious diseases can also be introduced through feed, hence strict biosecurity 
measures for feed are paramount (Vandekerchove et al., 2004; Wang et al., 2013). The more 
frequently carcasses are removed is another important factor associated with reducing the 
introduction and/or spread of APEC within the same flocks or different sheds in the farm by reducing 
the exposure time and dose of the agent (Vandekerchove et al., 2004a). 
Farm visitors or worker can act as a vector to introduce and spread APEC into the farms either directly 
or indirectly. The human role as a vector can be minimised by following hygiene procedures in 
regards to foot and hand sanitisisation and wearing protective clothes. The lack of disinfection of 
equipment before and after use in selected sheds can act as a predisposing factor for APEC infection 
in the chicken flocks (Barnes, 2013). 
Vandekerchove et. al (2004a) reported that the distance between chicken farms can play an important 
part as a potential risk factor associated with APEC infection. The closer the chicken farms the higher 
the prevalence of APEC detected on the chicken farms.  
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Previous studies have suggested an association between APEC infection and the source of drinking 
water as well as the treatment applied to the water and feed (Vandekerchove et al., 2004a). Several 
studies have reported that adding chlorine to the drinking water was an effective measure to reduce 
the economic losses associated with APEC infection in chickens (Vandekerchove et al., 2004a). 
The literature review highlighted the absence of data regarding the potential risk associated with 
APEC infection in broiler flocks in Australia. There was no specific information in regards to the 
associations between farm management and the prevalence of APEC among commercial broiler 
chickens. 
1.8 Intervention strategies for avian colibacillosis 
1.8.1 Management procedures to control and/or prevent avian colibacillosis 
Commercial broiler poultry in Australia are raised in intensive farming systems; therefore, effective 
flock management and strict biosecurity protocols are crucial to prevent and control avian 
colibacillosis (Kabir, 2010). Effective control and prevention of colibacillosis depends on the ability 
to identify and eliminate any potential predisposing factors that are associated with APEC infection 
(Kabir, 2010). The main goal is to reduce the level of APEC exposure by reducing any stress related 
factors and the number of APEC in the chicken’s production environment (feed, drinking water, litter, 
dust) (Barnes, 2013). This goal can be achieved by improving husbandry and biosecurity, ventilation, 
nutrition, and immune status among the chicken flocks (Dhillon and Jack, 1996; Hasan et al., 2011; 
Nolan et al., 2013). Recommendations include the addition of chlorine into drinking water to reduce 
the introduction and spread of disease and decrease the mortality rates associated with APEC 
outbreaks (Vandekerchove et al., 2004). 
Applying and maintaining a high biosecurity level can improve the flock’s health, as well as, increase 
the productivity (Laanen et al., 2014; Moore, 1992; Ribbens et al., 2008). Strict biosecurity measures 
at the hatchery are considered the first step to preventing avian colibacillosis, as eggs contaminated 
with faecal materials can act as vehicles to introduce and/or spread APEC between different flocks 
(Barnes, 2013). Disinfecting and fumigating of all the eggs, grading the eggs on the basis of quality 
and discarding cracked or eggs heavily contaminated with faecal materials can reduce APEC 
contamination of broiler breeder (Kabir, 2010). 
Daily removal of bird carcasses is very important to control the spread of avian colibacillosis within 
the same flocks or the farm (Vandekerchove et al., 2004). In the case of an outbreak with APEC 
infection among the chicken flocks, the usage of strict biosecurity procedures including the use of 
foot and hand sanitizers and disinfecting of all equipment before and after use in the selected shed 
Page | 41  
 
will help reduce the spread of the disease to other chicken flocks (Barnes, 2013).  
The disposal of the litter and manure at the end of the flock cycle and the following of regular cleaning 
protocols on the farm after each flock is sent to slaughter will help to prevent the spread of the disease 
among future flocks (Barnes, 2013; Kabir, 2010; Vandekerchove et al., 2004). 
To minimise the introduction and spread of the disease strict biosecurity protocols should be applied 
to the farm to prevent contact between the farm birds and wild birds, rodents and insects, as well as 
restricting human movement between the farms by applying suitable farm management protocols 
(Barnes, 2013; Wang et al., 2013). The Australian government outlines biosecurity guidelines for 
bird producer in order to limit the spread of infectious diseases and pests, both within a farm and from 
one farm to others (Australian Chicken Meat Federation, 2014).  
1.8.2 Vaccinations 
The need for an effective vaccine to control this economically important poultry disease has become 
more significant after a European study reported an increase in the prevalence of the disease despite 
applying strict husbandry measures, as well as, advanced biosecurity rules (Vandekerchove et al., 
2005).  
However, controlling colibacillosis through an effective vaccine is faced by many challenges such as 
the ability of the vaccine to provide cross protection against different strains of APEC; the economic 
feasibility of the vaccine; methods of vaccine delivery, public safety and the age of the chickens at 
the time of vaccination (Ghunaim et al., 2014a). Examples of these challenges include administration 
of the vaccine at young ages, where the birds are vulnerable to APEC infection, will only provide a  
protective immune response for the chickens by the age of 21 days and the majority of the birds go 
to slaughter by 35 days (Ghunaim et al., 2014b). There are also the effects of immune-compromise 
by other diseases, which could be countered by the vaccination of the broiler or breeder flocks against 
other common respiratory pathogens to help decrease the occurrence of APEC infection in the flock 
(Kabir, 2010).  
Identification of successful vaccine candidates that can provide protection against the majority of 
APEC outbreaks may follow investigation of the expression of virulence genes. Several APEC 
associated virulence genes such as adhesins (de Pace et al., 2010; Ewers et al., 2004), iron-acquisition 
(Janben et al., 2001; McPeake et al., 2005), serum resistance (Nolan et al., 2003; Tivendale et al., 
2004) and VGs encoded in the ColV plasmids have been implicated in virulence through genetic 
analysis (Antao et al., 2008). In particular, the serum resistance APEC linked VGs such as traT and 
iss play a significant role in APEC pathogenicity (Lynne et al., 2006a; Lynne et al., 2012; Nolan et 
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al., 2003; Pfaff-McDonough et al., 2000; Rodriguez-Siek et al., 2005a).  
Early attempts to develop an effective vaccine that provided protection against APEC were focused 
mainly on using bacteria (Dho-Moulin and Fairbrother, 1999; Ghunaim et al., 2014a). An early study 
by Kariyawasam et al. (2002) identified Type 1 fimbriae, P-fimbriae, aerobactin receptor and 
lipopolysaccharide (LPS) as suitable vaccine candidates against APEC. Furthermore, a number of 
investigations took place to develop an effective vaccine that provided a heterologous protection 
against different APEC strains (Bao et al., 2013; Chaudhari et al., 2013; Lynne et al., 2006b). The 
continuing development of new vaccines that have the ability to control APEC infections is supported 
by the ongoing discovery of new APEC linked VGs combined with the analysis of E. coli whole 
genome sequences. Despite ongoing vaccine development there is no commercial vaccine available 
in Australia for avian pathogenic E. coli in poultry 
1.9 Escherichia coli  
Escherichia coli was named after the German physician Theodor Escherichia, who was the first to 
describe this bacterium at the end of nineteenth century after isolating it from faecal samples from 
neonates (Escherich, 1988). E. coli is a gram-negative, facultative anaerobic, non-sporulating, rod 
shaped bacteria that belongs to the Enterobacteriaceae family (Berg, 1996; Quinn et al., 2011). The 
bacteria co-exist normally in the gastrointestinal microbiota of healthy humans, mammalian animals 
and birds and their surrounding environment (Belanger et al., 2011; Wirth et al., 2006). While the 
majority of E. coli are non-pathogenic, though they may be linked with opportunistic infections in 
people, animals and birds, some strains are capable of causing intestinal or extraintestinal diseases 
(Ewers et al., 2009; Johnson and Russo, 2002; Russo and Johnson, 2009). 
1.9.1 Commensal E. coli  
The vast majority of E. coli are considered commensal or non-pathogenic (Kamada et al., 2013; 
Linton and Hinton, 1988; Russo and Johnson, 2000). Commensal E. coli protect the host by 
competing with pathogenic microorganisms for nutrients and receptors to ferment non-digestible 
dietary residues in the gastrointestinal tract helping to breakdown food, assist in food absorption and 
waste production. They also synthesise vitamin K (O'Hara and Shanahan, 2006). Some non-
pathogenic E. coli can cause disease if the animals are immunocompromised, the mucosal barrier is 
compromised, or if there is a change in the habitat of the organism, for example urinary tract 
infections caused by E. coli from the gastrointestinal tract which have been able to ascend into the 
bladder (Packey and Sartor, 2009). Microbiota that is altered, for example, after antimicrobial 
therapy, enhances the growth of pathogenic bacteria; therefore, the balance between beneficial and 
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detrimental intestinal bacteria species is disturbed potentially having a negative influence on health 
(Langdon et al., 2016). Furthermore, commensal E. coli can acquire VGs that allow them to adapt to 
and survive in new niches where they may be able to cause disease (Johnson et al., 2008a; Kaper et 
al., 2004).  
In birds, commensal E. coli are known as avian faecal E. coli (AFEC) (Kaper et al., 2004; Nolan et 
al., 2013). Globally, several studies have aimed to define AFEC and differentiate them from APEC 
(Johnson et al., 2008b; McPeake et al., 2005; Rodriguez-Siek et al., 2005a). Previous studies have 
also considered AFEC as potentially pathogenic because they may harbour large numbers of APEC-
associated VGs. This population of gut E. coli that contain APEC-associated VGs pose a risk for 
birds as they have the potential to cause avian colibacillosis (Ewers et al., 2009; Kemmett et al., 2013; 
McPeake et al., 2005). In the one Australian study, which screened 251 AFEC isolates cultured from 
healthy chickens for the presence of eight ExPEC-associated VGs (papAH, papC, afa/draBC, 
sfa/focDE, sfaS, aerJ, kpsMT II and focG), the authors reported that 10% of AFEC isolates carried 
two or more of the eight VGs and 68.1% harboured none of the VGs (Obeng et al., 2012). The 
detection of ExPEC-associated VGs among Australian AFEC isolates may pose a public health 
concern, as these isolates may act as a reservoir for the VGs. 
1.9.2 Intestinal pathogenic E. coli  
Intestinal pathogenic E. coli are found at a lower prevalence to commensal E. coli in the 
gastrointestinal tract and are capable of causing intestinal disease (Belanger et al., 2011). Intestinal 
pathogenic E. coli strains can be distinguished from commensal or ExPEC based on the clinical signs 
and VG profile (Leimbach et al., 2013). Intestinal E. coli are classified into enterotoxigenic E. coli 
(ETEC), enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enteroinvasive 
E. coli (EIEC), enteroaggregative E. coli (EAEC) and diffusely adherent E. coli (DAEC) (Belanger  
et al., 2011; Johnson and Russo, 2002). 
1.9.3 Extraintestinal pathogenic E. coli (ExPEC) 
Similar to intestinal E. coli, ExPEC can be found in the gastrointestinal tract (Russo and Johnson, 
2003). However, unlike intestinal pathogenic E. coli, this pathotype of E. coli is not capable of causing 
gastrointestinal disease (Russo and Johnson, 2003). ExPEC are responsible for a diverse spectrum of 
extraintestinal infections, which may lead to septicaemia in humans, mammals and birds (Johnson 
and Russo, 2002; Mokady et al., 2005). They have acquired specific VGs that enable them to 
overcome or challenge the host defence mechanisms and cause diseases at multiple sites outside the 
gastrointestinal habitat (Ewers et al., 2007; Johnson and Russo, 2002; Mokady et al., 2005). Virulence 
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genes are often located on mobile genetic elements (MGEs) such as plasmids, bacteriophages or 
pathogenicity islands (PAIs) and can be transferred to different strains of E. coli or different bacterial 
species (Gyles and Fairbrother, 2010; Russo and Johnson, 2000). 
Extraintestinal pathogenic E. coli can be classified into different subgroups: septicaemia associated 
E. coli (SePEC); uropathogenic E. coli (UPEC) and neonatal meningitis associated E. coli (NMEC) 
in mammals and APEC in birds; based on the target host and the clinical manifestation they cause 
(Belanger et al., 2011; Kaper et al., 2004). However, this classification is limited and it is not absolute 
as all ExPEC subgroups demonstrate overlapping phylogenetic groups and VGs (Ewers et al., 2007; 
Johnson and Russo, 2002).  
Johnson et al.(2009) proposed screening E. coli isolates for eight VGs to allow for the identification 
of ExPEC. In ExPEC two or more of the VGs: papAH (P fimbriae structural subunit); papC (P 
fimbriae assembly); sfa/foc (S and F1C fimbriae subunits); sfaS (S fimbriae (sialic acid-specific); 
afa/dra (Dr-antigen-binding adhesins); kpsMTII (group 2 capsular polysaccharide units); iutA 
(aerobactin receptor) and focG (F1C fimbriae) could be detected. 
1.9.4 Avian pathogenic E. coli (APEC) 
Escherichia coli that is capable of causing localised or systemic extraintestinal infections in chickens, 
turkeys, geese, ducks and other species of birds is known as APEC (Circella et al., 2012; Guabiraba 
and Schouler, 2015; Nolan et al., 2013). APEC can cause infections in all age groups of birds 
(Guabiraba and Schouler, 2015; Nolan et al., 2013), acting as a primary (Vandekerchove et al., 
2004b) or secondary pathogen (Guabiraba and Schouler, 2015; Kabir, 2010; Kaper et al., 2004; Nolan 
et al., 2013). Although APEC is present in the intestinal microbiota, the main route of entry into birds 
is through the respiratory system via inhalation of APEC contaminated aerosols. The bacteria can 
then translocate from the respiratory tract (air sac and lungs) to the blood stream and other internal 
organs (Delicato et al., 2003; Dissanayake et al., 2014). Systemic infection can also occur after  
E. coli in the cloaca or the intestinal tract gain access to the bloodstream (Kabir, 2010; Landman and 
Cornelissen, 2006).  
The pathogenicity of APEC strains are multifactorial, based on the presence and expression of 
different groups of VGs (Won et al., 2009). Globally, the economic, public health and animal welfare 
significance of avian colibacillosis, has led to a number of studies from United States of America 
aiming to define APEC and to identify pathogenicity mechanisms (Jeffrey et al., 1999; Kariyawasam 
and Nolan, 2009; Norton et al., 2000). Studies have identified a large number of VGs in E. coli 
cultured from birds with avian colibacillosis (Antão et al., 2008; Dissanayake et al., 2014; Guabiraba 
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and Schouler, 2015; Johnson et al., 2008b; Paixao et al., 2016; Wang et al., 2010). The involvement 
and relevance of these VGs in the pathogenicity of avian colibacillosis is still poorly understood and 
the majority of studies on APEC and APEC-associated VGs are descriptive (Dozois et al., 1994; 
Jeffrey et al., 1999; Norton et al., 2000; Obeng et al., 2012; Zhao et al., 2009). Few in vivo 
experimental studies have enhanced the understanding of the APEC pathogenicity mechanisms 
(Antão et al., 2008; Ask et al., 2006; Musa et al., 2009). However, no single or specific set of VGs 
have been systematically linked with APEC pathogenicity. It is very rare to find the same set of VGs 
in all APEC, in the same study and/or different studies (Kawamura-Sato et al., 2010; Kemmett et al., 
2013; Paixao et al., 2016; Rodriguez-Siek et al., 2005a; Zhao et al., 2005). Nevertheless, APEC 
harbour several VGs that enable the bacteria to invade, colonise, evade the immune system and cause 
avian colibacillosis (Guastalli et al., 2013; Horn et al., 2012; Kemmett et al., 2014; Pires-dos-Santos 
et al., 2013).  
The genetic diversity displayed by APEC makes it very challenging to diagnose, prevent and treat 
avian colibacillosis. Many E. coli strains are not virulent and a fast, accurate diagnostic test to 
distinguish whether an avian E. coli isolate is pathogenic or non-pathogenic, is required. However, 
several studies have suggested that the prevalence of certain VGs among E. coli isolates obtained 
from chickens with colibacillosis were useful to identify and characterise APEC and dis tinguish it 
from AFEC (Ewers et al., 2005; Johnson et al., 2008b; Moulin-Schouleur et al., 2007; Rodriguez-
Siek et al., 2005a). 
A study by Ewers et al. (2005) suggested that eight VGs: P-fimbriae (papC); aerobactin (iucD); iron-
repressible protein (irp2); temperature-sensitive hemagglutinin (tsh); vacuolating autotransporter 
toxin (vat); enteroaggregative toxin (astA); increased serum survival protein (iss) and colicin V 
plasmid operon genes (cva/cvi) contributed to the pathogenicity of APEC. The authors proposed that 
the presence of four of these eight VGs could identify APEC and differentiate between APEC and 
AFEC. However, only 14 APEC isolates were included in this study reducing the strength of their 
conclusions. In a study by Kemmet et al. (2013) a larger number of faecal E. coli isolates (n = 3,360) 
obtained from apparently healthy chickens and 324 E. coli isolates from birds with colibacillosis were 
screened for the presence of ten VGs (astA, iss, irp2, iucD, papC, tsh, vat, cvi, sitA and ibeA). The 
authors reported that 24% of the AFEC isolated from one-day-old healthy chickens harboured more 
than five of these VGs in comparison with 1% of AFEC sourced from chickens at slaughter. They 
found irp2, papC, iucD, cvi, sitA and ibeA genes were significantly associated with APEC.  
Rodriguez-Siek et al. (2005a) investigated the prevalence of 38 APEC-associated VGs among 451 
APEC and 104 AFEC isolates obtained from birds in the USA. They reported that the majority of 
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APEC isolates harboured ompT, several iron acquisition genes (iroN, iutA, sitA, fyuA and irp2) and 
other VGs genes that are carried in the APEC plasmid pTJ100 (cvaC, iss, tsh, iroN, iutA and sitA). 
Another study in the USA conducted by Johnson et al. (2008b) aimed to identify a minimum number 
of VGs that could identify APEC. In this study, 124 E. coli isolates of known pathogenicity underwent 
extensive genotyping and were screened for the presence of 46 VGs. The author identified five VGs 
(iutA, iss, ompT, iroN and hlyF) that were significantly associated with APEC strains. Johnson et al. 
(2008b) developed a pentaplex-PCR, targeting these five VGs, and subsequently screened 994 E. coli 
(794 APEC and 200 AFEC) to validate the selection of the five VGs. The results showed that highly 
pathogenic APEC strains harboured an average number of 4.6 VGs while an average of 4.3 and 3.9 
were found among medium and low pathogenic APEC strains, respectively. The average number of 
VGs in AFEC isolates was 1.3. 
Subsequently, studies have used the pentaplex-PCR described by Johnson et al. (2008b) and 
confirmed that it is a rapid diagnostic tool to differentiate between APEC and AFEC (de Oliveira et 
al., 2015; Dissanayake et al., 2014; Hussein et al., 2013). Despite the geographical variations of the 
studies, Kobayashi et al. (2011) (68% – 72%), Hussein et al. (2013) (90% – 94%) and de Oliverira 
et al. (2015) (82% – 95%) reported similar frequencies of the five VGs as Johnson et.al. (2008b) 
(78% – 85%) among APEC isolates cultured from lesions of birds affected with colibacillosis. 
However, Dissanayake et al. (2014) found that only 25% of the E. coli isolates (14 of 55), cultured 
from the lesions of birds with colibacillosis in Sri Lanka, harboured the five VGs. These authors 
identified four VGs (sitA, ompT, hlyF and iroN) that were significantly associated with APEC in their 
region. These four genes were possessed by 54.5% (30 of 55) of the APEC isolates in Sri Lanka.  
A study by Schouler et al. (2012) examined 1,491 E. coli (1,307 APEC and 184 AFEC). They 
identified 13 VGs (sitA, F1, iutA, tsh, frzorf4, tkt1, aec4, P(F11), aec26, neuC,sfa-focDE, cdt and 
eae) more frequently found in APEC and four different VG associations (A [iutA+, P(F11)+], B 
[iutA+, P(F11)−, frzorf4+], C [iutA+, P(F11)−, frzorf4−, O78+] and D [iutA−, sitA+, aec26+]). These 
four different VG associations identified 70.2% (247 of 352) of the pathogenic strains, based on a 
lethality test.  
In a more recent study, in Brazil, de Oliveria et al. (2015) investigated the association between the 
APEC VGs proposed by Johnson et al. (2008b) and the pathogenicity of the APEC strains. In partial 
agreement with Johnson et al. (2008b), they identified a positive association between the number of 
VGs and the pathogenicity score of avian colibacillosis. However, the authors found that 51% of the 
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AFEC harboured between two and four of the five VGs (average of three), compared to the average 
of 1.3 VGs identified in AFEC by Johnson et al. (2008b). 
Only two studies have investigated VGs associated with APEC in Australia. The first study 
investigated the presence of three VGs (iucA, tsh and iss) among the virulent pVM01 plasmid and 
their association with APEC pathogenicity. The authors verified the presence of the three VGs in the 
plasmid and identified a strong association between APEC and iss and iucA, which represents the 
entire aerobactin operon, but not the tsh gene (Tivendale et al., 2004).   
The second Australian study aimed to determine the frequency of eight ExPEC-linked VGs (iutA, 
papAH, papC, Afa/draBC, sfa/focDE, sfaS, kpsMTII and focG) among 251 E. coli isolates cultured 
from faeces of healthy chickens (Obeng et al., 2012). The authors found iutA, papC and kpsMTII 
genes were common among the AFEC, whilst none of the E. coli isolates harboured the sfa/foc gene.  
In summary, despite the genetic diversity of APEC, all the results obtained by different studies 
demonstrated the ability to differentiate APEC from AFEC based on a combination of frequently 
occurring VGs. Johnson et al. (2008b) used a large sample size, combined with extensive genotyping 
to select VG markers for APEC. Despite the variation in frequency of these five VGs in different 
overseas studies, a significant association between them and APEC has been reported (de Oliveira et 
al., 2015; Dissanayake et al., 2014; Hussein et al., 2013).  
Selecting a specific array of APEC VGs to use as markers to identify APEC in Australia would require 
regional studies to be conducted due to the large number of VGs associated with both APEC and 
AFEC, as well as the worldwide diversity in the VGs associate with avian colibacillosis. Individual 
VGs will be discussed in Section 1.10.6. 
1.10 Classification of E.coli 
1.10.1 Serological classification 
A serological classification scheme for E. coli was first described in the 1940s and was based on the 
immunogenicity of the bacterial surface structures. Initially, it consisted of somatic antigen ‘O’, 
capsular antigen ‘K’ and flagella antigen ‘H’ (Orskov and Orskov, 1992). A fimbrial antigen ‘F’ was 
included later (Wray and Woodward, 1994). Serotyping is widely used and is a well-established type 
of E. coli classification for pathogenicity detection and epidemiological studies (Nolan et al., 2013; 
Scheutz et al., 2004). Serotyping based on the O and H antigens are considered the ‘gold-standard’ 
as only limited laboratories have the ability to type the K-group (DebRoy et al., 2011). 
Overall, an association between ExPEC pathogenicity and serogroup ‘O’ antigens has been reported 
(Orskov and Orskov, 1992). ExPEC, and in particular APEC, have been associated with certain O-
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types particularly O78, followed by O1, O87, O2 and to a lesser extent O15, O8, O18, O53 and O55 
serogroups (Blanco et al., 1997; Dozois et al., 1992; Ewers et al., 2007; Gomis et al., 1997; Ngeleka 
et al., 1996; Vandekerchove et al., 2004b). Studies in Germany and the United Kingdom (UK) by 
Vandekerchove et al. (2004b) and McPeak et al. (2005) respectively, reported an association between 
avian colibacillosis and serogroup O78. Other studies have cautioned that the presence of a specific 
serogroup does not reflect the pathogenicity of APEC strains (Delicato et al., 2003; Ewers et al., 
2004; La Ragione and Woodward, 2002). Rodriguez-Siek et al. (2005a) proposed that plasmid related 
genes (pTJ100: large conjugative R plasmid) are more suitable than a serogroup to define APEC. 
Overall, serotyping is complex as currently there are 186 different O-groups as well as 53 H-groups 
among E. coli (Fratamico et al., 2016a). Furthermore, serotyping is labour intensive, time consuming 
and expensive (Fratamico et al., 2016a). Inaccuracy due to cross reactivity of the antisera with 
different serogroups can also be considered a disadvantage (Fratamico et al., 2016a). Traditional 
serotyping can only be performed in specialised laboratories, although some laboratories are now also 
using a PCR based typing system (Fratamico et al., 2016a; Iguchi et al., 2015; Lacher et al., 2014). 
In addition, many E. coli stains are non-typable (Fratamico et al., 2016b; Sharma et al., 2016).  
1.10.2 Enterobacterial repetitive intergenic consensus (ERIC) 
Enterobacterial repetitive intergenic consensus (ERIC) typing was first described in E. coli but has 
now been used for other members of the Enterobacteriaceae, as well as, Vibrio cholerae (Hulton et 
al., 1991; Sharples and Lloyd, 1990). The ERIC sequence is a repeated, short, conserved region of 
only 126 base pairs (bp) (Hulton et al., 1991; Sharples and Lloyd, 1990; Versalovic et al., 1991). 
ERIC-PCR typing detects these repeated DNA sequences that are distributed throughout the genome. 
Genetic relatedness is evaluated using the profile patterns, or “fingerprints”, that were created by the 
separation of the PCR products. The sole usage of this protocol to identify any genetic relatedness is 
not recommended due to interexperimental variation of ERIC-PCR results by computer software and 
laboratory variations (Meacham et al., 2003). However, this typing method is commonly used as it is 
rapid, cost-effective and can classify E. coli into different clonal groups for the purpose of 
epidemiological studies (Cherifi et al., 1991; Gillings and Holley, 1997; Meacham et al., 2003; 
Ranjbar et al., 2017; Ugorski and Chmielewski, 2000; Wilson and Sharp, 2006). Several studies have 
recommended the usage of ERIC-PCR for E. coli strains obtained from different sources due to it is 
power of differentiation (Dhanashree and Shrikara, 2012 ; Diab and Al-urk, 2011; Maryam, 2016) 
In addition, several other PCR based typing methods have been developed based on the repeated 
DNA sequence elements distributed throughout the genome. These include randomly amplified 
polymorphic DNA and restriction fragment length polymorphism (Jonas et al., 2003). 
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1.10.3 Phylogenetic classification  
Phylogenetic grouping provides a very popular method of classification that is based on the 
presence/absence of two genes chuA and yjaA as well as TspE4.C2, a DNA fragment. Originally,  
E. coli were classified into four phylogenetic groups (A, B1, B2 and D) (Clermont et al., 2000). This 
classification has been extended to identify additional groups C, E, F and Escherichia cryptic clade I 
(termed E. clade 1) using the Clermont phylogenetic grouping quadruplex PCR plus the follow up 
PCRs (Clermont et al., 2013). E. coli from specific biological niches are more likely grouped into 
certain phylogroups (Clermont et al., 2013). With ExPEC strains being more likely to be B2, D and 
F whereas, E. coli belonging to phylogroups A, B1, C and E are less likely to be associated with 
extraintestinal disease. Using the original classification scheme, human ExPEC derive mainly from 
E. coli phylogenetic group B2 and to a lesser extent group D, while groups B1 and A are the common 
groups found in commensal E. coli (Bingen et al., 1998; Ewers et al., 2007; Johnson et al., 2001; 
Johnson and Russo, 2002). Obeng et al. (2012) found the majority of Australian AFEC belonged to 
the commensal groups A (39.4%) and B1 (32.3%) with less in virulent groups B2 (11.2%) and D 
(17.1%). Previous research has reported a positive association between phylogenetic group B2 and 
the presence of larger numbers of VGs among ExPEC, APEC and AFEC (Danzeisen et al., 2013). 
However, APEC significantly differs in their phylogenetic assignment as they cluster predominantly 
in phylogenetic group A (Sola-Gines et al., 2015; Zhu Ge et al., 2014). 
Caution has to be taken when comparing studies that have used different classification schemes. 
Logue et al. (2017) found when comparing assignment of phylogenetic group using the old and 
revised Clermont schemes that 53.8% (243 of 452) of APEC strains were reclassified. There were 
significant changes from phylogenetic groups A to C and from D to E and F. 
1.10.4 Multilocus sequence typing (MLST)  
Currently, the global gold-standard for the clonal analysis of E. coli is multilocus sequence typing 
(MLST), which was introduced by Maiden et al. (1998). There are several MLST schemes available 
(Ahmed et al., 2016; Chaudhuri and Henderson, 2012; Jaureguy et al., 2008; Reid et al., 2000; Wirth 
et al., 2006), which classify E. coli into different sequence types (STs) (Larsen et al., 2012). This 
method amplifies short nucleotide sequences about (450 – 500 bp) by PCR of five to seven of the 
following housekeeping genes: adk (adenylate kinase); fumC (fumarate hydratase); gyrB (DNA 
gyrase); icd (isocitrate/isopropylmalate dehydrogenase); mdh (malate dehydrogenase); purA 
(adenylosuccinate dehydrogenase) and recA (ATP/GTP binding motif). The fragments are then 
sequenced and compared to an MLST database to obtain a sequence type (ST). 
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Multilocus sequence typing is a uniformly powerful typing method of classification that is 
standardised between different laboratories and the database can be accessed easily on a net-based 
computer enabling the global exchanging of molecular typing data (Maiden et al., 1998). Besides the 
classical MLST scheme, several other MLST classifications have been established targeting fewer 
genes (Sahl et al., 2012; Tchesnokova et al., 2013; Weissman et al., 2012). The most common STs 
detected among APEC and AFEC are globally disseminated and have emerged among different 
species of animals, regardless of pathogenicity, such as ST354 and ST10 (Abraham et al., 2015; 
Dissanayake et al., 2014; Kim et al., 2011; Maluta et al., 2014; Manges and Johnson, 2012; Mora et 
al., 2011; Pires-dos-Santos et al., 2013; Schaufler et al., 2015). 
Furthermore, new classification schemes using informative single-nucleotide polymorphisms (SNPs) 
collected from the MLST data are being used for E. coli typing (Fernandez-Romero et al., 2011). 
Hommais et al. (2005) reported similar results using the SNP method and other typing methods to 
differentiate particular E. coli strains. 
1.10.5 Whole genome sequence (WGS) 
The ability of whole genome sequencing (WGS) to provide massive data in regards to a pathogen’s 
fingerprint could potentially make this typing method the new “gold-standard” for classification. At 
present, there are no standardised methods to analyse the enormous amount of data produced by WGS 
(Franz et al., 2014; Oulas et al., 2015). Regardless of the large amount of information that can be 
provided by the whole genome analyses, the fact that the predicted products can’t be associated to a 
function or phenotype is considered as one of the major limitation of this type of analysis. A complete 
genome sequence for a virulent APEC strain detected several virulence and antimicrobial resistance 
genes (ARGs) among several plasmids (Wang et al., 2016). This finding reinforces the important role 
that plasmids play in distributing virulence and resistance genes among E. coli populations through 
horizontal gene transmission (Wang et al., 2016). There is a need for whole genome and plasmid 
sequencing studies to accurately determine the genetic variation within and between ExPEC, as well 
as, commensal E. coli. 
1.10.6 Virulence genes (VGs)  
Avian pathogenic E. coli harbours an assortment of VGs (Table 1.1) including, but not limited to, 
adhesins, iron uptake systems, increased serum survival and toxins, which contribute to APEC 
pathogenicity (Dissanayake et al., 2014; Ewers et al., 2007; Johnson and Russo, 2002; La Ragione 
and Woodward, 2002; Moulin-Schouleur et al., 2007; Rodriguez-Siek et al., 2005a). The presence of 
certain VGs enables APEC colonisation and infections to occur in extraintestinal locations. Virulence 
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genes may be encoded on PAIs, which harbour several VGs (Schubert et al., 1998). Furthermore, 
VGs can be found on plasmids such as R plasmids or CoIV plasmids in APEC (pAPEC-OI, pAPEC-
O2-CoIBM and Ptj100) and other MGEs enabling horizontal transmission of the VGs among E. coli 
isolates (Rankin et al., 2011; Rodriguez-Siek et al., 2005a). The plasmid-encoded genes play an 
important role in the virulence of APEC as they have been shown to be involved in toxin synthesis,  
iron acquisition systems, outer membrane proteins and adhesins (Skyberg et al., 2006; Toma et al., 
2004). 
1.10.6.1 Colicins 
Colicin E. coli producers can inhibit bacterial growth and interfere with membrane formation from 
the same or related species (Cascales et al., 2007). Colicins can be encoded by genes located on 
plasmids. These plasmids are frequently called Col plasmids. Colicins are encoded by several genes 
such as: Ia; Ib; E1; E2; E3; I; K; B and V, which have been shown to be more prevalent among APEC 
compared with AFEC (Dias da Silveira et al., 2002; Fantinatti et al., 1994).  
The majority of APEC strains harbour Colicin V plasmids (Wray and Woodward, 1994). These 
plasmids also contain other pathogenicity related genes, such as those that encode for the aerobactin 
iron uptake system and serum resistance (Mokady et al., 2005; Russo and Johnson, 2003; Valvano 
and Crosa, 1988). It has been demonstrated that mutations to ColV plasmids are linked with decreased 
APEC pathogenicity, suggesting that some VGs associated with ColV plasmids are involved in APEC 
pathogenicity mechanisms (Skyberg et al., 2008). Similar to other VGs, geographical location 
influences the prevalence of CoIV plasmid linked genes among chickens with colibacillosis. A 
variation in the prevalence of ColV plasmids of 99.1% and 66.8% were reported among APEC 
isolates in the UK and USA, respectively (McPeake et al., 2005; Rodriguez-Siek et al., 2005a). While 
a lower frequency was documented in Brazil (22%) and Spain (23%) (Blanco et al., 1997; Rocha et 
al., 2008). 
1.10.6.2 Toxins 
Cytotoxic activity in APEC was first described by Fantinatti et al. (1994) and by Parreira and Yano 
(1998). APEC is capable of producing several toxins such as: vacuolating autotransporter toxin (vat); 
enterohaemolysin (ehxA); cytotoxic necrotising factor 1 (cnf1); microcin ColV (cvaC); cytolethal 
distending toxin (cdt); haemolysin (hly) and secreted autotransporter toxin (sat) (Johnson et al., 2001; 
Toth et al., 2003). 
Originally, Vat, which is a serine protease autotransporter, was discovered in a septicaemic  
E. coli strain (Parreira et al., 1998; Parreira and Gyles, 2003). The vat gene encodes for the Vat 
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protein, which has cytotoxic activity against the chicken embryo fibroblast and kidney cells (Parreira 
and Gyles, 2003). Several studies have reported that the vat gene is encoded in the APEC PAI and 
occurs at a higher frequency among APEC compared with AFEC (Ewers et al., 2004; Ewers et al., 
2005). 
The presence of ehxA, sat and cnf1 have also been reported in APEC strains (Braga et al., 2016; 
Cunha et al., 2017). However, their role in pathogenesis is not fully elucidated. Furthermore, some 
of the toxin genes (hly, cdt and cvaC) have been linked with large transmissible plasmids indicating 
that these VGs could be easily transferred to other strains and bacterial species (Ewers et al., 2010; 
Johnson et al., 2010; Mellata et al., 2012).  
Several studies have reported that hlyF, one of the genes carried on the ColV plasmid, is a molecular 
marker for APEC (Dissanayake et al., 2014; Johnson et al., 2008b; Mbanga and Nyararai, 2015). 
Currently, little information is available in regards to the exact role of hlyF and how it contributes to 
pathogenicity. In an infectious chick embryo model, the transcription of hlyF was strongly 
upregulated, which could suggest an essential role of this gene in the establishment of avian 
colibacillosis (Skyberg et al., 2008). A recent study investigated the role of hlyF genes in establishing 
an extraintestinal infection and reported that this gene was directly involved in the production of outer 
membrane vesicles (Murase et al., 2016). This outer membrane acts as a channel to deliver bacterial 
virulence factors into the host, leading to infection (Murase et al., 2016). 
1.10.6.3 Serum resistance  
Resistance to complement-mediated lysis and opsonophagocytosis play an important role in APEC 
pathogenicity (Nolan et al., 2003; Vidotto et al., 1990; Wooley et al., 1992). Serum resistance VGs 
enable the bacteria to survive outside the gastrointestinal tract and overcome the host defence 
mechanisms (Johnson et al., 2002b; Lynne et al., 2007; Miajlovic and Smith, 2014; Rocha et al., 
2008; Tivendale et al., 2004). These VGs are frequently associated with septicaemia as they assist 
the bacteria in avoiding being killed by the essential defence mechanisms present in the blood, 
including complement, antimicrobial peptides and other serum components (Boerlin and Reid-Smith, 
2008; Jacobson et al., 1992; Jeffrey et al., 2002; Nolan et al., 2003). Several investigations have 
reported serum resistance VGs are widespread among APEC in comparison with AFEC and have 
suggested that these VGs contribute to APEC pathogenicity (Delicato et al., 2003; Dozois et al., 
1992; Dziva and Stevens, 2008; Lynne et al., 2007; Mellata et al., 2003; Mellata et al., 2012; Nolan 
et al., 2002; Ozawa et al., 2008; Rocha et al., 2008; Rodriguez-Siek et al., 2005a; Skyberg et al., 
2008; Tivendale et al., 2004; Wooley et al., 1992; Yaguchi et al., 2007; Yang et al., 2004; Zhao et 
al., 2005). Several VGs have been linked with serum resistance mechanisms and the association of 
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each of the serum resistance VGs with APEC pathogenicity mechanisms have also been 
independently studied (Nakazato et al., 2009; Rocha et al., 2008). However, limited information is 
known in regards to the presence of different serum resistance VG combinations and their 
contribution to APEC pathogenicity (Jeffrey et al., 2002; Nolan et al., 2002; Nolan et al., 2003; Sello, 
2012).  
The bacterial outer membrane, ColV colicin and/or outer membrane proteins can facilitate resistance 
to serum complement (Fantinatti et al., 1994; Gross, 1957; Gross, 1990; Lynne et al., 2007; Mellata 
et al., 2003; Nolan et al., 2003). Pfaff-McDonough et al. (2000) screened 294 E. coli isolates obtained 
from chickens with colibacillosis and 75 E. coli isolates sourced from healthy chickens to determine 
the associations between four serum resistance VGs (iss (increased serum survival, which is a 
cytotoxic inhibitor), traT (surface exclusion protein), cvaC (structural genes of colicin V operon) and 
ompA (outer membrane protein A)) and APEC. While the authors linked all four of the serum 
resistance VGs with APEC pathogenicity, iss was significantly associated with APEC in comparison 
with AFEC. They also suggested that iss was on the conjugative ColV plasmids, which occur in 
higher frequency among APEC compared to AFEC regardless of the serotype and the origin of the 
isolate. 
The traT and iss genes were first linked to APEC pathogenicity and serum resistance in 1979, with a 
100-fold increase in APEC pathogenicity reported in the presence of iss and traT (Binns et al., 1979). 
Both VGs are found on ColV plasmids and encode for outer membrane proteins (McPeake et al., 
2005; Mellata et al., 2003; Nolan et al., 2003; Rodriguez-Siek et al., 2005a; Sorsa et al., 2003; 
Tivendale et al., 2004; Vandekerchove et al., 2005). The role of these two genes in the APEC 
pathogenicity mechanism was identified by insertional mutagenesis (Wooley et al., 1992). Global 
variations in the prevalence of the iss gene in APEC have been reported, with a high prevalence of 
80.5% to 100% found in isolates from the USA, Germany and Egypt (Ewers et al., 2004; Hussein et 
al., 2013; Johnson et al., 2008b; Rodriguez-Siek et al., 2005a). However, Delicato et al. (2003) 
reported a lower prevalence (38.5%) of the iss gene among APEC isolates obtained from poultry with 
colibacillosis in Brazil. This variation in the prevalence of the iss gene among different APEC strains 
sourced from different countries may indicate a geographical effect on the presence of this VG. 
Several studies have reported a positive association between complement resistance, virulence and 
the presence of the iss gene in APEC (Johnson et al., 2008b; Lynne et al., 2012; Nolan et al., 2003; 
Tivendale et al., 2004). However, it is unknown whether the sole presence of the iss gene contributes 
to the pathogenicity or whether the iss gene is a marker for the presence of the plasmids associated 
with APEC pathogenicity (Hussein et al., 2013; Nilsson et al., 2014; Rodriguez-Siek et al., 2005a). 
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Chaffer et al. (1999) reported the iss gene was needed for complement resistance, but not for APEC 
pathogenicity. However, Mellata et al. (2003) reported that the absence of the iss gene did not 
influence the ability of APEC to resist serum complement. In addition to iss, APEC have other serum 
resistance mechanisms that enable them to survive in host serum. For example, Mellata et al. (2003) 
demonstrated that O78 polysaccharide and the K1 capsule increased bacterial serum resistance.  
The production of extracellular polysaccharide capsules are considered to be one of the E. coli serum 
resistance mechanisms that can lead to bacteraemia (Guabiraba and Schouler, 2015; Miajlovic and 
Smith, 2014). The somatic O-antigens and capsular K-antigens act as a barrier to the host defence 
mechanisms and were described in the 1960s and 1980s, respectively (Boerlin and White, 2013; Perry 
et al., 2014). Variation in serum resistance mechanisms among APEC could be due to the presence 
of different types, as well as, combinations of capsules (Mainil, 2013). Overall, the wide variation in 
the presence of certain serum resistance VGs and the prevalence of these VGs could be reflected in 
the different clinical symptoms and pathological changes seen with avian colibacillosis (Guabiraba 
and Schouler, 2015; Mellata et al., 2003).  
1.10.6.4 Iron acquisition mechanisms 
Iron is an essential element for the survival and growth of E. coli in the host and the external 
environment (Dho and Lafont, 1984; Searle et al., 2015). It is involved in several cellular activities 
such as electron transport and storage, gene regulation, nucleotide biosynthesis and is a cofactor of 
various enzymes (Heinemann et al., 2008; Raymond et al., 2003; Rouault and Tong, 2008). Since the 
concentration of free iron in the host physiological fluids is not enough for the survival of the 
pathogenic bacteria and much higher concentrations are needed for their metabolic activities. 
Pathogenic bacteria have been forced to develop multiple strategies to enable them to acquire iron 
(Belanger et al., 2011). The bacteria are equipped with efficient iron acquisition mechanisms, which 
enable them to compete with the host iron-binding proteins, such as transferrins, lactoferrin and for 
haemoglobin free iron. Several different iron acquisition systems, such as aerobactin, yersiniabactin, 
Sit system and ChuA (encoding heme transport protein) have been found among APEC isolates (Gao 
et al., 2012). The aerobactin iron acquisition system is considered the most common system in APEC. 
Previous studies have indicated that the aerobactin system is found in more than 72% of APEC 
isolates (Emery et al., 1992; Linggood et al., 1987). The aerobactin iron acquisition system consists 
of hydroxamate siderophore aerobactin and ferric aerobactin uptake proteins, which are encoded by 
iucA and iucC genes that are located on ColV plasmids (Boerlin and White, 2013). 
Avian pathogenic E. coli can up take iron indirectly utilising the shuttle mechanism, which is based 
on small-molecule compounds called siderophores (high-affinity ferric chelators) that are able to 
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capture ferric iron (Dho and Lafont, 1984; Gibson and Magrath, 1969; Ratledge and Dover, 2000; 
Wooldridge and Williams, 1993). Different types of siderophores have been identified: enterobactin; 
salmochelin; hydroxamate aerobactin and yersiniabactin (Binns et al., 1979; Searle et al., 2015). Each 
system is involved in different steps of APEC pathogenicity including: synthesis in the cytoplasm; 
secretion; reception of the ferri-siderophore at the outer membrane surface; internalisation and iron 
release in the cytoplasm (Belanger et al., 2011). An early study conducted on one-day-old chickens 
suggested a positive association between low iron levels, APEC survival and the pathogenicity of the 
tested APEC strains (Lafont et al., 1987). Furthermore, several studies have suggested that the 
expression of an iron acquisition system occurs mainly in APEC compared with AFEC (Dias da 
Silveira et al., 2002; Dozois et al., 1992; Emery et al., 1992; Linggood et al., 1987). Among APEC 
strains, iron acquisition systems can be encoded by genes located on plasmids (Sabri et al., 2008; 
Skyberg et al., 2006) or by chromosomal PAIs (Kariyawasam et al., 2006a). 
1.10.6.4.1 Salmochelin 
The first siderophore discovered was the enterobactin molecule, salmochelin, which was identified 
in Salmonella enterica (Hantke et al., 2003). The salmochelin biosynthesis and transport genes have 
generally been found on large pathogenic plasmids; ColV or ColBM, as well as, on the chromosome 
in APEC strains (Johnson et al., 2006). The salmochelin system is involved in the virulence 
mechanism of APEC strains (Sabri et al., 2008; Sabri et al., 2006) and includes sitABCDE in 
combination with other iron uptake systems. It can contribute to iron acquisition and to bacterial 
survival (Sabri et al., 2006). The salmochelin system contains five genes (iroB, iroC, iroD, iroE and 
iroN), which have been reported among APEC (Zhu et al., 2005). The presence of all five genes is 
required for APEC virulence (Caza et al., 2008). The iroN gene codes for an outer membrane 
siderophore and is considered as the main receptor for ferric salmochelin transport (Hantke et al., 
2003). 
1.10.6.4.2 Yersiniabactin 
The siderophore yersiniabactin was first recognised in Yersinia enterocolitica (Koebnik et al., 1993). 
The yersiniabactin system is encoded by fyuA (ferric yersiniabactin uptake) and irp-2 (iron-
repressible) genes (Karch et al., 1999; Pelludat et al., 1998; Schubert et al., 1998). A number of 
studies have demonstrated an association between the presence of these VGs and APEC pathogenicity 
(Janssen et al., 2001; Jeong et al., 2012; Mokady et al., 2005; Paixao et al., 2016). 
1.10.6.4.3 Aerobactin 
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Aerobactin is a hydroxamate siderophore, that was first isolated from Aerobacter aerogenes cultured 
in low iron selective medium (Gibson and Magrath, 1969). Aerobactin is synthesised by the iucABCD 
encoded gene (iron uptake chelate) and is taken up by the IutA-encoded receptor protein (Bindereif 
and Neilands, 1985; Ling et al., 2013). When compared to AFEC, aerobactin biosynthetic genes are 
more frequently detected in APEC and their incidence correlates with highly pathogenic strains 
(Dozois et al., 1992; Lafont et al., 1987; Linggood et al., 1987). Compared to the wild type, the 
virulence of an APEC strain deficient in aerobactin synthesis and uptake was reduced in a chicken 
systemic infection model (Dozois et al., 2003).  
Aerobactin uptake proteins are encoded by iucC and iucD genes, which are located on a conserved 
region of ColV plasmids (Dziva and Stevens, 2008; Johnson et al., 2006) or ColBM virulence 
plasmids, but can also be located on the chromosome in some strains (de Lorenzo and Neilands, 1986; 
Johnson et al., 2006; Oves-Costales et al., 2009). Skyberg et al. (2006) demonstrated that ColV 
plasmids in APEC, which contain an aerobactin system, can transfer to AFEC and enable the 
commensal isolate to cause mortality to chicken embryos. Originally, the iutA gene was found to be 
encoded on the pColV-K30 plasmid (Warner et al., 1981; Williams and Warner, 1980) and later it 
was detected in the chromosome (Crosa, 1989). A study in China investigated the contributions of 
the iutA gene to APEC pathogenicity mechanisms by deleting the iutA gene (Ling et al., 2013). This 
study reported a significant decrease in APEC pathogenicity of the mutant strains, which indicates 
that the iutA gene plays an important role in pathogenicity (Ling et al., 2013).  
The presence of more than one of the iron acquisition systems may indicate an adoption mechanism 
of the bacteria to allow it to survive in different environmental situations (De Carli et al., 2015; 
Janssen et al., 2001). Global studies have highlighted the higher prevalence rate of iron acquisition 
VGs such as: chuA; fyuA; irp2 and iucD among APEC in comparison to AFEC (Ewers et al., 2005; 
Horne et al., 2000; Janssen et al., 2001; Karch et al., 1999; Nakazato et al., 2009; Rodriguez-Siek et 
al., 2005a). 
1.10.6.5 Adhesin  
The bacterial adhesin to the host epithelium tissues is considered to be an important step for 
pathogenicity of many bacteria since it allows the bacteria to bind to and maintain close contact with 
the host epithelial tissues (Meyer et al., 1997; Moon, 1990). Specific surface receptor proteins in the 
host mediate the adhesin process of the pathogen. Initially, Arp and Jensen. (1980) suggested an 
association between APEC adherence capacity and pathogenicity of the bacteria, and reported a 
higher prevalence of fimbriated strains compared to afimbriated strains in the trachea of sick turkeys. 
The role of adhesin VGs in regards to establishing an attachment of APEC to chicken receptors both 
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in vitro and in vivo and its effect on the severity of APEC infections was first reported in 1984 (Naveh 
et al., 1984).  
Early studies suggested a positive association between the presence of adhesin VGs (fimbrial or 
afimbrial) and the successful ability of APEC to cause infections (Arp and Jensen, 1980; Fantinatti  
et al., 1994; Naveh et al., 1984) (Kariyawasam and Nolan, 2009; Moon, 1990). Further studies 
extensively characterised these VGs and their association with APEC and whether they could be used 
as a marker to identify and differentiate between APEC and AFEC (Ewers et al., 2007; Musa et al., 
2009; Nolan et al., 2003). However, the sole presence of adhesin VGs will not result in an infection, 
as other virulence factors are required for disease to occur (Marc et al., 1998; Ramirez et al., 2009).  
1.10.6.5.1 Fimbrial adhesins  
It is not surprising that several adhesin genes have been associated with APEC, including Type 1 
fimbriae (fimC, fimH), P fimbriae (papC), curli fibres (crl), S fimbriae (sfa/focCD), F1C fimbriae, Dr 
fimbriae, afimbrial (afa/drab) adhesins and many novel adhesin genes that have not yet been fully 
characterised (Antao et al., 2009; Dho-Moulin and Fairbrother, 1999; Ewers et al., 2005; Ewers et 
al., 2007; Kariyawasam and Nolan, 2009; Knöbl et al., 2004; La Ragione and Woodward, 2002; 
Monroy et al., 2005; Moon, 1990; Pourbakhsh et al., 1997; Stordeur et al., 2004; Vandekerchove et 
al., 2004b; Vidotto et al., 2004; Vidotto et al., 1990; Vidotto et al., 1997). Understanding the function 
of each of the APEC linked adhesin VGs is very important as the presence of each of these VGs have 
a unique function that enables APEC to recognise a specific receptor in the host where they are able 
to attach and colonise (Antao et al., 2009; Arp and Jensen, 1980; Naveh et al., 1984). 
1.10.6.5.2 F1 fimbriae (Type 1 pili)  
F1 fimbriae or Type 1 pili are non-flagella, hair-like proteinaceous long filaments or surface 
appendages anchored to the cell wall (Dziva and Stevens, 2008; La Ragione and Woodward, 2002). 
F1 fimbriae were first linked to APEC virulence in 1980 based on a study that revealed less fimbriated 
strains were easily removed from the respiratory tract of the chicken compared to virulent fimbriated 
strains (Arp and Jensen, 1980). Both fimbriae types 1 and P adhere to tracheal epithelial cells of 
chickens (La Ragione et al., 2000; Yerushalmi et al., 1990). Type 1 fimbriae can be found on more 
than 70% of APEC cultured from the respiratory tract of birds with colibacillosis (Dho-Moulin and 
Fairbrother, 1999; Dozois et al., 1994; Janssen et al., 2001; Pourbakhsh et al., 1997). In contrast, P 
fimbriae were expressed by less than 30% of APEC strains that were colonising the respiratory system 
and internal organs (Pourbakhsh et al., 1997; Stordeur et al., 2004). Furthermore, the expression of P 
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fimbriae in vivo suggests that these fimbriae are most likely not important for the initial colonisation 
of the upper respiratory tract, but are needed in the latter stages of infection (Pourbakhsh et al., 1997). 
The F1 fimbriae are encoded by nine fim genes and include a major protein known as FimA and minor 
proteins known as FimF, FimG and the adhesin FimH. Dozois et al. (1994) and Pourbakhsh et al. 
(1997) reported that the expression of type 1 fimbriae only take place in the upper respiratory tract 
and not in any other internal organs, which suggests they have a role in initial colonisation. An early 
study of APEC infection by La Ragione et al. (2000) was able to demonstrate the significant role of 
type 1 fimbriae for the adherence, colonisation and invasion of APEC into the host epithelial cells. In 
contrast, Marc et al. (1998) suggested that the presence of type 1 fimbriae alone had a limited role in 
APEC pathogenicity. Further, Arne et al. (2000) reported the failure of an APEC fimH mutant strain 
to adhere to the epithelial cells of the chicken trachea in vitro. 
A large number of studies have suggested that type AC/I fimbriae is associated with the adherence to 
the upper respiratory tract and the initial colonisation (de Pace et al., 2010; Delicato et al., 2003; 
Dozois et al., 1992; Dozois et al., 1995; Janssen et al., 2001; La Ragione et al., 2000; Marc et al., 
1998; Pourbakhsh et al., 1997; Vidotto et al., 2004; Wooley et al., 1992). In addition, further studies 
have reported an association between type AC/I fimbriae and serotype O78 APEC isolates (Babai et 
al., 1997; Lymberopoulos et al., 2006) indicating the importance AC/I fimbriae in pathogenicity. 
P fimbriae or Pap pili (pyelonephritis associated pili) were first defined in UPEC in humans and dogs, 
and later in APEC (Collinson et al., 1993; Kariyawasam et al., 2006b). The P fimbriae is encoded by 
the pap gene, which is located on the bacterial chromosome (Latham and Stamm, 1984). It is believed 
that the expression of P fimbriae only takes place in deeper tissues, not the upper respiratory tract, 
which suggests that P fimbriae are important for systemic infections (Dziva and Stevens, 2008; 
Pourbakhsh et al., 1997). Although the contribution of P fimbriae to urinary tract infections in humans 
is well documented, their role in APEC pathogenicity is still debatable. Achtmann et al. (1986) found 
that 52% of APEC isolates sourced from chickens with colibacillosis harboured P fimbriae. 
The pap operon, which is located on the bacterial chromosome, harbours different VGs that encode 
for P fimbriae (Latham and Stamm, 1984). The papA, papI and papB genes encode for the major 
structural protein (PapA), which is responsible for the phase variation process (Mol and Oudega, 
1996). The papE gene encodes the fimbriae l structure, papG gene encodes for the adhesin and papD, 
papH, papJ, papF and papK genes, are responsible for the expression of proteins related to the 
fimbrial structure (Mol and Oudega, 1996). Kariyawasam et al. (2006b) reported that the pap operon 
is present in a PAI of APEC strain APEC-O1 and it has been shown that the transformation of an 
avirulent strain into virulent strain could be due to pap horizontal transmission (Stacy et al., 2014).  
Page | 59  
 
Vandekerchove et al. (2004b) reported a significant association between avian colibacillosis and the 
detection of F11 fimbriae among the APEC isolates. Furthermore, they reported that the majority of 
the F11 fimbriae isolates belong to serotype O87. This serotype has been shown to be associated with 
APEC, as well as, ExPEC isolated from humans (Naveh et al., 1984).  
1.10.6.5.3 Curli  
Curli fimbriae are thin and curly appendices found on the outer cell surface of E. coli (Collinson et 
al., 1993; Olsen et al., 1989). These outer protein structures are important as they enable the binding 
of E. coli to the extracellular proteins (Collinson et al., 1993; Olsen et al., 1989). Historically, it was 
assumed that fimbrial adhesins were encoded by the crl gene. However, recently the csgA gene was 
recognised as encoding for curli, which have been found to be expressed equally among APEC and 
AFEC (Amabile de Campos et al., 2005; Cunha et al., 2017; Maluta et al., 2014). This may indicate 
that curli fimbriae initiate colonisation for both APEC and AFEC. Supporting this hypothesis, 
McPeake et al. (2005) found that the csgA gene existed among all E. coli isolates regardless of the 
health status of the chicken. In contrast, Maurer et al. (1998) found this gene only in APEC.  
The presence of fimbriae F17, Afa and Sfa among APEC strains may indicate that these adhesins can 
be found on the cell surface of APEC (Amabile de Campos et al., 2005; McPeake et al., 2005; 
Stordeur and Mainil, 2002) and therefore their presence could indicate virulence of a strain. Although, 
a study in China by Won et al. (2009) did not find Afa, F-fimbriae or AC/I amongst 118 E. coli 
isolates sourced from chickens with colibacillosis.  
The Afa/Dr family of adhesins is a diverse group of proteins encoded by the closely related afa, daa 
and dra gene clusters (Servin, 2005). The presence of these adhesin VGs were detected in APEC, as 
well as UPEC, and were found to be associated with infections by enabling adhesin and invasion 
(Goluszko et al., 1997; Lalioui and Le Bouguenec, 2001).  
 
 
 
 
1.10.6.5.4 Non fimbrial adhesins 
1.10.6.5.4.1 Temperature-sensitive hemagglutinin 
The temperature sensitive haemagglutination is a protein coded by the tsh gene, that can only be 
expressed at 26 °C and is blocked at 42 °C (Provence and Curtiss, 1994). This protein is an 
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autotransporter protein with dual function of adhesive and proteolytic activities. This protein remains 
in the outer membrane and supports the adhesin process during the early stages of the infection 
(Stathopoulos et al., 1999). Generally, this gene is detected on ColV plasmids at a higher frequency 
among APEC (Dozois et al., 2000; Johnson et al., 2006; Nakazato et al., 2009; Stehling et al., 2003). 
An early study by Maurer et al. (1998) reported a prevalence of 46% of tsh among APEC in 
comparison to zero among AFEC. Campos et al. (2008) reported 25% and 50% of APEC strains 
isolated from chickens with septicaemia and swollen-head syndrome, respectively, harboured the tsh 
gene and only 6% of AFEC. Similarly, a tsh prevalence of 55% was detected in Brazil and 53% in 
Germany from APEC isolates (E. coli isolates obtained from lesions of chicken with colibacillosis) 
(Ewers et al., 2004; Rocha et al., 2008). Other authors reported an even higher prevalence of tsh in 
APEC of 94% in Ireland (McPeake et al., 2005) and 99% in Canada (Ngeleka et al., 2002). This 
variation in the prevalence of tsh among different studies could be due to geographical variations. 
However, despite the utilisation of tsh as a molecular marker for APEC detection by Ewers et al. 
(2005), future studies are needed to identify the exact role of tsh in the pathogenicity of APEC. 
1.11 The prevalence of APEC related VGs  
Although several studies have suggested that APEC related VGs could be used as molecular markers 
for the identification and detection of APEC strains (Ewers et al., 2005; Johnson et al., 2008b; 
Tivendale et al., 2009), a clear discrimination between APEC and AFEC has not yet been achieved. 
Increased evidence has indicated that APEC-associated VGs are commonly clustered on plasmids, 
PAIs, or less often, the bacterial chromosome (Ewers et al., 2005; Johnson et al., 2008b; Mellata et 
al., 2012; Tivendale et al., 2009). Several studies have also found that the prevalence of VGs occurs 
at a higher rate among APEC in comparison with AFEC (Johnson et al., 2008b; Nolan et al., 2013). 
However, there are several factors that influence the prevalence of APEC-associated VGs from 
E. coli isolates obtained from healthy chickens and chickens with colibacillosis, such as bird age 
variations and geographical factors as shown in Table 1.1.  
A longitudinal study, where broiler chickens were sampled twice weekly from the day they were  
placed into the shed to approximately three-days prior to de-population (32 – 35 days) on two farms 
through two flock cycles, suggested that the chickens age can affect the prevalence of APEC-
associated VGs in AFEC. Kemmet et al. (2013) reported a wide diversity and higher prevalence of 
APEC-associated VGs in faecal E. coli from one-day-old chicks compared to older chickens. There 
was a noticeable decrease in the number of APEC-associated VGs in faecal E. coli detected at 
slaughter (Kemmett et al., 2013). However, these variations in the prevalence among young chickens 
could be as a result of young birds having more diverse microbiota and negative selection in the gut 
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for virulent strains. Furthermore, horizontal transmission of APEC related VGs could occur from the 
hatchery or the surrounding environment (Lu et al., 2003; Morris and Potter, 1997). 
The prevalence of APEC-associated VGs could be affected by the presence of the plasmids, which 
may harbour several VGs. For example, an association between the presence of seven APEC-
associated VGs (tsh, iucD, iroN, iss, cvi/cva, traT and iroN) on plasmids and E. coli isolates collected 
from chickens with colibacillosis have been reported (Ewers et al., 2007). 
The absence of an exact definition of APEC and/or AFEC either based on the presence of unique 
VGs or bird’s health status among different studies influences the ability to directly compare studies. 
The geographical effect on the prevalence of APEC related VGs is documented in several studies 
(Johnson et al., 2008b; Johnson et al., 2008c; Rodriguez-Siek et al., 2005a). Mbanga et al. (2015) 
detected all of the 12 VGs (iutA, hlyF, ompT, frz, sitD, fimH, kpsM, sitA, sopB, uvrY, pstB and vat) 
they screened for in APEC in South Africa. The three most prevalent VGs detected in the 45 APEC 
were iutA (80%), fimH (33%) and hlyF (24%) with genes kpsM, pstB and ompT being detected in 
only 2.2% of the isolates. Other studies in the USA and Iran have found higher occurrences of 98% 
and 62%, respectively, for the fimH gene in APEC isolates (Eftekharian et al., 2016; Rodriguez-Siek 
et al., 2005a). Jin et al. (2008) and Wang et al. (2010) found hlyF was one of the most prevalent 
genes in E. coli sourced from chickens with colibacillosis in China with 77% and 55%, respectively.  
Furthermore, variations in the prevalence of the tsh gene have been reported ((Delicato et al., 2003; 
Knobl et al., 2012). The tsh gene was detected in 78.3% of APEC and in only 21.7% of AFEC isolates 
obtained from commercial broiler chickens in Iran (Kafshdouzan et al., 2013). In contrast, tsh was 
reported at a higher prevalence in AFEC (93.3%) and APEC (93.9%) in the UK (McPeake et al., 
2005). In Brazil only 4% of the AFEC isolates harboured tsh compared to 39.5% of APEC (Delicato 
et al., 2003). In summary, the geographical variations in the prevalence of APEC-associated VGs 
reflect the vital role of defining APEC on the basis of VGs from Australian commercial broiler 
chickens. 
1.11.1.1 Current knowledge about APEC related VGs in Australia 
In Australia, there are few published studies that assess the prevalence of APEC linked VGs (Obeng 
et al., 2012; Tivendale et al., 2004). One study showed that among 251 AFEC (E. coli isolates 
obtained from the faeces of healthy chickens) the iutA gene was detected in 44% of the isolates 
followed by 4% for both kpsMTII and sfa and papC (3.2%) while none of the E. coli isolates 
harboured sfa/foc (Obeng et al., 2012). Tivendale et al. (2004) examined the role of tsh, iucA and iss 
genes in APEC pathogenicity and confirmed their presence in the pVM01 plasmid from Australian 
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isolates. The authors reported a positive association of iss and iucA with high levels of APEC 
virulence, with either one of the genes causing intermediate levels of virulence. The absence of the 
tsh gene did not affect levels of pathogenicity after aerosol exposure (Tivendale et al., 2004). 
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Table 1.1: Virulence genes screened and the number (N) of different virulence genes occurring among extraintestinal E. coli (ExPEC), avian 
pathogenic E. coli (APEC) and avian faecal E. coli (AFEC) among different studies. 
Date Country 
APEC 
(N) 
AFEC  
(N)  
ExPEC 
(N) 
Virulence genes screened 
Detected virulence genes 
Reference 
APEC AFEC ExPEC 
1992 - 2000 
France, 
Spain and 
Belgium 
1,491 0 0 
fimA, fimH, neuC, felA, papC, papG, prsG, tsh, iutA, cdt, cnf1, 
cnf2, VT1, VT2, LT STa, STb, F1, aec26, frzorf4 and F11 
sitA, F1, frzorf4, aec26 and 
iutA 
Not studied Not studied 
(Schouler et al., 
2012) 
1994 and 
2002 
UK 45 114 0 fimC, pap, sfa, afa, aer, crl, csg, tsh, hlyE, iss and cvaC. 
fimC, pap, crl, csg, aer, tsh 
and cvaC 
hlyE and tsh, Not studied 
(McPeake et al., 
2005) 
2005 Germany 14 9 17 stA, iss, irp2, papC, iucD, tsh, vat and cva/cvi 
stA, iss, irp2, papC, iucD, 
tsh, vat and cva/cvi 
Not studied 
papC, irp2, 
iss, iucD and 
vat 
(Ewers  et al., 
2005) 
2001 – 2006 Sri Lanka 196 0 0 
ompT, hlyF, aec26, iss, frz, cvaC, iroN, iutA, sitAP (plasmid), 
sitAC (chromosomal), papC, papG (III), felA, aec4 and iucD 
iutA, felA, tsh, ompT, iss and 
frz 
Not studied Not studied 
(Dissanayake et 
al., 2014) 
2005 - 2008 China 148 0 0 tsh, iss, iucA, hlyF, sitA, ibeA, traT, cdtB, iroN, cvaC and fimH 
traT, iroN, fimH, iss, tsh, 
iucA, hlyF, cvaC and sitA 
Not studied Not studied 
(Wang et al., 
2010) 
2005 USA 524 0 200 
ApA, fimH, kpsMTIII,, papEF, ireA, ibeA, cnf1, fyuA, iroN, 
bmaE, sfa, iutA, papGIII, hlyD, rfc, ompT, papGI, kpsMTII, 
papC, gafD, cvaC, fliC(H7), cdtB, focG, traT, papGII, ihA, afa, 
iss, sfaS and kpsMT(K1) 
iroN, iss, iucC, iutA, sitA, 
traT, cvaC and tsh 
Not studied 
sit, traT, iss, 
iroN, 
iucC, iutA 
and tsh 
(Rodriguez-Siek 
et al., 2005a) 
2007 
Germany, 
Brazil, 
France, 
Canada, 
USA, and 
Netherlands 
436 0 90 
afa/dra, crl, fimC, hra, iha, sfa/foc, papC, tsh, iroN, iss, chuA, 
chuA, ireB, sitB , chromosomal sit, irp2, iucD, sitB., cvi/cva, 
ompA, traT, sat, vat, neuC, EAST-1, cnF1/2, malX, pic, tia, ibeA 
and gimB 
cvi/cva, sitD., iucD, iss, 
traT, iroN and tsh 
Not studied 
traT, iucD, 
iss, cvi/cv 
and , 
chromosomal 
sit, 
(Ewers  et al., 
2007) 
2008 USA 794 200 0 
Episomal iss, iroN, episomal ompT, eitAB, cvaABC, cbi, cma, 
iutA, hlyF, and etsAB, chromosomal ompT, ireA, fyuA, 
papACEFG, and vat, gimB, kpsMT1, ibeA, kpsMT2 and malX, 
ompT, iss, hlyF, iutA and 
iroN 
Not studied Not studied 
(Johnson et al., 
2008b) 
2010 - 2012 Brazil 138 0 0 cvaC, iroN, iss, iutA, sitA, tsh, fyuA, irp-2, ompT and hlyF 
hlyF, sitA, ompT, fyuA, 
cvaC and irp-2 
Not studied Not studied 
(De Carli et al., 
2015) 
2008 - 2009 Australia 0 311 0 
papAH, papC, afa/draBC, sfa/focDE, sfaS, aerJ, kpsMTII and 
focG 
Not studied 
iutA, papC 
and kpsMTII 
Not studied 
(Obeng et al., 
2012) 
2015 South Africa 45 0 0 
frz, sitD, fimH, ompT, iutA, pstB,vat kpsM,, hlyF, uvrY, sitA and 
sopB 
iutA, fimH, hlyF and sopB Not studied Not studied 
(Mbanga and 
Nyararai, 2015) 
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1.12 The treatment of avian colibacillosis in the poultry industry 
The usage of antimicrobial drugs to control and reduce the economic losses associated with avian 
colibacillosis is considered the main way to control the disease (Dheilly et al., 2011; Nolan et al., 
2013). However, the emergence of antimicrobial resistant bacteria is now affecting the way 
colibacillosis is being treated (Nolan et al., 2013). The majority of current treatment strategies focus 
on early prevention of the disease in the broiler flocks rather than treatment after infection (Kabir, 
2010; Nolan et al., 2013). Historically, tetracycline have been used to treat colibacillosis, but with 
90% of E. coli isolates now displaying resistance to this drug it is no longer the treatment of choice 
(Wang et al., 2010). This increasing rate of AMR poses a global threat to the poultry industry as well 
as the public (Aarestrup, 2005). 
1.13 The usage of antimicrobial agents in the Australian poultry industry 
Australia has adopted a conservative position regarding the registration of antimicrobials for food-
producing animals. Australia is the only country never having permitted the use of fluoroquinolones 
in livestock (Cheng et al., 2012) and has also placed stringent label restrictions on the use of third 
generation cephalosporins, such as ceftiofur  
All veterinary antimicrobials that can be used in animals in Australia are registered with the 
Australian Pesticides and Veterinary Medicines Authority (APVMA). Information in regards to those 
chemicals can be accessed through the Public Chemical Registration Information System Search 
(PubCRIS) (Australian Pesticides and Veterinary Medicines Authority (APVMA), 2015). Few 
antimicrobials are registered for use in broiler chickens in Australia. Avilamycin is registered as a 
growth promoter and to aid in the prevention of necrotic enteritis, ionophores as coccidostats and the 
registered therapeutic antimicrobials are: β-lactams (amoxicillin and ampicillin); macrolides 
(erythromycin and tylosin); lincosamides (lincomycin); aminoglycosides (apramycin, neomycin and 
spectinomycin); streptogramin (virginimycin); tetracyclines (chlortetracycline and oxytetracycline); 
pleuromutilin (tiamulin); trimethoprim sulphonamide and polypeptides (zinc bacitracin) (Australian 
Pesticides and Veterinary Medicines Authority (APVMA), 2015). 
The Australian government regulates antimicrobial drug usage in the poultry industry, as well as the 
withholding period, which is the minimum period of time that must elapse between when the drug is 
used to use of the animal commodity for human consumption. Withholding periods ensures there is 
no antimicrobial drug residue in the chicken meat or eggs (van den Bogaard et al., 2001). The 
antimicrobial regulations cover the dosage, route of administration and the duration of administrated 
antimicrobial drug.  
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Despite the emergence of resistant strains among different bacterial species and public health 
concerns of the use of antimicrobials in food-producing animals, there continues to be a need for 
antimicrobials to be used as treatments, as well as, for prevention of infections. This highlights the 
importance of a proper disease diagnosis combined with the identification of the AMR prevalence 
among commensal and pathogenic bacterial species to allow for identification of specific treatments 
(Martinez et al., 2014). A national surveillance program is needed to determine the total usage of all 
antimicrobial drugs among different species of animals and the resistance profile of pathogens to all 
antimicrobial drugs used. This would inform on the usage effect and selection pressure of these 
antimicrobials for animals, as well as, for public health, guide antimicrobial stewardship programs 
and help veterinarians plan therapeutic and prevention/control strategies. 
In Australia, antimicrobial usage information can only be obtained from the Australian Pesticides and 
Veterinary Medicines Authority (Australian Pesticides and Veterinary Medicines Authority 
(APVMA), 2015). However, they only provide limited data in regards to the total drug sales without 
the exact quantities of the antimicrobial usage in different animal species (Australian Pesticides and 
Veterinary Medicines Authority (APVMA), 2015; Shaban et al., 2014). This is in contrast to 
antimicrobial monitoring systems applied in other countries, such as Denmark, Germany, Sweden 
and the UK, where they closely observe and provide detailed information in regards to the  
consumption of different types of antimicrobials among different animal species. The Danish 
Integrated AMR Monitoring and Research Program (DANMAP) is an example of such an extensive 
surveillance system (The Danish Integrated Antimicrobial Resistance Monitoring and Research 
Programme (DANMAP), 2014). 
1.14 Antimicrobial drugs 
The word “antimicrobial” is of Greek origin and consists of three components: anti meaning 
“against”, mikros meaning “little” and bios meaning “life” (Gottlieb and Nimmo, 2011; Guardabassi, 
2006). Antimicrobial agents are any natural, synthetic or semisynthetic elements that are capable of 
inhibiting the growth (bacteriostatic) or killing (bactericidal) microorganisms without causing any 
harm to the host cell (Giguère, 2006; Perry et al., 2014; Sello, 2012). Frequently, the two terms: 
antimicrobial and antibiotic are used interchangeably (Guardabassi, 2006). The accurate definition of 
an antibiotic is an agent that is produced by a microorganism and acts against other microorganisms 
(Perry et al., 2014). While antimicrobial agents are synthetic, as well as, semi-synthetic substances 
that are originated from different products and are also effective in the control of infections 
(Guardabassi, 2006). 
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Antimicrobial agents can be classified, according to their actions, into broad-spectrum (can either 
inhibit or kill a wide range of microorganisms) and narrow-spectrum (can only kill or inhibit a certain 
species or genus of bacteria) (Boerlin and White, 2013). Furthermore, antimicrobial agents can also 
be classified based on their mechanism of action into different groups such as: antimicrobials 
targeting bacterial cell wall synthesis (β-lactams); inhibiting nucleic acid synthesis (quinolones and 
fluoroquinolones) or function (sulphonamides and trimethoprim) and inhibiting protein synthesis 
(aminoglycosides, phenicols, macrolides, lincosamides and tetracyclines) (Boerlin and White, 2013; 
Mascaretti, 2003; Neu, 1992; Perry et al., 2014) 
1.15 Antimicrobial resistance 
Antimicrobial resistance is defined as the bacteria’s ability to survive and/or grow in the presence of 
a chemical (drug) that would normally kill them or inhibit their growth (Harbottle et al., 2006). The 
genetic flexibility of bacteria enables them to adapt, evolve and survive in their environment by 
developing different resistance mechanisms (Acar et al., 2012). The emergence, selection and the 
spread of strains also occurs due to selection pressure and antimicrobial consumption in animals, as 
well as, humans (Boerlin and Reid-Smith, 2008; Boerlin and White, 2013; da Costa et al., 2013; 
Guardabassi and Kruse, 2008). The complexity of AMR in veterinary medicine is due to different 
animal species, variations in bacterial species and the diversity of rearing environments (Wasyl et al., 
2012; Wasyl et al., 2013). Resistant bacteria can result in serious prolonged infections causing high 
morbidity and mortality and massive costs associated with prevention, treatment and control (Boerlin 
and White, 2013; Hawkey and Jones, 2009).  
1.15.1 Acquisition and transfer of antimicrobial resistance genes  
The majority of virulence and ARGs can be found either on the chromosome or on MGE, such as 
plasmids. Resistance mechanisms can develop due to mutations (vertical transmission) or through the 
acquisition of resistance genes from other bacterial strains by horizontal gene transfer (HGT) (Boerlin 
and Reid-Smith, 2008; Boerlin and White, 2013; da Costa et al., 2013; Davies, 1994; Martinez-
Medina et al., 2009). The transmission of genetic material from one generation to the next during 
replication is known as vertical gene transmission (Rodriguez-Rojas et al., 2013). Horizontal gene 
transfer is the most important mechanism increasing resistance and is due to the transfer of genes 
among different bacterial strains and/or species. Horizontal gene transfer occurs mainly through 
conjugation and MGE (Allen et al., 2013; Boerlin and White, 2013; Davies, 1994; Harbottle et al., 
2006).  
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1.15.2 Mobile genetic elements (MGEs)  
Mobile genetic elements can assist HGT. These elements include plasmids, transposons, integrons 
and phages, which vary in size and structure (Rankin et al., 2011; Wozniak and Waldor, 2010). 
1.15.2.1 Integrons  
Integrons are genetic units that can capture and express small MGEs (gene cassettes). Integrons can 
be found on plasmids or transposons as well as on the chromosome (Carattoli, 2001; Domingues et 
al., 2012). Class 1 integrons are the most ubiquitous having been found in 60% – 70% of gram-
negative pathogens (van Essen-Zandbergen et al., 2007). They have also been proven to play a role 
in distribution and spread of AMR (Deng et al., 2015). Several studies have reported a positive 
association between integrons and multidrug resistant E. coli isolates in food-producing animals 
(Cavicchio et al., 2015; Dou et al., 2016; Szmolka et al., 2015) as well as in humans (Lavakhamseh 
et al., 2016).  
Class 2 integrons are associated with the Tn7 transposon family and are generally identified at a lower 
prevalence in Enterobacteriaceae (Deng et al., 2015). Class 3 integrons have also been reported in  
E. coli (Deng et al., 2015). Class 1 and 2 integrons have been identified in APEC in poultry worldwide 
(Awad et al., 2016; Cavicchio et al., 2015; Nogrady et al., 2006).  
1.15.2.2 Plasmids  
Plasmids play a significant role in the transmission of ARGs and VGs (Allocati et al., 2013; Robicsek 
et al., 2006a; Schultsz and Geerlings, 2012). Plasmids are self-replicating, consisting of double 
stranded DNA, are capable of autonomous replication and are present in nearly all bacterial species 
(Thomas and Nielsen, 2005). They can vary in size from just a few hundred base pairs (bp) to a 
several kilo bp (Waters, 1999).  
In normal conditions, plasmids do not contribute to the host cell growth as they do not carry essential 
growth genes (Thomas and Nielsen, 2005). Plasmids contribute to the genetic diversity of the bacteria 
as they harbour a wide spectrum of genes that encode for nonessential functions, such as drug 
resistance, virulence factors, fitness or adaptation (Bergstrom et al., 2000; Carattoli et al., 2005). 
Plasmids can be categorised in different ways. One classification scheme is based on the failure of 
the complete transmission of the plasmid into new generations, which is known as incompatibility 
(Inc) (Couturier et al., 1988; Novick, 1987). Many different Inc groups have been identified among 
E. coli such as: IncFIB; IncI1; IncFIIA; IncP; IncB/O; IncN; IncFIC; IncA/C; IncHI2; IncT; IncN; 
IncW; IncFIA; IncY; IncFrep; IncX; IncHI1 and IncL/M (Carattoli et al., 2005). 
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The conjugation process, a survival mechanism developed by plasmids, enables the plasmids to 
maintain their stability during cell division among the bacterial population, regardless of other 
selective pressure. Plasmids containing ARGs have been shown to be transferred among different 
bacterial strains, as well as, different species of bacteria (Hayes, 2003). The majority of plasmids 
include replicon regions, which are responsible for the replication process (Carattoli et al., 2005; 
Couturier et al., 1988).  
Several studies have reported that plasmids contribute to the transfer of resistance genes among  
E. coli isolates (Jones-Dias et al., 2015; Kluytmans et al., 2013). Carattoli et al. (2011) described an 
association between certain types of plasmids and resistance genes such as blaDHA-1 (an AmpC β-
lactamase) and plasmid type IncF. However, Mate et al. (2012) found this AmpC β-lactamase was 
also associated with IncL/M plasmids. IncN plasmids have been detected from bacteria cultured from 
faecal samples from a variety of animals (Dolejska et al., 2013). Several studies have suggested that 
IncN and InA/C plasmids are associated with dissemination of extended-spectrum cephalosporins 
(ESC) and plasmid-mediated quinolone resistance (PMQR) genes in E. coli and Salmonella from 
animals and humans, as well as, their surrounding environment (Carattoli, 2011; Dolejska et al., 2013; 
Johnson et al., 2007; Moodley and Guardabassi, 2009; Rodrigues et al., 2013).  
The usage of antimicrobials alone is not enough to explain the frequency and spread of the different 
types of plasmids among E. coli isolates sourced from poultry (Svara and Rankin, 2011). However, 
there is evidence some plasmid replicons, such as IncI1, can survive in E. coli isolates without 
antimicrobial selection pressure with no or little fitness cost to the host (Fischer et al., 2014). 
Furthermore, the bacteria host can make use of some of the extra elements found on plasmids, such 
as the adhesin VGs, which help the E. coli adhere host cells (Carattoli, 2009).  
1.15.2.3 Plasmid related VGs 
Avian pathogenic E. coli have been found to commonly possess plasmids containing virulence and 
ARGs (Dobrindt, 2005; Johnson et al., 2002a; Johnson et al., 2007; Rodriguez-Siek et al., 2005a), in 
particular ColV and ColBM conjugative plasmids (Dias da Silveira et al., 2002; Johnson and Nolan, 
2009; Mellata et al., 2003). The ColV plasmid and pTJ100 and their associated VGs are widely 
distributed among APEC isolates in comparison to AFEC (Johnson et al., 2002a; Mellata et al., 2003; 
Rodriguez-Siek et al., 2005a). A number of studies have demonstrated a relationship between the 
possession of these plasmids and the pathogenicity of APEC (Parreira et al., 1998; Pfaff-McDonough 
et al., 2000; Rodriguez-Siek et al., 2005a). It also should be kept in mind that the occurrence of 
plasmid associated VGs are not restricted to plasmids as these genes can also be found in the E. coli 
genome (Rodriguez-Siek et al., 2005a). Previous studies have reported that ColV and ColBM 
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plasmids are significantly associated with the APEC pathotype (Johnson et al., 2007; Rodriguez-Siek 
et al., 2005a).  
Detection of different types of plasmids vary among APEC, with IncFIB being the most common, 
followed by IncI1, IncFIIA, IncP, IncB/O, IncN and IncFIC (Johnson et al., 2007). These plasmids 
are associated with the carriage of certain VGs and ARGs (Carattoli, 2013; Johnson et al., 2010). An 
overlap between the type of plasmid replicon circulating between E. coli isolates sourced from 
humans and birds has also been observed (Fernandez-Alarcon et al., 2011; Johnson et al., 2007). 
1.15.3 Antimicrobials targeting the bacterial cell wall  
1.15.3.1 ß-lactams 
ß-lactams are a broad group of antimicrobials that can be identified by the possession of a  
ß-lactam ring (Li et al., 2007). They are based on penicillin and its derivatives and are used to treat 
both human and animal infections caused by gram-positive and gram-negative bacteria (Matagne et 
al., 1998; Yao and Moellering, 2007). Based on the spectrum of activity and binding affinity, several 
classes of β-lactams have been synthesised including narrow-spectrum penicillins, narrow and 
extended-spectrum cephalosporins and broad-spectrum carbapenems (Bush, 2012). Their broad-
spectrum ability combined with low toxicity in comparison with other antimicrobials makes these 
antimicrobials ideal for human and veterinary medicine (Seiffert et al., 2013). For the majority of 
bacteria, the cell wall requires enzymatic linkage of pentapeptid precursor molecules into the 
peptidoglycan cell wall in order to synthesise. The enzymes responsible for this reaction are known 
as penicillin binding proteins (PBPs) (Hollenbeck and Rice, 2012). The structure of β-lactams is an 
analog of the pentapeptid precursors and therefore, it interferes with bacterial cell wall synthesis in 
the last stage, as it competes with the precursor molecule that is linking with the peptidoglycan for 
the PBP. The bacteria die as a result of impaired cell wall synthesis (Bush, 2012; Hollenbeck and 
Rice, 2012; Sosa, 2009). 
Amoxicillin and ampicillin are the only β-lactams used in poultry in Australia (Australian Pesticides 
and Veterinary Medicines Authority (APVMA), 2015)There are no cephalosporins available for use 
and as discussed in section 1.13, extended-spectrum cephalosporins are not registered for use in 
poultry in Australia (Australian Pesticides and Veterinary Medicines Authority (APVMA), 2015). 
The wide usage of β-lactam antimicrobials in both human and veterinary medicine creates a selection 
pressure (Schwaber et al., 2005) and plays an important role in the development of different resistance 
mechanisms enabling the bacteria to overcome the drug effects (Babic et al., 2006). There are a 
number of different resistance mechanisms associated with β-lactam resistance. The most important 
Page | 70  
 
mechanism associated with β-lactam resistance in gram-negative bacteria such as E. coli, involves 
the inactivation of the antimicrobial by the production of β-lactamase enzymes that are capable of 
hydrolysing and inactivating the ß-lactam ring (Allocati et al., 2013; Bradford, 2001; Bush, 2010; 
Bush, 2012; Li et al., 2007; Seiffert et al., 2013; Sosa, 2009). Resistance may also occur due to 
mutations in the PBPs, decreased outer membrane permeability and multidrug efflux pumps (Babic 
et al., 2006; Bush, 2010; Woodford et al., 2007). β-lactam resistance can develop due to vertical 
transmission of resistance genes from parent to daughter cells or via HGT. 
The β-lactamases are a heterogeneous group of enzymes encoded by genes located on chromosomes 
or plasmids (Bush, 2012; Livermore, 1995; Shah et al., 2004). Identification of the β-lactamase role 
in the penicillin-inactivating mechanism was first reported in 1940, which was a concern for the 
continuous usage of β-lactam antimicrobials (Abraham and Chain, 1988). Resistance to broad-
spectrum penicillins is usually conferred by plasmid-coded ß-lactamases, mainly of the TEM-type 
and to a lesser extent the SHV-type. Any single or multiple mutations in the TEM or SHV enzymes 
will expand their hydrolytic ability to include third- and fourth-generations of β-lactams and 
cephalosporins; these enzymes are referred to as extended-spectrum β-lactamases (ESBLs). 
Currently, more than 600 different ESBLs have been described (Bradford, 2001; Bush, 2010). The 
global distribution of these enzymes among gram-negative bacteria has been linked with MGEs, such 
as plasmids, and have been associated with the dissemination of MDR (Bush, 2012). β-lactamases 
TEM1, TEM2 and SHV1 are the major known members of the ESBLs produced by bacteria and are 
encoded by the genes, blaTEM and blaSHV, that are located on specific plasmids (Bradford, 2001).  
Historically, TEM and SHV type β-lactamases were the most common ESBLs (Ewers et al., 2012). 
Currently, the CTX-M types are replacing TEM and SHV and they are now considered the most 
common ESBLs in E. coli causing significant public health issues (Ewers et al., 2012). High 
prevalence of ESBL-producing E. coli have been detected in livestock in Europe and North America 
(Dahms et al., 2015; Ewers et al., 2012). In addition, ESBL-producing E. coli have been recently 
identified in Australian livestock, bovines and porcines (Abraham et al., 2015).  
AmpC β-lactamases are commonly isolated from extended-spectrum cephalosporin (ESC) resistant 
gram-negative bacteria. They facilitate resistance to most penicillins, cefoxitin, cefotetan, ceftriaxone 
and cefotaxime (Abraham and Chain, 1988; Bush et al., 1995). The majority of AmpC β-lactamases 
are encoded by bla genes that are mainly located on the bacterial chromosome, including blaCMY-2, 
blaACT-1 and blaDHA-1. To a lesser extent, bla genes are found on plasmids (Philippon et al., 2002). 
Currently, the blaCMY genes in E. coli encode the majority of AmpC β-lactamases. There are 99 known 
CMY alleles (Jacoby, 2009; National Center for Biotechnology Information (NCBI); Taneja et al., 
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2012). Globally, CMY-2 producing E. coli are the most common plasmid-mediated cause of 
resistance in livestock (Jacoby, 2009). AmpC β-lactamase producing bacteria often harbour other 
resistance genes resulting in MDR isolates (Chen et al., 2007; Hanson et al., 1999).  
CMY-2-producing E. coli isolates have been identified from faecal samples of healthy chickens in 
Spain (Brinas et al., 2003) and from cats, cattle, chickens, dogs, horses, pigs and turkeys (Borjesson 
et al., 2016; El-Shazly et al., 2017; Jacoby, 2009; Maamar et al., 2016). The blaCMY-2 gene has 
recently been detected in E. coli from Australian livestock (Abraham et al., 2015). Other AmpC β-
lactamases have been isolated from Salmonella spp. in poultry including DHA-1 (Rayamajhi et al., 
2010) and ACC-1 (Dierikx et al., 2010; Hasman et al., 2005). Furthermore, a large number of studies 
demonstrated the widespread occurrence of plasmid-mediated AmpC β-lactamase producing E. coli 
isolates producing a DHA-1 enzyme, which were significantly associated with increased minimum 
inhibitory concentration (MIC) of carbapenems (El-Shazly et al., 2017; Lee et al., 2010; Maamar et 
al., 2016; Pacholewicz et al., 2015; Rasmussen et al., 2015; Rayamajhi et al., 2010; Rayamajhi et al., 
2008; Yan et al., 2006).  
Mutational and/or alterations of the outer membrane permeability and efflux pumps can decrease 
entry and/or increase efflux of antimicrobials including β-lactams, which prevent access of the drug 
to its targets (Li et al., 2007). However, the resistance levels conferred by these mechanisms are low 
and very often they occur in combinations with β-lactamase production (Bush, 2012; Woodford et 
al., 2007).  
Resistance to β-lactams in E. coli is common; and previous studies of Australian E. coli poultry 
isolates have identified resistance to ampicillin (9.4% – 76.6%), potentiated amoxicillin (0% – 3.3%) 
and cephalothin (0% – 19%) (Abraham et al., 2015; Barton and Wilkins, 2001; Department of 
Agriculture, Fisheries and Forestry (DAFF), 2007; Obeng et al., 2012). Resistance genes blaTEM and 
blaSHV have been identified in E. coli isolates from Australian poultry (Obeng et al., 2012). 
1.15.4 Antimicrobials that inhibit protein synthesis  
1.15.4.1 Aminoglycosides 
Aminoglycosides are a group of broad-spectrum antimicrobials that were among the first antibiotics 
discovered. They are primarily active against gram-negative organisms and less active against gram-
positive bacteria (Magnet and Blanchard, 2005). Aminoglycosides are isolated from antibiotic 
producers, such as Streptomyces spp. (Craig et al., 2012). They are a group of drugs characterised by 
the existence of an aminocyclitol ring linked to amino sugars in their structure (Craig et al., 2012). 
The bactericidal effect of this class is based on irreversibly binding to the aminoacyl site of the 16S 
Page | 72  
 
rRNA within the bacterial 30S ribosomal subunits, resulting in mistranslation of the coding protein 
(Armstrong et al., 2012; Wright, 2010).  
Neomycin, apramycin and spectinomycin are the only aminoglycosides permitted for use in broiler 
chickens in Australia. Gentamicin, an aminoglycoside critically important to human medicine, is not 
permitted for use in food-producing animals in Australia, because the drug can sequester in the 
kidneys resulting in residues (Australian Pesticides and Veterinary Medicines Authority (APVMA)) . 
Escherichia coli can acquire several resistance mechanisms that enable them to survive in the 
presence of aminoglycosides. These mechanisms include: (1) enzymes that destroy or reduce 
aminoglycosides activity; (2) target alteration by mutation and methylation of ribosomal proteins and 
(3) reduction of the intracellular concentration of aminoglycosides by modification of outer 
membrane permeability, diminished inner membrane transport or increased export outside the cell by 
active efflux pumps (Craig et al., 2012; Jakobsen et al., 2007; Zarubica et al., 2011).  
Aminoglycoside resistance is widespread in E. coli isolates worldwide (Armstrong et al., 2012). Low 
levels of resistance to aminoglycosides: gentamicin (0% – 3.1%); neomycin (2.1% – 17.2%); 
spectinomycin (8.8% – 27.7%); streptomycin (33.5% – 34%) and apramycin (3.1%) in E. coli from 
poultry have been reported in previous Australian studies (Abraham et al., 2015; Barton and Wilkins, 
2001; Department of Agriculture, Fisheries and Forestry (DAFF), 2007). Obeng et al. (2012) detected 
aph(3’)-Ia and aadA2 genes from aminoglycoside resistant E. coli cultured from chickens from 
Australian chickens. 
1.15.4.2 Tetracycline  
Tetracycline was the first broad-spectrum antibiotic that could inhibit gram-positive and gram-
negative bacteria and protozoa. Tetracyclines are one of the oldest classes of antibiotics with the 
clinical usage of this drug introduced in 1952. This drug class inhibits cell growth by blocking protein 
synthesis (Nelson and Levy, 2011). Tetracyclines normally stop elongation of synthesising proteins, 
by impairing the stable binding of aminoacyl-transfer (t) RNA to the bacterial ribosomal A-site (Craig 
et al., 2012). Currently, based on their availability, low cost, low toxicity and broad-spectrum of 
activity, they are one of the most widely used therapeutic agents and they have been used in human, 
as well as, veterinary medicine (Castillo, 2013; Thaker et al., 2010). Currently, in Australia, 
chlortetracycline and oxytetracycline are first line therapeutic drugs for use in broiler chickens.  
Tetracycline resistance is usually mediated via the acquisition of resistance genes that confer 
resistance by one of three main mechanisms: ATP-dependent efflux; enzymatic inactivation of 
tetracycline; or bacterial ribosomal protection (Roberts, 2012). High tetracycline resistance (39.5% – 
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56.8%) in E. coli isolates sourced from chickens has been documented in Australia (Abraham et al., 
2015; Barton and Wilkins, 2001; Obeng et al., 2012) as well as, globally (Hasan et al., 2011; Saenz 
et al., 2001). Obeng et al. (2012) identified tet(A), tet(B) and tet(C) genes in Australian isolates. This 
finding is not surprising, because tetracycline has been widely used as a therapeutic and feed additive 
to improve feed efficiency in animal production systems since its approval in 1948 (Lwinger et al., 
2016). 
1.15.5 Antimicrobials that affect the synthesis and conformation of nucleic acids  
1.15.5.1 Quinolones 
Quinolones are a by-product of an anti-malarial drug and are known as 4-quinolones carboxylic acids 
and fluoroquinolones (Hernandez et al., 2011). Developed in the 1960s, the first quinolone-derived 
drug, known as nalidixic acid, showed antibacterial activity (Jacoby, 2005; Ruiz, 2003). Since then, 
many quinolone-derived agents have been developed, especially after the addition of a fluorine atom 
to the quinolone molecule (Ruiz et al., 2012). In the late 1980s, enrofloxacin was the first approved 
fluoroquinolone to be used in veterinary medicine (Martineza et al., 2006). The most commonly used 
quinolones in different animal species and poultry overseas are ciprofloxacin, norfloxacin and 
enrofloxacin (Al-Mustafa and Al-Ghamdi, 2000; Gouvêa et al., 2015; Rodriguez-Martinez et al., 
2006; Van Bambeke et al., 2005).  
The quinolones inhibit bacterial growth by interfering with DNA synthesis by binding to the target 
site and forming complexes between DNA and type II topoisomerases, namely DNA gyrase and 
topoisomerase IV (Van Bambeke et al., 2005). This target site is known as the quinolone resistance-
determining region (QRDR). The bacterial enzymes, DNA gyrase (encoded by gyrA and gyrB) and 
DNA topoisomerase IV (encoded by parC and parE) are necessary for DNA synthesis (Shen et al., 
1989). Inactivation of the enzymes due to irreversible attachment of the quinolones to the DNA-
topoisomerase complex can cause a rapid bactericidal effect due to the release of DNA double-strand 
breaks (Cambau and Guillard, 2012; Van Bambeke et al., 2005). 
Quinolones are classified into four generations based on their spectrum of activity (Van Bambeke et 
al., 2005). The first-generation (e.g. nalidixic acid) inhibit only gram-negative bacteria; while the 
second-generation agents, which were the first of the fluoroquinolones (e.g. ciprofloxacin and 
enrofloxacin) exhibit a wider spectrum against gram-negative bacteria, as well as, certain gram-
positive bacteria (Cambau and Guillard, 2012; Rodriguez-Martinez et al., 2006). The third- and 
fourth-generation fluoroquinolones have similar characteristics to the second with increased activity 
against gram-positive bacteria (Cambau and Guillard, 2012; Rodriguez-Martinez et al., 2006). 
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Globally, the usage of fluoroquinolones has been under strict regulation particularly in food-
producing animals because of the potential public health risk (Hernandez et al., 2011; Kools et al., 
2008). In Australia, the fluoroquinolone antimicrobials have never been registered for use in food- 
producing animals (Cheng et al., 2012). 
Quinolone resistance is multifactorial and can develop due to one or a combination of mechanisms 
such as target alteration, reduced uptake and by plasmid-mediated quinolone resistance (PMQR) 
(Hernandez et al., 2011; Jacoby, 2005; Moudgal and Kaatz, 2009). Primarily, fluoroquinolone 
resistance develops in gram-negative bacteria due to chromosomal mutations. The chromosomal 
mutations can result from deletions, substitutions or additions of nucleotide sequence/s in the QRDR.  
Target alteration in type II topoisomerase are usually associated with mutations in the gyrA or parC 
and to a lesser extend to gyrB or parE genes (Cambau and Guillard, 2012). The most common 
mutations reported in E. coli are on the codons 83 (Ser83Leu) and 87 (Asp87His) of GyrA, 
corresponding to the codons 80 and 84 of ParC (Cambau and Guillard, 2012). Increases in quinolone 
resistance may also be associated with alteration to the outer membrane and/or overexpression of 
chromosomally encoded efflux pumps (Schultsz and Geerlings, 2012). Efflux pump mechanisms 
enable the bacteria to pump out quinolones decreasing the susceptibility to quinolones as well as other 
antimicrobial agents (Cambau and Guillard, 2012). Target alterations and efflux are usually found 
together in resistant isolates and cause an increase in quinolone MIC (Jacoby, 2005). 
Plasmid-mediated quinolone resistance encodes for pentapeptide repeat proteins that bind and protect 
DNA gyrase and topoisomerase IV from the inhibitory effects of quinolones (Ruiz et al., 2012). The 
qnrA1 gene was discovered in 1998 (Martinez-Martinez et al., 1998). Since then, many other 
quinolone resistance (qnr) genes have been reported: qnrA; qnrB; qnrS; qnrC and qnrD (Cambau 
and Guillard, 2012; Ruiz et al., 2012). Ten years ago a plasmid-mediated enzymatic inactivation 
mechanism gene, aac(6′)Ib-cr, which could contribute to the development of quinolone resistance, 
was identified (Robicsek et al., 2006b). The aac(6′)Ib-cr gene encodes for a bifunctional 
aminoglycoside 6′-N-acetyltransferase enzyme, which has been associated with resistance to 
kanamycin, as well as, ciprofloxacin in several bacterial species, including E. coli (Cambau and 
Guillard, 2012; Szmolka et al., 2011; Zhao et al., 2015). The PMQR genes, oqxAB and qepA encode 
efflux pumps and result in resistance. All of the PMQR mechanisms result in low levels of resistance, 
but their presence promotes clinical levels of fluoroquinolone resistance to develop and the presence 
of multiple PMQR mechanisms may result in clinical levels of fluoroquinolone resistance without 
chromosomal mutations (Jacoby et al., 2014). 
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Jakobsen et al. (2010) reported variation among E. coli isolates collected from different sources 
(chicken meat vs chicken faecal samples). Higher levels of fluoroquinolone resistance were detected 
in E. coli cultured from imported broiler chicken meat (22%), compared to Danish poultry meat (12%) 
and broiler chicken’s faecal samples (7%). The correlation between the geographical source of 
isolates and resistance detected tends to follow fluoroquinolone usage or selection pressure 
(Chantziaras et al., 2014). After the USA banned the use of fluoroquinolones in food-producing 
animals in 2005, fluoroquinolone resistance in E. coli cultured from poultry decreased from 1% to 
0% (Doyle et al., 2013; Tadesse et al., 2012).  
High ciprofloxacin resistance levels (84% and 91.4%) have been detected in E. coli from chickens in 
China and Brazil, respectively (Lima-Filho et al., 2013; Yang et al., 2004). Lower levels of 
ciprofloxacin resistance have been detected in Iran (7.55%) and Slovakia (29%) in APEC isolates 
(Kmeť and KmeŤová, 2010; Talebiyan et al., 2014). The variation in resistance reflects the difference 
in the antimicrobial usage policy of this drug in food-producing animals among the different countries 
(Kools et al., 2008). China and Brazil use fluoroquinolones for the treatment and prevention of 
infections in chickens (Gouvêa et al., 2015; Yassin et al., 2017). 
In Australia, where fluoroquinolones are not used, resistance to ciprofloxacin (0.4%, 1/269) in AFEC 
from poultry has been reported only once (Department of Agriculture, Fisheries and Forestry (DAFF), 
2007). No ciprofloxacin resistance in E. coli from poultry has been reported in other Australian 
studies (Abraham et al., 2015; Barton and Wilkins, 2001; Obeng et al., 2012). 
1.15.5.2 Sulphonamide and trimethoprim  
The discovery of sulphonamides, which is a broad-spectrum antimicrobial occurred in Germany in 
1932 by Gerhard Domagk and the usage of this antimicrobial in medical practice followed three years 
later (Sköld, 2010). Trimethoprim was first used in 1962 (Eliopoulos and Huovinen, 2001). The mode 
of action of sulphonamides and trimethoprim is based on interfering with the synthesis of 
tetrahydrofolic acid (Sköld, 2010). In 1968 trimethoprim combined with sulphonamides were first 
registered for clinical use. The combined usage of these two drugs exhibits a wide spectrum of activity 
against gram-positive and gram-negative bacteria, as well as, protozoa (Prescott, 2013; Sköld, 2010). 
The majority of bacteria require folate to enable them to produce nucleic acids as they don’t have the 
ability to absorb folate from the environment (Hollenbeck and Rice, 2012). The mechanism of action 
of trimethoprim and sulphonamides is based on inhibiting the bacterial growth by interfering with 
enzyme systems involved in folate synthesis (Eliopoulos and Huovinen, 2001; Sköld, 2010). 
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Trimethoprim sulphonamides are used in the Australian poultry industry (Australian Pesticides and 
Veterinary Medicines Authority (APVMA), 2015). 
Resistance genes to sulphonamides and trimethoprim are normally found on the chromosome, small 
non conjugative plasmids or large multi-resistance plasmids where it is linked to other resistance 
genes (Sosa, 2009). Resistance to trimethoprim and sulphonamides are due to efflux pumps and 
mutations in the target enzymes (Cambau and Guillard, 2012; Eliopoulos and Huovinen, 2001). 
Acquired resistance is due to the acquisition of sul genes for sulphonamides and dfr for trimethoprim, 
genes that encode for alternative dihydropteroate synthase or dihydrofolate reductase. Trimethoprim 
sulphonamide resistance is common in APEC as class 1 integrons are widely disseminated in E. coli 
and almost always include the genes sul1 and dhfr1 (Bass et al., 1999).  
In Australian studies on E. coli from poultry, resistance to trimethoprim sulphonamides (11.9% – 
37.5%) and trimethoprim (36.2% – 46.2%) have been reported (Abraham et al., 2015; Barton and 
Wilkins, 2001; Department of Agriculture, Fisheries and Forestry (DAFF), 2007; Obeng et al., 2012). 
Obeng et al. (2012) identified sul1, sulII, dhfrV and dhfrXIII genes in Australian isolates.  
1.15.5.3 Phenicols 
Florfenicol and chloramphenicol belong to the phenicol family, and are bacteriostatic antimicrobials 
(Lambert, 2012). This class of drug has a broad-spectrum of activity, which includes gram-positive 
and gram-negative bacteria (Schwarz et al., 2004). Chloramphenicol, known previously as 
chloromycetin, was first acquired from Streptomyces venezuelae (Schwarz et al., 2004). Amphenicols 
inhibit bacterial growth by interfering with protein synthesis (Dowling, 2013; Sams, 1994). They 
prevent protein elongation by inhibiting the peptidyl transferase activity at the bacterial ribosome 
(Schwarz et al., 2004; Sosa, 2009).  
Despite the broad-spectrum activity of chloramphenicol, a severe side effect (bone marrow 
depression) identified in the mid-1960s, restricted their use in the treatment of human diseases 
(Lambert, 2012; Schwarz et al., 2004). Historically, chloramphenicol was used in all animals but now 
most countries, including Australia, have prohibited their use in food-producing animals (Australian 
Pesticides and Veterinary Medicines Authority (APVMA); Prescott, 2013; Sams, 1994; Yunis, 1988). 
Florfenicol, a fluorinated synthetic analog of thiamphenicol, is approved for use in veterinary 
medicine, in particular for controlling respiratory tract infections in cattle and pigs (Schwarz and 
Chaslus-Dancla, 2001). Florfenicol can cause a dose dependent bone marrow suppression in animals 
but does not cause idiosyncratic aplastic anaemia in humans (Dowling, 2013). Florfenicol, however, 
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is not used in Australian poultry (Australian Pesticides and Veterinary Medicines Authority 
(APVMA), 2015; Australian Veterinary Association, 2017). 
Multidrug efflux systems and mutations of the target site can contribute to chloramphenicol resistance 
in E. coli (Lambert, 2012; Schwarz et al., 2004). Another important resistance mechanism consists 
of the presence of resistance genes, such as floR gene. These genes are found on plasmids and on the 
chromosome of E. coli from poultry and can cause a combined resistance to chloramphenicol and 
florfenicol (Schwarz et al., 2004). In Australian studies on E. coli from poultry, resistance to 
chloramphenicol (0% – 1.8%) and florfenicol (0% – 3.4%) has been detected (Abraham et al., 2015; 
Department of Agriculture, Fisheries and Forestry (DAFF), 2007; Obeng et al., 2012).  
1.16 Antimicrobial resistance trend in E. coli from poultry 
Escherichia coli have the ability to cause several bacterial infections in both humans and animals and 
are the most prevalent commensal bacteria in the gastrointestinal tract (Johnson and Russo, 2002; 
Mohammad, 2010). They have great genetic flexibility and can acquire several AMR mechanisms. 
This is why E. coli is often used as an indicator organism to evaluate AMR in the environment and 
from diverse host species (Guenther et al., 2011; Stedt et al., 2014). Currently, E. coli is known as an 
important reservoir of resistance genes to critically important antimicrobials in human medicine, 
including ESC, fluoroquinolones, aminoglycosides and trimethoprim sulfamethoxazole (Pitout, 
2012). In a longitudinal survey from 1993 to 2013, an increase in APEC resistance to 14 tested 
antimicrobial drugs in China was observed (Zhang et al., 2017). Similar increases in resistance trends 
in APEC over eight years (2002 to 2010) were reported in the USA (Tadesse et al., 2012). Increases 
in the prevalence of AMR in gram-negative pathogens such as E. coli have also been reported in 
Europe (ECDC, 2012). 
In 2011, the European Antimicrobial Resistance Surveillance Network (EARS-Net) reported a wide 
distribution of resistant E. coli strains in both human and food-producing animals (ECDC, 2012). 
These MDR E. coli isolates demonstrated a significant increase in resistance, with combined 
resistance to third-generation cephalosporins, fluoroquinolones and aminoglycosides (ECDC, 2012). 
de Jong et al. (2012) reported a higher resistance to older generations of antimicrobials in comparison 
to newer drugs (such as cefotaxime and ciprofloxacin) in food-producing animals. A systematic study 
in Germany in 2009 detected AMR in E. coli among isolates obtained from faecal samples of healthy 
food-producing animals (poultry, cattle and pigs) (Kaesbohrer et al., 2012). In summary, the authors 
reported resistance to newer drugs such as fluoroquinolones and third-generation cephalosporins, as 
well as, older generation drugs, such as sulphonamides and tetracycline. The E. coli isolates obtained 
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from 49 broiler chickens demonstrated higher resistance rates to ciprofloxacin in comparison to 
E. coli isolates sourced from cattle and pig production chains (Kaesbohrer et al., 2012).  
Overall, resistance rate to critically important antimicrobials (especially to quinolones) has increased 
in E. coli sourced from food-producing animals worldwide (Giufre et al., 2012; Halova et al., 2014; 
Jiang et al., 2011; Lohren et al.; Wasyl et al., 2013). The emergence of MDR E. coli isolates, in 
particular resistance to critically important antimicrobials for humans, is alarming and highlights the 
need for AMR monitoring systems (Canton et al., 2012; Machado et al., 2008). Future studies are 
needed for every country to identify the prevalence of antimicrobial resistant E. coli isolates from 
food-producing animals and their association with the antimicrobial usage in the veterinary medicine.  
1.17 Public health significance of APEC 
Bacteria (pathogens and commensals) can be transferred directly either via food (e.g. meat and eggs) 
or contact with an animal. Indirect transmission can occur through the release of animal waste into 
the environment (Aidara-Kane, 2012; da Costa et al., 2013; Ewers et al., 2007; Gonzalez-Zorn and 
Escudero, 2012; Graham et al., 2008). Antimicrobial resistance genes and VGs can be transferred 
from bacteria found in animals, to bacteria found in humans, through MGE, such as plasmids or 
transposons (Arias and Carrilho, 2012; da Costa et al., 2013; Johnson et al., 2010; Szmolka and Nagy, 
2013).  
Studies have looked at the direct transfer of bacteria from animals to humans (Alexander et al., 2010; 
Aslam et al., 2009; Wang et al., 2012). In humans, ExPEC is considered to be an important cause of 
neonatal meningitis, septicaemia and urinary tract infections (Belanger et al., 2011). Despite the 
difficulty in identifying the origin of human ExPEC, the genetic overlap reported globally between 
human ExPEC and avian E. coli suggests that APEC may be a zoonotic pathogen (Ewers et al., 2009; 
Mora et al., 2013; Moulin-Schouleur et al., 2007). The ability of APEC to cause disease in rats, in a 
study by Tivendale et al. (2010), shows APEC can cause disease in mammals. A study in Denmark, 
by Jakobsen et al. (2010), found E. coli isolates sourced from human patients, broiler meat and other 
food-producing animals, including pigs, could not be differentiated on the basis of their VGs nor their 
AMR profile. They found resistant isolates clustered in the same phylogenetic group regardless of 
the source of the isolates (Jakobsen et al., 2010). Johnson et al. (2012) reported an association 
between MDR and plasmid content among commensal E. coli (AFEC) and ExPEC obtained from 
humans and poultry.  
Human ExPEC and APEC share common VGs and APEC may act as reservoir vehicle for VGs that 
aid bacteria to cause disease in human (Ewers et al., 2004; Ewers et al., 2007; Mora et al., 2013). 
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Furthermore, STs such as ST10, ST95, ST131, ST117, ST746 and ST23 have been found to be 
common between ExPEC, APEC and clonally related isolates from humans, poultry and poultry 
products. This strengthens the hypothesis that chickens can act as a reservoir for ExPEC infection in 
humans (Adiri et al., 2003; Danzeisen et al., 2013; Ewers et al., 2007; Johnson et al., 2008c; Johnson 
et al., 2007; Kohler and Dobrindt, 2011; Rodriguez-Siek et al., 2005a; Tivendale et al., 2010).  
The direct food chain is also believed to be a major contributor to the emergence and persistence of 
AMR in pathogenic, as well as, commensal bacteria (Kluytmans et al., 2013; Liu et al., 2012; Vieira 
et al., 2011). Several studies have identified the presence of resistant bacterial strains and resistance 
genes from food animals at all stages of processing (Abdallah et al., 2015; Acar et al., 2012; Marshall 
and Levy, 2011). The presence of these antimicrobial resistant bacteria within animal products may 
be due to multi factorial contamination at different stages of food production and provides indirect 
evidence of transmission of these resistance genes during food handling and/or consumption. 
Contamination can happen via faecal splash during slaughter, during food processing or at the final 
stage when the consumer handles the food (Alexander et al., 2010; Verraes et al., 2013).  
The emergence of AMR among bacteria of food-producing animals is of public health concern as 
humans and animals use the same classes of antimicrobials for therapy and AMR mechanisms are the 
same for human and animal pathogens (Cogliani et al., 2011). 
Furthermore, the use of antimicrobials for treatment, as well as, prevention can cause a selective 
pressure, which contributes to the spread of resistance across different bacteria, including 
commensals. A positive association has been found between an increase in antimicrobial usage in 
veterinary medicine and the increasing prevalence of antimicrobial resistant bacteria detected in food-
producing animals and food products (Altalhi et al., 2010; Borjesson et al., 2013; Castellanos et al., 
2017; da Costa et al., 2010; Hammerum et al., 2012; Hasan et al., 2011; Hordijk et al., 2013; Jiang 
et al., 2011; Nilsson et al., 2014; Ojer-Usoz et al., 2013). 
The poultry industry uses antimicrobials that are classified as highly important or critically important 
for human medicine by the World Health Organisation, such as tetracycline (chlortetracycline). This 
potentially provides selective pressure for the maintenance of, or emergence of resistant strains of 
bacteria in humans. Globally, AMR to critically important antimicrobial drugs has become a public 
health concern particularly with the global increase in the prevalence of ESC resistant E. coli and the 
mortality associated with it (FAO/WHO/OIE, 2008). 
In the Netherlands, the association and distribution of ESBL genes, plasmids and strain genotypes 
among E. coli isolates obtained from human patients, poultry and poultry meat was evaluated. The 
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authors reported similarities between all of these, which suggests that retail chicken meat and poultry 
could be a possible source of the ESBL genes in E. coli that have transferred from animals to humans 
or vice versa (Leverstein-van Hall et al., 2011).  
1.18 Antimicrobial resistance in E. coli and its association with VGs  
The significant role of MGE in the transmission of AMR genes makes studies about plasmids the 
core of the majority of the AMR epidemiological studies. However, the transmission role of MGEs 
is not limited to ARGs, but also to VGs, as they can be found on the same plasmids (Da Silva and 
Mendonca, 2012). 
Recent studies have reported the correlation between resistance to certain antimicrobials (cefoxitin, 
gentamicin, kanamycin, streptomycin, tetracycline and ceftiofur) and APEC-associated VGs (astA, 
iucD, cvaC, iss, iutA and traT) in avian-sourced E. coli (Lynne et al., 2012; Wang et al., 2010). 
Despite the evidence that there is an association between virulence and AMR, the interplay between 
them is still controversial and needs further study to reveal the genetic mechanisms regulating this 
interplay in order to improve infectious disease management. 
1.19 Summary 
The present review found that there is not enough information available to define and differentiate 
between APEC and commensal E. coli. The majority of the studies included in the current review 
were from overseas and there is limited information published on the prevalence of VGs and their 
association with APEC in Australia. The APEC prevalence and its associated risk factors especially 
the ones related to the bird’s surrounding environment are unknown in the Australian context. The 
literature review also highlights the need for further studies on the epidemiology and association of 
AMR, virulence genes and phylogenetic groups to identify risk factors associated with human health.
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2 Chapter 2: Research and project outline 
 
2.1 Knowledge gaps and rationale for the project 
Avian colibacillosis is considered one of the most common diseases affecting the global poultry 
industry (Guabiraba and Schouler, 2015; Nolan et al., 2013). The disease results in substantial 
economic losses due to impacts on productivity, reductions in the marketability of poultry and poultry 
products, high mortality, morbidity and the costs associated with prevention and treatment (Cavero 
et al., 2009; Jakob et al., 1998; Nolan et al., 2013). Avian pathogenic Escherichia coli (APEC), the 
causative agent of avian colibacillosis, is a subgroup of extraintestinal pathogenic E. coli (ExPEC), 
which is capable of causing diseases outside the gastrointestinal tract in poultry and humans (Johnson 
and Russo, 2002; Mellata, 2013; Russo and Johnson, 2009). Biosecurity, management, as well as the 
administration of antimicrobial agents (potentiated sulphonamides, penicillin, tetracycline, colistin, 
spectinomycin, aminoglycosides and fluoroquinolones) are currently considered the most effective 
measures to treat and control avian colibacillosis (Boerlin and White, 2013; Guardabassi and Kruse, 
2008; Nolan et al., 2013). The long-term usage of antimicrobials has contributed to an increase in 
resistance among APEC to older generation, as well as newer antimicrobials, threatening public 
health, as well as compromising poultry health and welfare (Barros et al., 2012; Pitout, 2012). 
Several studies have aimed to identify APEC isolates and differentiate them from avian faecal E. coli 
(AFEC) isolates based on phylogenetic grouping, virulence genotyping, plasmid profiling, 
serotyping, sequence typing, genotyping, enterobacterial repetitive intergenic consensus (ERIC) PCR 
and/or pulsed-field gel electrophoresis (PFGE) and/or whole genome sequencing (Cordoni et al., 
2016; Johnson et al., 2008b; Landman et al., 2014; Lynne et al., 2012; Rodriguez-Siek et al., 2005a; 
Won et al., 2009). The current diagnosis of avian colibacillosis is based on clinical signs, macroscopic 
lesions and the isolation of E. coli from the lesions using traditional culture methods (Guabiraba and 
Schouler, 2015; Kabir, 2010). However, culture methods are labour intensive and time consuming in 
comparison to molecular methods (Baron, 2011; Garofalo et al., 2007; Lleo et al., 2005) and without 
further virulence characterisation, simple isolation of E. coli from diagnostic samples does not 
specifically identify APEC. 
The direct application of molecular techniques to faecal samples to identify APEC may be limited by 
the ability to extract sufficient DNA of a PCR quality that is free from PCR inhibitors (Abu Al-Soud 
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and Radstrom, 1998; Johnson et al., 2008b; McOrist et al., 2002). Several extraction methods 
(physical, mechanical and chemical) have been used to extract the DNA from faeces from many 
animal species and there are specifically designed commercial kits available (McOrist et al., 2002; 
Yu and Morrison, 2004). However, there is a lack of information pertaining to the quality and quantity 
of extracted DNA from chicken faecal samples using these different methods (Barnard et al., 2011). 
Due to the nature of poultry faeces (i.e. combined faecal and urinary wastes), it is not necessarily 
appropriate to extrapolate methods and results from other species. In addition, no data is available 
comparing the screening of virulence genes (VGs) in poultry faeces compared to isolation of E. coli 
from birds and screening for VGs in the cultured isolates.  
The literature review undertaken in Chapter 1 shows that up-to-date knowledge regarding the 
molecular, and indeed the general epidemiology of APEC in poultry in Australia, is very limited. 
There is also no clear definition of APEC based on specific VG patterns or phylogenetic 
classification, nor any clear knowledge of the association between VGs and phylogenetic groups. The 
major predisposing risk factors associated with APEC infections are not well understood (Kemmett 
et al., 2013; Nolan et al., 2013). Additionally, very little knowledge is available regarding 
antimicrobial resistance (AMR) profiles, as well as plasmid replicon presence in either APEC and/or 
AFEC in Australia.  
In the current research, all of the E. coli isolates will be firstly categorised based on the bird’s health 
status and independently from the VG profiles into faecal E. coli (FEC) and clinical E. coli (CEC). 
FEC are isolates cultured from the faeces of healthy birds (which are defined as birds that are 
apparently free from any clinical disease symptoms) and CEC are cultured from the faeces or organs 
of birds with colibacillosis (which are defined based on the clinical signs and the detection of E. coli 
from the affected lesions). At the molecular level, E. coli isolates sourced from anywhere (except 
from lesions of colibacillosis) that harbour four or more of the APEC VG markers ( iroN, iutA, iss, 
hlyF and ompT) will be defined as an avian pathogenic E. coli (APEC). Therefore, FEC isolates will 
be molecularly classified into APEC or AFEC, dependant on whether they harbour four or more or 
less than four of the selected APEC VGs. CEC isolates cultured from lesions, which harbour four or 
more of the five APEC-associated VGs, will be defined as clinical avian pathogenic E. coli (cAPEC). 
Clinical E. coli, which contain less than four of the selected VGs are identified as potential APEC 
(pAPEC). The VGs were selected because they have previously been identified as successful marker 
genes for APEC identification (Johnson et al., 2008b).  
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Figure 2.1: Illustration flow chart for the classification applied to all of the E. coli isolates 
included in the current study. 
1 The selected VGs are: iss; iutA; iroN; ompT and hlyF. 
 
2.2 Aims and objectives 
2.2.1 Overall thesis aim 
To investigate avian pathogenic E. coli in Australian broiler flocks, explore antimicrobial 
susceptibility and molecular epidemiology to improve the identification of this pathotype. 
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2.3 Thesis hypotheses 
2.3.1 Primary hypothesis 
Avian pathogenic E. coli can be defined and differentiated from avian faecal E. coli based on a 
specific set of avian pathogenic E. coli associated virulence genes, phylogenetic group and plasmid 
replicons. 
2.3.2 Secondary hypothesis 
There is a difference in the antimicrobial susceptibility profile between clinical E. coli and faecal  
E. coli and certain plasmid replicons are associated with specific antimicrobial resistance profiles. 
2.3.3 Risk factor hypothesis 
Specific management procedures are associated with an increased risk of avian colibacillosis and 
avian pathogenic E. coli prevalence on commercial broiler chicken farms in South East Queensland, 
Australia. 
2.4 Specific aims, objectives and methodological approaches 
2.4.1 Aim 1 (Chapter 3): To compare direct DNA extraction methods from faecal samples and 
to estimate the prevalence of avian pathogenic E. coli between healthy birds and birds with 
colibacillosis.  
2.4.1.1 Objective 1: To compare and evaluate the relative efficiency and effectiveness of three 
different published approaches for DNA extraction methods from faecal/cloacal swabs and/or 
faeces of broiler chickens. 
2.4.1.2 Methodological approach:  
Three different published methods for DNA extraction (a) QIAamp DNA Stool Mini Kit, b) repeated 
bead beating plus column methods (RBB+C) and c) Chelex methods will be evaluated in triplicate to 
detect the most effective and practical method to extract high quality and quantity DNA from the 
cloacal and faecal swabs of broiler chickens. The efficiency of DNA extraction will be assessed by 
determining the level of DNA yield, the purity of DNA and the presence of impurities, either from 
the faeces or the extraction process. 
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2.4.1.3 Objective 2: To investigate the assertion that in healthy chickens E. coli is present in the 
cloacal and intestinal swabs (i.e. intestinal tract) and no other internal organs. To identify if the 
five APEC related VGs are positively associated with birds affected with colibacillosis and 
validate their selection as an APEC marker in this research. 
2.4.1.4 Methodological approach:  
Isolates for this study will be obtained from apparently healthy chickens and chickens with 
colibacillosis. From each chicken, swabs will be cultured from sites expected to be sterile (heart, 
liver, spleen, air sac and lung) and the cloaca/intestine. The E. coli isolates will be screened by PCR 
for the presence of five APEC-associated VGs and a statistical comparison will be done on the 
prevalence of the VGs in healthy birds versus birds with colibacillosis. 
2.4.2 Aim 2 (Chapter 4): To estimate the farm-level prevalence of avian pathogenic  
E. coli in clinically healthy chickens from commercial broiler farms in South East Queensland 
(SEQ), Australia and to identify farm-level risk factors associated with avian pathogenic E. coli 
prevalence. 
2.4.2.1 Objective 1: To estimate the farm-level prevalence of APEC related VGs in intestinal  
E. coli from healthy broiler chickens in SEQ, Australia.  
2.4.2.2 Methodological approach:  
Isolates for this study will be obtained from cloacal swabs of clinically healthy chickens at one 
abattoir located in SEQ, Australia. Four hundred cloacal swabs will be collected from chickens from 
40 poultry farms. Swabs will be cultured and five to ten E. coli colonies per chicken will be selected 
and screened by PCR for the five APEC-associated VGs. 
2.4.2.2.1 Objective 2: To identify the farm-level risk factors associated with the prevalence 
of APEC among the intestinal E. coli isolates. 
2.4.2.3 Methodological approach:  
Information on potential farm-level risk factors (farm management practices, biosecurity measures, 
vaccination protocols and chicken health) associated with the prevalence of APEC will be obtained 
through questionnaires and interviews from farms that had supplied birds for slaughter. Binominal 
general linear models will be used to identify the farm-level risk factors associated with APEC 
prevalence among the intestinal E. coli sourced from broiler chicken farms in SEQ.  
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2.4.3 Aim 3 (Chapter 5): To determine the antimicrobial resistance profile prevalence and 
their association with phylogenetic group, avian pathogenic E. coli related virulence genes and 
plasmid replicon profiles among clinical and faecal E. coli isolates sourced from Australian 
commercial broiler chickens.  
2.4.3.1 Objective 1: To determine, compare and identify the association between antimicrobial 
susceptibility, phylogenetic group and plasmid replicon profiles of 50 clinical E. coli (CEC) and 
187 faecal E. coli (FEC) cultured from Australian commercial broiler chickens. 
2.4.3.2 Methodological approach:  
Fifty CEC and 187 FEC will be collected from chickens with colibacillosis and healthy chickens, 
respectively. All of the E. coli isolates will be subjected to disc diffusion antimicrobial susceptibility 
testing (20 antimicrobials), phylogenetic grouping, plasmid replicon typing and VG PCR screening 
for iroN, iutA, iss, hlyF and ompT.  
2.4.3.3 Objective 2: To characterise the extended-spectrum cephalosporin (ESC) and/or 
fluoroquinolone (FQ) resistant isolates. 
2.4.3.4 Methodological approach: 
Isolates resistant to ESCs and/or FQs will undergo minimum inhibitory concentration testing (MIC), 
multilocus sequence typing (MLST) and screening for plasmid-mediated ARGs. The quinolone 
resistance-determining region (QRDR) of FQ resistant isolates will be sequenced and FQ resistant 
isolates will also be screened for the presence of an efflux pump using Phe-Arg-β-naphthylamide. 
2.4.4 Aim 4 (Chapter 6): To determine the prevalence of 35 extraintestinal pathogenic E. coli 
related virulence genes in E. coli circulating in commercial broiler chicken flocks in South East 
Queensland, Australia and relate these to defining features of the pathotype to derive an 
improved genetic definition for avian pathogenic E. coli.  
2.4.4.1 Objective 1: To determine the clonal relatedness between 237 E. coli isolates sourced 
from healthy chickens and chickens with colibacillosis.  
2.4.4.2 Methodological approach:  
An ERIC-PCR will be performed on the 50 CEC and 187 FEC isolates to identify clonal relationships 
in the isolates that have been previously characterised (Chapter 5).  
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2.4.4.3 Objective 2: To determine the association between ExPEC-associated VGs and avian 
colibacillosis.  
2.4.4.4 Methodological approach:  
A subset of isolates that display resistance to the most antimicrobials and represent a different ERIC 
cluster will be selected for further virulence profiling and will be screened for an additional 30 
extraintestinal pathogenic E. coli related VGs. 
2.5 Thesis overview 
Chapter 1 reviews the following: literature on avian colibacillosis and its effects on the poultry 
industry; APEC (the causative agent); diagnosis and treatment of the disease including antimicrobials 
(and their mechanism of action and resistance mechanisms); VGs associated with APEC; risk factors 
associated with APEC and the zoonotic potential of APEC. Chapter 2 summarises the overall thesis 
aims, hypothesis and objectives. Chapter 3 compares and evaluates three different published methods 
for DNA extraction from cloacal swabs and faecal samples from healthy and unhealthy broiler 
chickens to identify the most practical and effective methods to extract adequate amounts of PCR 
quality DNA. Chapter 4 identifies the prevalence of APEC among E. coli cultured from the faeces of 
clinically healthy chickens and the risk factors associated with the carriage of APEC on commercial 
broiler chicken farms in SEQ, Australia. Chapter 5 characterises the antimicrobial profile pattern and 
determines the phylogenetic groups, virulence and plasmid replicon profiles of 50 CEC and 187 FEC 
isolates cultured from Australian commercial broiler chickens. The presence of AmpC and extended-
spectrum β-lactamases and/or FQ resistance genes is examined. Furthermore, the presence/absence 
of the most common and important plasmids from an animal or public health perspective is 
determined. Finally, the phylogenetic groups, genotypes, AMR patterns, VGs and plasmid replicon 
profiles of avian clinical and faecal E. coli isolates cultured from Australian commercial broiler 
chickens are compared. Chapter 6 examines the prevalence of 35 ExPEC related VGs among E. coli 
isolates sourced from the cloacal swabs of healthy chickens and chickens with colibacillosis. Chapter 
7 summarises all of the concepts and major findings that were identified in chapters 3 to 6, provides 
a general discussion, summarises the major findings, their implications and progresses to general 
conclusions and provides suggestions for future work. 
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2.6 Anticipated deliverables and practical outcomes 
Achieving the overall thesis aim would benefit Australia and other parts of the world, which are 
geographically similar to Australia. Due to the global variation in APEC the outcome of our studies 
might be most specific to the Australian context; however, these findings do add to the global 
knowledge of variance between APEC and risk factors associated with colibacillosis and can further 
be used to explore the epidemiology of APEC strains. The results obtained by the current study should 
help to improve the identification of APEC by providing a set of VGs that can be used as a marker 
for the early detection of the presence of APEC on commercial broiler chicken farms in SEQ, 
Australia. The selection of VGs will allow veterinary diagnostic laboratories to identify APEC. The 
current thesis explores the possibilities of identifying APEC directly from faecal samples by 
determining the best extraction methods that can be applied to chicken faeces to obtain PCR quality 
DNA. The DNA extraction methods that will be recommended by the current thesis can be used to 
detect other resistance and/or VGs and pathogens. The early detection of APEC directly from faecal 
samples can reduce the economic losses associated with avian colibacillosis, positively impacting the 
health and welfare of commercial broiler chickens.  
Determining the farm-level prevalence of the intestinal/cloacal carriage of APEC in Australian broiler 
flocks is one of the outcomes, which should be obtained by the current thesis, and will lead to better 
recognition of sub-clinical carriage and transition to pathogenicity. Furthermore, the possible 
associations between potential management risk factors and the farm-level prevalence of carriage of 
APEC among healthy commercial broiler chicken flocks in SEQ will be investigated and will inform 
on how to improve control and prevention strategies for avian colibacillosis. The findings of the 
current thesis should also provide more knowledge of the antimicrobial susceptibility of APEC to 
guide veterinarians in developing successful prevention and treatment schemes in Australia.   
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3 Chapter 3: An optimised protocol for molecular screening 
of avian pathogenic Escherichia coli from broiler chickens 
in South East Queensland, Australia. 
 
3.1 Foreword 
Currently, the diagnosis of avian colibacillosis is based on clinical signs, post-mortem examination 
and the detection of Escherichia coli in the lesion(s), which is time consuming, as well as labour 
intensive. Establishing a methodology to allow the direct detection of avian pathogenic E. coli 
(APEC) from faecal samples of birds without the requirement for culture of isolates would allow a 
more rapid diagnostic process to detect the causative agent of avian colibacillosis, an economically 
important poultry disease.  
However, the ability to extract sufficient PCR quality DNA has proved problematic, specifically for 
bird faecal samples, due to the presence of large amounts of PCR inhibitors. The current chapter 
compares three published methods for extracting DNA directly from the faecal and cloacal samples 
of broiler chickens, aiming to detect the most effective and practical method(s) to extract high 
quantity and quality DNA and determine if APEC can be detected directly from faeces.  
Faecal samples and E. coli isolates were obtained from apparently healthy chickens and chickens with 
colibacillosis. The DNA extracted from faecal samples and E. coli isolates were screened with a 
pentaplex-PCR for the detection of five APEC-associated virulence genes (VGs): (haemolysin gene 
(hlyF); increased serum survival gene (iss); outer membrane protease gene (ompT) and two iron 
acquisition system genes (iutA and iroN)). The objectives to confirm that in healthy chickens E. coli 
is present only in the intestinal tract and to validate the pentaplex-PCR for Australian APEC isolates 
by showing that E. coli cultured from the cloaca of healthy chickens have less VGs compared to   
E. coli cultured from chickens with colibacillosis. 
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3.2 Abstract 
Avian pathogenic Escherichia coli (APEC) is the causative agent of avian colibacillosis and causes 
localised and/or systemic infections in poultry. The presence of various virulence genes (VGs) may 
be a useful marker for the detection of APEC directly from faecal samples. The objectives of this 
study were to evaluate and compare three different DNA extraction methods from cloacal swabs and 
faecal samples of broiler chickens and determine if APEC can be detected directly from faeces. The 
DNA extraction methods were assessed by measuring DNA yield and purity; absence of DNA 
shearing, 16S ribosomal DNA amplification and reproducibility. Repeated bead beating plus column 
(RBB+C) was the preferred extraction method, as it yielded an adequate amount of quality DNA for 
PCR directly from faeces. The DNA extracted from faces, with RBB+C method, and DNA extracted 
from E. coli isolates, of organs and faeces, taken from 23 broiler chickens (10 healthy, 9 with 
colibacillosis and 4 unhealthy with other infections) were screened with a pentaplex-PCR for the 
prevalence of APEC-associated VGs: iroN; ompT; iutA; iss and hlyF. There was a statistically 
significant correlation between the presence of the five VGs in E. coli cultured from the cloaca, faecal 
and organs samples and colibacillosis. However, screening extracted DNA from the faeces for the 
selected VGs was not an effective diagnostic tool to detect APEC as all of the VGs were detected in 
the extracted faecal DNA from all chickens. 
3.3 Introduction 
Avian colibacillosis causes multimillion-dollar annual losses for the poultry industry worldwide 
(Ewers et al., 2004; Hussein et al., 2013; Johnson et al., 2008b; Nolan et al., 2013). Production losses 
are associated with decreased productivity, high mortality and morbidity and are in addition to the 
costs associated with treatment and prevention on-farm and abattoir carcass condemnations (Ewers 
et al., 2004; Kabir, 2010; Nolan et al., 2013). Avian pathogenic Escherichia coli (APEC), a subgroup 
of extraintestinal pathogenic E. coli (ExPEC), is the causative agent of avian colibacillosis. Although 
a number of studies have aimed to identify the virulence mechanisms of APEC, it remains an ill-
defined pathotype (Nolan et al., 2013; Rodriguez-Siek et al., 2005a). Healthy chickens and their 
surrounding farm environment can be colonised by APEC without the chickens displaying any signs 
of disease (Antão et al., 2008). Recent studies have suggested that the presence of various virulence 
genes (VGs) were useful markers for the detection of APEC and can differentiate between APEC and 
avian faecal E. coli (AFEC) (Circella et al., 2012; Ewers et al., 2005; Johnson et al., 2008b; 
Rodriguez-Siek et al., 2005a). Johnson et al. (2008b) developed a PCR targeting five VGs: 
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haemolysin gene (hlyF); increased serum survival gene (iss); outer membrane protease gene (ompT) 
and two iron acquisition system genes (iutA and iroN), which could be used as a diagnostic tool for 
the identification of APEC. 
Diagnosis of avian colibacillosis is traditionally based on clinical signs, macroscopic lesions and the 
isolation of E. coli from lesions. Culture methods are considered to be the gold-standard for isolation 
and identification of E. coli (Kabir, 2010). However, culture methods are labour intensive, expensive 
and time consuming in comparison to molecular methods (Blessmann et al., 2002; Garofalo et al., 
2007). The direct application of molecular techniques to identify APEC from faecal samples may be 
limited by the ability to extract a high quality and quantity DNA that is free from PCR inhibitors, 
such as bile salts, haemoglobin, degradation products and complex polysaccharides (Abu Al-Soud 
and Radstrom, 1998; McOrist et al., 2002). There are several methods (physical, mechanical and 
chemical), as well as specifically designed commercial kits (McOrist et al., 2002; Yu and Morrison, 
2004) used to extract DNA from faeces. However, the complex matrix of faecal samples make it a 
challenging job to choose the most suitable extraction protocol as some methods, such as the cell lysis 
by boiling method, are incapable of removing faecal inhibitors (Rapp, 2010; Wilson, 1997). 
Furthermore, there is a lack of information pertaining to the quality and quantity of extracted DNA 
from chicken faecal samples using these different methods (Barnard et al., 2011). 
The aims of this study were to: (i) compare and evaluate three different published methods for DNA 
extraction from cloacal swabs and faecal samples from broiler chickens (selection of these methods 
was based on their popularity of use by the veterinary laboratory and/or the poultry industry and ease 
of use); (ii) identify chickens with colibacillosis by sampling the cloaca and organs and screening 
cultured E. coli for the presence of five APEC-associated VGs to determine if E. coli cultured from 
the cloaca of healthy chickens have less VGs compared to E. coli cultured from chickens clinically 
affected with colibacillosis; (iii) confirm that clinically healthy chickens do not harbour E. coli in 
their organs and (iv) determine if direct application of molecular techniques to faecal samples could 
identify APEC.  
3.4 Materials and methods 
3.4.1 Samples collection 
Twenty chickens were collected from three different commercial broiler chicken farms located in 
South East Queensland (SEQ) between June and July 2013 (Animal ethics approval number: QAAFI 
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/478/12/ POULTRY CRC). The minimum sample size for the pilot study required to detect the 
difference between probabilities of 0.10 and 0.70 at a two-side significance level of 0.05 and a power 
of 0.90, requires a replication of 12 for each sample and in order to detect the difference between 
probabilities 0.10 and 0.80, at a two sided significance level 0.05 and a power of 0.90 requires a 
replication of 9 for each sample. The farm managers selected nine chickens that appeared to be 
unhealthy (showing clinical signs of weakness, respiratory distress and ruffled feathers (4 from farm 
A, 3 from farm B and 2 from farm C) and 11 apparently healthy chickens (4 from farm A, 3 from 
farm B and 4 from farm C). Additionally, three unhealthy chickens from farm C were collected as 
part of their daily culling protocol. The age of the chickens ranged between 28 and 48 days. Post-
mortem examination and specimen collection were performed on the farms on a total of 23 chickens. 
A numeric lesion scoring classification scheme representing the severity of each macroscopic gross 
lesion attributed to E. coli was assigned to five organs: heart; liver; spleen; air sac and lung (Antão et 
al., 2008; Ginns et al., 1998) according to the following scale: 0 = no lesions; 1 = small amount of 
fibrin on a single small pin size lesion; 2 = small amount of fibrin on two small pin sized lesions; 3 = 
thin layer of fibrinous exudate covering the organ; 4 = severe, thick and extensive layer of fibrinous 
exudate covering the organ. Chickens with lesions in the lung and/or air sac were considered to have 
a respiratory tract infection and chickens with lesions in the liver and/or spleen and/or heart were 
considered to have a systemic infection. Liver, lung, heart and spleen tissues were collected from 
each chicken and fixed in an excess of 10% neutral buffered formalin for histopathological 
processing. From each chicken, nine samples were collected with Amies transport swabs (Sarstedt 
Australia Pty. Ltd., Technology Park, South Australia, Australia), one from each of the five organs 
listed previously and four replicate samples from the cloaca (one to be used for E. coli culture and 
three for DNA extraction). Fresh faecal samples were also collected from the cloaca or the end of the 
large intestine into a sterile container if the cloaca was empty. The swabs and faecal samples were 
transported on ice to the laboratory for processing within three hours of collection. 
3.4.2 Processing of samples 
3.4.2.1 Histological examination 
Tissues samples were processed from one healthy and five unhealthy chickens overall,  representing 
various health and disease statuses. Each sampled organ underwent routine paraffin-embedding and 
sectioning (4 μm thickness). Tissues were stained with haematoxylin and eosin while Period Acid 
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Schiff stains were used for fungi (Gridley, 1957). A board-certified veterinary pathologist reviewed 
histopathology. 
3.4.2.2 Bacterial culture of samples identification and DNA extraction 
In order to identify all the bacterial growths all the organ swabs were cultured on 5% sheep blood 
agar (SBA; Oxoid, Thebarton, South Australia, Australia), MacConkey agar (MCA; Oxoid), 
chocolate agar (Oxoid), xylose-lysine deoxycholate agar (Oxoid) and brilliant green agar (Oxoid). 
The plates were incubated aerobically overnight at 37 °C. An additional SBA plate for each sample 
was incubated anaerobically using the AnaeroGen system (Oxoid) overnight at 37 °C. In addition, 
the liver swabs were cultured on campylobacter blood-free agar (Oxoid) and incubated under 
microaerophilic conditions using the CampyGen system (Oxoid) for 48 h at 37 °C. Isolates were 
single colony picked onto an appropriate agar, incubated under appropriate conditions and then 
identified using routine veterinary phenotypic diagnostic methods such as Gram stain reaction, 
morphology and biochemical tests e.g. Microbact 24E (Thermo Fisher Scientific Australia Pty Ltd, 
Brendale, Queensland, Australia) or API® Staph (bioMerieux, Baulkham Hills, New South Wales, 
Australia). One cloacal swab from each chicken was cultured onto MCA and incubated aerobically 
at 37 °C overnight. From each MCA plate, three colonies showing the typical colony morphology of 
E. coli were selected and subcultured onto SBA and incubated aerobically at 37 °C overnight. Isolates 
(from organs and cloacal swab), which were indole positive and pyrrolidonyl arylamidase negative, 
were identified as suspected E. coli and DNA was extracted (Abraham et al., 2012). An E. coli 
specific PCR targeting the uspA gene (Chen and Griffiths, 1998) was performed to confirm 
identification. All E. coli isolates were stored at -80 °C in brain heart infusion (BHI) broth (Oxoid) 
containing 20% glycerol (Promega, Corporate Park, Sydney, Australia) until further analysis. The 
extracted DNA (100 µl) was stored at -20 °C for further analysis.  
3.4.2.3 DNA extraction from the cloacal and faecal samples 
On arrival at the laboratory, each faecal sample was vortexed by adding 1 mL RNA/DNA free water 
and then six swabs were taken from this homogenate. Three cloacal swabs and the six faecal swabs 
from each chicken were stored at 4 °C for DNA extraction the next day. All samples were processed 
within 24 hours of collection. Three different extraction methods were evaluated: 1) QIAamp DNA 
Stool Mini Kit (Qiagen Pty Ltd, Chadstone, Victoria, Australia); 2) the Chelex DNA extraction 
protocol and 3) the repeated bead beating plus column (RBB+C) as described below. To test 
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reproducibility each method was performed using two faecal swabs from each chicken for each DNA 
extraction method. All extracted DNA was stored at -20 °C for further analysis. 
3.4.2.3.1 Method one (QIAamp DNA Stool Mini Kit) 
The QIAamp DNA Stool Mini Kit was used according to the manufacturer’s protocol with a minor 
modification; the DNA was eluted with 50 µl of AE buffer instead of 200 µl.  
3.4.2.3.2 Method two (Chelex DNA extraction protocol) 
Each sample was suspended in 5.0 mL phosphate-buffered saline (pH 7.2) and centrifuged at 100 x 
g for 15 min at 4 °C in order to remove the faecal pellets. The DNA was extracted from each sample 
using a modified Chelex method (Yang et al., 2008). Briefly, the pellet was suspended in 1.5 mL 
acetone (Sigma-Aldrich, Castle Hill, New South Wales, Australia) and then centrifuged at 13,000 x 
g for 10 min in order to remove any potential PCR inhibitors. The supernatant was discarded and the 
pellet dissolved in 200 μL of Chelex-100 (6%) (Sigma-Aldrich) and 0.2 mg protease K (Sigma-
Aldrich). The mixture was heated at 56 °C for 30 min, vortexed for 1 min and centrifuged at 10,000 
x g for 5 min. Supernatant (100 μL) was stored. 
3.4.2.3.3 Method three (repeated bead beating plus column (RBB+C) 
The RBB+C method was performed as previously described (Yu and Morrison, 2004) with two minor 
modifications. In this study, the DNA pellets were dried in a biosafety cabinet after washing with 
70% ethanol and the DNA was eluted with 50 µl of AE buffer instead of 200 µl as previously 
described. 
3.4.2.3.4 Assessment of DNA extraction 
DNA extraction was assessed on the basis of the following criteria: 1) DNA yields; 2) DNA purity 
and 3) the presence of low-level PCR inhibitors (based on the 16S rDNA PCR amplification results). 
In addition, the shearing of the DNA and the reproducibility of each method was examined. The 
quantity (referred to as yield) and quality (referred to as purity) of the extracted DNA was assessed 
using the Nano Drop ND-1000 Spectrophotometer (Thermo Fisher Scientific Australia Pty Ltd, 
Scoresby Victoria, Australia). The yield of the extracted DNA was calculated by the amount of light 
absorbed by 1 µl of the DNA at 260 nm (Desloire et al., 2006) and the purity of DNA was determined 
by calculating the A260/A280 ratio. DNA was defined as pure if the 260/280 absorbance ratio ranged 
between 1.8 and 2.0. The shearing of the extracted DNA obtained from the three different methods 
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was evaluated by running 5 µl of extracted DNA on 1% agarose gel in 1% sodium borate buffer (SB) 
(Sigma-Aldrich) at 80 volts (V) for 30 min. The DNA fragment size was evaluated using λ DNA cut 
with HindIII as a DNA marker (Life Technologies Australia, Mulgrave, Victoria, Australia), stained 
with SYBR Safe (Invitrogen Australia Pty Limited, Mount Waverley, Victoria, Australia) and 
visualised using the GelDoc System (Bio-Rad Laboratories, Gladesville, New South Wales, 
Australia). The ability to detect the bacterial 16S rDNA from the extracted DNA, which reflects the 
presence or absence of PCR inhibitors in the extracted DNA, was evaluated using the 16S rDNA PCR 
(Sakamoto et al., 2002). Amplified PCR products were electrophoresed on 1% agarose gel in 1% SB 
buffer at 80 V for 30 minutes stained and visualised using SYBR Safe and the GelDoc System.  
3.4.2.4 Molecular detection of virulence genes 
A pentaplex-PCR targeting five VGs (iroN, iutA, iss, hlyF and ompT) was performed as previously 
described (Johnson et al., 2008b) on the DNA extracted from the cloacal and faecal swabs using the 
previously determined best extraction method (repeated bead beating plus column) and from the DNA 
extracted from E. coli that were cultured from the organs and cloacal swabs. E. coli STJ-1 (Fagan et 
al., 1999) and E. coli ATCC 8739 were used as positive and negative controls, respectively. 
3.4.2.5 Spiked faecal samples 
The spiking experiments were performed to evaluate the sensitivity for each DNA extraction method. 
Two faecal samples were collected from two healthy commercial broiler chickens (A and B) and were 
spiked with six different ten-fold serial dilutions of E. coli (STJ-1) ranging between 1.6 × 10 and 1.6 
× 106 colony forming units (CFU) per mL. One hundred microliters of each serial dilution was added 
to 20 mg of faeces from each bird, A and B, and the DNA was extracted from the six spiked samples 
per bird in triplicate using the three different extraction methods.  
3.4.2.6 Definition of avian colibacillosis, APEC, cAPEC, pAPEC and AFEC 
In the current study, avian colibacillosis was diagnosed based on the presence of clinical signs 
associated with colibacillosis, macroscopic lesions (assessed on a grading of zero to four) and the 
isolation of E. coli from the affected lesions. A numeric grading representing the severity of the 
disease was assigned according to the following scale: 0 = no colibacillosis; 1 = mild case of 
colibacillosis with lesions affecting a single organ; 2 = moderate case of colibacillosis with lesions 
covering two organs; 3 = moderate case of colibacillosis with lesions covering three organs; 4 = 
severe case of colibacillosis with lesions covering four or more organs (Antão et al., 2008). For a bird 
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to be defined as having avian colibacillosis, the bird has to show some clinical signs associated with 
colibacillosis, a lesion score of 1 or more and had E. coli cultured from at least one lesion site. 
Clinical avian pathogenic E. coli (cAPEC) was defined as an E. coli cultured from an organ of a 
chicken with colibacillosis that harboured four or more of the five APEC-associated VGs. APEC was 
defined as an E. coli isolate sourced from anywhere (except from an organ of a chicken with 
colibacillosis) that harboured four or more of the five APEC VG markers ( iroN, iutA, iss, hlyF and 
ompT). Clinical E. coli, which contain less than four of the selected VGs are identified as potential 
APEC (pAPEC). On the other hand, avian faecal E. coli (AFEC) was defined as an E. coli isolate, 
cultured from the faeces of chicken, with less than four of the selected APEC VG markers (Johnson 
et al., 2008b). 
3.4.2.7 Statistical analysis 
Analyses were performed with Stata software (13th edition, Blackburn North Victoria, Australia, 
www.stata.com). The mean, median and interquartile range of the yields (ng/µL) and purity for the 
extracted DNA for faecal and cloacal samples were calculated for the three DNA extraction methods. 
Normality of yield and purity were examined using histograms and data transformations were 
performed when necessary. The mean of the normalised DNA yield and purity of the faecal sample 
was compared to the mean of the duplicate faecal sample for the subgroups (healthy and unhealthy 
chickens) of the three different DNA extraction methods using t-tests. If the overall mean of the faecal 
subgroup did not differ from the subgroup duplicate at p < 0.05, then the mean of the DNA yield and 
purity for both faecal samples for each individual chicken was created and used for future analysis. 
Yield and purity were compared between the three different DNA extraction methods in two separate 
models using the General Estimation Equation (GEE) procedure (Twisk, 2013). GEE models were 
chosen to account for clustering of repeated observations within chickens and a negative binomial 
distribution with a log link function was used in these models. The health status of the chickens 
(healthy vs unhealthy as previously described) and the interactions between the health status of the 
chickens and the three types of DNA extractions were added as fixed effects. 
Exchangeable correlation structures were used for all analyses. Standard errors were estimated using 
‘robust’ Huber/white/sandwich estimators of variance. The Chelex method was used as the reference 
category. Data analysis was conducted stratified for the faecal and cloacal samples.  
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It was also assumed that the purity value of the extracted DNA alone might not be sufficient to 
characterise the ability of the extraction methods to produce PCR quality DNA. Therefore, a new 
variable was created (‘amplified-PCR’) which was a combination of the measured purity and the 
presence or absence of PCR inhibitors. DNA purity was dichotomized with ‘1’ being assigned for 
purity measurements between 1.8 and 2.1 and ‘0’ for lower or higher values. Similarly, if the PCR 
was able to amplify DNA (indicating no PCR inhibitors were present) the PCR test result was coded 
as ‘1’ and ‘0’ if the DNA failed to amplify (indicating the present of PCR inhibitors). Thus , four 
combinations of dichotomized purity values and dichotomized PCR inhibitor results indicating the 
quality of the extracted DNA were derived 1): Amplified-PCR = 1 if both the DNA ratio and the PCR 
were one; amplified-PCR = 2 if DNA ratio was 0 and the PCR was 1; amplified-PCR = 3 if DNA 
ratio was 1 and the PCR was 0; amplified-PCR = 4 if the DNA ratio as well as the PCR were 0.  
The frequency of the cross-tabulated dichotomized purity and dichotomized PCR inhibitor results for 
three DNA extraction methods conducted on cloacal and faecal samples collected from APEC 
infected chickens were compared using the Fisher’s exact test. 
The total number of VGs from E. coli isolates cultured from the cloaca of healthy birds versus birds 
with colibacillosis (three E. coli isolates were selected from each bird) was compared using GEE 
models to account for clustering of repeated observations within chickens. A Poisson distribution 
with a log link function was used in this model. Furthermore, to explore if VGs were more common 
in E. coli cultured from organs than from cloacal swabs in chickens with colibacillosis, the total 
number of VGs detected was compared between E. coli cultured from organ swabs (any organ coded 
as 1) and cloacal swabs (coded as 2) using also a GEE Poisson models. 
3.5 Results  
3.5.1 Pathology and bacteriology 
Of the 11 selected healthy chickens, one chicken (chicken 7) displayed multifocal necrotic lesions on 
the liver suggestive of necrotising hepatitis and the subcutaneous tissue over the thigh and breast were 
red and swollen, consistent with cellulitis. As a result of this finding, chicken 7 was reclassified as 
unhealthy after post-mortem leaving ten healthy chickens. All other healthy chickens displayed no 
signs of disease. Histopathology on the organs of one healthy chicken confirmed the absence of 
disease. No macroscopic lesions were observed in any organ of the ten heal thy chickens and no 
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microscopic lesions were detected in the tissues of the one healthy chicken which had histopathology 
performed. E. coli was not cultured from any organs of healthy chickens. 
Of the 13 unhealthy chickens (12 selected and chicken 7), four showed lesions consistent with non 
E. coli related systemic infections. Chickens 6, 7 and 16 showed signs of a systemic infection, based 
on multifocal necrotic lesions on the liver and spleen consistent with staphylococcosis (Nolan et al., 
2013). Histopathology of the livers and the lungs of these chickens displayed a marked multifocal 
granulomatous pneumonia with fibrosis. Staphylococcus aureus was isolated from the livers and 
lungs of the three chickens. Chicken 9 displayed yellow nodules in the air sacs that were consistent 
with Aspergillus (Nolan et al., 2013; Whiteman et al., 1979). Histopathology of the lung displayed a 
marked multifocal granulomatous pneumonia with fibrosis and Aspergillus fumigatus was cultured 
from the air sac and the lung.  
The remaining nine of 13 unhealthy chickens presented with lesions, which were consistent with 
colibacillosis (Figure 3.1). All of the nine chickens had lung and/or air sac macroscopic lesions with 
a lesion score ranging between one and four. Cellulitis and macroscopic lesions of varying severity 
were detected on the other internal organs of all of the nine chickens. Three chickens (2, 5 and 10) 
had a thick and extensive layer of fibrinous exudate (heterophilic and fibrinous peritonitis) covering 
all five organs and signs of severe sepsis or systemic infection; consistent with a colibacillosis grade 
of 4. Three chickens (23, 22 and 21) displayed a thin layer of fibrin on one or more of the organs, 
colibacillosis grade 3, while three chickens (1, 4 and 11) showed one or two small pin sized lesions 
per lung and air sac (colibacillosis grade 1 or 2). Histopathology of three chickens affected with 
colibacillosis (5, 23, and 11) displayed pathophysiological alterations of the lung, liver, heart and  
spleen tissues, which is characteristic of systematic infection. The anaerobic and/or microaerophilic 
growth conditions did not yield any bacterial growth.  
Seventy four E. coli (68 lactose positive isolates from liver, lung, air sac, spleen and heart of eight 
chickens and six lactose negative isolates from the liver and spleen of chicken number 12) were 
obtained and identified, by biochemical and molecular methods, from all five organs from the nine 
chickens clinically diagnosed with colibacillosis.  
Sixty nine E. coli were isolated and identified, by biochemical and molecular methods, from all  of 
the cultured cloacal swabs: 27 E. coli isolates were isolated from the cloacal swabs of chickens with 
colibacillosis (n = 9); 30 E. coli isolates were collected from the cloacal swabs of healthy chickens (n 
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= 10) and 12 E. coli isolates from the cloacal swab of chickens with staphylococcosis (n = 3) and 
aspergillosis (n = 1).  
3.5.2 DNA extraction  
3.5.2.1 Quantity of the extracted DNA 
Overall, the Chelex method produced the highest DNA yields from the cloacal swabs with median 
DNA concentration of 802 ng/µL (interquartile range [IQR] 249 - 1811), followed by 36 ng/µL (IQR 
3.4 - 548) for the RBB+C methods and 15 ng/µL (IQR 1.4 - 112) for the QIAamp DNA Stool Mini 
Kit. The faecal swabs yielded a comparatively higher DNA quantity in comparison to the cloacal 
swabs. Nonetheless, the Chelex method again yielded the highest concentration of DNA from the 
faecal swab with median of 997 ng/µL (IQR 603 - 2963) followed by 171 ng/µL (IQR 72 - 458) for 
the RBB+C and 90 ng/µL (IQR 7 - 256) for the QIAamp DNA Stool Mini Kit (Figure 3.2). 
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Figure 3.1: Comparison of the three extraction methods: Chelex; QIAamp and RBB+C for 
DNA extracted from the cloacal swabs (n = 23) and on the mean of duplicate faecal samples (n 
= 23). (A) Compares the DNA yield (ng/µL). (B) Compares the quality of the DNA extracted 
(260/280 ratio). 
 
The GEE models of log-transformed DNA yield for comparing the three DNA extraction methods 
indicated that RBB+C and QIAamp DNA Stool Mini Kit produced lower DNA yield values than the 
Chelex in both cloacal samples (n observations = 69, n groups = 23, Wald χ2 = 149.21, d.f. = 2, p < 
0.001) and faecal samples (n observations = 69, n groups = 23, Wald χ2 =138.46, d.f. = 2, p < 0.001). 
Health status and interaction between health status and type of diagnostic test was not associated with 
the log-transformed DNA yield. The final GEE model results for log2-transformed DNA yield are 
shown in Table 3.1 
 
Table 3.1: Results from General Estimation Equation Models of log-transformed DNA yield 
derived from three DNA extraction methods on individual cloacal swabs (n = 23) and on the 
mean of duplicate faecal samples (n = 23) collected from healthy and unhealthy chicke ns. The 
Chelex method was used as the reference group. 
Type of sample DNA extraction method Ratio of mean yield 95% Confidence  
Interval 
p-value 
Cloacal Chelex Reference group 
  
 
QIAamp 0.037 0.021, 0.063 < 0.001  
RBB+C 0.074 0.034, 0.161 < 0.001 
Faecal Chelex Reference group 
  
 
QIAamp 0.075 0.048, 0.116 < 0.001  
RBB+C 0.155 0.111, 0.217 < 0.001 
 
3.5.3 Quality of the extracted DNA 
In regards to the DNA purity, the RBB+C achieved a similar A260/A280 ratio to the QIAamp DNA 
Stool Mini Kit extraction with the median of 2 (IQR 1.9 - 2.1) and 1.94 (IQR 1.67 - 2.1) respectively, 
for faecal swabs and median of 1.99 (IQR 1.9 - 2.06) and 2.03 (IQR 1.94 - 2.19) respectively, for the 
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cloacal swabs. The Chelex method gave the lowest DNA ratio with median of 1.3 (IQR 1.2 - 1.4) and 
1.25 (IQR 1.25 - 1.37) for faecal and cloacal swabs, respectively. The GEE models of log-transformed 
DNA purity for comparing the three DNA extraction methods indicated that RBB+C and QIAamp 
DNA Stool Mini Kit produced higher DNA purity values than the Chelex in both cloacal samples (n 
observations = 69, n groups = 23, Wald χ2 =1596.87 d.f. = 2, p < 0.001) and faecal samples (n 
observations = 69, n groups = 23, Wald χ2 = 3435.27, d.f. = 2, p < 0.001). Health status and interaction 
between health status and type of diagnostic test was not associated with the log-transformed DNA 
purity. The final GEE model results for log2-transformed DNA purity are shown in Table 3.2. 
 
Table 3.2: Results from General Estimation Equation Models of log-transformed DNA purity 
derived from three DNA extraction methods on individual cloacal swabs (n = 23) and on the 
mean of duplicate faecal samples (n = 23) collected from healthy and unhealthy chickens. The 
Chelex method was used as the reference group. 
Type of sample DNA extraction method Ratio of mean purity 95% Confidence 
Interval 
p-value 
Cloacal Chelex Reference group 
  
 
QIAamp 1.503 1.459, 1.549 < 0.001  
RBB+C 1.521 1.490, 1.554 < 0.001 
Faecal Chelex Reference group 
  
 
QIAamp 1.543 1.518, 1.569 < 0.001  
RBB+C 1.509 1.487, 1.531 < 0.001 
 
3.5.4 Combination of DNA purity and PCR inhibitor results 
The summary of the DNA purity and PCR inhibitor results for the cloacal and faecal swabs obtained 
from healthy and unhealthy chickens is shown in Table 3.3. There was a significant difference (p < 
0.001) between dichotomized purity and dichotomized PCR inhibitor results between the three DNA 
extraction methods for both, cloacal and faecal samples. The RBB+C produced the highest quality 
DNA and DNA amplification followed by the QIAamp DNA Stool Mini Kit that yielded a similar 
quality to the RBB+C, however, did not amplify as much DNA. Conversely, the Chelex method 
produced low ratio DNA that could not be amplified (except for 3 cloacal and 3 duplicate faecal 
samples).  
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Table 3.3: Cross-tabulation of dichotomized purity and dichotomized PCR inhibitor results for 
three DNA extraction methods conducted on individual cloacal swabs (n = 23) and on the mean 
of duplicate faecal samples (n = 23) collected from healthy and unhealthy chickens. 
¹DNA purity was 1 for purity measurements between A260/A280 absorbance ratio 1.8 and 2.1 and 0 for lower or higher 
values. 
²The PCR test result was coded as 1 if the PCR was able to amplify DNA and 0 if the DNA failed to amplify. 
 
The overall integrity of the extracted DNA using the three different methods was of high quality as 
no shearing was observed on gel electrophoresis. Amplification of the 16S rRNA gene varied between 
the three different extraction methods utilised. Successful amplification of the 16S rRNA gene was 
achieved in 91% (63 of 69) of the DNA extracted using the RBB+C, 51% (35 of 69) of the DNA 
extracted using the QIAamp DNA Stool Mini Kit and 13% (9 of 69) of the DNA extracted using the 
Chelex method. The three DNA extraction methods yielded reproducible results in regards to the 
DNA yields, DNA ratio and amplification of the PCR products. 
In regards to the spiking experiment, the PCR on the DNA extracted from faeces with the RBB+C 
was able to amplify all five APEC-associated VGs from all six different spiked dilutions (101 to 106 
CFU/mL). While the DNA extracted using the QIAamp DNA Stool Mini Kit amplified the five 
APEC-associated VGs from only the two highest spike concentrations. While the DNA extracted by 
the Chelex method failed to amplify any of the five APEC-associated VGs from DNA extracted from 
all six dilutions. 
Type of sample DNA extraction method 
DNA purity¹ = 0  DNA purity¹ = 1 
PCR² = 0 PCR² = 1  PCR² = 0 PCR² = 1 
Cloacal Chelex 20 3  0 0 
 QIAamp 1 0  17 5 
 RBB+C 0 0  2 21 
 Total 21 3  19 26 
Faecal Chelex 20 3  0 0 
 
QIAamp 0 1  8 14 
 
RBB+C 0 0  2 21 
 Total 20 4  10 35 
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3.5.4.1 Molecular detection of APEC virulence genes 
All five selected VGs were detected in 100% (63 of 63) of the DNA extracted directly from the 
cloacal and faecal samples from both healthy chickens and unhealthy chickens using the RBB+C. 
However, PCR on DNA from E. coli cultured from the cloacal swabs (n = 69) failed to detect the 
same VGs from the same chicken (healthy and unhealthy). The prevalence of the VGs identified from 
E. coli isolates cultured from the cloacal swabs of chickens affected with colibacillosis was 
statistically significantly higher in comparison to E. coli cultured from the cloacal swabs of healthy 
chickens as shown in Figure 3.3 (GEE model: n observations = 378, n groups = 21, Wald χ2 = 58.78, 
d.f. = 1, p < 0.001).  
 
 
Figure 3.2: The frequency of virulence genes in E. coli cultured from the cloacal swabs of ten 
healthy chickens (n = 30) and nine chickens with colibacillosis (n = 27). 
 
The frequency of the VGs in the 27 E. coli isolates that were cultured from the cloacal swabs of nine 
chickens with colibacillosis were 85% for iss, hlyF and ompT, 82% for iutA and 76% for iroN. The 
frequency of the VGs was lower in the 30 E. coli isolates cultured from the cloacal swabs of ten 
healthy chickens; iss (36%) was detected most frequently, followed by iutA (30%), hlyF (21%), ompT 
(12%) and iroN (9%).  
Among birds with colibacillosis, significantly more VGs were detected from E. coli cultured from 
organs than E. coli cultured from cloacal swabs (GEE model: n observations = 182, n groups = 11, 
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Wald χ2 = 25.27, d.f. = 1, p < 0.001). PCR data showed that 100% (74 of 74) of the E. coli isolates 
that were cultured from the lesions of chickens affected with colibacillosis harboured all five VGs. 
Seventy percent (19 of 27) of the E. coli that were cultured from the cloacal swabs of chicken affected 
with colibacillosis harboured all five VGs.  
Furthermore, all of the E. coli isolates that were cultured from the organs (n = 74) of chickens affected 
with colibacillosis (n = 9) were classified as cAPEC. While, 85% of the cloacal swabs (23 of 27) of 
chickens with colibacillosis were classified as pAPEC. However, only 17% of the E. coli (5 of 30) 
isolates cultured from cloacal swabs of apparently healthy chickens were classified as APEC. 
All the E. coli isolates (n = 9) that were cultured from the organs and the cloacal swabs of chickens 
with aspergillosis (n = 1) were classified as APEC. None of the E. coli isolates (n = 9) from the cloacal 
swabs of clinically unhealthy chickens with staphylococcosis (n = 3) were classified as APEC. 
3.6 Discussion 
Currently, the diagnosis of avian colibacillosis relies on clinical signs, typical macroscopic lesions 
and culture of E. coli from the affected tissues (Nolan et al., 2013). Traditional bacterial culture can 
be labour intensive, expensive and time consuming. While multiple VGs have been defined as useful 
molecular markers for the detection and characterisation of APEC from cultured E. coli obtained from 
chickens diagnosed with avian colibacillosis (Johnson et al., 2008b) the direct application of 
molecular techniques to faecal samples has been hampered by the inability to extract high quality 
DNA (Henderson et al., 2013). There are several methods and commercial kits specifically designed 
for DNA extraction from faecal samples. However, to be able to obtain repeatable, accurate PCR 
results, careful consideration must be given to the methodology (McOrist et al., 2002) to ensure 
adequate yield concentrations are achieved, shearing of the DNA is minimised and the presence of 
impurities, either from the faeces or the extraction process, is negligible. 
The presence of PCR inhibitors in faecal samples is well documented and variation in the composition 
and consistency of faecal samples from different animal species may affect the quality of extracted 
DNA (Abu Al-Soud and Radstrom, 1998; Abu Al-Soud and Radstrom, 2000; Gioffre et al., 2004). 
Therefore, it is necessary to conduct species-specific testing of all extraction protocols. Chicken 
faeces are low in moisture in comparison with other animals (Akhtar et al., 2013) which leads to 
difficulty in dissolving the faeces in a buffer (Barnard et al., 2011) and chickens may also have 
additional inhibitors in comparison to other mammalian faeces as they excrete urinary waste in the 
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faeces (i.e. common cloaca) (Chambers et al., 2001). Therefore, it is important to test detection 
methods specifically for chickens, rather than rely on extrapolation from other species. This is the 
first study to report on such findings. 
This study compared three DNA extraction methods directly in order to detect the most effective and 
practical method(s) to extract a high quantity and quality of DNA from the cloacal and faecal swabs 
of broiler chickens; a) QIAamp DNA Stool Mini Kit, b) repeated bead beating plus column method 
(RBB+C) and c) Chelex method. Selection of these methods was based on their popularity of use by 
the veterinary laboratory and/or the poultry industry and ease of use (Garofalo et al., 2007). There 
was a positive correlation between the purity and quality of DNA achieved during extraction and the 
subsequent suitability of the extracted DNA as template for PCR amplification. The RBB+C method 
was determined to be the best method to extract an adequate yield of PCR quality DNA from the 
cloacal and faecal samples. The high quality DNA obtained using the RBB+C has been well 
documented in previous studies where DNA was extracted from the rumen digesta and faecal samples 
of cattle (Henderson et al., 2013; Yu and Morrison, 2004). The enhanced performance of the RBB+C 
on chicken faecal extractions, in comparison with the other two methods, may be due to the two 
additional purification steps, which may minimise the presence of PCR inhibitors, in conjunction 
with a reduced final elution volume, which may maximise the DNA concentration. The increased 
sensitivity could also been seen in the spiking experiment, where DNA extracted by the RBB+C 
yielded positive results for all dilutions tested compared to the other two methods which yielded 
positive results for two of the six dilutions at best. However, the RBB+C was more laborious and 
time consuming method in comparison with QIAamp DNA Stool Mini Kit and the Chelex. The cost 
of the RBB+C was another disadvantage, as it was the most expensive method followed by the 
QIAamp DNA Stool Mini Kit, while the Chelex method was the most economical.  
The QIAamp DNA Stool Mini Kit method also produced pure DNA with similar A260/280 ratio to 
the RBB+C, in accordance with previous studies (Gioffre et al., 2004; Monteiro et al., 1997). 
However, amplification of the 16S rDNA failed in 49% of the extracted DNA samples. Monteiro et 
al. (1997) also reported a similar limitation and concluded this was due to the QIAamp DNA Stool 
Mini Kit eliminating some but not all PCR inhibitors. However, other DNA extraction studies suggest 
that the use of the QIAamp DNA Stool Mini Kit (in human, cattle and horse faeces) can reduce the  
presence of PCR inhibitors by 98% in the extracted DNA (Verweij et al., 2004; Verweij et al., 2007). 
  
Page | 106  
 
While the Chelex method gave a superior DNA yield, as also reported by others (Miller et al., 1999; 
Yang et al., 2008), the quality of DNA produced in this study was low with an A260/280 ratio range 
between 1.2 - 1.4 and an 87% failure of this DNA to produce PCR product using the 16S rDNA PCR. 
The limitations of the Chelex method have been observed previously in several other species 
(Desloire et al., 2006; Hill and Gutierrez, 2003). However, Yang et al. (2008) reported that the Chelex 
method extracted a relatively pure DNA, free from contamination (with absorbance ratio A260/280 
of 1.80 - 2.00) from 10-day-old healthy gosling faecal samples.  
This variation in the result obtained by the current study and that of Yang et al. (2008) could be due 
to the fact that the faeces of geese contain more water, as geese consume large amounts of water with 
their food (Janet Kear, 1963). The increased water content of the faeces mean less faecal inhibitors  
are present, which may result in better quality extracted DNA as seen by the higher quality DNA 
obtained by Yang et al. (2008) in comparison to the poor quality DNA obtained in the current study 
from the chicken faecal samples. 
DNA yields did differ between the cloacal swabs and faecal samples. This could be attributed to the 
quantity of original sample, as in some cases the cloacal swabs contained only small quantities of 
faeces. Other studies have also reported a correlation between the amount of the faecal material and 
DNA yield (Ariefdjohan et al., 2010; Zhang et al., 2006). 
Previous studies have identified an association between the prevalence of different combinations of 
VGs and the pathogenicity of APEC (da Rocha et al., 2002; Ewers et al., 2004; Johnson et al., 2008b; 
Rocha et al., 2008). Further, they have reported that certain VG combinations are a useful tool to 
differentiate between APEC and AFEC (Johnson et al., 2008b; Rodriguez-Siek et al., 2005a; 
Schouler et al., 2012) when the E. coli was isolated from the lesions or the cloacal swabs of chickens 
affected with colibacillosis. In the present study, a PCR was used to screen E. coli isolates (obtained 
from cloaca and organs) and DNA directly extracted from faeces and the cloaca for the presence of 
five APEC-associated VGs (Johnson et al., 2008b). All five VGs were detected from E. coli cultured 
from both healthy and unhealthy chickens when the pentaplex-PCR was applied to the DNA extracted 
directly from faecal and/or cloacal samples. However, in contrast, the VGs occurred in lower 
frequency in the E. coli cultured from healthy chickens. As well, the PCR of E. coli cultured from 
cloacal swabs of the same chickens failed to detect the same VGs as those detected in the direct PCR 
examination of the cloacal swabs. These VGs can be possessed by other bacterial species that are 
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often found in the intestines of chickens, suggesting that these VGs may not necessarily only be 
associated with APEC when identified from a faecal sample.  
In summary, the presence of the five VGs in all birds highlights the need to improve biosecurity 
practices, such as restriction of the movement and entry of farm visitors as well as workers to assist 
in minimising the spread and transmission of APEC between and among farms. Furthermore, early 
detection of these genes (which may indicate the presence of APEC) using the pentaplex PCR 
highlights the need to evaluate the management policies priority in order to minimise the presence of 
these genes and associated bacteria in the sheds. The reduction of these bacteria will help to reduce 
the risk of inhaling dust contaminated with APEC and therefore, reduce respiratory disease that is 
often followed by systematic infections characterised by poor flock performance and high mortality.  
Data obtained from this study suggests that the presence of these VGs was more likely associated 
with E. coli isolates cultured from lesions in the organs of birds with colibacillosis. This finding 
agrees with previous studies where they also found associations between the presence of these five 
VGs and E. coli isolates cultured from lesions in the organs of birds affected with colibacillosis 
(Circella et al., 2012; Rodriguez-Siek et al., 2005a).  
All chickens with colibacillosis in this study were assigned a macroscopic as well as a microscopic 
lesion (for three chickens) score of three and above in the lung and/or air sac and had lesions 
(macroscopic and microscopic) in one or more of the following organs: liver; spleen and heart (scores 
of three and above). An association has been found between the presence of four or more of the 
selected APEC VGs in all of the E. coli isolates that were cultured from organs (n = 74) of chicken 
with colibacillosis. Similarly, Ask et al. (2006) reported a direct correlation between the colibacillosis 
lesions and the occurrence of similar VGs. Of the 74 E. coli isolates cultured from organs, 8% (n = 
6; isolates from liver and spleen of chicken 12) were lactose negative and harboured all of the five 
selected VGs. The occurrence of lactose negative APEC has been previously reported by Rodriguez-
Siek et.al (2005a). 
With the exception of chicken 7 (which was diagnosed with staphylococcus), all chickens that were 
identified by the farmers as healthy had no macroscopic or microscopic lesions on the internal organs 
and all organs were sterile when cultured. 
The main limitation of this study was the small sample size of commercial broiler chickens. However, 
the fact that this is an exploratory study that aims to assist with the future thesis experiments justifies 
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the sample size, furthermore, three farms were selected to be sampled to increase the bird variation 
coming from different management and health backgrounds. Another limitation of this study is that 
while the faecal samples were processed in duplicate, only one cloacal sample was processed. This 
was due to the small amount of sample obtained from the cloacal swabs in some birds. However, our 
sample size was large enough to see a statistical difference.  
3.7 Conclusion 
Avian pathogenic E. coli is a significant disease for the poultry industry and is potentially of public 
health concern. This study aimed to identify a method to detect APEC directly from the faeces of 
chickens, which could be used as a rapid diagnostic test. The repeated bead beating plus column 
method was the preferred DNA extraction method, as it yielded adequate PCR quality and quantity 
DNA directly from the faecal material of chickens. However, identifying APEC directly, by detecting 
the five selected VGs (iroN, iutA, iss, hlyF and ompT) from the faecal material was not feasible 
because these five VGs that were most commonly found among E. coli from birds with colibacillosis 
were also detected in E. coli from healthy birds and are possibly associated with other bacterial 
species present in the digestive tract of broiler chickens. Therefore, although the RBB+C method is 
adequate and this study can recommend it for DNA extraction from poultry faeces and/or cloacal 
swabs, other genetic markers will need to be investigated to identify APEC directly from faecal 
material. 
 
 
. 
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4 Chapter 4: Risk factors associated with the carriage of 
pathogenic Escherichia coli from healthy commercial 
broiler chickens in South East Queensland, Australia 
 
4.1 Foreword 
Avian pathogenic Escherichia coli (APEC) have been identified according to the presence of a 
specific array of APEC-associated virulence genes (VGs). As discussed previously in this thesis , 
APEC was defined based on the presence of four or more of five selected APEC-associated VGs: 
haemolysin gene (hlyF); increased serum survival gene (iss); outer membrane protease gene (ompT) 
and two iron acquisition system genes (iutA and iroN). Avian faecal E. coli (AFEC) was defined as 
an E. coli isolate cultured from a faecal sample from a healthy chicken that harboured less than four 
of the VGs. In Chapter 3, the five VGs were used to screen DNA extracted directly from faeces to 
identify APEC. However, the five VGs were detected in faecal DNA from both healthy chickens and 
chickens with colibacillosis, and it was concluded that these VGs might have originated from other 
bacteria and not only from APEC. Hence, in further studies, including this one, faeces were cultured 
and APEC status based on screening for VGs among selected E. coli isolates rather than use DNA 
extracted from faecal or cloacal samples. 
The primary selection of four or more VGs to identify APEC was validated by the results obtained 
by the pilot study (Chapter 3). That study showed that 85% of the 27 E. coli isolates cultured from 
the faeces of nine chicken with colibacillosis harboured four or more VGs, while only 17% of isolates 
cultured from the faeces of healthy birds harboured four or more. The low level of APEC in healthy 
chickens also suggested their role as a reservoir for APEC-associated VGs and potentially 
colibacillosis in Australia. The occurrence and severity of avian colibacillosis depends on the 
pathogenicity of the APEC, the immune status of the chickens and the presence of predisposing risk 
factors. However, little knowledge is available in regards to APEC prevalence and the potential 
predisposing risk factors (biosecurity and farm management protocols and environmental factors) 
associated with APEC among commercial broiler chicken flocks in Australia. 
Therefore, the aims of the current study were to estimate APEC prevalence and to determine the 
possible risk factors associated with intestinal/cloacal carriage of APEC among commercial healthy 
broiler chickens in South East Queensland. 
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4.2 Abstract  
Avian pathogenic E. coli (APEC) is the aetiological agent of avian colibacillosis, an acute 
extraintestinal disease of poultry. Avian colibacillosis is an economically significant disease globally 
with losses due to the high costs associated with the preventions and treatments and increased 
mortality and morbidity. Little is known about APEC in the context of Australian conditions. 
Accordingly, the current study aims to estimate the APEC prevalence and to determine the risk factors 
associated with the intestinal/cloacal carriage of APEC among commercial healthy broiler chickens 
in South East Queensland (SEQ).  
In the current study, four hundred cloacal swabs were collected at slaughter from 400 healthy broiler 
chickens originating from 40 poultry farms in SEQ. A total of ten birds per farm were sampled. Swabs 
were cultured and 2,200 E. coli isolates were selected and screened for the presence of five APEC-
associated virulence genes (VGs) by PCR. Data on potential within-farm risk factors associated with 
APEC prevalence were collected using a questionnaire that was completed by the managers and/or 
owners of the broiler farms. The questionnaire sought information in regards to farm management 
practices, biosecurity protocols and chicken health. For the purposes of this study, APEC was defined 
as an E. coli isolate that was cultured from the intestinal/cloacal swab and harboured four or more of 
the selected five APEC related VGs (iutA, iss, ompT, hlyF and iroN). At the bird-level, a chicken was 
considered to be APEC positive if it carried at least one E. coli isolate, which harboured four or more 
of the APEC-associated VGs. A farm was considered as APEC positive if at least one bird was APEC 
positive. Binominal general linear models were used to identify farm-level risk factors associated 
with bird-level APEC prevalence within individual broiler farm.  
Thirty four percent of the cultured E. coli isolates (n = 751) were classified as APEC. All of the tested 
farms (n = 40) were APEC positive, with the overall bird-level prevalence of APEC being 63.0% 
(95% Confidence Interval (CI): 55.8, 70.2).  
Higher APEC within-farm bird-level prevalence was positively associated with the usage of well 
water as a source of drinking water (Odd Ratio (OR) = 6.2, 95% CI: 2.3, 16.5, p < 0.001); not having 
shower facilities available for farm visitors (OR = 3.6, 95% CI: 1.8, 7.1, p < 0.001), distances greater 
than 20 m between the car park and the poultry shed (OR = 2.2, 95% CI: 1.4, 3.4, p = 0.001), not 
applying water line disinfections after each flock cycle (OR = 2.2, 95% CI: 1.4, 3.5, p = 0.001) and 
the presence of wild birds within 50 m of the poultry shed (OR = 2.3, 95% CI: 1.4, 3.7, p = 0.001). 
The use of chlorine combined with automatic drinking water filtration reduced within-farm bird-level 
APEC prevalence (OR = 0.07, 95% CI: 0.02, 0.34, p = 0.001). This study identified a number of 
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important potential risk factors for APEC carriage that need to be addressed by the poultry industry. 
The surprisingly high APEC prevalence on all farms requires further epidemiological investigations.  
4.3 Introduction 
Avian colibacillosis is considered one of the most common diseases to affect the poultry industry, 
and results in significant economic losses and increased welfare concerns (Collingwood et al., 2014; 
Dho-Moulin and Fairbrother, 1999; Ewers et al., 2004; Guabiraba and Schouler, 2015; Johnson and 
Russo, 2002; Nolan et al., 2013). Despite all of the improvements and modernisation in poultry 
production systems and the fact that avian pathogenic Escherichia coli (APEC) has been a recognised 
cause of avian colibacillosis for over a century (Collingwood et al., 2014; Dho-Moulin and 
Fairbrother, 1999; Johnson and Russo, 2002; Nolan et al., 2013), it remains as one of the major 
pathogens posing a considerable challenge to the global poultry industry (Collingwood et al., 2014; 
Dho-Moulin and Fairbrother, 1999; Johnson and Russo, 2002; Nolan et al., 2013). The genetic 
overlap between APEC and other extraintestinal pathogenic E. coli (ExPEC) that cause neonatal 
meningitis, septicaemia and urinary tract infections in humans suggests that APEC is a zoonotic 
pathogen (de Pace et al., 2010; Ewers et al., 2009; Ewers et al., 2007; Johnson and Russo, 2002; 
Johnson et al., 2008b; Manges and Johnson, 2012; Tivendale et al., 2010; Zhao et al., 2009). 
Avian pathogenic E. coli can act as a primary or secondary pathogen (Antão et al., 2008; Bauchart et 
al., 2010; Kemmett et al., 2013; Kohler and Dobrindt, 2011; Maluta et al., 2014) and can result in 
localised and/or systemic infections in birds (Guabiraba and Schouler, 2015; Nolan et al., 2013; 
Rodriguez-Siek et al., 2005a). The severity of the disease depends on the virulence of APEC strains, 
chicken age and immune status and the presence of predisposing risk factors (Dho-Moulin and 
Fairbrother, 1999; Guabiraba and Schouler, 2015; Vandekerchove et al., 2004a).  
Recent studies have indicated that various virulence genes (VGs) are useful markers for the definition 
of APEC and that they can be used to differentiate between APEC and avian faecal E. coli (AFEC) 
(Circella et al., 2012; Ewers et al., 2005; Johnson et al., 2008b; Rodriguez-Siek et al., 2005a). It is 
likely that the combinations of different APEC VGs are associated with APEC pathogenicity (Ewers 
et al., 2005; Johnson et al., 2008b; Kemmett et al., 2013). Thus Johnson et al. (2008b) developed a 
PCR targeting five VGs, which have been used as a tool for the identification of APEC (de Oliveira 
et al., 2015; Dissanayake et al., 2014; Hussein et al., 2013; Johnson et al., 2008b; Kobayashi et al., 
2011). 
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Healthy chickens can harbour both APEC and avian faecal E. coli (AFEC) in their gut flora 
(Guabiraba and Schouler, 2015; McPeake et al., 2005; Rodriguez-Siek et al., 2005a). Hence, healthy 
chickens can act as a reservoir for the dissemination of APEC to other chickens, as well as their 
surrounding environment, potentially causing recurring infections in new flocks (Guabiraba and 
Schouler, 2015; Rodriguez-Siek et al., 2005a; Schouler et al., 2012).  
Bird-level risk factors are likely to be associated with APEC infection. Kemmett et al. (2013) 
described an association between the prevalence of APEC and age of birds. The authors reported a 
higher APEC prevalence in the intestinal flora of one-day-old healthy chicks compared to adult 
chickens at slaughter-age. Contrarily, Kwon et al. (2008) found a higher APEC prevalence (31%) in 
layer birds (approximately 21 to 70 weeks of age), compared to slaughter-age broiler chickens 
(approximately up to12 weeks of age) (APEC prevalence 14%) in Korea. However, these differences 
might be related to farm management practices rather than age, as layer and broiler management are 
very different. Bird breed, and therefore genetic resistance, also differs between broiler and layer 
production systems. Hassan et al.(2004) showed that some breeds of chickens had lower mortalities, 
while others were highly susceptible to virulent infectious bursal disease virus and Newcastle disease 
virus.  
A positive association between the build-up of the E. coli pathogen in the faeces, and birds’ 
surrounding environment, and the increase in bird’s susceptibility to APEC infection among broiler 
chickens has been found (Guabiraba and Schouler, 2015; Kabir, 2010). The main risk factors that 
were associated with bird’s susceptibility were the duration of exposure, virulence of the APEC strain, 
breed and the immune status of the bird (Kabir, 2010). There were positive associations between 
increased risk of avian colibacillosis and increased infection pressure in the environment (Nolan et 
al., 2013). Such environmental pressures can result from unfavourable husbandry management, poor 
biosecurity protocols and seasonal changes (Gross and Siegel, 1997; Kabir, 2010; Leitner and Heller, 
1992; Nolan et al., 2013).  
Farm-level risk factors associated with a high prevalence of avian colibacillosis relate to poultry 
management practices (Nolan et al., 2013; Vandekerchove et al., 2004a; Wang et al., 2013b). 
Impaired biosecurity protocols for example might result in the entry of APEC into the chicken sheds 
and can contribute to increased APEC prevalence (Kabir, 2010). On the other hand, good biosecurity 
practices, such as frequent carcass removal and the use of disinfectants for cleaning decreased the 
prevalence and the spread of avian colibacillosis (Vandekerchove et al., 2004a).  
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The potential predisposing farm-level risk factors such as: biosecurity measures; farm management 
protocols and environmental factors are associated with APEC among commercial broiler flocks in 
Australia are unknown. Therefore, the aims of the current study were to: (i) determine the farm-level 
and bird-level prevalence of the intestinal/cloacal carriage of APEC and to (ii) investigate the possible 
associations between potential management risk factors and the within-farm APEC prevalence among 
healthy commercial broiler chicken flocks. 
4.4 Materials and methods 
4.4.1 Study design 
A cross-sectional study was conducted to estimate APEC prevalence and identify farm-level risk 
factors associated with APEC prevalence.  
4.4.2 Sample collection 
The sample size was calculated based on an unknown prevalence of birds carrying APEC (thus 
prevalence was set to 0.5), a precision of 5% for the prevalence estimate, and a 95% confidence 
interval (CI) (Dohoo et al., 2009). A total of 400 samples were needed to yield a CI up to 0.10 wide 
if the observed prevalence was between 0.3 and 0.7. A total of 400 chickens from 40 commercial 
broiler farms were sampled at slaughter between October 2013 and July 2014 in South East 
Queensland (SEQ), Australia (Animal ethics approval number: SVS /323/13/ POULTRY CRC). The 
sampling focussed on a 2-stage prevalence study, with birds nested within farms; thus, we aimed to 
sample 40 farms with 10 birds to be sampled within a farm. 
The broiler farms sampled belonged to the same commercial broiler company. The selected broiler 
company was willing to participate in this research project and provided access to their farm premises. 
The 40 commercial broiler farms were operating in different spatial locations.  
The broiler company owned one slaughterhouse and chickens were sampled at that premise to reduce 
disturbance of on-farm production. The slaughterhouse processed up to 15 commercial broiler flocks 
from different farms within a day. The slaughterhouse was visited every Monday for eight 
consecutive weeks and birds from four to six farms were sampled at each visit. Sampling of birds 
from a particular farm was completed within a day – i.e. birds from the same farm were not sampled 
across days. 
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Chickens are submitted to slaughterhouses in flocks, with each flock representing a farm and flocks 
are clearly distinguished in the slaughterhouse (they were clearly labelled as different flocks/farms). 
Thus, birds from each farm were kept together in cages (up to 20 chickens per cage). From each cage, 
only one bird was selected and restrained whilst a cloacal swab (Sarstedt Australia Pty. Ltd., 
Technology Park, South Australia, Australia) was collected. In this way, a total of ten chickens from 
ten cages representing one broiler farm were sampled. The swabs were transported on ice to the 
laboratory at the School of Veterinary Science, The University of Queensland, within two hours of 
collection. 
4.4.3 Collection of risk factor data 
A questionnaire was developed to collect data on potential risk factors associated with 
intestinal/cloacal carriage of APEC in the sampled broiler chickens (Human ethics approval number: 
SVS /2014000327/ POULTRY CRC). 
Questionnaire questions focussed on risk factors previously reported to be associated with APEC in 
commercial broiler chickens (Kabir, 2010; Nolan et al., 2013; Vandekerchove et al., 2004a). The 
surveyed included questions on the number of sheds and chickens kept on the farm, the location of 
the farm in relation to other livestock farms, and on specific management practices and biosecurity 
measures on the farm and general flock health. Management risk factors evaluated included: the age 
structure of broiler flocks; restocking practices; sources of drinking water used; number of workers 
on the farm; type of visitors; reasons for visits and frequency of their visit(s) to the farm; the presence 
and the frequency of unwanted animals (rats, mice, wild birds, domestic animals such as dogs, cats, 
cattle or pigs, stray/feral animals, amphibians, reptiles, kangaroos, possums) inside or outside the 
chicken shed within a categorised distance (less than and equal to 50 m and more than 50 m) and the 
frequency of litter removal. Biosecurity measures assessed related to routine cleaning practices (bird 
disposal, shed and equipment cleaning), precautionary measures used by farm worker and/or visitors 
before and after entering chicken sheds, the frequency of using foot baths, use of protective clothing, 
use of showers and hand sanitisers, cleaning and disinfecting protocols used, distance between the 
broiler shed and the car park; and the frequency of cleaning and disinfection of transport vehicles’ 
tyres and of equipment (feeder, drinker, ladder, fixing tools, etc.) before entering the farm, and 
ownership of livestock or pets by the farm manager and workers. Potential flock health data collected 
comprised information on previous colibacillosis infections and others diseases on the farm, mortality 
rates per shed, frequency of removing dead bird carcasses from the sheds, and on the administration 
of antimicrobial drugs. 
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The questionnaire was piloted in February 2014 in face-to-face interviews with three individual 
broiler farm managers and five questions were revised to increase their clarity. The final questionnaire 
contained 52 questions of binary, ordinal and open-ended responses (Supplementary Table 1).  
The questionnaire, information on the background and purpose of the research study, a consent form, 
and a pre-addressed stamped envelope for posting the completed questionnaire to the researcher were 
mailed out to the farm manager of the broiler farms in April 2014. In June 2014, a reminder was posted 
and followed by a phone call to remind the farm managers to complete questionnaires. With managers 
of ten broiler farms, face-to-face or a phone interviews were conducted after receiving the completed 
questionnaires to clarify some responses.  
4.4.4 Bacterial culture of samples, identification and DNA extraction 
All samples were processed within 24 hours of sampling. Each cloacal swab was cultured onto 
BrillianceTM E. coli coliform selective agar (BECS; Oxoid, Thebarton, South Australia, Australia) 
(Wohlsen, 2011) and incubated aerobically overnight at 37 °C. From each agar plate, five or ten 
presumptive E. coli colonies (for each broiler farm, five colonies were selected from nine chickens 
and ten colonies from one chicken) were collected. If the selected isolate was not confirmed as  
E. coli, further isolates were selected from the BECS plate until 2,200 E. coli isolates were collected 
from the 40 farms. 
Presumptive E. coli isolates were subcultured onto sheep blood agar (SBA; Oxoid) and incubated 
aerobically at 37 °C overnight. Isolates, which were indole positive and pyrrolidonyl arylamidase 
negative, were presumed to be E. coli and DNA was extracted (Abraham et al., 2012). An E. coli 
specific PCR targeting the uspA gene (Chen and Griffiths, 1998) was performed to confirm E. coli 
identification. All E. coli isolates were stored at -80 °C in brain heart infusion (BHI) broth (Oxoid) 
containing 20% glycerol until further analysis. The extracted DNA (100 µl) was stored at -20 °C for 
further analysis.  
4.4.5 Molecular detection of virulence genes 
All 2,200 E. coli isolates were screened for the presence of the five APEC related VGs ( iroN, iutA, 
iss, hlyF and ompT) using the pentaplex-PCR. Escherichia coli STJ-1 (Fagan et al., 1999) and E. coli 
ATCC 8739 were used as positive and negative controls, respectively. A total of 400 E. coli isolates 
were then selected, with each isolate representing one chicken. The E. coli selected to represent each 
bird was the E. coli cultured from that bird which contained the most VGs in order to increase the 
sensitivity of identifying APEC positive birds. If more than one E. coli isolate from the same chicken 
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carried the same number of VGs, random selection was applied using a random number generator by 
Excel Microsoft (Microsoft Corporation, Sydney, NSW, Australia, www.microsoft.com). 
4.4.6 Case definition 
For the purpose of this study, APEC was defined as an E. coli isolate that was cultured from the 
intestinal/cloacal swab and harboured four or more of the selected five APEC related VGs ( iutA, iss, 
ompT, hlyF and iroN) (Johnson et al., 2008b). AFEC was defined as an E. coli isolate that was 
cultured from the intestinal/cloacal swab of healthy chickens and harboured less than four of the 
selected five APEC related VGs. 
At the bird-level, a chicken was considered APEC positive if at least one E. coli isolate of the five or 
ten cultured E. coli isolates from that bird harboured four or more of the selected APEC-associated 
VGs. The farm was considered as APEC positive if at least one bird was APEC positive. 
4.4.7 Number of E. coli colonies that need to be screened to detect APEC VGs  
To identify the number of E. coli colonies that needed to be screened to detect four or more of the 
selected five APEC related VGs, five colonies (obtained from nine chickens within a single farm) 
and ten colonies (obtained from one chicken within a single farm) were selected from BrillianceTM 
E. coli coliform selective agar (BECS; Oxoid). The E. coli colony selected to represent each bird was 
the E. coli colony, which contained the most number of VGs. This E. coli isolate (and the individual 
bird) was then classified as either APEC positive or negative. We used the Kappa statistic to evaluate 
the agreement in classifying an isolate APEC positive or negative when either five or ten colonies 
were selected from the agar plates(Landis and Kochi, 1977a; Landis and Kochi, 1977b). 
4.4.8 Virulence gene prevalence in APEC positive and negative birds 
The prevalence of the five VGs (with 95% Confidence Interval (CI)) among APEC positive and 
negative birds was summarised. As samples were clustered within broiler farms, survey estimation 
commands were used with farm being defined as the primary sampling unit (Rao and Cott, 1984; Rao 
and Scott, 1981). Hence the clustering was accounted for in the standard error and confidence interval 
estimation. The prevalence of each VG was compared between APEC positive and negative birds 
using the Pearson chi square statistic with Rao and Scott second order correction (Rao and Scott, 
1981, 1984). Thus the Pearson chi square statistic was converted into a survey-design adjusted F 
statistic (Rao and Cott, 1984; Rao and Scott, 1981).  
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4.4.9 APEC farm-level, bird-level and within-farm prevalence 
The farm-level prevalence was the proportion of farms that had at least one bird that was APEC 
positive. The farm-level prevalence was the proportion of farms that had at least one bird that was 
APEC positive. Overall, bird-level prevalence was calculated as the number of APEC positive birds 
out of the total number of birds (n = 400) sampled in this study. Within-farm prevalence was 
calculated as the number of APEC positive birds out of the ten birds sampled per farm.  
4.4.10 Risk factors for APEC within-farm prevalence 
Questionnaire data were entered into a Microsoft Access 2013 database (Microsoft Corporation) and 
examined for errors and missing values. Missing information or errors were discussed with farm 
managers over the phone and corrected. Data analyses were performed using Stata (13th edition, 
Blackburn North Victoria, Australia, www.stata.com).  
A total of 120 individual risk factors were derived from the 52 questions in the questionnaire. 
Binominal general linear models with a log-link function were used to investigate the association of 
APEC within-farm prevalence and potential APEC farm-level risk factors (Barros and Hirakata, 
2003; Skov et al., 1998). The mean was the number of birds positive for APEC for the farms 
associated with the level of the risk factor. The risk factors with p < 0.15 in the univariate analysis 
were included in the multivariable model. For variables with more than two levels, the overall 
significance of the levels of the categorical variable was evaluated using the Wald test (Harrell, 2001). 
A forward stepwise model building strategy was used to develop the multivariable model. Models 
were compared using the Akaike Information Criterion (AIC) (Akaike, 1973; Akaike, 1974; Dohoo  
et al., 2009). The analysis was continued by successively re-fitting models with explanatory variables 
that were not significant at p < 0.15 in the univariate analysis and applying the same rules for model 
comparisons until all remaining variables in the multivariable model were statistically significant at 
p < 0.05. In addition, potential confounding variables was explored by identifying if adding or 
removing a variable would result in at least a 20% relative change in the coefficients of variables in 
the multivariable model (Dohoo et al., 2009). If this was the case, such a variable was included in the 
final multivariable model (Dohoo et al., 2009). Interactions between the different explanatory 
variables in the final model were also tested. Overall assessment of how well the final multivariable 
model fitted the observed data was conducted by exploring residuals and covariate patterns and by 
calculating Pearson X2, deviance and conducting the Hosmer-Lemeshow tests (Hosmer, 2013). 
  
Page | 118  
 
4.5 Results 
4.5.1 Overview about broiler farm management and biosecurity practices 
Ninety seven percent of the questionnaires (n = 39) were completed by broiler farm managers and 
2.5% by a broiler farm owner (n = 1). Variation in the shed numbers among the participating farms 
was noted, with the smallest farm consisting of only two sheds that produced up to 50,000 chickens 
per broiler growing cycle (range 30 to 60 days). The largest farm was composed of 19 sheds 
producing up to 180,000 chickens per broiler growing cycle. Fifty percent of the surveyed farms were 
composed of five to eight sheds. 
The integrated company livestock managers (which are independent from the farm manager and/or 
owner) visited each farm weekly to check on farm management, birds’ health and the progress of the 
broiler chickens. The livestock manager supported and supervised all of the participating 40 broiler 
farms, all of which followed the same biosecurity protocols that were developed by the integrated 
company. 
Twenty five percent of the broiler farms were housing broiler flocks of the same age (range 1 - 50 
days-old) in the same shed at the same time when an all-in all-out system of rearing was used. Sixty 
five percent of broiler farms housed flocks of different ages within the same shed. Ten percent of the 
farms housed single and multiple aged birds at different sheds at one time.  
Fifty percent of the sampled farms used tunnel ventilation (n = 20), 47.5% used natural ventilation (n 
= 19) and 2.5% (n = 1) used negative pressure ventilation. About 63% of farms (n = 25) used fans as 
a second source of ventilation.  
All farm workers (including manager/owner) and visitors (on all farms) used footbaths. Hand 
sanitisers were used by 42.5% of farm workers (n = 17) and 55% of farm visitors (n = 22) . The 
majority of farm workers (97.5%, n = 39) and farm visitors (80%, n = 32) did not wear protective 
overalls when entering the chicken sheds. Only one farm failed to disinfect equipment such as 
repaired tools or ladders used by farm workers and visitors prior to the equipment re-entering the 
sheds.  
Seventy five percent of farms (n = 30) used town water as the only source of drinking water for 
chickens, 7.5% of the farms (n = 3) used a well as the only source of drinking water, while 17.5% of 
farms (n = 7) used a combination of town and dam water as the source of drinking water. Seventy 
five percent of the farms treated the drinking water either by chlorine alone or in combination with 
other treatment methods such as automatic filtration.  
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On all broiler farms, used litter was removed after each batch and sheds were cleaned with a pressure 
hose using a mild detergent before sheds were restocked with new batches of chickens. Ninety seven 
percent of the farms washed the walls as part of the shed cleaning protocols and shed sanitisation was 
conducted by 80% of the farms (n = 32). As part of their cleaning protocols, all farms used insecticides 
inside the shed after cleaning.  
Thirteen of the broiler farms were located within 500 m of other farms housing animals (9 cattle, 2 
horse and 2 camel farms). Only 10% of the farm managers/owners owned a dog and/or a cat, however, 
no contact between their pet(s) and the broiler chickens were reported. 
Avian colibacillosis had been diagnosed previously, in the last year, on 40% (n = 16) of the surveyed 
farms on the basis of clinical signs, post-mortem examination and the isolation of E. coli from the 
affected lesions. Antimicrobial treatment (trimethoprim-sulfamethoxazole) had only been 
administered to bird flocks in four of these 16 farms. Furthermore, no other respiratory or any other 
diseases had been diagnosed on any of the farms within the period the sampled flock were kept on 
the farm. 
4.5.2 Number of E. coli colonies that need to be screened to detect APEC VGs  
Twenty out of the 2,200 E. coli isolates that were cultured had to be reselected, as the original isolate 
selected as presumptive E. coli on phenotype was not identified as E. coli by molecular testing. Of 
the 2,200 E. coli isolates cultured, 34% (n = 751) carried four or more VGs (average: 4.9 VGs) and 
were classified as APEC. While 66% (n = 1,449) were classified as AFEC with an average of 2.2 
VGs per isolate.  
The kappa statistics data comparing the agreement of using five or ten E. coli colonies for classifying 
a chicken as APEC positive or negative is shown in Table 4.1. The agreement varies between almost 
perfect and moderate agreement (Landis and Kochi, 1977a) and provides confidence that the selection 
of five colonies was sufficient to correctly classify birds as APEC positive or negative.  
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Table 4.1: The Kappa statistics comparing detection of APEC virulence genes following the 
selection of five or ten E. coli colonies cultured from broiler chickens from South East 
Queensland.  
Virulence genes Observed 
agreement % 
Expected agreement 
% 
Kappa Standard 
Error 
p-value 
iutA 97.5 88.25 0.787 0.155 < 0.001 
Iss 97.5 69.5 0.918 0.158 < 0.001 
hlyF 92.5 79.75 0.629 0.147 < 0.001 
ompT 92.5 83.75 0.539 0.140 < 0.001 
iroN 97.5 72.75 0.908 0.157 < 0.001 
 
4.5.3 Virulence gene prevalence in APEC positive and negative birds 
At the bird-level, 63.0% of birds were identified as APEC positive (n = 252), based on at least one of 
the isolates harbouring four or more VGs. The prevalence of individual VGs in the 400 bird-level 
isolates (each isolate representing one sampled chicken) is shown in Table 4.2. Overall, the 
prevalence of APEC related VGs was significantly higher in APEC positive birds in comparison to 
APEC negative chickens. The iutA VG was the most frequently occurring VG in APEC negative 
chickens with 75.7% prevalence.  
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Table 4.2 The prevalence of five virulence genes (VGs) with 95% Confidence Interval (CI) 
among 252 avian pathogenic Escherichia coli (APEC) positive chickens and 148 APEC negative 
chickens that were sampled between October 2013 and July 2014 from commercial broiler 
farms in South East Queensland. 
Virulence 
Genes 
Number of E. coli 
isolates with VG 
 
Prevalence of VG in APEC 
positive chickens 
(95% Cl) 
Prevalence of VG in 
APEC negative chickens 
 (95% Cl) 
p-value 
iss 269 0.99 (0.97, 0.99) 12.5 (7.52, 20.1) < 0.001 
iroN 259 0.99 (0.95, 0.99) 7.2 (3.52, 14.3) < 0.001 
ompT 322 0.10 46.1 (0.34, 0.58) < 0.001 
hlyF 318 0.99 (0.97, 0.99) 44.1 (31.4, 57.6) < 0.001 
iutA 352 0.94 (0.90, 0.97) 75.7 (63.9, 84.5) < 0.001 
 
4.5.4 The prevalence of birds with Avian pathogenic E. coli  
All of the 40 farms in the current study, were positive for APEC (i.e. at least one bird per farm was 
APEC positive). At bird-level, the overall prevalence of APEC in commercial broiler chickens (n = 
400) was 63.0% (95% CI: 55.8, 70.2). The frequency of APEC positive birds sampled per farm across 
the 40 commercial farms is shown in Figure 4.1. Fifty eight percent of the farms (n = 23) had six or 
more APEC positive birds (of 10 sampled birds). Only one farm had only one bird (of 10 sampled 
birds) identified as APEC positive while four farms had all 10 sampled chickens identified as APEC 
positive.  
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Figure 4.1: Frequency of boiler farms with number of broiler chickens tested as avian 
pathogenic E. coli (APEC) positive (out of 10 birds sampled per farm) in South East 
Queensland.  
 
4.5.5 Risk factors for APEC bird-level prevalence 
The univariate analysis in this study, showed that four risk factor variables were associated with 
decreased APEC within-farm prevalence (p < 0.15) (Table 4.3) while eight risk factors were 
associated with increased APEC farm prevalence (p < 0.15) (Table 4.4).  
The final multivariable model describing the association between the farm-level risk factors and 
within-farm APEC prevalence is shown in Table 4.5. Higher APEC within-farm bird-level prevalence 
was positively associated with the usage of well water as a source of drinking water (OR 6.2, 95% 
CI: 2.3, 16.5, p < 0.001); not having shower facilities available for farm visitor (OR = 3.6, 95% CI: 
1.8, 7.1, p < 0.001), distances greater than 20 m between the car park and the poultry shed (OR = 2.2, 
95% CI: 1.4, 3.4, p = 0.001), the failure to disinfect the waterline after each flock (OR = 2.2, 95% CI: 
1.4, 3.5, p = 0.001) and the presence of wild birds within 50 m of the poultry shed (OR = 2.3, 95% 
CI: 1.4, 3.7, p = 0.001). The use chlorine combined with the automatic drinking water filtration 
reduced within-farm bird-level level APEC (OR = 0.07, 95% CI: 0.02, 0.34, p = 0.001). 
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Table 4.3: Univariate analysis of possible farm-level risk factors associated (p-value < 0.15) with decreased within-farm prevalence of avian 
pathogenic E. coli (APEC). Data were collected on commercial broiler farms in South East Queensland between October 2013 and July 2014. 
Risk factor coefficents are presented as Odds ratios (OR) with 95% confidence intervals (CI). The number (N) of farms represents the number 
of broiler farms that possess or do not possess the risk factor of interest. The APEC prevalence represents the mean number of APEC positive 
birds within the farms that have or do not have the risk factor of interest. 
Risk factor group Number (%) 
APEC 
prevalence 
OR (95% CI) p-value 
Wald test 
p-value 
Separate age groups of birds housed in a farm at the same time      
No 10 (25) 0.62 Reference   
Yes 30 (75) 0.46 0.52 (0.32 - 0.82) 0.005  
Drinking water treatment      0.01 
None 10 (25) 0.53 Reference   
Chlorine 28 (70) 0.51 0.94 (0.44 - 1.99) 0.87  
Chlorine and automatic water filtration 2 (5) 0.10 0.09 (0.05 - 0.19) 0.01  
Number of days per week external (casual) farm worker were present on the farm     0.01 
None 16 (40) 0.59 Reference   
Category 1 ≤ 5 days 9 (22.5) 0.43 0.52 (0.31 - 0.88) 0.02  
Category 2 > 5 days 15 (37.5) 0.43 0.52 (0.33 - 0.82) 0.01  
Use of protective overalls by farm workers      
Never 39 (97.5) 0.50 Reference   
Always 1 (2.5) 0.40 0.67 (0.48 - 0.93) 0.02  
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Table 4.4: Univariate analysis of possible farm-level risk factors associated (p-value < 0.15) with increased within-farm prevalence of avian 
pathogenic E. coli (APEC). Data were collected on commercial broiler farms in South East Queensland between October 2013 and July 2014. 
Risk factor coefficents are presented as Odds ratios (OR) with 95% confidence intervals (CI). The number (N) of farms represents the number 
of broiler farms that possess or not possess the risk factor of intrest. The APEC prevalence represents the mean number of APEC positive birds 
within the farms that have or have not the risk factor of intrest.  
Risk factors 
Number of 
farms (%) 
APEC prevalence OR (95% CI) p-value 
Wald test 
p-value 
The usage of water well as source of drinking water      
No 37 (92.5) 0.48 Reference   
Yes 3 (7.5) 0.66 1.81( 1.19, 2.74) 0.005  
The animal species found outside the shed      
None 39 (97.5) 0.49 Reference   
Horses 1 (2.5) 0.89 9.47 (6.88, 13.0) 0.03  
Availability of a shower facility on the farm      
Yes 7 (17.5) 0.37 Reference   
No 33 (82.5) 0.52 1.86 (1.09, 3.17) < 0.001  
Frequency of water line disinfection after each flock      
Always 21 (52.5) 0.43 Reference   
Often 19 (47.5) 0.57 1.72 (1.16, 2.56) 0.007  
The mortality variations between the sheds within the last 12 months      
No 9 (22.5) 0.39 Reference   
Yes 31 (77.5) 0.53 1.77 (0.88, 3.55) 0.10  
Presence of wild birds within 50 m of the broiler shed(s)      
No 17 (42.5) 0.49  Reference   
Yes 23 (57.5) 0.51 1.15 (0.63, 1.45) 0.11  
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Risk factor group 
Number of 
farms (%) 
APEC prevalence OR (95% CI) p-value 
Wald test 
p-value 
Number of rats outside the shed within 50 m      
None 8 (20) 0.33 Reference  0.01 
Category 1 ≤ 5 6 (15) 0.46 1.27 (0.85, 1.91) 0.24  
Category 2 >5 26 (65) 0.56 3.39 (2.26, 5.10) 0.01  
Distance between the car park and the shed      
Category 1≤ 20 23 (57.5) 0.44 Reference 0.007  
Category 2 > 20 m 17 (42.5) 0.58 1.73 (1.16, 2.59)   
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Table 4.5: Final multivariable model of possible farm-level risk factors associated (p-value < 0.05) with within-farm prevalence of avian 
pathogenic E. coli (APEC). Data were collected on commercial broiler farms in South East Queensland between October 2013 and July 2014. 
Risk factor coefficents are presented as Odds ratios (OR) with 95% confidence intervals (CI). The number (N) of farms represents the number 
of broiler farms that possess or not possess the risk factor of intrest. The APEC prevalence represents the mean number of APEC positive birds 
within the farms that have or have not the risk factor of interest. 
Risk factors Number of farms (%) APEC prevalence OR (95% CI) p-value 
Wald test 
p-value 
The usage of a water well as a source of drinking water       
No  37 (92.5) 0.48    
Yes 3 (7.5) 0.66 6.20 (2.32, 16.5) < 0.001  
Drinking water treatment     0.01 
None 10 (25) 0.53    
Chlorine only 28 (70) 0.51 0.77 (0.46, 1.26) 0.317  
Chlorine and automatic water filtration  2 (5) 0.10 0.07 (0.02, 0.34) 0.001  
Distance between the car park and the shed      
Category 1≤ 20 23 (57.50) 0.44    
Category 2 > 20 m 17 (42.5) 0.58 2.16 (1.38, 3.38) 0.001  
Availability of a shower facility on the farm      
Yes 7 (17.5) 0.37    
No 33 (82.5) 0.52 3.59 (1.75, 7.11) < 0.001  
Frequency of water line disinfection after each flock      
Always 21 (52.5) 0.43    
Often 19 (47.5) 0.57 2.21 (1.41, 3.47) 0.001  
Presence of wild birds within 50 m of the broiler shed(s)      
No 17 (42.5) 0.49    
Yes 23 (57.5) 0.51 2.28 (1.39, 3.72) 0.001  
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4.6 Discussion 
The current study has revealed a high APEC prevalence in healthy commercial broiler chickens in 
SEQ. However, direct comparisons between research studies is difficult due to: the high genetic 
diversity of APEC; the variety of VGs associated with and used to classify APEC; large variability 
in sampling strategies and microbiological methods (Ewers et al., 2009; Johnson et al., 2008b; 
Mbanga and Nyararai, 2015).  
The selection of five VGs that were proposed by Johnson et al. (2008b) as an APEC marker was 
based on the significant association between these VGs and APEC isolates found in the previous 
chapter of the current study. Johnson et al. (2008b) reported such an association, as did a number of 
other overseas studies (Ahmed et al., 2013; Hasan et al., 2011; Kobayashi et al., 2011). These genes 
(iutA, hlyF, iss, iroN and ompT) are carried by plasmids that typify the APEC pathotype (Johnson et 
al., 2008b; Rodriguez-Siek et al., 2005a). The current study reported an average number of 2.2 genes 
in E. coli cultured from the faeces of healthy broiler chickens in Australia in comparison to 1.3 genes 
found in faecal E. coli Johnson et al. (2008b).  
The current study reported that the most prevalent of the tested VGs was ompT (100%) followed by 
iss, hylF, iroN and iutA, which were all detected in more than 94% of the E. coli isolates from APEC 
positive chickens. Johnson et al. (2008b) reported a lower prevalence of these five VGs ranging 
between 21% to 36% in 200 E. coli isolates sourced from the faecal samples of healthy broiler 
chickens in the United States of America (USA). A higher prevalence of ompT (42.5%) and a lower 
prevalence of iss (18.3%) and iroN (13.5%) were found by Rodriguez-Siek et al. (2005a) in E. coli 
isolates sourced from the faecal samples of healthy birds from the USA. The selection of five to ten 
E. coli isolates per bird may result in a better representation of the E. coli populations found in the 
bird’s gastrointestinal tract. The results obtaiend by the current study, showed that the selection of 
five colonies was sufficient to identify the strains of E. coli carried by the birds with the maximum 
number of VGs, allowing birds to be correctly identified as APEC positive or negative. Additionally, 
only one E. coli isolate, with the highest number of VGs, was chosen to identify APEC status per 
bird, which may explain the high prevalence of APEC found at farm-level in the current study in 
comparison with other studies.  
Furthermore, the geographical locations, climate, age variables and number of VGs used as APEC 
markers may contribute to variations in the prevalence of APEC between different studies. For 
example, despite bird age similarity between the current study and Kemmett et al. (2013), 
considerable APEC prevalence variations were found. A lower APEC prevalence of 1% was reported 
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by Kemmett et al. (2013) in 160 E. coli isolates sourced from broiler chickens in the United Kingdom. 
However, the usage of larger number, and a different range, of VGs (astA (heat-stable cytotoxin), iss, 
irp2 (iron-repressible protein), iucD (aerobactin), papC (fimbriae), tsh (temperature-sensitive 
hemagglutinin), vat (vacuolating autotransporter toxin), cvi (colicin V plasmid operon), sitA and ibeA 
(invasion of brain endothelium)) could explain the lower APEC prevalence they reported. The same 
authors identified higher bird-level prevalence of APEC (harboured five or more of the ten VGs) of 
24.1% in one-day-old chickens compared to 1% prevalence at slaughter-age (Kemmett et al., 2013). 
At the bird-level, a 14% APEC prevalence was reported in a Korean study where they used a different 
set of eight APEC VGs (astA, iss, irp2, papC, iucD, tsh, vat and cva/cvi) to screen 216  
E. coli isolates sourced from chickens and environmental samples at the hatcheries (Kwon et al., 
2008). Thus, studies that screen for a greater number of VGs and define APEC with more VGs 
generally identify a lower prevalence of APEC than those studies using fewer VGs. The development 
of a defined set of VGs for the definition of APEC would aid in the direct comparison of multiple 
studies.  
Understanding the risk factors associated with the increased prevalence of APEC can assist managers 
to implement strategies to minimise the presence of the pathogen on the farm. Previous studies have 
suggested that good biosecurity and management protocols are crucial in controlling and reducing 
environment contamination of APEC and preventing colibacillosis (Collingwood et al., 2014; Dho-
Moulin and Fairbrother, 1999; Guabiraba and Schouler, 2015; Kabir, 2010). The current study 
identified risk factors that are in line with results of a number of studies described in various countries 
such as poor quality water sources, no treatment of drinking water and direct and/or indirect contact 
of wild birds with the broiler chickens (Shobrak and Abo-Amer, 2014; Vandekerchove et al., 2004a; 
Wang et al., 2013b). 
The ability of bacteria to survive in water makes drinking water used on broiler farms a potential 
source of infections (Amaral, 2004). Droppings and secretions of wild birds and other animals could 
contaminate water sources on poultry farms. It is common on poultry farms for a single water source 
to supply a large number of birds (Amaral, 2004). Applying basic biosecurity to the drinking water 
source, such as chlorinated water mains, covered water tanks, cleaning and disinfection of tanks and 
water lines between flocks, are important practices to assist in reducing the presence of APEC and/or 
other pathogens in the drinking water (Dhillon and Jack, 1996). 
Water wells have been previously been linked to carriage of APEC (Coleman et al., 2012) and 
Campylobacter coli (Whiley et al., 2013). The use of a water wells as a source of drinking water in 
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three of the surveyed farms in the current study, was associated with higher prevalence of APEC (OR 
= 6.2) compared to farms that used chlorinated mains water and/or dam water. Interestingly, one of 
the three farms that used a well did not use any treatment on the drinking water and the other two 
farms treated the water with chlorine only. The combination of using a water well and the absence of 
water treatment may have contributed to the observed high APEC prevalence. The current study 
highlighted the benefit of using a combined water treatment of chlorination and filtration to reduce 
the prevalence of APEC carriage in broiler chickens. Arsenault et al. (2007) also reported the addition 
of chlorine to the drinking water helped reduce the risk of Campylobacter and Salmonella 
colonisation of the intestinal flora. Similarly, other studies have also reported the benefits  of 
chlorination in reducing prevalence of E. coli and/or other pathogens and/or decreasing mortality 
associated with disease (Dhillon and Jack, 1996; Guerin et al., 2007; Nather et al., 2009; Vandeplas 
et al., 2010). In this study, not disinfecting the water line between each flock increased the APEC 
prevalence by 2.2-fold. This reflects the role of appropriate infection control measures for drinking 
water in reducing the prevalence of APEC as well as other infectious agents (Henry et al., 2011; 
Nather et al., 2009). Hence, the usage of untreated water can be considered as a potential risk factor 
for broiler flock carriage of APEC, and potentially, other infectious agents. It can be recommended 
that farms which utilise a well as a source of drinking water should disinfect the water with chlorine 
and use automatic filtration in order to reduce the prevalence of APEC carriage. Disinfection of the 
water lines after each flock should also be included as a best practise management technique on-
farms.  
One concerning finding of the current thesis was that the majority of farm workers and/or visitors did 
not implement appropriate on-farm biosecurity measures whilst conducting daily work. It was 
reported that employees were not allocated specific personal protective equipment per shed. Rather , 
the same pair of overalls and gumboots were utilised across sheds on the same farm. This can facilitate 
the spread of E. coli as well as other infectious agents from one shed to another or introduce agents 
to the shed from the surrounding environment (Newell et al., 2011). This policy should be re-
evaluated in order to minimise the incidence and spread of infectious agents. Each shed should have 
specific allocated gumboots and overall that are worn exclusively when only working within that 
shed. 
Little data is available regarding the importance of facilities locations and layouts on-farms. The 
current study identified that a distance greater than 20 m between car park and sheds was associated 
with 2.2-fold increase in the APEC prevalence. This finding relates not so much to the proximity of 
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the car park to the sheds, but more to how much farm personnel need to move around the farm before 
undertaking biosecurity procedures (e.g. showering, use of dedicated clothing) and entering the sheds. 
A number of studies showed that APEC is found in the surrounding environment around farms (Anza 
et al., 2014; Cortes et al., 2010; Sola-Gines et al., 2015). The reported overlap between APEC strains 
isolated from farm workers clothes, hands and boots, and poultry farms, suggest that people may act 
as a significant vehicle for the introduction and spread of APEC and other pathogens to the poultry 
farms from the external environment (Belanger et al., 2011; Cho et al., 2012; Johnson et al., 2008b; 
Lynne et al., 2012; Zhu Ge et al., 2014). Movement of staff and visitors between sheds that potentially 
harbour APEC and/or other pathogens may also pose a source of infection (Anza et al., 2014). 
Essentially, parking should be close to the changing area, and stringently imposed requirements for 
the changing of protective overalls and boots is imperative for infection control (Vandekerchove et 
al., 2004a; Wang et al., 2013b). Further studies should aim to investigate these potential risk factors 
and identify the extent that greater distances from car parking to farm facilities has in the increased 
prevalence of pathogens. Guidelines for the design of future poultry farms should consider the 
location of parking facilities relative to the farm offices and change room amenities. In addition to 
this, procedures for all staff and visitors to shower in and out of the facilities can reduce the presence 
of APEC on-farms. This study found that not having shower facility available on the farm premises 
was associated with a 3.6 increase in APEC carriage prevalence on seven farms. Hence, this is a 
management procedure that can be implemented on all farms to reduce the presence of pathogens, 
such as APEC, within the poultry farm boundaries.  
Wild birds present a source of contamination for the poultry flock environment. The presence of wild 
birds within 50 m of the broiler sheds in this study was significantly associated with increased APEC 
prevalence. A previous Australian study investigating Newcastle virus and overseas studies on APEC 
and other infectious agents also identified wild birds as an important biosecurity risk (East, 2007; 
Keawcharoen et al., 2008; Wang et al., 2013b). Wild birds can directly or indirectly encounter broiler 
flocks in their sheds, and they can function as mechanical and/or biological vectors for introducing 
and/or spreading APEC and other avian diseases. The similarity between APEC strains that are 
extracted from wild birds’ faeces and broiler flocks may implicate wild birds as a potential  source of 
risk (Belanger et al., 2011; Oh Jae-Young, 2016). Furthermore, the presence of wild birds can induce 
stress, which is a known predisposing factor for APEC (Nolan et al., 2013). Therefore, there is a need 
to control the presence of wild birds near broiler sheds. This can be achieved by applying restricted 
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biosecurity measures, such as cleaning feed spills and minimising the amount of surface water on the 
farms, to discourage the presence of wild birds (Darrell et al., 2014). 
All farms that were surveyed in this research tested positive for APEC, providing further evidence 
that APEC is common even in the gut of healthy broiler chickens. Exposure to APEC might be a 
contributing factor in cases of avian colibacillosis (Kabir, 2010). Thus, there is a need to implement 
strict biosecurity to reduce the level of APEC exposure on-farms and decrease the prevalence of 
APEC. It is known that the occurrence and severity of avian colibacillosis depends on the 
pathogenicity of the APEC strain, the chicken’s immune status, and the presence of predisposing risk 
factors (Kabir, 2010; Nolan et al., 2013). This study has highlighted some of these risk factors 
including management practices that could currently be contributing to an increased carriage of 
APEC in healthy chickens. Nevertheless, this study has not taken into consideration that there might 
be some interplay between farm management and the immune status of the birds. Further research 
might look at farm management practices to prevent damage to the birds’ immune systems and to 
mitigate the negative impacts of APEC risk. It is also recommended that further investigation should 
seek to identify how the potential risk factors identified in this study contribute to APEC prevalence. 
Other biosecurity questions, such as farm infrastructure, location and surrounding environment, could 
also be further investigated. 
The current study was able to overcome some of the difficulty associated with self-reporting 
questionnaires by conducting piloted face-to-face interviews with three individual broiler farm 
managers to help simplify any unclear questions and as a result, five questions were revised to 
increase their clarity. Face-to-face interviews took place on all of the farms that did not respond to 
overcome the low response rate associated with self-reporting questionnaires. By doing this, we 
achieved 100% responce rate from all the sampled commercial broiler farms.The main limitation of 
this study is that only one integrated large commercial broiler company participated. The broiler 
farms that were sampled belonged to the same company that had implemented the same biosecurity 
practices recommend by the integrated large commercial broiler company. There are currently three 
commercial broiler companies operating in Queensland, and future research could compare 
biosecurity practices with APEC prevalence across these different companies. The commercial 
consolidation of the poultry sector renders it feasible to have an overall biosecurity plan for an 
integrated poultry company that is representative of all Australian poultry production, because these 
three major companies produce 95% of the total poultry produced (Australian Chicken Meat 
Federation, 2014). Another limitation of this study is that it was conducted as a cross-sectional study, 
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and causal associations are difficult to detect with this study type (e.g. whether management 
interventions lead to increased/decreased APEC prevalence, or whether management interventions 
were implemented in response to increased/decreased APEC prevalence). Furthermore, it is difficult 
to compare the prevalence findings between studies accurately based on a cross-sectional research 
design, because there are too many uncontrolled variables. Future investigations could use 
longitudinal or cohort approaches to explore temporal patterns of APEC prevalence and associated 
risk factors. 
4.7 Conclusions 
In summary, the current study identified a high prevalence of APEC carriage in healthy broiler 
chickens in SEQ. Practices such as disinfecting the water lines after each flock, the availability of a 
shower facility on the farm, treatment of water sources, decreased distance between the car park and 
the sheds and/or providing a buffer area close to each shed, where visitors or workers can change into 
protective clothes, are recommended to decrease the risk of APEC carriage and potentially infections. 
Particular attention is needed to control risk factors related to impaired biosecurity protocols on the 
farm, such as direct and indirect contact between chickens and wild birds.   
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5 Chapter 5: Antimicrobial susceptibility, plasmid replicon 
typing, phylogenetic grouping and virulence potential of 
Escherichia coli cultured from Australian broiler chickens 
with and without colibacillosis 
 
5.1 Foreword 
The emergence of multidrug resistance (MDR) (resistance to three or more classes of antimicrobial 
agents) among avian Escherichia coli challenges the treatment of avian colibacillosis and other 
bacterial poultry diseases. Currently, antimicrobials such as amoxicillin and 
trimethoprim/sulfamethoxazole are commonly used to treat and prevent avian colibacillosis. 
Antimicrobials are also commonly used to treat and prevent other bacterial pathogens. The continuous 
use of veterinary growth promoters and antimicrobials in veterinary and human medicine has 
contributed to increased antimicrobial resistance among pathogenic and faecal E. coli strains in 
poultry, causing significant economic and health concerns, for humans and the poultry industry 
(Allocati et al., 2013). 
Chapter 4 identified several risk factors that were associated with increased avian pathogenic E. coli 
(APEC) carriage among commercial broiler chickens. Addressing these risk factors may reduce 
APEC carriage in healthy chickens, decreasing the risk of colibacillosis and hence lowering the need 
for antimicrobials, improving food safety and positively influencing poultry and public health. 
However, data is still required on the current antimicrobial susceptibility of avian E. coli to guide 
veterinarians in the development of appropriate treatment and control strategies. Overseas studies 
have characterised APEC and avian faecal E. coli (AFEC) and described their antimicrobial 
susceptibility (Yang et al., 2004; Zhao et al., 2005). In Australia, prior to this research, few studies 
have investigated the antimicrobial susceptibility of avian E. coli (Abraham et al., 2015; Obeng et 
al., 2012). 
The first aim of the current chapter was to determine and compare the antimicrobial susceptibility 
profile, phylogenetic group, virulence and plasmid replicon profiles of clinical E. coli (CEC) and 
faecal E. coli (FEC) cultured from Australian commercial broiler chickens between 2006 and 2014. 
The second aim was to identify any associations between antimicrobial resistance (AMR) and 
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plasmid replicons, and/or APEC related VGs and/or the phylogenetic groups of the CEC and FEC. 
Further molecular investigation of a subset of these isolates is described in Chapter 7. 
5.2 Abstract  
Avian colibacillosis is a common disease affecting the poultry industry globally. However, little is 
known about Escherichia coli from healthy or diseased poultry in Australia. The aim of the current 
study was to determine and compare antimicrobial susceptibility, phylogenetic group and the profile 
of virulence genes (VGs) and plasmid replicon types of avian clinical E. coli (CEC) and avian faecal 
E. coli (FEC) isolates cultured from Australian commercial broiler chickens. 
Fifty CEC cultured from chickens with colibacillosis and 187 FEC from healthy chickens were 
subjected to antimicrobial susceptibility testing, phylogenetic grouping, plasmid replicon typing and 
VG profiling. Isolates resistant to extended-spectrum cephalosporins (ESCs) and/or fluoroquinolones 
(FQs) underwent further characterisation. 
Twenty six percent of CEC (13/50) and FEC (49/187) were susceptible to all antimicrobials. 
Resistance was most commonly detected to sulfamethoxazole/trimethoprim (44%) and (40%), 
tetracycline (54%) and (28%), streptomycin (24%) and (22%) and ampicillin (28%) and (31%) for 
the CEC and FEC, respectively. Multidrug resistance (resistance to three or more antimicrobial 
classes) was detected in 18% of the CEC and 14% of the FEC. Six percent of the CEC and 4% of the 
FEC were resistant to FQs and/or ESCs. FQ resistant isolates (n = 9) had chromosomal mutations in 
the quinolone resistance-determining region (QRDR), including those within gyrA (83Ser-Leu; 
87Asp-Asn), parC (80Ser-Ile; 84Glu-Gly), parE (458Ser-Ala) and gyrB (476Cys-Met; 477Gly-Val; 
460Lys-Glu; 465Gln-Asp). Thirty three percent of the FQ resistant isolates (n = 3) contained the qnrS 
gene and 44% (n = 4) were sequence type (ST) 354 with other STs (10, 224, 2705 and 6053) also 
represented. One of the ESC isolates (which was also FQ resistance) was ST10 and contained blaCMY-
2 while the other ESC resistant isolate harboured the blaDHA-1 gene and was ST624. 
Clinical E. coli were 65 times more likely to contain five avian pathogenic E. coli associated VGs 
(haemolysin gene (hlyF), increased serum survival gene (iss), outer membrane protease gene (ompT) 
and two iron acquisition system genes (iutA and iroN)) compared to FEC. The majority of CEC and 
FEC were phylogenetic group A (50% and 16%) and C (16% and 29%), respectively. The most 
common plasmid replicon types observed in CEC and FEC were IncFIB (90% and 64%) and IncFrep 
(64% and 61%), respectively. 
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The current study showed diversity in antimicrobial phenotypic resistance, VGs and plasmid replicon 
profiles regardless of the pathogenicity of the E. coli isolates, suggesting that there exists a substantive 
reservoir for associated resistance, VGs and plasmid replicons among E. coli populations from 
commercial broiler chickens. Resistance to older as well as newer antimicrobial drugs was reported 
among the CEC and FEC. Despite no history of use of FQs or ESCs in the Australian broiler chicken 
industry, resistance of E. coli to ESCs and FQs was detected in Australian chickens for the first time. 
ST354 was the most common ST associated with FQ resistance and this sequence type has been 
previously identified in FQ resistant E. coli from people, other domestic animals and wild birds. The 
source of FQ and ESC resistant E. coli may be external to the production facility. The identification 
of resistance to critically important antimicrobials and globally disseminated STs in broiler chickens 
suggests the need for further studies to identify how poultry is included within the broader 
epidemiology of resistance amongst extraintestinal pathogenic E. coli, and the potential significance 
to public health. This approach will assist in guiding improvements in infection control practices at 
the broiler farm production level and optimise both bird health, welfare and public health outcomes. 
5.3 Introduction 
Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), 
is the causative agent of avian colibacillosis in chickens and other poultry species (Collingwood et 
al., 2014; Nolan et al., 2013). Avian colibacillosis is one of the most common systemic infections in 
poultry and is responsible for significant economic losses worldwide (Ewers et al., 2003; Nolan et 
al., 2013). The use of antimicrobial drugs for the treatment as well as the prevention of colibacillosis 
contributes to increased antimicrobial resistance (AMR) among pathogenic and commensal E. coli 
strains (known as avian faecal E. coli (AFEC) in poultry) (Allocati et al., 2013). Avian pathogenic 
Escherichia coli is considered a potentially zoonotic pathogen (Ewers et al., 2007). It has a similar 
phylogenetic background and virulence gene (VG) suite as human ExPEC and, beyond direct 
pathogenic potential, can act as a reservoir for VGs and antimicrobial resistance genes (ARGs), which 
via plasmids or other mobile integrative elements may transfer to other ExPECs (da Costa et al., 
2010; Diarra et al., 2007; Manges and Johnson, 2012; Partridge, 2011) and other pathogenic or 
commensal bacteria (Carattoli, 2013).  
Globally, there is increasing discussion about antimicrobial usage in animals and its impact on public 
health (Landers et al., 2012). Of greatest concern is the use of what the World Health Organisation 
classify as critically important antimicrobials for human medicine (World Health Organization 
(WHO), 2016) in livestock production. Among these are extended-spectrum cephalosporins (ESC) 
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and their potential to select for plasmid-encoded AmpC β-lactamases and CTX-M extended-spectrum 
β-lactamases (ESBLs) in gram-negative pathogens and commensals (Trott, 2013) and subsequent 
transfer of the resistance genes or bacteria to humans via the food chain (Ewers et al., 2012; 
Hammerum and Heuer, 2009; Trott, 2013). A similar concern exists with respect to fluoroquinolone 
(FQ) resistant gram-negative pathogens (Poole, 2000).  
The majority of APEC VGs and ARGs are commonly found on plasmids (Johnson et al., 2007). 
Despite the critical role of plasmids in promoting the spread of VGs and ARGs, only a limited number 
of studies have screened for these plasmids in E. coli in Australia (Abraham et al., 2012; Moran et 
al., 2015) and these have been in isolates originating from pigs and humans. Few Australian studies 
have performed molecular characterisation of virulence, phylogroups and AMR in E. coli strains 
isolated from broiler chickens (Obeng et al., 2012; Obeng et al., 2014) and none have screened for 
the presence of the plasmid replicons among CEC and FEC populations. 
Australia has adopted a conservative position regarding the registration of antimicrobials for food-
producing animals and is the only country to never have permitted the use of FQs in food-producing 
animals (Cheng et al., 2012; Joint Expert Advisory Committee on Antibiotic Resistance (JETACAR), 
1999). Australia also has stringent label restrictions on the use of ESCs in livestock (Australian 
Commission on Safety and Quality in Health Care, 2013 ; Australian Pesticides and Veterinary 
Medicines Authority (APVMA), 2015). Consequently, the level of resistance to all antimicrobials in 
commercial livestock in Australia is low (Abraham et al., 2014; Abraham et al., 2015; Department 
of Agriculture, Fisheries and Forestry (DAFF), 2007). In addition, very few antimicrobials are 
registered for use in broiler chickens in Australia (Australian Pesticides and Veterinary Medicines 
Authority (APVMA), 2015). 
The first aim of the current study was to determine and compare the antimicrobial susceptibility 
profile, phylogenetic group, virulence and plasmid replicon profiles of CEC and FEC isolates cultured 
from Australian commercial broiler chickens. The second aim was to identify the association between 
AMR and plasmid replicons, APEC related VGs and the phylogenetic groups of CEC and FEC. 
5.4 Materials and methods 
5.4.1 Bacterial isolates 
The 237 E. coli study isolates, comprised 50 CEC and 187 FEC, cultured from commercial broiler 
chickens between 2006 and 2014 (Table 5.1) (Animal ethics approval number: Queensland Alliance 
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for Agriculture and Food Innovation/478/12/ Poultry Cooperative Research Centre). All FEC samples 
were from intensive broiler farms located in South East Queensland. 
One hundred and ninety six isolates were previously identified as E. coli by standard biochemical 
tests and PCR amplification of the uspA gene (Chen and Griffiths, 1998) in Chapter 3 (9 CEC and 5 
FEC isolates) and in Chapter 4 (182 FEC isolates). In the current chapter, 41 CEC were confirmed as 
E. coli using the same methods. Isolates were stored in Luria–Bertani broth (Thermo Fisher Scientific 
Australia Pty Ltd, Thebarton, South Australia 5031 Australia) with 20% (v/v) glycerol (Thermo 
Fisher) at -80 °C until further analysis. 
5.4.2 Antimicrobial susceptibility testing and phenotypic testing 
Antimicrobial susceptibility testing was performed by disc diffusion as per Clinical and Laboratory 
Standards Institute guidelines (CLSI) for 20 antimicrobials of veterinary and/or human health 
importance: amikacin (30 μg); amoxicillin/clavulanic acid (30 μg); ampicillin (10 μg); apramycin (15 
μg); cefoxitin (30 μg); ceftazidime (30 μg); ceftiofur (30 μg); cefovecin (30 μg); cephalothin (30 μg); 
chloramphenicol (30 μg); ciprofloxacin (5 μg); florfenicol (30 μg); gentamicin (10 μg); imipenem 
(10 μg); neomycin (30 μg); spectinomycin (100 μg); streptomycin (10 μg); 
sulfamethoxazole/trimethoprim (1.25/23.75 μg); tetracycline (30 μg) and ticarcillin/clavulanic acid 
(75/10 μg) (Clinical and Laboratory Standards Institute (CLSI), 2013; Clinical and Laboratory 
Standards Institute (CLSI), 2015a; Clinical and Laboratory Standards Institute (CLSI), 2015b). All 
antimicrobial discs were obtained from Thermo Fisher Scientific Australia Pty Ltd. The quality 
control organism used was E. coli ATCC 25922. As none of the antimicrobials tested has a veterinary 
specific breakpoint for poultry, interpretative criteria was extrapolated from the CLSI guidelines for 
other animal species (including human) for Enterobacteriaceae as recommended (Clinical and 
Laboratory Standards Institute (CLSI), 2015a; Clinical and Laboratory Standards Institute (CLSI), 
2015b). For antimicrobials that lacked published CLSI break points, apramycin (Bayer Australia, 
Pymble, NSW, 2073, Australia) and neomycin (Zoetis, West Ryde, NSW, 2114, Australia), 
breakpoint information was obtained directly from the respective manufacturers. For cefovecin 
breakpoints, the interpretative criteria proposed by Šeol et al. (2011) were applied. For antimicrobials 
florfenicol and spectinomycin, which have no CLSI breakpoints for E. coli, breakpoints established 
for bovine Pasteurella multocida were used (Clinical and Laboratory Standards Institute (CLSI), 
2015a). For the purpose of the current study, E. coli isolates with intermediate susceptibility were 
defined as not resistant and isolates were considered multidrug resistant (MDR) if they were resistant 
to three or more antimicrobial classes. 
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Isolates that demonstrated resistance to ciprofloxacin by disc diffusion underwent minimum 
inhibitory concentration (MIC) testing by broth dilution to enrofloxacin and ciprofloxacin as per 
CLSI guidelines (Clinical and Laboratory Standards Institute (CLSI), 2013; Clinical and Laboratory 
Standards Institute (CLSI), 2015a; Clinical and Laboratory Standards Institute (CLSI), 2015b). The 
MIC was defined as the lowest antimicrobial concentration that inhibited bacterial growth. E. coli 
ATCC 25922 was used as the quality control organism and the MIC interpretation was based on the 
breakpoints provided by the CLSI guidelines (Clinical and Laboratory Standards Institute (CLSI), 
2015a; Clinical and Laboratory Standards Institute (CLSI), 2015b). In addition, isolates underwent 
ciprofloxacin and enrofloxacin MIC testing in the presence of the efflux pump inhibitor, Phe-Arg-β-
naphthylamide (Sigma-Aldrich, Castle Hill, NSW, 1765, Australia) at 64 mg/L (Platell et al., 2011). 
Pseudomonas aeruginosa ATCC 27853, E. coli A100, E. coli AG100A, E. coli AG112 (Kern et al., 
2006) were used as quality control organisms. All antimicrobial powders were obtained from Sigma -
Aldrich. Isolates that were resistant to ESCs underwent MIC testing by broth dilution to cefoxitin and 
ceftiofur as per CLSI guidelines (Clinical and Laboratory Standards Institute (CLSI), 2013; Clinical 
and Laboratory Standards Institute (CLSI), 2015a; Clinical and Laboratory Standards Institute 
(CLSI), 2015b). The quality control strain used was E. coli ATCC 25922. All ESC resistant isolates 
were examined for the presence of extended-spectrum and plasmid-mediated AmpC β-lactamases 
using the MAST DISCS ™ ID AmpC and ESBL (D68C, Mast Group Ltd, UK). 
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Table 5.1: Number, source, samples site, location and date of isolation of 50 clinical E. coli (CEC) and 187 faecal E. coli (FEC) isolates cultured 
from commercial broiler chickens in Australia. 
Type of isolates Number of 
isolates 
Source and samples site Location Date of isolation Reference 
FEC 182 Cloacal swab of healthy chickens Various locations within 
South East Queensland 
2013 - 2014 Chapter 4 
FEC 5 Cloacal swab of healthy chickens 3 chicken farms within 
South East Queensland 
2013 Chapter 3 
CEC 9 Colibacillosis site in chicken 
liver (n = 2), air sac (n = 1), lung (n = 2), heart (n = 2), spleen (n = 
1) and cloacal swabs (n = 1) 
3 chicken farms within 
South East Queensland 
2013 Chapter 3 
CEC 30 Colibacillosis site in chicken 
abdomen (n = 2), air sac (n = 1), cloaca (n = 3), heart (n = 1), 
infraorbital sinus (n = 1), intestine (n = 1), liver (n = 4), lung (n = 
7), pericardium (n = 1) peritoneum (n = 3), pleura (n = 1), nasal 
cavity (n = 1), trachea (n = 1) and yolk sac (n = 3) 
Various locations around 
Australia 
2006 - 2013 Chapter 5 
CEC 11 Colibacillosis site in chicken 
liver (n = 1), lung (n = 3), pericardium (n = 1), air sac (n = 1) 
intestinal (n = 1), peritoneum (n = 2), duodenum (n = 1), and 
subcutaneous (n = 1) 
Various locations around 
Australia 
2013 - 2014 (Abraham et 
al., 2015)  
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5.4.3 Identification of virulence genes 
In the current Chapter, 41 CEC isolates were screened for the presence of five APEC related VGs 
(iroN, iutA, iss, hlyF and ompT) using a pentaplex-PCR developed by Johnson et al. (2008b). While 
previously, in Chapter 3, nine CEC and five FEC and in Chapter 4 182 FEC were screened for the 
presence of these APEC related VGs using the same pentaplex-PCR. The positive and negative 
controls for the pentaplex-PCR were E. coli STJ-1 (Fagan et al., 1999 ) and E. coli ATCC 8739, 
respectively. 
5.4.4 Phylogenetic analysis, plasmid replicon typing and plasmid multilocus sequence typing 
Each of the E. coli isolates were assigned to one of the eight distinct phylogenetic groups A, B1, B2, 
C, D, E, F and Escherichia cryptic clade I (termed E. clade 1) using the Clermont phylogenetic 
grouping quadraplex PCR plus the follow up PCRs (Clermont et al., 2013). Isolates were also 
examined for the presence of 18 plasmid replicons: IncFIB; IncI1; IncFIIA; IncP; IncB/O; IncN; 
IncFIC; IncA/C; IncHI2; IncT; IncN; IncW; IncFIA; IncY; IncFrep; IncX; IncHI1 and IncL/M, using 
three multiplex panels (Johnson et al., 2007). Plasmid multilocus sequence typing (pMLST) based 
on pill; sogS; ardA; repI1 and trbA was performed on ten isolates (3 CEC and 7 FEC) which contained 
the Incl1 plasmid [://pubmlst.org/plasmid/] (Garcia-Fernandez et al., 2008). 
5.4.5 Molecular characterisation of isolates resistant to FQs and/or ESCs 
All ESC and FQ resistant isolates underwent multilocus sequence typing (MLST) according to the 
University of Warwick MLST scheme, which is based on seven housekeeping genes: adk; fumC; 
gyrB; icd; mdh; purA and recA (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli).  
Polymerase chain reaction and subsequent amplicon-sequencing of the QRDR of gyrA, gyrB, parC 
and parE genes and screening for plasmid-mediated quinolone resistance (PMQR) genes: qnrA; 
qnrB; qnrS; qepA and aac(6’)-Ib-cr were performed on all FQ resistant isolates as previously 
described (Gibson et al., 2010; Platell et al., 2011). Amplified PCR products were sequenced at the 
Animal Genetic Laboratory Facility, University of Queensland, Gatton, Australia on a 3130xl DNA 
Analyser. Identification of the sequenced regions was completed using the GenBank DNA database 
using the BLAST alignment (http://blast.ncbi.nlm.nih.gov). 
All isolates resistant to ESCs were screened for the presence of AmpC β-lactamase genes as 
previously described (Perez-Perez and Hanson, 2002). The primer pair CMY25F1 and CMYDR1 was 
used to amplify and sequence the entire structural gene of blaCMY-2 (Hanson et al., 2002). The primer 
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pair DHA-1A and DHA-1B was used to amplify and sequence the entire structural gene blaDHA-1 
(Mata et al., 2012). 
5.4.6 Statistical analysis 
Analyses were performed in Stata software (13th edition, Blackburn North Victoria, Australia, 
www.stata.com). Odds ratios (OR) with a 95% confidence interval (CI) for AMR, phylogenetic 
group, VGs and plasmid replicon status relative to CEC and FEC designation were calculated using 
logistic regression. Differences in the prevalence and association of AMR, different phylogenetic 
groups, plasmid replicons and VGs were assessed between FEC and CEC using the Fisher exact test. 
Statistical significance was set at a p-value of < 0.05.  
5.5 Results 
5.5.1 Antimicrobial susceptibility and phenotypic results 
The prevalence of antimicrobial resistance for CEC and FEC isolates are shown in Table 5.2. All of 
the isolates were susceptible to amikacin, ceftazidime, ceftiofur, imipenem and florfenicol. Twenty 
six percent of both the CEC (13/50) and FEC isolates (48/187) were susceptible to all antimicrobials. 
Clinical E. coli isolates demonstrated the most resistance to tetracycline (54%), 
sulfamethoxazole/trimethoprim (44%), ampicillin (28%) and streptomycin (24%). Faecal E. coli 
isolates demonstrated resistance to sulfamethoxazole/trimethoprim (40%), ampicillin (31%), 
tetracycline (28%), cephalothin (25%) and streptomycin (22%). One CEC isolate was resistant to 
ESCs, one to FQs and one CEC was resistant to both ESCs and FQs. Seven FEC were resistant to 
FQs. Compared to FEC, CEC isolates had a significantly greater prevalence of resistance (p < 0.05) 
to tetracycline, gentamicin, apramycin and spectinomycin (Table 5.2). Faecal E. coli were more 
resistant to cephalothin (p < 0.002). Nine resistance patterns were identified among the CEC isolates 
and 28 different resistance patterns in the FEC isolates. Multidrug resistance was detected in 18% of 
the CEC isolates (n = 9) and 14% of the FEC isolates (n = 26) (p < 0.997).  
All isolates resistant to ciprofloxacin by disc diffusion were resistant to ciprofloxacin and 
enrofloxacin by MIC. The ciprofloxacin and enrofloxacin MICs showed a two to four-fold decrease 
in the presence of the efflux inhibitor in FQ resistant clinical and FEC isolates (Table 5.6). 
Two CEC isolates were resistant to ESCs, one isolate (B1) was resistant to both ceftiofur and cefoxitin 
on MIC, while B3 was resistant to cefoxitin and showed intermediate susceptibility to ceftiofur. An 
AmpC β-lactamase was detected in both of these isolates using the MAST DISCS ™. All quality 
control values were within the stated range for all tests. 
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Table 5.2: Number (N), prevalence (%) and Odd ratio (OR) with 95% confidence interval (CI) of antimicrobial resistance by disc diffusion 
among 50 clinical E. coli (CEC) and 187 faecal E. coli (FEC) isolates from commercial broiler chickens in Australia. 
Drug classes 
Drug 
sub classes 
Antimicrobial drug 
CEC 
N (%) 
FEC 
N (%) 
OR 
(95% CI) 
p-value 
 
β-lactams Penicillin Ampicillin 14 (28) 59 (31) 0.84 (0.39, 0.75) 0.765 
 Potentiated penicillins Amoxicillin/clavulanic acid 2 (4) 8 (4) 0.93 (0.19, 4.89) 1.000 
  Ticarcillin/clavulanic acid 1 (2) 2 (1) 1.88 (0.31, 36.8) 1.000 
 
1st generation 
cephalosporin 
Cephalothin 3 (6) 47 (25) 0.19 (0.36, 0.64) 0.002 
 3rd generation 
cephalosporin 
Ceftazidime 0 0   
 Cefoxitin 2 (4) 0 9.18 (0.71, +∞) 0.087 
 Cefovecin 2 (4) 0 9.18 (0.71, +∞) 0.087 
 *Ceftiofur 0 0   
 Carbapenem Imipenem 0 0   
Fluoroquinolones  Ciprofloxacin 2 (4) 7 (4) 1.03 (0.96, 1.01) 0.841 
Amphenicols  Chloramphenicol 1 (2) 2 (1) 1.85 (0.03, 36.2) 1.000 
  Florfenicol 0 0   
Aminoglycosides  Gentamicin 6 (12) 5 (3) 4.91 (1.19, 21.4) 0.026 
  Apramycin 4 (8) 1 (0.5) 15.7 (1.51, 792) 0.015 
  Neomycin 4 (8) 4 (2) 3.95 (0.71, 22.0) 0.127 
  Spectinomycin 4 (8) 0 20.9 (2.57, +∞) 0.003 
  Streptomycin 12 (24) 41 (22) 1.12 (0.48, 2.45) 0.887 
  Amikacin 0 0   
Potentiated 
sulphonamide 
 Sulfamethoxazole/trimethoprim 22 (44) 75 (40) 1.17 (0.59, 2.31) 0.734 
Tetracycline  Tetracycline 27 (54) 52 (28) 3.01 (1.51, 6.05) < 0.001 
* One isolate was intermediately susceptible to ceftiofur on disc diffusion, therefore was identified as not resistant. However, on minimum inhibitory concentration (MIC) testing this 
isolate was resistant.  
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5.5.2 Identification of virulence genes and relationships between resistance and virulence  
genes 
The prevalence of the five APEC related VGs detected in the CEC and FEC isolates are presented in 
Table 5.3. Four percent (n = 2) of the CEC isolates contained none of the five VGs (the two FQ 
resistant isolates), compared with 19% (n = 36) of the FEC isolates (Table 5.3). An association 
between certain VGs and some phenotypic resistances were detected among the CEC. This included: 
iroN with resistance to ampicillin and iss, iutA, ompT, hlyF and iroN with resistance to gentamicin 
(Supplementary Table 2). An association between iutA and iroN with resistance to cephalothin and 
iss with sulfamethoxazole/trimethoprim was observed among the FEC (Supplementary Table 2). 
There was no association between MDR isolates and the APEC related VGs: 77.8% of the CEC MDR 
(7 of 9) contained all five APEC related VGs while two harboured none (p < 0.412). Four percent of 
the FEC MDR isolates (1 of 26) contained no APEC related VGs in comparison with 8% that 
harboured all five APEC related VGs (2 of 26) (p < 0.2493). 
One of the FQ resistant FEC isolates didn’t harbour any APEC related VGs. However, different VGs 
patterns were observed among the other six FQ resistant FEC isolates. One isolate harboured four 
VGs (iss, iutA, ompT and hlyF), one harboured two (iss and iutA), three harboured only iutA and one 
only contained iss (Table 5.6). One of the ESC resistant CEC isolates contained all five VGs while 
the other ESC resistant isolate (which was also FQ resistant) harboured none of the CEC related VGs 
(Table 5.6). 
 
Table 5.3: Number (N), prevalence (%) and Odd ratio (OR) with 95% confidence interval (CI) 
of five virulence genes among 50 clinical E. coli (CEC) isolates and 187 faecal E. coli (FEC) 
isolates from commercial broiler chickens in Australia. 
Category 
CEC 
N (%) 
FEC 
N (%) 
OR 
(95% CI) 
p-value 
Virulence Genes 
iroN 45 (90) 71 (38) 14.55 (5.43, 49.2) < 0.001 
ompT 48 (96) 106 (57) 18.19 (4.63, 162) < 0.001 
iss 48 (96) 82 (43) 30.4 (7.58, 265) < 0.001 
hlyF 48 (96) 102 (56) 19.83 (4.94, 173) < 0.001 
iutA 48 (96) 110 (58) 16.67 (4.06, 142) < 0.001 
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5.5.3 Identification of plasmid replicons and relationships between resistance and plasmid 
replicons 
Multiplex PCR analysis for 18 plasmid replicon types for the CEC (n = 50) and FEC isolates (n = 
187) are presented in Table 5.4. Fifteen plasmid types were identified with at least one or more 
plasmids detected among 94% and 92% of the CEC and FEC isolates, respectively. None of the 
isolates contained plasmid replicons IncT, IncFIC and IncW. The most frequently observed plasmid 
replicons were IncFIB (90% and 64%, CEC and FEC, respectively), followed by IncFrep (64% and 
61%, respectively). IncFIB was three times more likely to be found in CEC than FEC isolates (p < 
0.003). The IncB/O (p < 0.001) and IncK/B (p < 0.018) replicons were detected in a higher frequency 
among the FEC isolates in comparison with CEC isolates. Three CEC (6%) and 15 FEC isolates (8%) 
had no plasmid replicons detected. The plasmid replicons IncP, IncK/B, IncFIIA and IncL/M were 
not found in the CEC isolates, while the replicons IncA/C and IncX were not found in the FEC 
isolates. Other plasmid replicons were identified infrequently among FEC and CEC isolates. Seventy 
percent of CEC isolates (n = 35) contained two plasmid replicon types and 24% (n = 12) contained  
one plasmid replicon. Nineteen percent of FEC isolates (n = 35) contained two plasmid replicon types; 
30% (n = 56) contained three plasmid replicons, six percent (n = 12) contained four plasmid replicons 
and one percent (n = 2) contain more than five plasmid replicons.  
The plasmid replicons that were linked with a higher prevalence of resistance among CEC included 
IncB/O (resistance to ampicillin and gentamicin), IncK/B (neomycin) and IncFIB (cephalothin) (p < 
0.05). Plasmid replicon IncFIB was significantly associated with cephalothin resistance among FEC 
(p < 0.003). The faecal isolates demonstrate a significant association (p < 0.05) between plasmid 
replicon IncN, IncA/C and IncL/M and resistance to gentamicin, streptomycin and chloramphenicol , 
respectively. While the FQ resistant CEC shows a significant association with plasmid replicon IncY 
(p < 0.004). 
The plasmid replicon profiles for the FQ and ESC resistant CEC and FEC are presented in Table 5.6. 
None of the CEC isolates had the same profile and no replicon profile was common across the CEC 
and FEC isolates. Only two of the seven FEC isolates shared the same replicon profile.  
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Table 5.4: Number (N), prevalence (%) and Odd ratio (OR) with 95% confidence interval (CI) 
of plasmid replicon among 50 clinical E. coli (CEC) isolates and 187 faecal E. coli (FEC) isolates 
from commercial broiler chickens in Australia. 
Category 
CEC  
N (%) 
FEC  
N (%) 
OR 
(95% CI) 
p-value 
IncB/O 3 (6) 65 (35) 0.12 (0.02, 0.40) < 0.001 
IncA/C 3 (6) 0 14.9 (1.58, +∞) 0.018 
IncP 0 1 (0.5) 3.74 (0, 145) 1.000 
IncK/B 0 18 (10) 0.12 (0, 0.75) 0.018 
IncFIIA 0 1 (0.5) 3.74 (0, 145) 1.000 
IncFIA 4 (8) 9 (5) 1.73 (0.33, 6.64) 0.676 
IncFIB 45 (90) 120 (64) 3.41 (1.42, 9.50) 0.003 
IncY 2 (4) 5 (3) 1.53 (0.14, 9.59) 0.909 
IncI1 5 (10) 30 (16) 0.56 (0.16, 1.57) 0.355 
IncFrep 32 (64) 114 (61) 1.10 (0.55, 2.24) 0.913 
IncX 1 (2) 0 3.74 (0.09, + ∞) 0.422 
IncHI1 3 (6) 1 (0.5) 11.7 (0.91, 626) 0.060 
IncN 5 (10) 9 (5) 2.19 (0.54, 7.70) 0.296 
IncHI2 1 (2) 1 (0.5) 2.18 (0.54, 7.70) 0.378 
IncL/M 0 2 ( 1) 1.54 (0, 20.1) 1.000 
1 Plasmid replicons IncT, IncFIC and IncW were not detected.  
 
5.5.4 Identification of phylogenetic group and relationships between resistance and 
phylogenetic group 
The distribution of phylogenetic groups of the 50 CEC and the 187 FEC is summarised in Table 5.5. 
The clinical E. coli isolates were three times more likely to be phylogenetic group A compared to 
FEC (p < 0.001). No other significant differences between phylogenetic group and CEC or FEC were 
detected (Supplementary table 3).  
The association between phenotypic antimicrobial resistance and phylogenetic groups among CEC 
and FEC is show in Supplementary Table 3. A significant association was detected between 
phylogenetic group B2 and CEC isolates resistance to trimethoprim-sulfamethoxazole (p < 0.02). 
Phylogenetic group F was significantly associated with FQ resistant faecal isolates (p < 0.03). 
All FQ and ESC resistant CEC belonged to phylogenetic group A. Seventy one percent of the FQ 
resistant FEC isolates (n = 5) belonged to group F and 29% (n = 2) group B1 (Table 5.6). 
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Table 5.5: Number (N), prevalence and odd ratio with 95% confidence interval (CI) of 
phylogentic group1 among 50 clinical E. coli (CEC) isolates and 187 faecal E. coli (FEC) isolates 
from commercial broiler chickens in Australia. 
Category 
CEC 
N (%) 
FEC 
N (%) 
OR 
(95% CI) 
p-value 
Phylogenetic Group 
A 25 (50) 30 (16) 4.79 (2.30, 10.0) < 0.001 
B1 2 (4) 18 (10) 0.39 (0.04, 1.73) 0.325 
B2 5 (10) 12 (6) 1.61 (0.42, 5.25) 0.550 
C 8 (16) 54 (29) 0.13 (0.003, 0.89) 0.321 
D 1 (2) 24 (13) 0.486 (0.172, 1.19) 0.128 
E 0 12 (6) 0.232 (0, 1.46) 0.138 
F 9 (18) 31 (17) 1.25 (0.50, 2.91) 0.703 
E. clade 1 0 5 (3) 0.547 (0, 4.10) 0.605 
All of the E. coli isolates were assigned to one of the eight distinct phylogenetic groups using the Clermont phylogenetic 
grouping quadraplex PCR plus the follow up PCRs (Clermont et al., 2013). 
5.5.5 Plasmid multilocus sequence typing 
The results for the pMLST sequence typing for the 10 MDR avian isolates (seven FEC and three 
CEC) that contained IncI1 are present in Table 5.7. In summary, there was no common ST between 
the faecal and CEC isolates. The three CEC isolates each had a unique ST - ST3, ST183 and ST200. 
Of the seven FEC isolates, two isolates were allocated to each of ST21 and ST201 while the remaining 
three isolates had a unique ST: ST119; ST148 and ST202. In terms of clonal complex (CC), ST3 
belongs to CC3 and ST21 belongs to CC5.  
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5.5.6 Molecular characterisation of isolates resistant to FQs and/or ESCs.  
One of the CEC FQ resistant isolates was ST10 while the others were ST224 and ST624 (Table 5.6). 
The majority of the FQ resistant FEC isolates (n = 4) were ST345, while the others were ST57, 
ST2705 and ST6053 (Table 5.6). 
The two FQ resistant CEC isolates demonstrated known mutations in the QRDRs, including a double 
mutation in gyrA (83Ser-Leu; 87Asp-Asn) and a single mutation in parC (80Ser-Ile). A single 
mutation in parE (458Ser-Ala) was also detected in both isolates. Both isolates had two mutations in 
gyrB, B1 (476Cys-Met, 477Gly-Val) and B2 (460Lys-Glu, 465Gln-Asp), although these mutations 
are not in known quinolone resistance-determining sites. No PMQR genes were identified. The seven 
FQs resistant FEC isolates demonstrated known mutations in the QRDRs, including a double 
mutation in gyrA (83Ser-Leu; 87Asp-Asn) and a double mutation in parC (80Ser-Ile; 84Glu-Gly). 
No mutations were detected in parE. Isolates 107D, 368B and 255H had one mutation in gyrB 
(460Lys-Glu), although this mutation is not in a known quinolone resistance-determining site. Three 
out of the seven FEC FQ resistant isolates harboured the qnrS1 gene.  
AmpC β-lactamase genotyping showed that one of the ESC resistant isolates (B1) contained blaCMY-
2 and belonged to ST10. The other ESC resistant isolate (B3) harboured the blaDHA-1 gene and was 
ST624 (Table 5.6). 
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Table 5.6: Characterisation of extended-spectrum cephalosporin and/or fluoroquinolone resistant CEC (n = 3) and FEC (n = 7) cultured from 
commercial broiler chickens.  
Location 
of the 
isolate 
Isolate 
ID 
Sample/ 
Farm 
MIC mg/L Antibiogram 
Phylo-
genetic 
group 
ST Plasmid replicon 
Virulence 
genes 
pARG 
   CIP CIP 
EPI 
ENR ENR 
EPI 
EFT FOX       
  Clinical E. coli isolates 
Various locations 
around Australia  
B1 Nasal 
Cavity 
64 16 64 8-16 8 32 FOX, CIP AMC, AMP, 
KF, STR,GN, SH, SXT, 
TE  
A 10 IncY, IncI1 ND blaCMY2 
Various locations 
around Australia 
B2 Air 
Sac 
64 16 128 8-16 NT NT CIP, AMP, STR, KF, 
CHL, GN, N, SH, SXT, 
TE 
A 224 ND ND  
Various locations 
around Australia 
B3 Cloaca NT NT NT NT 2-4 256 FOX, AMP, STR AMC, 
KF, N, SXT, TE,  
A 624 IncFIA, IncFIB, 
IncFrep 
iss, iutA, 
ompT, hlyF, 
iroN 
blaDHA1 
  Faecal E. coli isolates 
SEQ 107D 9 64 32 128 8 NT NT CIP, GN, TE  F 6053 IncFIA, IncFIB iss, iutA  
SEQ 131D 11 64 32 128 8 NT NT CIP, GN, TE,  F 354 IncB/O, IncK/B, 
IncFIA, IncFIB 
iutA qnrS1 
SEQ 196B 15 64 32 128 8 NT NT AMP, KF, CIP, GN, SXT, 
STR  
F 354 IncB/O, IncK/B, 
IncFIA, IncFIB, 
IncFrep 
iss qrnS1 
SEQ 255H 24 64 32 128 8 NT NT AMP, CIP, TE, APM F 354 
 
IncFIA, IncFIB, 
IncI1 
iutA  
SEQ 412A 39 64 32 128 8 NT NT KF, GN, CIP F 354 IncB/O, IncK/B, 
IncFIA, IncFIB 
iutA  
SEQ 56E 4 64 32 128 8 NT NT AMP, CIP, SXT, TE, STR B1 2705 IncFIB iss, iutA, 
ompT, hlyF 
 
SEQ 368B 35 64 32 64 8 NT NT AMP, KF, CIP, GN, SXT, 
TE, STR 
B1 57 IncFrep, IncN ND qnrS1 
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MIC, minimum inhibitory concentration, EPI, Efflux Pump Inhibitor (PaβN) 64mg/L; ST, sequence type; pARG, Plasmid-mediated antimicrobial resistance genes; ND, not detected; 
NT, not tested; AMC, amoxicillin/clavulanic acid; AMP, ampicillin; KF, cephalothin; STR, streptomycin; GN, gentamicin; SEQ, South East Queensland; SH, spectinomycin; SXT, 
trimethoprim-sulfamethoxazole; ENR, enrofloxacin; EFT, ceftiofur; FOX, cefoxitin; TE, tetracycline; CIP; ciprofloxacin; CHL, chloramphenicol; N, neomycin; APM, apramycin.  
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Table 5.7: Plasmid multilocus sequence typing (pMLST) of the IncI1 from three clinical (CEC) 
and seven faecal E. coli isolates (FEC) from broiler chickens in Australia. 
Isolate ID 
Allele IncI1 typing 
Sequence typing Repl1 ardA trbA SogS PilL 
Clinical E. coli isolates 
B1 1 2 8 10 10 183 
B3 2 1 4 1 2 3 
B4 1 2 17 3 2 200 
Faecal E. coli isolates 
29C 1 2 17 6 18 119 
62C 1 2 11 3 3 21 
84E 1 4 3 4 3 148 
200C 1 9 3 4 3 201 
177D 1 2 11 3 3 21 
295F 1 9 3 4 3 201 
365C 1 3 5 4 3 202 
 
5.6 Discussion 
This study investigated antimicrobial susceptibility of CEC and FEC from Australian broiler chickens 
and looked for associations between AMR, VGs, phylogenetic groups and plasmid replicons. AMR 
was low, though resistance to important antimicrobials was detected at very low levels. Clinical  
E. coli harboured more APEC linked VGs in comparisons with FEC. A significant association 
between plasmid replicons type IncFIB and IncA/C occurred among CEC in comparison with FEC. 
Clinical E. coli isolates were also three times more likely to belong to phylogenetic group A compared 
to FEC. 
The majority of CEC and FEC isolates which were resistant to antimicrobials were resistant to well 
established antimicrobial drugs such as ampicillin, tetracycline and trimethoprim/sulfamethoxazole 
that have been registered and used for many years in the poultry industry in Australia. Previous studies 
in Australia and further afield for both pigs and poultry have shown similar (Abraham et al., 2015; 
Department of Agriculture, Fisheries and Forestry (DAFF), 2007). The long and continuous usage of 
these antimicrobials in Australia, as well as residual environmental contamination, may explain the 
persistence of AMR among E. coli isolates sourced from broiler chickens (Walsh and Fanning, 2008). 
The current study showed that compared to FEC, CEC had a significantly greater prevalence of 
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resistance (p < 0.05) to tetracycline, gentamicin, apramycin and spectinomycin. This may be due to 
the chickens from which CEC isolates were cultured being treated with antimicrobials prior to 
sampling. Although, gentamicin is no longer registered for use in food-producing animals, other 
aminoglycosides drug such as apramycin, neomycin and spectinomycin are still used in the Australian 
broiler industry. The use of these aminoglycoside drugs can cause cross-resistance to gentamicin 
(Choi et al., 2011; Jensen et al., 2006). Co-resistance, may also occur and selection pressure 
associated with the commonly used antimicrobials such as amoxicillin, tetracycline and 
trimethoprim/sulfamethoxazole may select for gentamicin resistance (Schwarz and Chaslus-Dancla, 
2001).  
The low levels of AMR detected in the current study reflects the strict regulation of antimicrobials 
used in food-producing animals in Australia and can be compared to similar studies undertaken in 
other countries, such as Denmark and the Netherland which also have restricted antimicrobial use 
and low levels of AMR (NORM/NORM-VET, 2007; Swedish Veterinary Antimicrobial Resistance 
Monitoring (SVARM), 2007). In comparison, higher levels of resistance were detected in countries 
with less stringent antimicrobial use regulations such as Egypt, Korea and China (Aarestrup, 2005; 
Hussein et al., 2013; Kim et al., 2007; Yang et al., 2004).  
Very low level of resistance to critically important antimicrobials, ESCs and FQs, were detected 
among the clinical and FEC isolates. Extended-spectrum cephalosporins and FQs have never been 
used in the poultry industry in Australia (Australian Pesticides and Veterinary Medicines Authority 
(APVMA), 2015). In fact, Australia is the only country that has never permitted the use of 
fluoroquinolones in food-producing animals (Cheng et al., 2012; Ndi and Barton, 2012). 
Furthermore, cephalosporins are not used in poultry in Australia (Australian Pesticides and 
Veterinary Medicines Authority (APVMA), 2015). However, resistance to FQs and ESCs have 
recently been reported in Australia in other food-producing animals (Abraham et al., 2015). 
Identification of resistance in the absence of antimicrobial selection may indicate that these resistant 
isolates originated from humans (Meyer et al., 2010), wild birds (Smith et al., 2014) and/or from the 
environment (Alves et al., 2014; Sjolund et al., 2008) and gained access to the poultry production 
environment. Further screening and characterisation of antimicrobial resistant E. coli isolates from 
wild bird species, wild animals and the environment as occurred in some studies already (Guenther  
et al., 2011; Radhouani et al., 2014) could provide evidence of a potential risk pathway for the 
transmission of bacteria as well as the resistance genes. Furthermore, vertical and/or horizontal co-
selection pressure could be considered as a possible explanation for the FQ and ESC resistance 
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reported in the current study (Oz et al., 2014). An efflux pump was identified phenotypically in all 
FQ resistant isolates. Efflux pumps may select for resistance to FQs and other antimicrobial drugs 
simultaneously. Additionally, a PMQR gene (qnrS) was detected in three of the FEC isolates. This 
finding is in agreement with a previous study in dogs and humans in Australia (Tagg et al., 2015) as 
well as globally (Cremet et al., 2011; Rodriguez-Martinez et al., 2006; Yang et al., 2014), where qnrS 
were detected either alone or in combination with other PMQR gene. The dissemination of the PMQR 
genes among some of the FQ resistant faecal isolates suggests horizontal co-selection pressures due 
to the use of other antimicrobial drugs (Liu et al., 2013; Osinska et al., 2016).  
The current study has, for the first time, reported the detection of blaCMY-2 and blaDHA-1 in ESC 
resistant E. coli isolates cultured from broiler chickens in Australia. The blaCMY-2 and blaDHA-1 genes 
have been previously reported in other animals and other bacterial species in Australia (Abraham et 
al., 2014; Cherif et al., 2015; Rogers et al., 2014; Sidjabat et al., 2007). This is of great public health 
significance as those genes can be transmitted directly (via the food chain or environment) or 
indirectly (via mobilised plasmid) to other bacterial species  
The blaCMY-2 gene is the most frequently detected AmpC β-lactamases in food-producing animals 
worldwide (Jacoby, 2009; Sidjabat et al., 2007). This gene has been detected among E. coli isolates 
sourced from animals as well as humans and may be transmitted via horizontal gene transfer via 
conjugation of plasmids such as IncI1 (Carattoli, 2009; Johnson et al., 2007). The blaDHA-1 gene has 
recently increased in prevalence, which may suggest the acquisition of new plasmids among AmpC 
β-lactamases harbouring E. coli sourced from broiler chickens (Mata et al., 2012; Tagg et al., 2015).  
The majority of the sequence types (ST10, ST57 ST 224, ST354 and S624) identified in the current 
study from FQ and ESC resistant isolates have been previously described and are globally distributed 
amongst humans as well as animals (Fernandes et al., 2016; Kim et al., 2011; Maluta et al., 2014; 
Sola-Gines et al., 2015; Zhao et al., 2014). ST2705 and ST6053 are host restricted and have been 
previously isolated from poultry and wild birds (Dahms et al., 2015; Day et al., 2016; Jones-Dias et 
al., 2015). The majority of the FQ resistant FEC were identified as ST354 belonging to phylogenetic 
group F. This ST has been previously identified in pathogenic E. coli from chickens, dogs, cats and 
pigs as well as in non-pathogenic E. coli, worldwide (Kim et al., 2011; Mora et al., 2011; Schaufler  
et al., 2015). Furthermore, ST354 has been recently reported in Australia from FQ resistant faecal 
and pathogenic E. coli isolates sourced from humans, birds, canines and the environment (Guo et al., 
2015; Vangchhia et al., 2016).  
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Genetic diversity was reported among the FQ resistant isolates with none of the FEC belonging to 
phylogenetic group A, only CEC were group A. The current study reported a variation in the ST 
among the clinical FQ resistant isolates (keeping in mind that there was only two clinical FQ resistant 
isolates) with one assigned as ST224 while the other was ST10. Both STs have previously been 
identified in horses, dogs, buffalos and human pathogenic and non-pathogenic E. coli (Abraham et 
al., 2015; Aizawa et al., 2014; Dissanayake et al., 2014; Maluta et al., 2014; Manges and Johnson, 
2012; Pires-dos-Santos et al., 2013; Vignaroli et al., 2012; Zhao et al., 2014). 
Determining the origin of the STs, which are common among humans and birds is difficult, but the 
identification of these STs could imply a possible transmission link between humans and poultry. 
Chickens may also act as a source for the transmission of bacteria into the surrounding environment 
(Fernandes et al., 2016). Wild birds and other animals, such as vermin and rodents, (Dahms et al., 
2015) could also disseminate resistant E. coli (Guenther et al., 2010; Laube et al., 2014). Similarly, 
humans could act as a direct or indirect source of transmission to poultry and the environment 
(Marathe et al., 2013). On the other hand, poultry meat contaminated with antimicrobial resistant 
bacteria and or ARGs can be transmitted to humans directly through the food chain (Radhouani et 
al., 2014). 
Similar to other studies worldwide, the majority of the FEC isolates were phylogenetic group C, A 
and B1 (Hiki et al., 2014; Jakobsen et al., 2010; Sola-Gines et al., 2015). In this current study, fifty 
percent of the CEC isolates belonged to phylogenetic group A, which is typically identified as a 
commensal, non-pathogenic E. coli (Clermont et al., 2013). Other studies have also reported that the 
majority of CEC belong to group A (Rodriguez-Siek et al., 2005a; Sola-Gines et al., 2015). However, 
there are reports that the majority of CEC are group D (Campos et al., 2008; Clermont et al., 2000). 
Variation in identified phylogenetic grouping between studies may be due to geographical and 
temporal variations. Geographical variations have been reported in a recent study where 35.3% and 
56.1% of APEC isolates belonged to phylogroup B2 in Germany and the United Kingdom, 
respectively. While in Italy, 53.3% of APEC isolates belonged to phylogroup A (Cordoni et al., 
2016). 
The current study also used the new phylogenetic group determination methods that reassigns group 
A and D that failed to correctly assign in the old Clermont method (Clermont et al., 2013). The most 
significant advantage of the new Clermont quadruplex PCR method for E. coli phylogenetic grouping 
assignment is its ability to classify the E. coli strains into four further groups: C; E; F; and E. clade 1 
(Clermont et al., 2013). The association between phylogenetic group B2 and pathogenicity has been 
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well documented (Carattoli, 2009; Lynne et al., 2012). In this study, only 10% of the CEC and 6% 
of the FEC were phylogenetic group B2.  
In the current study, there was no association between AMR phenotype and phylogenetic group. This 
finding could suggest that resistance among E. coli cultured from broiler chickens in Australia, 
regardless of their pathogenicity, was not due to clonal spread but most likely due to the transmission 
of ARGs (Chah et al., 2010). However, not all of the isolates were pathogenic, 187 were cultured 
from the faeces of healthy birds. Forty one CEC were submitted from a diagnostic laboratory, where 
only one isolate per sample submitted from a clinically sick bird was further investigated. The isolate 
selected may not have been the pathogenic strain. This might explain why, as seen in this study, not 
all CEC isolates contained APEC-associated VGs. It must also be noted that the current study only 
involved screening for five VGs. Finally, the isolate selected by the diagnostic laboratory may also 
have a different antimicrobial susceptibility profile then the isolate responsible for disease. 
Plasmids play a major role in the spread of blaCMY-2 and other resistance genes in E. coli and other 
bacterial species. Similar to other studies screening for plasmids in chicken meat and FEC, IncFIB 
and IncFrep were the most common plasmids found (Da Silva and Mendonca, 2012; Lynne et al., 
2012). These plasmids and others including IncFIB, IncFrep, IncHI1, IncHI1, IncY, IncI, IncFIA, 
IncN and IncL/M have been shown to encode for multidrug resistance in previous studies among  
E. coli and other Enterobacteriaceae from humans and food-producing animals (Carattoli, 2009). 
These replicons are often linked with ESBLs (Garcia-Fernandez et al., 2008; Woodford et al., 2007).  
The detection of IncA/C plasmids were of concern as previous studies (Guo et al., 2015; Mataseje et 
al., 2010) have shown that IncA/C plasmids are associated with horizontal gene transfer and they 
have been implicated in transfer of ARGs between Salmonella and E. coli from food animals, the 
environment and humans, as well as being associated with MDR and the AmpC β-lactamase gene 
blaCMY-2, specifically (Fernandez-Alarcon et al., 2011). However, the three isolates that were 
identified in the current study harbouring an IncA/C plasmid were susceptible to all antimicrobials. 
And the isolates with the blaCMY-detected did not have an IncA/C plasmid.  
The IncI1, IncFIB, IncY and IncN plasmids have been identified in poultry previously and were 
associated with MDR and ESBLs producing E. coli (Bortolaia et al., 2010; Garcia-Fernandez et al., 
2008; Kluytmans et al., 2013; Lynne et al., 2012; Seni et al., 2016; Wang et al., 2013a). One of the 
ESC resistant isolates contained IncY and IncI1 plasmid types, while the other contained IncFIA, 
IncFIB and IncFrep plasmids. IncFrep plasmids have previously been isolated from the environment, 
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animals and humans, harbouring ESBLs and PMQR mechanisms in addition to other ARGs (Dolejska 
et al., 2013). 
Overall, the usage of antimicrobials, disinfectants and/or heavy metals in Australian poultry is not 
sufficient to explain the prevalence and dissemination of the tested plasmid replicons in the poultry 
isolates in the current study. However, there is evidence that some plasmid replicons, such as IncI1, 
can survive in E. coli isolates without antimicrobial selection pressure with no or little fitness cost to 
the host (Fischer et al., 2014). Furthermore, the host bacteria can use some extra elements encoded 
by plasmids for their survival (Carattoli, 2009). Several studies (Carattoli, 2013; Lynne et al., 2012) 
have shown a low prevalence of MDR encoding plasmids among human sourced E. coli isolates in 
comparison with the avian E. coli isolates. Which may suggest that the transfer of these plasmids 
from poultry to humans might be uncommon.  
Several studies (Carattoli, 2009; Mata et al., 2012) have reported a strong association between blaDHA-
1 and IncF plasmids. However, the isolate in our study which, contained blaDHA-1 did not carry the 
IncF plasmid (Carattoli, 2009; Mata et al., 2012). Globally, an association between plasmid replicon 
types N, L/M and HI2 among E. coli and Salmonella spp. and qnrS1 from human and animals were 
reported which are consistent with the finding of the current study (Carattoli, 2013).  
Johnson et al. (2008b) suggest that CEC isolates can be distinguished from FEC isolates by their 
possession of five APEC related VGs. The current results show that the presence of the five genes 
predicting pathogenicity was significantly higher in the CEC isolates compared with the FEC isolates 
(Johnson et al., 2003; Johnson et al., 2008b). However, the presence of APEC-associated VGs among 
the FEC suggests a possible reservoir of the VGs in the commensal E. coli population.  
Overall, the CEC also showed more resistance to antimicrobials compared to the FEC. This may be 
due the fact that the CEC isolates were sourced from farms with disease outbreaks and were thus 
more likely to have been exposed to antimicrobials than those FEC isolates that were sourced from 
healthy flocks. Alternatively, it could be that resistant isolates are more virulent. Interestingly, the 
current study suggested that the FEC isolates exhibit more diversity in their resistance profiles than 
CEC isolates. It has been previously suggested that commensal E. coli flora are a source of emerging 
and developing E. coli resistant strains and/or resistance genes (da Costa et al., 2013). 
The FQ resistant FEC in this study have various VG patterns and none of the two FQ resistant CEC 
isolates harboured any APEC related VGs. Similar findings have occurred in earlier studies in other 
parts of the world where low prevalence of VGs were detected among FQ resistant CEC isolates 
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(Horcajada et al., 2005; Huang et al., 2009; Kawamura-Sato et al., 2010). These isolates may have 
been opportunistic pathogens that acquired FQ resistance (Drews et al., 2005; Vila et al., 2002) or 
they may be CEC isolates that lost their VGs after they developed mutations in the QRDR (Horcajada 
et al., 2005; Moreno et al.; Sawma-Aouad et al., 2009). Furthermore, the virulence profile of the 
AmpC harbouring E. coli isolates also varied. The first ESC resistant E. coli harboured none of the 
CEC related VGs, while the other ESC resistant isolate harboured all five VGs. The fact that all of 
the FQ and ESC resistant isolates do not belong to phylogenetic group B2, the most common 
phylogenetic group of pathogenic ExPEC, could support the theory of low pathogenic opportunistic 
isolates.  
There are a number of limitations that apply to the current study. Firstly, all of the FEC isolates were 
obtained from one geographical area (SEQ), while the CEC isolates were sourced from across 
Australia, so the FEC isolates examined may not be representative of the larger population. There 
was a limited number of resistant isolates, especially ESC and FQ resistant, limiting the power of 
statistical comparisons. There was also no available history of previous antimicrobial use for the 
clinical and faecal isolates. The fact that the current study did not screen the resistant isolates for the 
presence of antimicrobial resistance genes was a limitation of the current study.  
Another limitation was the lack of clinical break points available for interpretation of antimicrobial 
susceptibility in E. coli cultured from poultry, and as such, interpretations had to be extrapolated from 
human E. coli data or from other pathogens from other host species. A high level of resistance was 
detected to cephalothin in the current study, despite the fact that this antimicrobial has never been 
used in the poultry industry, calling into question the validity of using human breakpoints, as there is 
no clinical breakpoint for cephalothin available for E. coli in poultry.  
Future antimicrobial and resistance surveillance investigations are needed using structured sampling 
strategies involving much larger sample sizes, and not relying on laboratory-acquired isolates with 
limited history in order to highlight and identify resistance mechanisms with public health potential.  
5.7 Conclusion 
The key finding of the current study is that a low level of resistance to both well established and 
critically important antimicrobials such as FQs and ESCs were reported. This demonstrates that the 
strict Australian regulations around the use of antimicrobials in Australian poultry have provided 
some protection to the industry. Therefore, the observed prevalence of FQ and ESC resistance, despite 
the nil usage of those antimicrobial drugs, may indicate they have been the acquired by the result of 
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co-selection and/or co-resistance pressure mediated by the usage of other antimicrobials and/or 
disinfectants or clones introduced from sources outside the sheds. 
A high diversity of plasmid replicons, phylogenetic groups and APEC related VGs were detected 
among CEC and FEC of broiler chickens in Australia, suggesting that E. coli from broiler chickens 
could act as reservoirs for virulence and resistance genes for E. coli or other bacterial species and 
contribute to the spread of these genes.  
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6 Chapter 6: Virulence associated genes in faecal and clinical 
Escherichia coli isolates cultured from broiler chickens in 
Australia 
 
6.1 Forward 
Escherichia coli organisms are genetically diverse and both commensal and avian pathogenic 
Escherichia coli (APEC) harbour a wide variety of virulence genes (VGs). Several studies have 
demonstrated that not all APEC-associated VGs are present in isolates cultured from birds with 
colibacillosis (Ewers et al., 2003; Johnson et al., 2008b; Qabajah et al., 2014) and it is not known 
which VGs or combinations of VGs are required for colibacillosis to occur.  
Studies from different countries have aimed to define and differentiate APEC from avian faecal  
E. coli (AFEC) in order to establish an association between the carriage of several VGs and disease. 
In Australia, prior to this investigation, the only available information on APEC was published in 
2004 and identified the roles of tsh, iss and iucA and the pVM01 plasmid in pathogenicity (Tivendale 
et al., 2004). However, that study did not screen for the presence of APEC VGs among faecal isolates 
nor compare AFEC and APEC on the basis of VG carriage. 
In this thesis, five VGs (iutA, ompT, hlyF, iss and iroN) were selected to define APEC (Johnson et 
al., 2008b). However, these five genes were detected with a high prevalence (63%) among faecal 
isolates (Chapter 4), highlighting the need to extend screening to identify additional VGs associated 
with APEC in Australia. The phylogenetic groups and the presence of five APEC related VGs were 
examined among all the clinical and faecal isolates in the previous chapter (Chapter 5). In this chapter 
a sub set of avian clinical and faecal E. coli isolates were selected based on genetic diversity and 
antimicrobial susceptibility profile for further analysis. In total, 88 E. coli isolates were selected and 
screened for the presence of 30 additional extraintestinal pathogenic E. coli (ExPEC) associated VGs 
to identify the association between these VGs and avian colibacillosis. 
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6.2 Abstract 
The healthy bird’s intestinal flora harbours a rich reservoir of Escherichia coli as part of the 
commensal microbiota. However, some E. coli strains known as extraintestinal pathogenic E. coli 
(ExPEC) carry certain virulence genes (VGs) that enable them to invade and cause extraintestinal 
infections, such as avian colibacillosis. In birds, the causative agent for avian colibacillosis is a 
subgroup of ExPEC known as avian pathogenic E. coli (APEC). The pathogenic mechanisms 
associated with APEC are ill-defined, although several VG combinations have been identified which 
are believed to enable APEC to invade and cause disease outside the gastrointestinal tract.  
The current study compared ExPEC-associated VGs in E. coli cultured from birds with colibacillosis 
and healthy birds to determine which genes were more abundant in E. coli from Australian birds with 
colibacillosis. A subset of 88 E. coli isolates from commercial poultry flocks in Australia, including 
29 E. coli isolates cultured from chickens with colibacillosis (referred to as clinical E. coli: CEC) and 
59 faecal E. coli (FEC) from clinically healthy chickens were screened for the presence of 30 ExPEC-
associated VGs (in addition to the 5 APEC-associated VGs screened for in previous chapters). The 
88 isolates were selected from the 237 E. coli isolates that were investigated (in Chapter 5) based on 
their enterobacterial repetitive intergenic consensus (ERIC) and AMR profile.  
The current study identified the presence of 34 of the 35 VGs, with prevalence ranging from 3.4% 
(focG) among FEC to 100% (astA) among CEC. All of the tested isolates were positive for the 
presence of at least four VGs. The nine most prevalent virulence genes in the 29 CEC isolates were: 
astA (100%); feoB (96.6%); iutA; iss; ompT; iroN and hlyF (all 93.1%); vat (89.7%) and fimC 
(86.2%). The iucA gene was not detected in any of the E. coli isolates.  
However, a set of VGs: iroN; iss; iutA; tsh; fimC; papC; papEF; vat; hlyF; astA; ibeA; feoB; ireA; 
cvi/cvaC and ompT were significantly more likely to be found in the CEC isolates in comparison with 
FEC. Further investigations are needed to identify the roles of these VGs in pathogenicity. These VGs 
may be able to be used to better define APEC, and diagnostically to detect APEC in Australia. 
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6.3 Introduction 
Avian colibacillosis is caused by a subgroup of extraintestinal pathogenic E. coli (ExPEC), known as 
avian pathogenic Escherichia coli (APEC), which have the ability to invade various internal organs 
and cause systemic disease (La Ragione and Woodward, 2002; Mokady et al., 2005). However, the 
majority of E. coli are commensals and coexist in the gut microbiota of healthy birds, do not cause 
disease and are known as avian faecal E. coli (AFEC) (Johnson et al., 2008b; Nolan et al., 2013; Oh 
et al., 2011; Rodriguez-Siek et al., 2005a). 
A large number of overseas studies have aimed to define and differentiate APEC from AFEC based 
on phylogenetic grouping, virulence genotyping, serotyping, as well as finger printing methods (such 
as enterobacterial repetitive intergenic consensus (ERIC) PCR, randomly amplified polymorphic 
DNA and restriction fragment length polymorphism) (Johnson et al., 2008b; Nolan et al., 2013; 
Obeng et al., 2012; Oh et al., 2011; Rodriguez-Siek et al., 2005a). Nevertheless, APEC are still not 
clearly defined. Several virulence genes (VGs) have been found to be associated with APEC, 
however, no specific VG or set of VGs that contribute entirely to the pathogenicity of APEC have 
been identified (Hussein et al., 2013; Vandekerchove et al., 2005). 
Several overseas studies have differentiated APEC and AFEC on the basis of the presence of five 
VGs that Johnson et al. (2008b) identified as having a significant association with APEC 
(Dissanayake et al., 2014; Hussein et al., 2013; Nolan et al., 2013). The VGs are: iss (increase serum 
survival); ompT (outer membrane proteinase); hlyF (putative avian hemolysin); iroN (salmochelin 
siderophore receptor) and iutA (aerobactin receptor) (Johnson et al., 2008b). Johnson et al. (2008b) 
concluded that E. coli could be considered an APEC if it was cultured from a lesion in an internal 
organ of a chicken with colibacillosis and possessed four or more of these five APEC-associated VGs. 
The first aim of the current study was to determine the clonal relatedness between 237 E. coli (50 
clinical and 187 faecal E. coli) isolates that were previously characterised (Chapter 5) and sourced 
from chickens with colibacillosis and healthy chickens. Secondly, a subset of isolates representing 
diverse clonality and the most resistant isolates were selected to determine the distribution of 35 
APEC-associated VGs between clinical and faecal E. coli cultured from Australian broiler chickens.  
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6.4 Materials and methods 
6.4.1 Bacterial isolates and subset selection criteria  
In total, 237 E. coli isolates that were described in Chapter 5 (187 FEC and 50 CEC) underwent 
fingerprinting using ERIC-PCR and antibiogram analysis to assist in subset selection of isolates. 
Selection criteria for the E. coli isolates for further characterisation included (i) one isolate from all 
of the clusters (≥ 80% similar) identified by ERIC profile, (ii) antimicrobial  resistance profile, the 
most resistant isolate from each cluster were included (Chapter five) and (iii) bird’s health status (the 
CEC isolates were selected prior to the FEC isolates if both CEC and FEC isolates belonged to the 
same cluster and had the same resistance profile). Random selections were applied if there was more 
than one isolate belonging to the same cluster with the same resistance and health profile. 
6.4.2 Enterobacterial repetitive intergenic consensus (ERIC)-PCR 
Clonality between the 237 E. coli isolates that were previously studied in Chapter 5 were determined 
by ERIC-PCR (Versalovic et al., 1991). Banding patterns were analysed using Gel ComparII 
(Applied Maths, Sint-Martens-Latem, Belgium). Similarity was estimated with a Dice Coefficient of 
0.1% and a tolerance of 1% and cluster analysis was performed with Dice Coefficients and 
unweighted-pair group method with arithmetic mean (UPGMA). Rooted rendered tree was generated 
using the UPGMA. 
Similar to other studies, isolates with a > 93% similarity in their ERIC profile were assumed to be 
closely related (a clonal group) (Moreno et al., 2006; Sabate et al., 2008). A cluster was defined as a 
group of isolates that shared ≥ 80% similarity in their ERIC-PCR profile patterns.  
6.4.3 Virulence genotyping 
The selected E. coli isolates were previously screened for the presence of the five APEC related VGs 
(iroN, iutA, iss, hlyF and ompT) (Johnson et al., 2008b) (Chapter 5). Isolates were then screened for 
a further 30 APEC-associated VGs using published single and multiplex PCR assay panels. The first 
PCR panel targeted astA, irp2, papC, iucD, tsh, vat and cvalAB (Ewers et al., 2005). The second panel 
targeted chuA and traT (Ewers et al., 2007). The third panel amplified the following genes: fyuA; 
papG and kpsMT k1 (Johnson and Stell, 2000).The fourth panel screened for fimH, papEF, ireA and 
ibeA (Rodriguez-Siek et al., 2005a). Group five targeted sitA and feoB (Rodriguez-Siek et al., 2005a). 
Primers for the following genes: sfaS and focG were included in the sixth panel (Obeng et al., 2012). 
The seventh group screened the following genes: cbi; cma and cvaC (Johnson et al., 2006). The 
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following genes: kpsMTII; hlyA; fimC; neuC; afa/drab and sfa/foc were amplified using the protocol 
validated by Ewers et al. (2007). The last PCR amplified iucA (Johnson et al., 2006). 
6.4.4 Case definition 
All of the E. coli isolates were categorised based on the bird’s health status and independently from 
the VG profile into faecal E. coli (FEC) and clinical E. coli (CEC) as shown in Figure 6.1. Faecal E. 
coli were isolates cultured from the faeces of healthy birds and CEC were cultured from the faeces or 
organs of birds with colibacillosis. Faecal E. coli and CEC were further characterised as APEC if they 
were sourced from faeces or the cloaca and harboured four or more of the APEC VG markers ( iroN, 
iutA, iss, hlyF and ompT). Clinical E. coli isolates cultured from lesions from birds with colibacillosis, 
which harboured four or more of the five APEC-associated VGs, were defined as clinical avian 
pathogenic E. coli (cAPEC). While CEC cultured from lesions or faeces and contained less than four 
of the selected VGs were identified as potential APEC (pAPEC). Faecal E. coli isolates were 
molecularly classified into avian faecal (AFEC) if they harboured less than four of the selected APEC 
VG markers.  
6.4.5 Statistical analysis 
Analyses were performed in Stata software (13th edition, Blackburn North Victoria, Australia, 
www.stata.com). Comparisons of the associations between VGs for CEC and FEC were carried out 
using Fisher’s exact test (Fisher exact was used instead of the Chi-square in case of small values), 
odds ratio (OR) and their 95% confidence interval (CI) were calculated. A p-value of < 0.05 was 
considered significant.  
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Figure 6.1: Illustration flow chart for the classification applied to all of the E. coli isolates 
included in the current study. 
1 The selected VGs are: iss; iutA; iroN; ompT and hlyF. 
6.5 Results 
6.5.1 Bacterial isolates 
The E. coli isolates (n = 88) investigated in this study consisted of 59 avian faecal isolates (FEC) and 
29 clinical E. coli isolates (CEC) (Table 6.1). 
6.5.2 Enterobacterial repetitive intergenic consensus (ERIC)-PCR 
A comparison of the clustering pattern produced by the data obtained by ERIC-PCR for the 237  
E. coli (50 CEC and 187 FEC) isolates revealed 88 distinct ERIC clusters (Figure 6.2). The 237  
E. coli did not form distinct clusters with respect to CEC and FEC and/or antimicrobial  resistance 
profile. There were eight larger clusters, which comprised 51.1% (121/237) of the E. coli isolates 
(clusters 3, 4, 16, 19, 26, 37, 55 and 69), observed among the isolates. Of all isolates, cluster 16 was 
the largest with 22 isolates (9.28%) aligned with 88% similarity. Cluster 69 contained 19 (8.01%) 
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isolates, cluster 3 and 4 both contained 16 (6.75%) isolates, cluster 26 and 37 both contained 14 
(5.91%) isolates, cluster 19 contained 11 (4.67) isolates and cluster 55 contained nine (3.80%) 
isolates.  
Within cluster 4, four isolates were clonal and were cultured from chickens from one farm. Within 
cluster 7, three isolates (out of eight) were clonal, with all three isolates being > 95% similar in their 
ERIC profile. Two out of these three isolates were collected from the same farm at the same time, 
although the third isolate was cultured from a chicken from a different Australian state. Similarly, 
five isolates in cluster 27 (out of seven) and four (out of eight) in cluster 42 were clonal; however, 
isolates did not appear to be related in time or space (these isolates were collected from different 
Australian states at different time).  
Thirty of the 88 E. coli isolates, each representing one cluster, were MDR, resistant to three or more 
antimicrobial classes; 42 were resistant to two classes; while 16 were resistant to only one 
antimicrobial class. Out of the 29 CEC isolates, two did not harbor any VGs, while 27 were previously 
classified as cAPEC. Nineteen of the FEC were previously classified as APEC, while 40 were AFEC. 
6.5.3 Virulence genotyping 
Figure 6.3 illustrates the virulence genotype for the 88 isolates. Table 6.2 shows the number and 
prevalence of the 31 ExPEC related VGs among the 29 CEC and 59 FEC isolates. Overall, none of 
the CEC or FEC isolates harboured iucA. The following VGs: sfa/foc; focG and hlyA couldn’t be 
found among the CEC isolates. The following VGs were identified with significant (p-value of less 
than 0.05) prevalence among CEC: astA (100%); foeB (96.6%); iroN (93.1%); ompT (93.1%); iss 
(93.1%); iutA (93.1%); hlyF (93.1%); vat (89.7%); fimC (86.2%); cvi/cvaC (79.3%), tsh (55.2%); 
ireA (51.7%); papC (44.8%); papEF (41.4%) and ibeA (37.9%). The following VGs: papG; irp2; 
chuA; kpsMT11; kpsMTK1; cbi; cma; sitA; traT; fimH; afa-drab; fyuA; sfaS; iucD; neuC and maxI 
were found with a similar prevalence among the CEC and FEC isolates. Seven percent, 51.7% and 
41.4% of the CEC harbored 10, 20 and 30 VGs in comparison with 22%, 71.2% and 6.7% of the 
FEC. 
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Table 6.1: Number, source, samples site, location and date of isolation of 29 clinical E. coli (CEC) and 59 faecal E. coli (FEC) isolates obtained 
from commercial broiler chickens in Australia. 
Type of 
isolates  
Number of 
Isolates 
Source and samples site 
  
Location Date of 
isolation 
Reference  
FEC 59 Cloacal swab of healthy chickens Various locations within 
Southeast Queensland 
2013 - 2014 Chapter 4 
CEC 9 Colibacillosis site in chicken 
liver (n = 2), air sac (n = 1), lung (n = 2), heart (n = 2), spleen (n 
= 1) and cloacal swabs (n = 1) 
3 chicken farms within Southeast 
Queensland 
2013  Chapter 3 
CEC 15 Colibacillosis site in chicken 
abdomen (n = 2), air sac (n = 1), heart (n = 1), infraorbital sinus 
(n = 1), intestine (n = 1), liver (n = 1), lung (n = 3), pericardium 
(n = 1) peritoneum (n = 1), pleura (n = 1), nasal cavity (n = 1) and 
trachea (n = 1)  
Biosecurity Sciences Laboratory 2006 - 2013 Chapter 5 
CEC  5 Colibacillosis site in chicken  
liver (n = 1), lung (n = 1), pericardium (n = 1), air sac (n = 1) and 
subcutaneous (n = 1) 
Australian diagnostic laboratories 2013 - 2014 (Abraham et 
al., 2015) 
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Figure 6.2: Rooted rendered tree by enterobacterial repetitive intergenic consensus PCR profile  
of 237 E. coli study isolates, comprised of 50 clinical E. coli (CEC) isolates and 187 faecal E. coli 
(FEC) cultured from commercial broiler chickens between 2006 and 2014.
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Figure 6.3: Virulence genotype of each of 29 clinical E. coli (CEC) and 59 faecal E. coli (FEC) from broiler chickens in Australia.  
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Table 6.2: Number (N), prevalence (%) and Odd ratio (OR) with 95% confidence interval (CI) 
of 31 virulence genes among 29 clinical E. coli (CEC) and 59 faecal E. coli (FEC) from broiler 
chickens in Australia. 
Putative Gene  
Function 
Virulence gene1 OR (95% CI) CEC 
N (%) 
FEC 
N (%) 
p-value 
PTJ100 related genes 
 
cvi/cvaC1 3.42 (1.14, 11.8) 23 (79.3) 31 (52.5) 0.026 
iroN2 21.9 (4.76, 208) 27 (93.1) 22 (37.3) < 0.001 
iss2 15.6 (3.39, 147) 27 (93.1) 27 (45.8) < 0.001 
traT 1.45 (0.50, 4.45) 22 (72.4) 38 (64.4) 0.616 
iutA2 11.9 (2.59, 112) 27 (93.1) 31 (52.5) 0.002 
Tsh 4.27 (1.51, 12.6) 16 (55.2) 13 (22.1) 0.005 
sitA 4.38 (0.94, 43.9) 27 (93.1) 44 (74.6) 0.064 
Adhesins fimC 7.24 (2.13, 32.2) 25 (86.2) 27 (45.8) 0.004 
papC 6.98 (2.08, 26.3) 13 (44.8) 6 (10.2) 0.001 
papG 2.88 (0.89, 9.46) 10 (34.5) 9 (15.3) 0.079 
papEF 3.85 (1.24, 12.4) 12 (41.4) 9 (15.3) 0.017 
fimH 1.55 (0.58, 4.22) 16 (55.2) 26(44.1) 0.451 
afa/drab 1.16 (0.27, 4.36) 5 (17.3) 9 (15.3) 1.000 
Iron acquisition irp2 0.48 (0.05, 2.62) 2 (6.9) 8 (13.6) 0.591 
chuA 2.10 (0.69, 7.33) 23 (79.3) 38 (64.4) 0.242 
fyuA 1.27 (0.47, 3.41) 15 (51.7) 27 (45.8) 0.761 
ireA 2.84 (1.03, 8.04) 15 (51.7) 16 (27.1) 0.043 
feoB 7.80 (1.06, 348) 28 (96.6) 46 (77.9) 0.041 
sfaS 1.38 (0.11, 12.8) 2 (6.9) 3 (5.08) 1.000 
Protectins/serum resistance iucD 1.61 (0.54, 5.22) 22 (75.9) 39 (66.1) 0.496 
kpsMTII 2.27 (0.73, 7.05) 10 (34.5) 11 (18.6) 0.173 
neuC 0.82 (0.28, 2.29) 9 (31.1) 21 (35.6) 0.86 
Invasions kpsMTK1 2.27 (0.73, 7.05) 10 (34.5) 11 (18.6) 0.173 
Toxins ibeA 3.34 (1.06, 10.8) 11 (37.9) 9 (15.3) 0.038 
Vat 11.5 (3.02, 65.7) 26 (89.7) 25(42.4) < 0.001 
Colicin genes hlyF2 12.7 (2.78, 120) 27 (93.1) 30 (50.9) < 0.001 
Cbi 2.41 (0.68, 8.46) 8 (27.6) 8 (13.6) 0.139 
Cma 2.09 (0.61, 7.11) 8 (27.6) 9 (15.3) 0.276 
Miscellaneous maxI 0.71 (0.24, 1.97) 9 (31.1) 23 (38.9) 0.627 
ompT2 12.7 (2.78, 120) 27 (93.1) 30 (50.9) < 0.001 
astA 9.99 (1.55, ∞) 29 (100) 47 (79.7) 0.011 
 
1 afa/draB, afimbrial/Dr antigen-specific adhesin; astA, EAST1 (heat-stable cytotoxin associated with enteroaggregative 
E. coli); cbi, corresponding immunity; cma, Colicin M-resembles B-lactam; chuA, heme receptor gene (heme uptake); 
cvi/cva, structural genes of colicin V operon (microcin ColV);feoB, ferrous iron transport protein B fimC, type 1 fimbriae 
(d-mannose-specific adhesin); fimH, adhesive subunit of type 1 fimbriae; fyuA, ferric yersiniabactin uptake (yersiniabactin 
receptor); hlyA, haemolysin A; ibeA, invasion of brain endothelium; ireA, iron-responsive element (putative catecholate 
siderophore receptor); iroN, catecholate siderophore (salmochelin) receptor; irp2, iron-repressible protein (yersiniabactin 
synthesis); iss, increased serum survival; iucD, aerobactin synthesis; iutA, ferric aerobactin receptor (iron 
uptake/transport); kpsMTI, group I capsule antigens; kpsMT K1, group I capsule antigens; kpsMT II, group II capsule 
antigens; maxI, pathogenicity-associated island marker; neuC, K1 capsular polysaccharide; ompT, outer membrane 
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protease; papC, P-fimbriae; sitA, putative iron transport gene; sfa/focDE, sfa (S fimbriae) and foc (F1C fimbriae; traT, 
surface exclusion protein (serum survival factor); tsh, temperature-sensitive haemagglutinin; vat, vacuolating 
autotransporter toxin. 
2The PCR for these genes was performed in Chapter 4 and 5.  
 Virulence gene iucA was not detected in CEC and FEC while hlyA, focG and sfa/foc were not detected in CEC. 
 
6.6 Discussion 
Globally, colibacillosis is considered one of the major problems that affects the poultry industry and 
translates into multimillion-dollar losses annually (Guabiraba and Schouler, 2015; Johnson et al., 
2008b; Nolan et al., 2013). Interestingly, although there has been some development of vaccines to 
alleviate this problem, none have been effective in fully controlling this infection or disease (Lynne 
et al., 2012; Lynne et al., 2007). Despite the intensive research globally, the genetic diversity of 
APEC make it hard to reach a consensus on definition of APEC (Johnson et al., 2008b; Lynne et al., 
2007; Rodriguez-Siek et al., 2005a).  
In the current study, the E. coli isolates (29 CEC 59 and FEC) carried an assortment of VGs, with 
some genes being significantly associated with CEC. The prevalence of VGs reported in this study 
are similar to a number of overseas studies, which have reported variation in VG frequency and 
combinations in CEC and FEC isolates (Johnson et al., 2008b; Lynne et al., 2012; Maturana et al., 
2011; Olsen et al., 2012; Rodriguez-Siek et al., 2005a).  
In the current study, ERIC-PCR was used to investigate the genetic diversity of isolates, since it is a 
simpler method to identify relationships in comparison to other molecular typing methods and allows 
processing of a large number of isolates. It has the benefits of being rapid, cost-effective and can 
classify E. coli into different clonal groups or clusters for the purpose of epidemiological studies 
(Cherifi et al., 1991; Gillings and Holley, 1997; Meacham et al., 2003; Ranjbar et al., 2017; Ugorski 
and Chmielewski, 2000; Wilson and Sharp, 2006). The lack of repeatability and discriminatory power 
and lower type ability compared to other finger printing methods, such as multilocus sequence typing 
(MLST) and pulse field gel electrophoresis (PFGE), are some of the disadvantages of this protocol 
(Meacham et al., 2003). Ewers et al. (2004) and Knobl et al. (2012) have reported that none of the 
molecular typing methods have the ability to differentiate between clinical and FEC isolates. In this 
study, ERIC-PCR was not able to differentiate between clinical and FEC and there was not a clear 
association between VG pattern and ERIC-PCR profile. This may suggest independent VG patterns 
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within clonal groups or clusters, highlighting the potential of previous genetic transfers between 
different strains.  
Phylogenetic analysis using whole genome sequencing (WGS) is recommended to provide rapid, 
accurate and valuable genetic data (Franz et al., 2014; Oulas et al., 2015; Wang et al., 2016). This 
data has the discriminatory power for future APEC pathogenesis studies and epidemiological 
investigations that will improve the bird’s welfare and help in the development of prevention and 
control measures against avian colibacillosis (Wang et al., 2016). The ability of WGS to compare and 
link with international bacterial typing databases is considered one of the advantages in comparison 
with other genetic typing methods such as ERIC where data is not standardised and cannot be 
compared between laboratories.  
The frequency of APEC related VGs among E. coli strains vary and VG profile may be influenced 
by several factors such as geographical locations, season, bird immune status, variation in the 
sampling sites, different husbandry and vaccination protocols (Johnson et al., 2008b; Qabajah et al., 
2014; Wang et al., 2013a). Therefore, APEC VG markers specific to Australian conditions need to 
be defined in order to better identify APEC and reduce the economic losses associated with the disease 
in the poultry industry. 
Statistical analysis of the CEC and FEC VG characterisation showed a significant association  
(p < 0.05) between clinical E. coli and 15 VGs: cvi/cvaC; iroN; iss; iutA; tsh; fimC; papC; papEF; 
ireA; feoB; ibeA; vat;, hlyF; ompT and astA. The presences of each of these VGs were more than 
twice as likely to be detected among CEC than among the FEC in the current study. The positive 
association between avian colibacillosis and the presence of these VGs either individually or in 
different combinations has been previously documented in other parts of the world (Circella et al., 
2012; Delicato et al., 2003; Guastalli et al., 2013; Jeong et al., 2012; Johnson et al., 2008b; 
Rodriguez-Siek et al., 2005a). 
The current study reported 93.1% of CEC carried the five VGs (iutA, iss, ompT, iroN and hlyF) that 
were used in earlier chapters of this thesis to define APEC and were identified by Johnson et al. 
(Johnson et al., 2008b) as a group of VGs that could be screened to predict APEC. Studies in Brazil 
(82% – 95%) and Egypt (90% – 94%) have reported a similar frequency of these five VGs among 
APEC isolates cultured from lesions of birds with colibacillosis, supporting the selection of the 
pentaplex-PCR to identify APEC (Dissanayake et al., 2014; Hussein et al., 2013). 
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The combination of APEC linked VGs that were identified in the current study play roles in various 
aspects of the extraintestinal pathogenesis of APEC and can be categorised into different groups 
according to their functions and contribution to the APEC pathogenicity mechanisms (Dziva and 
Stevens, 2008; Nolan et al., 2013). At different stages of infection, alternative VGs could be involved 
in the pathogenicity mechanism of APEC, including colonisation (fimH, fimC, papC, papEF and tsh), 
invasion (ibeA, vat), iron acquisition (iutA, iroN, IreA, feoB), serum complement resistance (iss) and 
putative iron transport (sitA). Resistance to serum complement can be facilitated by iss, which 
encodes for a lipoprotein of the bacterial outer membrane (McPeake et al., 2005; Mellata et al., 2003; 
Nolan et al., 2013; Rodriguez-Siek et al., 2005a; Sorsa et al., 2003; Tivendale et al., 2004; 
Vandekerchove et al., 2005). In the current study the prevalence of iss in APEC was 93.1%, in other 
countries such as the USA (80.5%), Germany (82.7%), Spain (91%), Egypt (72%) and Brazil (51%) 
prevalence varied (De Carli et al., 2015; Ewers et al., 2004; Hussein et al., 2013; Johnson et al., 
2008b; Sola-Gines et al., 2015). 
The current study reported a significant association between CEC and adhesin genes, with 86.2% and 
44.8% prevalence of fimC and papC genes, respectively. These genes mediate the adherence of  
E. coli to host epithelial cells to enable colonisation (Pourbakhsh et al., 1997). The reported 
prevalence of fimC in this study (86.2%) is similar to published data from Germany (92%), Brazil 
(86%) and Korea (90.1%) from E. coli obtained from chickens with colibacillosis (Ewers et al., 2004; 
Jeong et al., 2012; Knobl et al., 2012). The positive association of papC as well as iss, tsh, cva/cvi 
and vat with APEC were found in E. coli isolates sourced from chickens affected with colibacillosis 
in Germany. Ewers et al. (2005) found that those five VGs as well as iucD, irp2 and astA could 
identify and differentiate APEC from AFEC.  
The prevalence of the papC gene, which enables the adherence and the survival of E. coli in the 
internal organs (Pourbakhsh et al., 1997), was 44.8% in the current study. Lower prevalence were 
found in E. coli isolates sourced from broiler chickens with colibacillosis from the United States of 
America (USA) (24.8%) and Germany (22.7%) (Ewers et al., 2004; Johnson et al., 2008b). 
There was a significant association between CEC isolates and the tsh gene which contributes mainly 
to the respiratory form of avian colibacillosis by mediating bacterial adhesin to the respiratory tract 
(Dozois et al., 2000; Maurer et al., 1998; Servin, 2005; Stehling et al., 2003). In this study, 55% of 
CEC isolates carried this gene. Other studies have also identified this association (Dozois et al., 2000; 
Maurer et al., 1998), though these studies reported prevalence of tsh as low as 19% (Dozois et al., 
2003) and as high as 85.3% in CEC (Delicato et al., 2003; Zhao et al., 2005).  
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The vat gene encodes for the Vat protein with has cytotoxic activity for the chicken embryo fibroblast 
and kidney cells (Parreira and Gyles, 2003). Several studies have reported that the vat gene is encoded 
in the APEC PAI and occurs in a higher frequency among APEC compared with AFEC (Ewers et al., 
2004; Ewers et al., 2005).  
The current study also found that seven pTJ100-plasmids related genes (iroN, traT, iutA, sitA, iss, 
cvaC and tsh) were widely distributed among clinical isolates (Johnson et al., 2008b; Rodriguez-Siek 
et al., 2005a; Zhao et al., 2009). This finding reflects the role of plasmids in the pathogenicity and 
the transfer of certain VGs among the pathogenic as well as commensal E. coli isolates. This 
highlights the need for further molecular studies to identify the role of plasmids and other forms of 
horizontal gene transfer in APEC pathogenicity (Won et al., 2009; Zhao et al., 2009).  
The following VGs: papG; irp2; chuA; kpsMT11; kpsMT K1; cbi; cma; traT; fimH; afa-drab; fyuA; 
sfaS; iucD; neuC and maxI were detected at a similar prevalence among both CEC and FEC. The 
presence of those APEC linked VGs in FEC indicate that FEC may act as reservoir for some VGs 
(Janssen et al., 2001; Mokady et al., 2005; Vandekerchove et al., 2005). 
In the current study, the absence of the iucA gene, which is one of the iron acquisition systems from 
both the clinical and faecal E. coli isolates, differs from the previous Australian study by Tivendale 
et al. (2004). Tivendale et al. (2004) identified the presence of iss, tsh and iucA in plasmids found in 
E. coli strains isolated from birds with severe colibacillosis in Australia. This difference in the 
detection of iucA between the studies could be correlated with variation of the levels of virulence of 
the E. coli isolates in the Tivendale et al. (2004) study in comparison with the current study. Tivendale 
et al. (2004) demonstrated the ability of the three most virulent APEC strains to amplify the  iucA 
gene in comparison with less virulent APEC strains. Other studies have also suggested that iucA plays 
an important role in the pathogenicity of APEC (Ling et al., 2013; Xiong et al., 2012).  
Despite the fact that the large number of VGs suggested in the current study to define APEC are more 
sensitive than previous protocols, there are some limitations. The fact that three PCRs were needed 
to investigate the presence of APEC makes it not a practical approach and highlights the need to use 
faster and more accurate methods to screen for the presence of the APEC associated VGs. A number 
of methods may be suitable for multiplex analysis in one assay, such as Luminex that allows 
multiplexing of up to 100 analytes in a single well of a microtiter plate (Sheikholvaezin, et al, 2011). 
In addition to PCR and genotyping methods, DNA microarrays are able to characterise bacteria by 
detecting large numbers of VGs and antimicrobial resistance genes (Anjum et al., 2007). Furthermore, 
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microarrays can identify genomic variations between different strains of bacteria. With the advances 
seen in recent years, whole genome sequencing will become feasible for practical routine screening 
to rapidly characterise and identify large numbers of virulence genes (Fratamico et al., (2016; Pallen, 
2016).  
Although the current thesis identified a set of APEC related VGs (iroN, iss, iutA, tsh, fimC, papC, 
papEF, vat, hlyF, astA, ibeA, feoB, ireA, cvi/cvaC and ompT) that were more likely associated with 
CEC, time limitations restricted further work into the pathogenicity of these VGs. The inability to 
screen all 237 isolates of E. coli collected during this thesis and the fact that FEC isolates were 
obtained from poultry farms located in a restricted geographically area (SEQ) during a limited time 
were also considered as limitations. However, the testing of representative isolates from 88 clusters, 
and the fact that the CEC isolates were collected from diverse geographical locations were strengths 
of the current research.  
6.7 Conclusion  
In conclusion, there was a wide diversity of VG profiles detected among CEC and FEC cultured from 
Australian broiler chickens. Overall, the VG profiles were similar with those previously reported in 
other countries. The detection of VGs among the faecal isolates may suggest their role as a reservoir 
for ExPEC-associated VGs. The current study proposes an APEC molecular screening tool composed 
of VGs (iroN, iss, iutA, tsh, fimC, papC, papEF, vat, hlyF, astA, ibeA, feoB, ireA, cvi/cvaC and ompT) 
that were significantly more likely to be found in the avian E. coli strains sourced from chickens with 
colibacillosis in Australia. Five of these VGs were ones that had been selected earlier in this thesis to 
identify APEC, and their selection as an APEC marker has now been validated. VGs are often located 
on plasmids, such as PTJ100 related genes iroN, traT, iutA, sitA, iss, cvaC and tsh, which highlights 
the association between the pathogenicity of avian E. coli strains and the possession of MGE. Further 
studies are required to investigate the possibility of utilising these VGs in the field and in diagnostic 
laboratories to identify avian colibacillosis in Australia. Rapid detection of avian colibacillosis could 
minimise the economic losses and welfare effects associated with the disease. A study to investigate 
the role of these VGs and their contribution to the pathogenicity of avian pathogenic E. coli is also 
recommended. 
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7 Chapter 7: Discussion 
 
7.1 Introduction  
The overarching aim of this thesis was to gain a better understanding of the epidemiology of avian 
pathogenic Escherichia coli (APEC) in Australian broiler flocks, and the potential risk factors 
associated with higher carriage of APEC in Australian broilers. Of particular interest was the 
identification of virulence genes (VGs) and how these genes could be used to improve the 
identification of this pathotype in Australia. In addition, the ability to diagnose APEC directly from 
faeces by detecting a particular set of VGs was investigated. In this thesis, E. coli isolates were 
categorised based on the health status of the bird from which they were cultured and their carriage of 
five APEC-associated VGs: iss (increase serum survival); ompT (outer membrane proteinase); hlyF 
(putative avian hemolysin); iroN (salmochelin siderophore receptor) and iutA (aerobactin receptor). 
E. coli containing these five VGs were previously identified by Johnson et al. (2008b) and others as 
having a strong association with avian colibacillosis.  
Prior to this research, little was known about APEC in Australia, with only two investigative studies 
on the prevalence of APEC-associated VGs in E. coli cultured from healthy chickens and chickens 
with colibacillosis having been undertaken (Obeng et al., 2012; Tivendale et al., 2004). Neither study 
differentiated APEC from avian faecal E. coli (AFEC), nor was there any data in regards to the 
prevalence of APEC carriage in healthy chickens or associated risk factors. Very few studies had 
investigated the antimicrobial susceptibility of commensal and clinical E. coli isolates sourced from 
broiler chickens (Abraham et al., 2015; Obeng et al., 2012; Shaban et al., 2014) and none had 
compared the susceptibility of clinical and faecal E. coli isolates. Investigations of the prevalence of 
plasmid replicons and their associations with antimicrobial resistance was absent from all studies.  
A pilot study (Chapter 3) evaluated methods for DNA extraction directly from cloacal swabs or faeces 
of broiler chickens and screened faecal DNA, as well as DNA from isolated E. coli, for the five 
APEC-associated VGs. This pilot study identified the most effective method for DNA extraction from 
avian faeces; defined as yielding high quantity and quality DNA. The presence of the five VGs 
previously identified as significant in APEC were identified in Australian isolates, validating the use 
of the pentaplex-PCR published by Johnson et al. (Johnson et al., 2008b). This pilot study also 
confirmed healthy chickens only harbour E. coli in their cloaca/faeces and intestines, and not in other 
internal organs. As screening for VGs in DNA extracted directly from faecal samples could not 
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confirm the presence of APEC, a cross-sectional study (Chapter 4) was conducted, which cultured  
E. coli from faecal samples to then screen for VGs to confirm the presence of APEC. In this chapter, 
the prevalence of carriage of APEC among healthy commercial broiler chickens was estimated, and 
potential risk factors identified. Furthermore, the association between antimicrobial susceptibility, 
phylogenetic group, virulence and plasmid replicon profiles of clinical E. coli (CEC) and faecal  
E. coli (FEC) isolates cultured from Australian commercial broiler chickens was investigated 
(Chapter 5). Lastly, subgroups of CEC and FEC isolates were screened for additional VGs to further 
characterise the pathotype of APEC in Australia (Chapter 6).  
7.2 Major findings and future directions 
7.2.1 Investigating the optimised protocol for molecular screening of avian pathogenic 
Escherichia coli from broiler chickens in Australia (Chapter 3) 
Extracting DNA directly from faeces and performing molecular identification of pathogens offers 
many advantages over conventional cultural methods, which may be time consuming and laborious 
(Zhao et al., 2014). Molecular methods have high sensitivity, specificity and are generally time 
efficient (Law et al., 2014) for rapid detection of pathogens. Therefore, the objective of this study 
was to determine if direct application of molecular techniques to faecal samples could identify APEC, 
which would save time (compared to screening cultured isolates) and thereby decrease economic 
losses associated with colibacillosis through more rapid diagnosis and response.  
This study found that the repeated bead beating plus column (RBB+C) method extracted a high 
quantity and quality of DNA from cloacal and faecal swabs from broiler chickens (p < 0.001) in 
comparison to the QIAamp DNA Stool Mini Kit and the Chelex method. DNA yields differed 
between cloacal swabs and faecal samples, with faecal samples yielding a higher DNA quantity. This 
finding could be attributed to more faeces being contained in the faecal samples compared to cloacal 
swabs. There was no variation in the purity of the DNA extracted from faecal samples and cloacal 
swabs with both producing DNA at a quality suitable for molecular investigations. Therefore, 
collecting faeces by swabbing the cloaca is an adequate sampling method, causes minimal stress to 
the bird and little opportunity for sample contamination. 
The detection variation of APEC-associated VGs between the DNA extracted from cloacal swabs 
and/or faecal samples of a chicken in comparison with DNA obtained from the E. coli isolates was a 
particularly interesting finding. All five VGs were detected from DNA extracted directly from faecal 
and/or cloacal samples from all birds, both healthy birds and birds with colibacillosis. However, when 
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screening the E. coli cultured from cloacal swabs, differences between CEC and FEC were observed, 
with more VGs detected in E. coli isolates cultured from birds with colibacillosis compared to healthy 
birds (p < 0.001).  
Escherichia coli failed to be cultured from internal organs (excluding the gastrointestinal tract) of 
healthy chickens. However, E. coli was cultured from the intestine and cloaca of all healthy chickens 
and chickens with colibacillosis, as well as from organ lesions of chickens with colibacillosis. All (n 
= 74) of the E. coli isolates that were cultured from the lesions of chickens with colibacillosis 
harboured all five VGs. The primary selection of four or more VGs to identify APEC based on the 
recommendation of Johnson et al. (2008b) was validated by the results obtained in this pilot study. 
That is, 85% of the E. coli isolates (23 of 27) cultured from the faeces of chickens with colibacillosis 
harboured four or more VGs, while only 17% (5 of 30) of isolates cultured from the faeces of healthy 
birds harboured four or more VGs. This noteworthy finding also suggests that healthy birds could act 
as a reservoir for APEC-associated VGs in Australia. 
A NCBI BLAST search (http://blast.st-va.ncbi.nlm.nih.gov/Blast.cgi, accessed 16/01/16) found that 
at least four other bacterial species, Salmonella enterica, Klebsiella oxytoca, Kluyvera intermedia and 
Enterobacter cloacae may also harbour these APEC-associated VGs. These bacterial genera are often 
found in the intestines of chickens (Amit-Romach et al., 2004; Pan and Yu, 2014) suggesting that the 
VGs of interest in this study may not necessarily be associated with APEC only. Thus, further research 
is warranted in order to gain a better understanding of their distribution. 
7.2.2 Investigating the prevalence of carriage of avian pathogenic Escherichia coli from 
healthy commercial broiler chickens in South East Queensland, Australia and associated risk 
factors (Chapter 4) 
This Chapter estimated prevalence of APEC in commercial broiler chickens, and investigated the 
possible associations between the detected APEC prevalence and biosecurity measures, flock health 
and management practices. Methodology of APEC prevalence estimation was validated in Chapter 
3. A cross-sectional study involving healthy commercial broiler chickens allowed the comparison and 
identification of many different potential risk factors simultaneously.  
Thirty four percent of the cultured E. coli isolates (751 of 2200) were classified as APEC. All of the 
tested farms (n = 40) were APEC positive and 63% (252 of 400) of birds were identified as APEC 
positive. APEC-associated VGs (iss, hlyF, ompT, iroN and hlyF) were commonly detected in E. coli 
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cultured from the faeces of healthy commercial broiler chickens. Therefore, healthy birds may be a 
reservoir for APEC-associated genes. 
The analysis of risk factors revealed many similar contributors associated with the carriage of APEC 
in Australia compared to overseas studies (Vandekerchove et al., 2004a; Wang et al., 2013b). The 
risk factors that were significantly associated with higher APEC prevalence in Australia included 
using water wells as a source of drinking water; not having shower facilities available for farm 
visitors, distances greater than 20 m between the car park and the poultry shed; not applying water 
line disinfections after each flock cycle and the presence of wild birds within 50 m of the poultry 
shed. The use of chlorine combined with automatic filtration of drinking water was identified as a 
protective factor and reduced farm-level APEC prevalence.  
Water is considered a substantial source of various infections on poultry farms (Amaral, 2004; Saidy 
et al., 2015). Seventy five percent of the farms (n = 30) in this study used treated, reticulated water 
as the only source of drinking water for chickens, 7.5% of farms (n = 3) used water wells as the only 
source of drinking water, while 17.5% of farms (n = 7) used a combination of town and dam water. 
If the same water sources are used to supply the entire farm stock, any contamination with pathogens 
would result in widespread infection. Although a zero bacterial level is recommended in the drinking 
water, less than 100 bacteria per millilitre of drinking water is acceptable (Watkins, 2008). The 
detection of more than 50 coliform bacteria per millilitre reflects faecal contamination of the water 
(Watkins, 2008). In this study, water wells as a source of drinking water increased the prevalence of 
APEC by six-fold, which is suggestive of contamination. 
It is important to explore where such contamination might originate; at the source of the water well 
or during the transport of the water to the poultry sheds. Contamination may occur through droppings 
of wild birds, rats or other animals if the water source is not covered or supply lines not adequately 
cleaned. Furthermore, poor well design and construction and location of wells in close proximity to 
sewerage systems might also increase the risk of water contamination (Amaral, 2004). Shallow, aged 
and/or poorly maintained water wells can lead to contamination (Saidy et al., 2015) therefore, these 
should be investigated and any potential issues rectified.  
This study revealed that failure to disinfect the water lines between each flock contributed to the 
increased prevalence of APEC by more than two-fold. Avian pathogenic E. coli has been previously 
detected in standing water sources on poultry farms (Amaral, 2004; Pandey et al., 2014), 
consequently, adequate water treatment is paramount (Pandey et al., 2014; Saidy et al., 2015). Dhillon 
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and Jack (1996) reported that adding chlorine to drinking water provided control in the spread of 
avian colibacillosis and decreased bird mortality associated with the disease. Filtration of the water 
source removes insoluble particulates and further reduces contamination by filtering microorganisms 
of a certain size from the water. Filtration also helps to prevent dripping and obstruction of the 
waterline (Folorunso et al., 2014). Seventy percent of farms (n = 28) treated drinking water with 
chlorine alone, whilst 5% of farms (n = 2) used chlorine in combination with automatic filtration. 
There was a significant decrease in the prevalence of APEC on-farms that incorporated both 
chlorination and filtration into their management practices, supporting the benefits of this technique 
as recommended by Saidy et al. (2015) and Watkin et al. (2008).  
Identifying drinking water as a significant risk factor for contamination enables management 
mechanisms to be put in place in order to reduce the prevalence of APEC. These include chlorination 
and filtration of drinking water, covering of water wells and all water sources, as well as cleaning and 
disinfecting tanks and water lines between each flock. Applying appropriate management measures 
such as these are essential in disease control on poultry farms (Henry et al., 2011; Nather et al., 2009).  
Humans may be either directly or indirectly involved in the introduction and transmission of APEC 
between farms and the poultry sheds. A distance greater than 20 m between the car park and the shed 
which can relate to overall design of the farm and human movement, a lack of shower facilities and/or 
people not showering prior to entering the sheds were risk factors for increased incidence of APEC 
carriage. It has been highlighted previously that APEC might be common in the surrounding farm 
environments (Guenther et al., 2011) and that people entering poultry sheds can introduce APEC 
from the external environment (Anza et al., 2014). Further studies, which investigate the importance 
and benefits of spatial containment (i.e. distance to car park) and personal hygiene between sheds on 
disease prevention, have shown these to be crucial (Johnson et al., 2012; Maluta et al., 2014). 
Wild birds have been shown to be vectors that can introduce and disseminate APEC on poultry farms 
(Vandekerchove et al., 2004a). Common sequence types and strains of E. coli have been isolated 
from wild birds’ faeces and broiler chickens (Elmberg et al., 2017; Shobrak and Abo-Amer, 2014). 
In the current study, a higher prevalence of APEC was found to be associated with the presence of 
wild birds outside the poultry sheds. Furthermore, the presence of wild birds may induce stress and 
create unfavourable housing conditions, which are also known to be predisposing factors for APEC 
(Vandekerchove et al., 2004a). 
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The association between APEC prevalence and the potential risk factors identified in the current 
thesis highlights the need for further investigation across more regions and with more farms 
representing different companies to address the associations between risk factors and APEC using 
different study designs such as a cohort study. The data presented in this thesis indicates a need for 
careful reassessment of current biosecurity programs and the adoption of a higher level of biosecurity 
on poultry farms in Australia.  
Further investigations exploring the location of the farms, structure of the farm buildings, water 
sources and surrounding environment are also recommended in order to investigate how these 
potential risk factors contribute to APEC carriage so that a holistic approach to farm-wide disease 
prevention and controls can be developed and stringently applied. 
7.2.3 Investigation of the prevalence of antimicrobial susceptibility, plasmid replicon typing, 
phylogenetic grouping and virulence potential of Escherichia coli cultured from Australian 
broiler chickens with and without colibacillosis (Chapter 5) 
This study determined the prevalence and association of antimicrobial-resistance profiles with 
phylogenetic groups, APEC-associated VGs and plasmid replicon profiles among and between CEC 
and FEC isolates cultured from Australian commercial broiler chickens. The finding of low 
antimicrobial resistance among all E. coli isolates cultured from healthy birds and birds with 
colibacillosis reflects the strict regulations of antimicrobial registration applied to the poultry industry 
in Australia (Australian Pesticides and Veterinary Medicines Authority (APVMA), 2015; Australian 
Veterinary Association, 2017). Twenty six percent of both the CEC and FEC were susceptible to all 
twenty tested antimicrobial agents. All isolates were susceptible to amikacin, ceftazidime, imipenem 
and florfenicol, which mirror the nil usage of these critically important antimicrobials in the 
Australian poultry industry (Australian Pesticides and Veterinary Medicines Authority (APVMA), 
2015; Australian Veterinary Association, 2017). 
As expected, the most commonly found resistances were to older antimicrobials that are still in 
common use in the broiler industry. Resistance in CEC and FEC were identified, respectively, to 
sulfamethoxazole/trimethoprim (44% and 40%) introduced in 1936; tetracycline (54% and 28%); 
introduced in 1948 followed by ampicillin (28% and 31%) introduced in 1961 (Tadesse et al., 2012). 
Previous Australian studies, which investigated antimicrobial resistance in commensal organisms in 
poultry, identified similar resistances (Abraham et al., 2015; Department of Agriculture, Fisheries 
and Forestry (DAFF), 2007; Obeng et al., 2012; Obeng et al., 2014). The widespread and continuous 
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use of these antimicrobials in Australia, as well as residual environmental contamination, may explain 
the persistence of antimicrobial resistance among E. coli isolates sourced from broiler chickens 
(Walsh and Fanning, 2008). A number of studies have highlighted the fact that resistance to one 
antimicrobial can result in resistance to other classes of antimicrobials in E. coli (Dragana et al., 2016; 
EFSA European Food Safety Authority, 2015; Velhner and Milanov, 2015). The use of certain 
antimicrobials will select for resistant organisms and the potential for cross-resistance across different 
antimicrobial classes is acknowledged, for example, the overlapping of targets and drug efflux 
(Boerlin and Reid-Smith, 2008). Resistance genes associated with mobile genetic elements (MGE), 
such as integrons or plasmids, are linked, and the use of any antimicrobial that is a substrate for one 
of the resistance mechanisms will co-select for resistance to other antimicrobials (Rankin et al., 2011).  
Multidrug resistance, (MDR) was identified in 18% of the clinical isolates and 14% of the FEC in the 
current study. The most common resistances reported in multidrug resistant CEC were to the well 
established antimicrobials sulfamethoxazole/trimethoprim, aminoglycosides, β-lactams and 
tetracylines (Tadesse et al., 2012; Zhao et al., 2005). The potential public health risk from the 
emergence of MDR among E. coli from food-producing animals is considered one of the biggest 
issues facing both human and veterinary medicine (Cogliani et al., 2011). The detection of strains 
resistant to antimicrobials commonly being used to treat poultry should alert the poultry industry of 
the need for routine antimicrobial susceptibility testing of isolates, rather than simply using 
antimicrobials empirically. Reviews of treatment protocols applied across the Australian poultry 
industry are highly recommended so as to improve animal welfare and ensure public health is 
protected.  
Overall, the CEC isolates were more resistant to antimicrobials in comparison to FEC isolates. The 
CEC isolates were cultured from birds with colibacillosis that might have been exposed to 
antimicrobials prior to sampling. However, history of prior antimicrobial use was not available.  
Not all antimicrobial resistance detected in the current study reflects antimicrobials used in the 
Australian poultry industry. A major finding in this study was the identification of a low-level 
resistance to critically important antimicrobials, extended-spectrum cephalosporins (ESCs) and 
fluoroquinolones (FQs) among both the clinical and faecal isolates. Australia is the only country to 
have never permitted the use of fluoroquinolone antimicrobials in food-producing animals (Cheng et 
al., 2012), and the benefits are evident. Furthermore, ESC are not registered for use in poultry in 
Australia (Australian Pesticides and Veterinary Medicines Authority (APVMA), 2015). However, 
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resistance to FQs and ESCs have been reported previously in Australia in other food-producing 
animals (Abraham et al., 2014; Abraham et al., 2015). 
The majority of sequence types found among the FQ and ESC resistant isolates in the current study 
(ST354, ST10, S648 and ST 224) have been previously described globally among humans as well as 
animals (Abraham et al., 2015; Aizawa et al., 2014; Dahms et al., 2015; Day et al., 2016; Dissanayake 
et al., 2014; Kim et al., 2011; Maluta et al., 2014; Manges and Johnson, 2012; Sola-Gines et al., 
2015; Vignaroli et al., 2012). Nonetheless, four of the FQ resistant FEC isolates belonged to the same 
sequence type (ST354), but were cultured from different geographical regions indicating that they 
did not originate from one shed. However, the same company owned these farms. Thus, birds 
originated from the same breeding stock and all followed the same management and biosecurity 
protocols. Therefore, the resistant isolates may not be truly independent. Sampling population of birds 
from other companies, in other geographical regions and breeding stock is required to determine how 
widespread resistance is to these critically important drugs in Australia and the clonal linkage across 
companies, sheds and locations. 
Alternatively, the detection of FQ and ESC resistant bacteria without selection pressure could imply 
that the bacteria have been introduced into the shed from outside (Alves et al., 2014; Kmeť et al., 
2013; Smith et al., 2014). The finding of host restricted sequence types (ST2705 and ST6053) in this 
study, which have been previously isolated from poultry and wild birds (Dahms et al., 2015; Day et 
al., 2016; Jones-Dias et al., 2015) supports this hypothesis. The globally disseminated sequence types 
may have been introduced into the sheds by people, fomite or other animal movement. 
Wild birds and animals such as vermin and rodents can disseminate resistant E. coli (Guenther et al., 
2010; Laube et al., 2014). FQ and ESC resistant E. coli strains have been identified in wild birds 
(Allen et al., 2010; Literak et al., 2010) and from Australian wildlife rehabilitation centres (Blyton et 
al., 2015). Chapter 4 of this thesis identified wild birds as a potential risk factor associated with 
increased APEC carriage in healthy birds. However, many factors such as strict farm biosecurity will 
minimise the contact between wild bird and poultry inside the sheds, thus decreasing the transmission 
of strains. Humans may also act as a direct or indirect (via faeces, water, food) transmission source 
(Marathe et al., 2013).  
The current study reported for the first time the detection of blaCMY-2 and blaDHA-1 in ESC resistant 
APEC in Australia. These genes have been previously found in ESC resistant E. coli isolates cultured 
from chickens and other farm animals (Abgottspon et al., 2014; Cortes et al., 2010; Pitout, 2012; 
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Schaufler et al., 2015) and from humans worldwide (Deshpande et al., 2006; Halova et al., 2014; 
Literak et al., 2010; Woodford et al., 2007). Plasmids play a major role in the spread of virulence and 
resistance genes in E. coli and other bacterial species. Despite extensive studies on plasmids in ExPEC 
and APEC (Carattoli, 2011; Carattoli, 2013; Carattoli et al., 2002), there is limited information about 
the role and the impact of these plasmids in APEC.  
The presence of the following plasmids in this study were reported in both clinical and faecal isolates: 
IncHI1; IncHI1; IncY; IncI; IncFIA and IncN. However, it was also found that the most common 
plasmid replicon types observed in CEC and FEC were IncFIB (90% and 64%, respectively) and 
IncFrep (64% and 61%). Johnson et al. (2007) also reported plasmid IncFIB type as the most 
prevalent among E. coli isolates of avian, human and poultry meat followed by IncI1. The virulence 
and resistant genes found in APEC have been detected on IncFIB plasmids, such as pAPEC-1 
(Mellata et al., 2012). All plasmid replicons reported in the current study have been previously 
detected in E. coli isolates sourced from the environment, other animals and humans (Bortolaia et al., 
2010; Garcia-Fernandez et al., 2008; Kluytmans et al., 2013; Lynne et al., 2012; Seni et al., 2016; 
Wang et al., 2013a; Woodford et al., 2007).  
Commonly, ESC resistance is associated with transferable plasmids that harbour resistance genes 
such as AmpC β-lactamases. In this study, the plasmid profile for the two ESC resistant isolates did 
not contain the same plasmid replicons, with one isolate containing IncY and IncI1 plasmid types, 
while the other contained IncFIA, IncFIB and IncFrep plasmids. There is evidence that some types 
of plasmid replicons, such as IncI1, can survive in E. coli isolates without the antimicrobial selection 
pressure with little to no fitness cost to the host (Carattoli, 2011; Garcia-Fernandez et al., 2008). 
Here, APEC was identified by the possession of four out of the five VGs, which have been linked 
with IncFIB plasmids (also known as ColV plasmids) (Johnson et al., 2006). Several studies have 
found that ColV plasmids contain a highly conserved region that harbors VGs and/or resistance genes 
that contribute to the virulence of APEC (Johnson and Russo, 2002; Johnson et al., 2006; Johnson et 
al., 2005; Kariyawasam et al., 2006a). 
IncA/C plasmids are associated with horizontal gene transfer and can be transferred between 
Salmonella and E. coli from food-producing animals, the environment and humans (Mataseje et al., 
2010), and are associated with MDR and the AmpC blaCMY-2 (Fernandez-Alarcon et al., 2011). Only 
three isolates harboured the IncA/C plasmid, they did not exhibit multidrug or ESC resistance, but 
there is a potential for acquired resistance as the plasmid is in the population of E. coli on the farms.  
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In this thesis, 96% of the CEC isolates harboured all five VGs in comparison with 36% of the FEC 
isolates (p < 0.001). Four percent of the clinical isolates (n = 2) contained none of the five VGs 
compared with 19% of the FEC isolates. Interestingly, the two clinical isolates that contained no VGs 
were both FQ resistant, supporting the theory that these represent low pathogenic opportunistic 
isolates. Similar findings have occurred in earlier studies in other parts of the world where low 
prevalence of VGs were detected in FQ resistant CEC isolates (Horcajada et al., 2005; Huang et al., 
2009; Kawamura-Sato et al., 2010). These isolates may have been opportunistic pathogens that 
acquired FQ resistance (Drews et al., 2005; Vila et al., 2002) or they may be CEC isolates that lost 
their VGs after they developed mutations in the quinolone resistance-determining region (QRDR) 
(Horcajada et al., 2005; Moreno et al., 2006; Sawma-Aouad et al., 2009). Furthermore, the virulence 
profile of the AmpC β lactamase harbouring E. coli isolates also varied. One of the ESC resistant 
E. coli isolate harboured none of the CEC related VGs, while the other ESC resistant isolate 
harboured all five VGs. The fact that all of the FQ and ESC resistant isolates do not belong to 
phylogenetic group B2, the most common phylogenetic group of pathogenic ExPEC, could support 
the theory that they are opportunistic. Further investigation of FQ and ESC resistant E. coli using 
whole genome sequencing technology establishing antimicrobial resistance mechanisms is justified. 
This might be part of a much larger study, which may explore the distribution of AmpC β-lactamase 
genes in avian E. coli isolates at different geographical locations and how similar Australian isolates 
are to overseas strains.  
Overall, the current thesis found that the prevalence of antimicrobial resistance, plasmids and VGs in 
FEC occur at a lower frequency in comparison with the CEC. However, their presence in faecal 
isolates suggests that FEC may act as a reservoir for plasmids, antimicrobial resistance and VGs. 
Interestingly, the current study showed that the faecal isolates exhibited more diversity in their 
resistance profiles than the clinical isolates, supporting the suggestion that commensal E. coli flora 
are a source of emerging and developing E. coli resistant strains and/or resistance genes (da Costa et 
al., 2013). 
Antimicrobial resistance surveillance investigations using structured sampling strategies involving 
larger sample sizes to represent all food-producing animal species in Australia, which does not rely 
on laboratory-acquired isolates with limited history, is recommended. The information provided by 
the surveillance study will be able to identify the antimicrobial consumption in each animal, resistance 
trends and emergence of pathogens at national levels, thereby highlighting any emerging resistance 
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characteristics with public health potential. These data will guide and help farm managers and 
veterinarians in their treatment strategies and ultimately improve bird health, welfare and production. 
The VGs and antimicrobial resistance profile detected in the current thesis proposes the need to 
investigate the role of plasmids in transferring ARGs and VGs among avian E. coli isolates and the 
ability of the plasmids to transfer into other bacteria that are found in the normal gut flora of birds. 
7.2.4 Virulence associated genes in faecal and clinical Escherichia coli isolates cultured from 
broiler chickens in Australia (Chapter 6) 
This final study aimed to produce a more in-depth understanding of the range of ExPEC-associated 
VGs present in E. coli circulating in commercial broiler chicken flocks and derive a set of VGs which 
could be used to better define and identify APEC in Australia. Thirty four of 35 VGs were detected 
in Australian E. coli isolates, with prevalence ranging from 3.4% (focG) among faecal isolates to 
100% (astA) among clinical isolates. The following VGs were identified with significant (with p-
value less than 0.05) prevalence among CEC: astA (100%); foeB (96.6%); iroN (93.1%); ompT 
(93.1%); iss (93.1%); iutA (93.1%), hlyF (93.1%); vat (89.7%), fimC (86.2%), cvi/cvaC (79.3%), tsh 
(55.2%); ireA (51.7%); papC (44.8%); papEF (41.4%) and ibeA (37.9%). Previous studies have 
shown that these VGs are predominantly found on plasmids (Collingwood et al., 2014; da Rocha et 
al., 2002; Johnson et al., 2005; Nakazato et al., 2009). The presence of ExPEC-associated genes 
among the FEC and CEC isolates in the current study supports the hypothesis that clinical and faecal 
avian E. coli have zoonotic potential.  
Numerous studies (Ewers et al., 2004; Johnson et al., 2008b; McPeake et al., 2005; Rodriguez-Siek 
et al., 2005a) have compared CEC isolates sourced from birds affected with colibacillosis with faecal 
isolates from clinically healthy birds. Although the current study identified a set of VGs that were 
significantly associated with CEC isolates, none of the VGs were associated exclusively with CEC 
isolates. These VGs were also found in FEC isolates, though at a much lower prevalence.  
In conclusion, the five VGs that were used to define APEC in the United States by Johnson et al. 
(2008b) can be used to identify APEC in Australian conditions. However, in addition to those five 
VGs, the current study identified ten more VGs (tsh, fimC, papC, papEF, vat, astA, ibeA, feoB, ireA 
and cvi/cvaC) that were significantly associated with APEC. Further investigation with a larger 
sample size is recommended to validate the selection of these 15 VGs as future markers for APEC 
detection in the field and in the veterinary diagnostic laboratory. Using the five initially identified 
VGs, the detection of APEC directly from faecal material proved to be unreliable. However, utilising 
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the repeated bead beating plus column (the recommended DNA extraction method validated in the 
first study) in combination with a more stringent subset of the ten further identified VGs would be a 
useful tool in investigating the possibility of rapid methods based on detection of APEC directly from 
faecal material. Furthermore, assessment of the role and contributions to the pathogenicity of avian 
pathogenic E. coli of the ten VGs is warranted. 
7.3 General discussion  
The current thesis reported resistance to ESCs and FQs from E. coli isolates sourced from broiler 
chickens in Australia for the first time. Extended-spectrum cephalosporin resistance was encoded by 
blaCMY-2 and blaDHA-1 genes, which have been previously reported in other animals and other bacterial 
species in Australia (Abraham et al., 2014; Cherif et al., 2015; Rogers et al., 2014; Sidjabat et al., 
2007), but not previously in poultry. The blaCMY-2 gene is the most frequently detected AmpC β-
lactamase in food-producing animals worldwide (Borjesson et al., 2013; Bortolaia et al., 2010; Cherif 
et al., 2015; El-Shazly et al., 2017; Ewers et al., 2012; Jacoby, 2009). Furthermore, a large number 
of studies have recently demonstrated a widespread increase in the prevalence of plasmid-mediated 
AmpC E. coli isolates harbouring the blaDHA-1 gene from livestock (El-Shazly et al., 2017; Lee et al., 
2010; Maamar et al., 2016; Mataseje et al., 2010; Pacholewicz et al., 2015; Rasmussen et al., 2015; 
Rayamajhi et al., 2010; Rayamajhi et al., 2008; Tagg et al., 2015; Yan et al., 2006).  
The detection of the plasmid-mediated genes blaCMY-2, blaDHA-1 and qnrS1 indicates the existence of 
a potential animal reservoir for these genes in poultry in Australia. This is of public health significance 
as these genes that encode for critically important antimicrobial resistance can be transmitted to other 
bacterial species by horizontal gene transfer (HGT) (Allen et al., 2013; Boerlin and Reid-Smith, 2008; 
da Costa et al., 2013; Davies, 1994; Martinez-Medina et al., 2009). Further investigations are needed 
to identify the plasmids associated with the ARGs among E. coli isolates sourced from chickens in 
Australia. 
The two host restricted sequence types ST2705 and ST6053 found in the current thesis may have 
originated from the breeder flock (vertical transmission) or via horizontal transmission (Dahms et al., 
2015; Day et al., 2016; Jones-Dias et al., 2015). The globally disseminated STs (ST354, ST10, S624, 
ST57 and ST224) suggest horizontal transmission sources that are likely external to the production 
facility. The majority of these sequence types have been previously described and are globally 
distributed amongst humans as well as animals (Fernandes et al., 2016; Kim et al., 2011; Maluta et 
al., 2014; Sola-Gines et al., 2015). This may suggest that the resistant isolates originated from humans  
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(Meyer et al., 2010), wild birds (Smith et al., 2014) and/or from the farm environment such as water 
sources (Alves et al., 2014; Sjolund et al., 2008) and then gained access to the poultry production 
environment.  
The horizontal transmission to the sheds from the external environmental may be facilitated by the 
presence of wild birds, as a number of studies have reported that wild birds can act as reservoirs and 
vectors in the global dissemination of APEC-associated VGs and ARGs (Belanger et al., 2011; Foster 
et al., 2006; Wang et al., 2017). If biosecurity is poor on-farm, faecal droppings of wild birds may 
contaminate poultry feed and drinking water (Fogarty et al., 2003; Lévesque et al., 2000). Resistance 
to disinfectants often occurs in conjunction with ARGs (Bragg et al., 2014; Wales and Davies, 2015). 
Therefore, resistant E. coli isolates may be able to survive inside the poultry shed despite the usage 
of sanitisation products. Further screening and characterisation of E. coli isolates from wild bird 
species, wild animals and the farm environment (Guenther et al., 2011; Radhouani et al., 2014) is 
required to identify the potential risk pathways for the introduction as well the transmission of APEC 
and/or antimicrobial resistance genes into the poultry shed.  
Biosecurity is critically important - the presence of wild birds and unnecessary human contact on the 
poultry farm should be minimised to reduce the risk of infection by APEC and other pathogens. This 
study found that a lack of shower facilities on the farm or people not showering prior to entering the 
shed were associated with an increase in APEC prevalence. Strict biosecurity measures such as  
wearing overalls before entering each shed should be in place when human presence cannot be 
avoided in order to reduce the prevalence of APEC (Tadesse et al., 2012). 
The introduction and spread of APEC is not limited to the farm worker, farm visitors play a 
noteworthy role also. They are a potential risk, especially if they move from one farm to another using 
their own vehicles, equipment, boots and clothing (Newell et al., 2011). In this study, 80% of the 40-
surveyed farms reported that their farm visitors (n = 30) did not wear protective overalls before 
entering the shed and 17.5% of farms (n = 7) did not have a shower facility on the premises. The lack 
of protective wear and personal hygiene and/or biosecurity can facilitate the spread of the E. coli as 
well as other infections agents from one shed to another or, introduce agents to the shed from the 
surrounding environment. It is recommended that the poultry companies re-evaluate this policy and 
incorporate mechanisms to minimise the incidence and spread of infectious agents. 
A distance of more than 20 m between car park and shed was also identified as a potential risk factor 
for APEC. The greater distance relates not so much to the proximity of the car park to the sheds, but 
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more to the movement of farm workers/visitors around the farm before reaching the entry point to the 
shed. Combined with a lack of biosecurity procedures this identified risk factor increase the 
possibility of environmental contamination introduced to the shed via people. It also points to the 
importance of design and workflow on the farm to avoid introduction of pathogens into the poultry 
shed. A review of current biosecurity procedures applied on-farm that identifies areas where farm 
policy needs to modify in regards to visitors is recommended. 
The current study identified three risk factors related to poor quality water sources as well as 
inappropriate water management in regards to treatment and sanitation of drinking water (Shobrak 
and Abo-Amer, 2014; Vandekerchove et al., 2004a; Wang et al., 2013b). The identification of water 
related risk factors suggest that applying strict water biosecurity and management protocols on 
commercial broiler farms can be improved in Australia and this should contribute to the reduction of 
the prevalence of APEC within the flock. However, further longitudinal investigation to estimate the 
carriage of APEC in one-day-old chickens through to slaughter, and measures of carcass rejections 
in the same flocks at the abattoirs, is necessary to identify associations between the prevalence of 
APEC in healthy chickens and carcass rejection at the slaughterhouse.  
Selecting a specific array of APEC-associated VGs to identify APEC in Australia was difficult due 
to the lack of regional studies, the large number of VGs associated with APEC and AFEC, as well as 
the worldwide genetic variations in VGs. This research proposes using VGs ( iroN, iss, iutA, tsh, fimC, 
papC, papEF, vat, hlyF, astA, ibeA, feoB, ireA, cvi/cvaC and ompT) to identify APEC in Australia. 
These VGs were significantly associated with avian E. coli strains sourced from chickens with 
colibacillosis. Five of these VGs were those that had been selected in the first chapters of the thesis 
to define APEC. These five genes have been used worldwide to identify APEC and this study shows 
they can also be used in Australia. Screening for these and the ten additional VGs will increase 
specificity. Seven out of the 15 VGs are plasmid related genes, which highlights the association 
between the pathogenicity of avian E. coli strains and the possession of plasmids. Further studies are 
required to investigate the possibility of utilising these VGs as markers for field practitioners for the 
early identification of APEC and avian colibacillosis in Australia.  
The current study data showed that APEC associated VGs were found in the faecal samples of healthy 
birds, which could indicate the presence of APEC. Keeping in mind that the presence of these VGs 
does not automatically mean that those genes are expressed and avian colibacillosis will occur. The 
occurrence of the disease depends on the interaction outcome between the host, agent and surrounding 
environment. The pathogenicity of the bacteria depends on the expression of VGs, which has to be 
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co-ordinated for invasion and disease to occur in the host. Very often, expression involves very 
complex cascades of component systems and quorum sensing (Thomas and Wigneshweraraj, 2014). 
However, the early detection of these genes highlights the need to evaluate the priorities of 
management policies in order to minimise the presence of these genes and associated bacteria in the 
sheds. The reduction of these bacteria will help to reduce the inhalation risk of dust contaminated 
with APEC and therefore, reduce respiratory disease that is often followed by systematic infections 
that are characterised by poor flock performance and high mortality.  
Rapid detection of APEC directly from faecal samples could minimise the economic losses associated 
with the disease as more specific control and treatment measures could be applied earlier , e.g. 
decreasing mortality and the costs associated with inappropriate therapy and/or rejecting of the 
carcass at the slaughterhouse. This thesis identified and validated an effective method to extract DNA 
from faeces. The repeated bead beating plus column method effectively extracted PCR quality DNA. 
The ability to use the RBB+C to detect APEC directly from the faecal samples using the APEC VGs 
that were suggested in Chapter 6 (iroN, iss, iutA, tsh, fimC, papC, papEF, vat, hlyF, astA, ibeA, feoB, 
ireA, cvi/cvaC and ompT) should be investigated. It needs to be noted that five of those VGs (iutA, 
iss, ompT, iroN and hly) have been found to be associated with other bacterial species also found in 
chicken faeces samples.  
The genetic diversity of E. coli was demonstrated by the variation in the VG prevalence and pattern 
as well as the resistance profiles of the E. coli isolates cultured from the faecal samples of the birds. 
In Chapter 4, after cloacal culture, five and ten colonies of E. coli were selected and screened for the 
five VGs. The statistical analysis showed good VG profile agreement in the five versus ten E. coli 
isolates picked. Five E. coli colonies were identified as the less-resource intensive method that was 
able to capture the variation of E. coli strains (based on VG profile) in the faecal samples. Hence, it 
is recommended that further studies use five as a sample size. Birds affected with colibacillosis had 
a higher prevalence of APEC and were more likely to contain less variation in VG carriage in Chapter 
3 and 5. However, avian pathogenic E. coli was detected in healthy chickens. Therefore, healthy birds 
can act as reservoir for VGs and ARGs. The fact that healthy birds carry APEC points to the fact that 
the occurrence of the disease does not only depend on the presence of APEC.  
The ability of APEC to cause localised and systemic avian colibacillosis infection by acting either as 
a primary or secondary disease agent depends on the interaction outcome between the environment, 
pathogenicity of the agent and the bird’s immunity. The ability of APEC to reach the respiratory tract 
and reach the blood stream causing systematic infection depends on any challenging conditions in the 
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environment (such as high dust and ammonia level and poor ventilation), stress and 
immunocompromised birds (due to pre viral and/or bacterial infection) combined with the 
pathogenicity and the duration of APEC exposure. Addressing the potential risk factors suggested in 
the current study can enhance farm biosecurity and improve the production system, which may help 
to prevent the occurrence and spread of avian colibacillosis. The combination of certain bird’s breed, 
strict biosecurity protocols and farm management as well as an effective vaccine may help to prevent 
the occurrence of avian colibacillosis or reduce the severity of the disease. 
Despite the ability to use the large number of APEC associated virulence genes suggested in the 
current study to detect the presence of APEC on the farm, the regulation of their expression has not 
been investigated in the current study. Further studies to explore their role in APEC pathogenicity are 
needed. Furthermore, the fact that three PCRs were needed to investigate the presence of APEC 
makes it impractical and highlights the need for faster and more accurate method to screen for the 
presence of these APEC associated virulence genes. Methods using whole genome sequencing 
(WGS) are recommended to provide rapid, accurate and valuable genetic data (Wang et al., 2016; 
Franz et al., 2014; Oulas et al., 2015). These data hae the discriminatory power for future APEC 
pathogenesis studies and epidemiological investigations that will improve the bird’s welfare and help 
in the development of prevention and control measures against avian colibacillosis (Wang et al., 
2016). 
7.4 Limitations 
Defining and identifying APEC is challenging. Many studies simply identify all E. coli cultured from 
birds with colibacillosis as APEC and all cultured from healthy birds as AFEC, irrespective of VG 
carriage. Many factors potentially limited the outcomes of this thesis. The geographically diverse 
sources for the clinical samples was one of the strengths of the current thesis, with the CEC profiles 
in regards to the VGs, AMR, plasmid replicons and phylogenetic groups representing a large 
geographical area. However, the FEC isolates were obtained from poultry farms, which were 
restricted geographically (South East Queensland) at a different point of time to the CEC isolates, 
limiting the strength of the current thesis when comparing the clinical and faecal isolates. Although 
this study found a small number of resistant isolates, especially ESC and FQ resistant isolates, limited 
knowledge of historical farm practices, especially in regards to previous antimicrobial usage, were 
limiting factors. 
 Page | 190  
 
The risk factor study was conducted as a cross-sectional study, and therefore it was not possible to 
conclude that there were causal relationships (e.g. whether management interventions lead to 
increased/decreased APEC prevalence or if management interventions were implemented in response 
to increased/decreased APEC prevalence). Further studies that use designs in advance of 
observational studies are thus indicated to better explore the causal pathways. 
Another limitation was the lack of clinical break points available for interpretation of antimicrobial 
susceptibility in E. coli isolates cultured from poultry, and as such, interpretations had to be 
extrapolated from humans or other pathogens. An example for this limitation was highlighted with 
the resistance detected to cephalothin among the FEC in the current study. Despite the fact that this 
antimicrobial is no longer used in the poultry industry, it calls into question the validity of using 
human breakpoints. Studies are required to set recommended clinical and/or epidemiological 
breakpoints for common bacteria in all animal species.  
Although the current thesis identified a set of APEC-associated VGs, their contributions to 
pathogenicity were not investigated nor were all isolates screened for all VGs. With the increasing 
availability of whole genome sequencing, this could be investigated in future studies using a large 
number of isolates.  
7.5 Industry application and practical outcomes 
The current study offers several practical outcomes for the poultry meat industry. The identification 
of a suitable DNA extraction method for bird faecal samples is of importance because chicken faeces 
has additional faecal inhibitors in comparison with other animals (Akhtar et al., 2013; Barnard et al., 
2011; Chambers et al., 2001). Identifying pathogens including APEC directly from samples will lead 
to faster and more effective treatments of disease whereby improving bird welfare and reducing 
economic losses associated with disease. The identification of a pathogen’s resistance profile can 
reduce costs associated with treatment and guide the veterinarian to effective therapy. The similarity 
of the sequence types and VG prevalence in E. coli isolates sourced from broiler chickens in the 
current study with data obtained from overseas studies suggest that poultry products could act as a 
source of ExPEC in humans (Manges and Johnson, 2012). This finding should emphasise the 
importance of applying strict biosecurity measures and adequate hygiene practices in the poultry 
farms in order to protect not just poultry health and productivity, but human health and the safety and 
marketability of the associated food chain.  
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At the beginning of the current study, no knowledge was available about the possible associations 
between risk factors and the prevalence of APEC in commercial broiler chickens in Australia. 
Reporting the prevalence of APEC among healthy commercial broiler chickens helps to gain a better 
understanding of the epidemiology of APEC in Australian broiler flocks, which will lead to better 
recognition of sub-clinical carriage and transition to pathogenicity. Furthermore, the current study 
reported potential risk factors associated with APEC carriage and suggests that addressing these 
potential factors will lead to better prevention strategies at the broiler farms. Overall, the study has 
opened the way to launch into a larger Australian wide prevalence study to help determine farms that 
harbor APEC and the identified risk factors in this study can be addressed to keep APEC out of the 
farm environment. APEC is not associated with high disease levels in Australia; however, the fact 
that antimicrobial resistance to critical human antimicrobials has been found makes the potential of 
resistance transmission an important incentive to implement strategies to prevent transmission of 
virulence and resistance genes and bacteria. Antimicrobial resistance varies between countries and 
the identification of resistance points to the need of an antimicrobial resistance surveillance program 
for Australia. This study has established the approaches and tools to do large-scale studies and 
implement biosecurity measures. 
7.6 General conclusions 
In conclusion, the current thesis contributes significantly to better defining APEC and produces 
preliminary data on the prevalence of APEC in Australian poultry. A set of VGs that can be used to 
identify APEC in the field or laboratory has been suggested, and identification and validation of an 
effective method to extract DNA directly from faecal samples was achieved. 
Despite ESCs and FQs not being used in the poultry industry in Australia, resistance to these critically 
important antimicrobials was detected in E. coli isolates from broiler chickens. The identification of 
resistance to these antimicrobials in globally disseminated STs suggests the need for further studies 
to identify how poultry is included within the broader epidemiology of resistance amongst 
extraintestinal pathogenic E. coli, and the potential significance to public health. This approach will 
assist in guiding improvements in infection control practices at the broiler farm production level and 
optimise bird health, welfare and public health outcomes. 
Addressing and controlling the potential risk factors identified can possibly reduce the risk of APEC 
colonisation on commercial poultry farms across Australia. Australian poultry producers should focus 
on improving biosecurity and applying strict biosecurity protocols at the farm-level to not only 
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prevent the transmission of APEC but also to prevent the spread of E. coli strains or their genes to 
humans. It is highly likely that the FQ and ESC resistant E. coli isolates originated from the birds’ 
external environment. Additionally, the birds can act as a vehicle to transmit antimicrobial resistance 
genes to the external environment via people visiting the shed and/or be transmitted by their protective 
clothing.  
Data obtained through the current study suggests a diverse population of antimicrobial resistance 
genes, plasmid replicons, phylogenetic groups and ExPEC related VGs among avian E. coli, 
regardless of the health status of the broiler chickens in Australia. Many of the VGs reported in the 
current thesis are human ExPEC genes, suggesting that CEC and FEC may represent a potential health 
risk (Manges and Johnson, 2012). Detection of antimicrobial resistance supports the general concern 
that avian E. coli can act as a reservoir for the resistance genes and spread resistance to humans 
through the food chain. The direct and indirect linkage of chicken products as a source of ExPEC 
infections and antimicrobial resistance to humans will continue to challenge the control and treatment 
of APEC infections. This ongoing emergence of multidrug resistance, points to the need to enhanc e 
the biosecurity strategies on-farms as well as food safety measures to control APEC infections.  
  
 Page | 193  
 
8 Chapter 8: References 
Aarestrup, F.M., 2005. Veterinary drug usage and antimicrobial resistance in bacteria of animal 
origin. Basic Clinical Pharmacology and Toxicology 96, pp 271-281. 
ABARES, 2011. Agricultural Commodities: The chicken meat industry in Australia, 1 September 
Quarter 2011, [Available from 
http://adl.brs.gov.au/data/warehouse/pe_A20110920.01/AC2011.V1.1_AgCommodities1.2.
0_LR.pdf]; Accessed March 2014. 
Abdallah, H.M., Reuland, E.A., Wintermans, B.B., Al Naiemi, N., Koek, A., Abdelwahab, A.M., 
Ammar, A.M., Mohamed, A.A. and Vandenbroucke-Grauls, C.M., 2015. Extended-spectrum 
β-lactamases and/or carbapenemases-producing Enterobacteriaceae isolated from retail 
chicken meat in Zagazig, Egypt. PLoS One 10, pp e0136052. 
Abgottspon, H., Stephan, R., Bagutti, C., Brodmann, P., Hachler, H. and Zurfluh, K., 2014. 
Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli isolated from 
Swiss and imported poultry meat. Journal of Food Protection 77, pp 112-115. 
Abraham, E.P. and Chain, E., 1988. An enzyme from bacteria able to destroy penicillin. Reviews of 
Infectious Diseases 10, pp 677-678. 
Abraham, S., Chin, J., Brouwers, H.J., Zhang, R. and Chapman, T.A., 2012. Molecular serogrouping 
of porcine enterotoxigenic Escherichia coli from Australia. Journal of Microbiological 
Methods 88, pp 73-76. 
Abraham, S., Groves, M.D., Trott, D.J., Chapman, T.A., Turner, B., Hornitzky, M. and Jordan, D., 
2014. Salmonella enterica isolated from infections in Australian livestock remain susceptible 
to critical antimicrobials. International Journal of Antimicrobial Agents 43, pp 126-130. 
Abraham, S., Jordan, D., Wong, H.S., Johnson, J.R., Toleman, M.A., Wakeham, D.L., Gordon, D.M., 
Turnidge, J.D., Mollinger, J.L., Gibson, J.S. and Trott, D.J., 2015. First detection of extended-
spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-
producing animals Journal of Global Antimicrobial Resistance 3, pp 273-277. 
Abu Al-Soud, W. and Radstrom, P., 1998. Capacity of nine thermostable DNA polymerases to 
mediate DNA amplification in the presence of PCR-Inhibiting samples. Applied and 
Environmental Microbiology 64, pp 3748-3753. 
 Page | 194  
 
Abu Al-Soud, W. and Radstrom, P., 2000. Effects of amplification facilitators on diagnostic PCR in 
the presence of blood, feces, and meat. Journal of Clinical Microbiology 38, pp 4463-4470. 
Acar, J.F., Moulin, G., Page, S.W. and Pastoret, P.P., 2012. Antimicrobial resistance in animal and 
public health: introduction and classification of antimicrobial agents. Revue Scientifique et 
Technique 31, pp 15-21. 
Achtman, M., Heuzenroeder, M., Kusecek, B., Ochman, H., Caugant, D., Selander, R.K., Vaisanen-
Rhen, V., Korhonen, T.K., Stuart, S. and Orskov, F., 1986. Clonal analysis of Escherichia 
coli O2:K1 isolated from diseased humans and animals. Infection and Immunity 51, pp 268-
276. 
Adiri, R.S., Gophna, U. and Ron, E.Z., 2003. Multilocus sequence typing (MLST) of Escherichia 
coli O78 strains. FEMS Microbiology Letters 222, pp 199-203. 
Ahmed, A.M., Shimamoto, T. and Shimamoto, T., 2013. Molecular characterization of multidrug-
resistant avian pathogenic Escherichia coli isolated from septicemic broilers. International 
Journal of Medical Microbiology 303, pp 475-483. 
Ahmed, S., Besser, T.E., Call, D.R., Weissman, S.J., Jones, L.P. and Davis, M.A., 2016. Evaluation 
of two multi-locus sequence typing schemes for commensal Escherichia coli from dairy cattle 
in Washington State. Journal of Microbiological Methods 124, pp 57-61. 
Aidara-Kane, A., 2012. Containment of antimicrobial resistance due to use of antimicrobial agents in 
animals intended for food: WHO perspective. Revue Scientifique et Technique 31, pp 277-
287. 
Aizawa, J., Neuwirt, N., Barbato, L., Neves, P.R., Leigue, L., Padilha, J., Pestana de Castro, A.F., 
Gregory, L. and Lincopan, N., 2014. Identification of fluoroquinolone-resistant extended-
spectrum β-lactamase (CTX-M-8)-producing Escherichia coli ST224, ST2179 and ST2308 
in buffalo (Bubalus bubalis). The Journal of Antimicrobial Chemotherapy 69, pp 2866-2869. 
Akaike, H. 1973. Information Theory and an Extension of the Maximum Likelihood Principle. In: 
Petrov, B.N. and Csaki, F. (Eds.), Proceedings of the 2nd International Symposium on 
Information Theory, Akademiai Kiado, Budapest, pp 267-281. 
Akaike, H., 1974. A new look at the statistical model identification. IEEE Transaction Automatic 
Control 19, pp 716-723. 
 Page | 195  
 
Akhtar, S., Shakeel, S., Mehmood, A., Hamid, A. and Saif, S., 2013. Comparative analysis of animal 
manure for soil conditioning. International Journal of Agronomy and Plant Production 4, pp 
3360-3366. 
Al-Mustafa, Z.H. and Al-Ghamdi, M.S., 2000. Use of norfloxacin in poultry production in the eastern 
province of Saudi Arabia and its possible impact on public health. International Journal of 
Environmental Health Research 10, pp 291-299. 
Alexander, T.W., Inglis, G.D., Yanke, L.J., Topp, E., Read, R.R., Reuter, T. and McAllister, T.A., 
2010. Farm-to-fork characterization of Escherichia coli associated with feedlot cattle with a 
known history of antimicrobial use. International Journal of Food Microbiology 137, pp 40-
48. 
Allen, H.K., Donato, J., Wang, H.H., Cloud-Hansen, K.A., Davies, J. and Handelsman, J., 2010. Call 
of the wild: antibiotic resistance genes in natural environments. Nature Reviews. 
Microbiology 8, pp 251-259. 
Allen, S.E., Janecko, N., Pearl, D.L., Boerlin, P., Reid-Smith, R.J. and Jardine, C.M., 2013. 
Comparison of Escherichia coli recovery and antimicrobial resistance in cecal, colon, and 
fecal samples collected from wild house mice (Mus musculus). Journal of Wildlife Diseases 
49, pp 432-436. 
Allocati, N., Masulli, M., Alexeyev, M.F. and Di Ilio, C., 2013. Escherichia coli in Europe: an 
overview. International Journal of Environmental Research and Public Health 10, pp 6235-
6254. 
Altalhi, A.D., Gherbawy, Y.A. and Hassan, S.A., 2010. Antibiotic resistance in Escherichia coli 
isolated from retail raw chicken meat in Taif, Saudi Arabia. Foodborne Pathogens and Disease  
7, pp 281-285. 
Alvarez-Fernandez, E., Cancelo, A., Diaz-Vega, C., Capita, R. and Alonso-Calleja, C., 2013. 
Antimicrobial resistance in E. coli isolates from conventionally and organically reared 
poultry: A comparison of agar disc diffusion and sensi test Gram-negative methods. Food 
Control 30, pp 227-234.  
Alves, M.S., Pereira, A., Araujo, S.M., Castro, B.B., Correia, A.C. and Henriques, I., 2014. Seawater 
is a reservoir of multi-resistant Escherichia coli, including strains hosting plasmid-mediated 
 Page | 196  
 
quinolones resistance and extended-spectrum beta-lactamases genes. Frontiers in 
Microbiology 5, pp 426-410. 
Amabile de Campos, T., Stehling, E.G., Ferreira, A., Pestana de Castro, A.F., Brocchi, M. and Dias 
da Silveira, W., 2005. Adhesion properties, fimbrial expression and PCR detection of adhesin-
related genes of avian Escherichia coli strains. Veterinary Microbiology 106, pp 275-285. 
Amaral, L.d., 2004. Drinking water as a risk factor to poultry health. Revista Brasileira de Ciência 
Avícola 6, pp 191-199. 
Amit-Romach, E., Sklan, D. and Uni, Z., 2004. Microflora ecology of the chicken intestine using 16S 
ribosomal DNA primers. Poultry Science 83, pp 1093-1098. 
Antão, E.M., Glodde, S., Li, G., Sharifi, R., Homeier, T., Laturnus, C., Diehl, I., Bethe, A., Philipp, 
H.-C., Preisinger, R., Wieler, L. and Ewers, C., 2008. The chicken as a natural model for 
extraintestinal infections caused by avian pathogenic Escherichia coli (APEC). Microbial 
Pathogenesis 45, pp 361-369. 
Antao, E.M., Wieler, L.H. and Ewers, C., 2009. Adhesive threads of extraintestinal pathogenic  
Escherichia coli. Gut Pathogens 1, pp 1-12. 
Anza, I., Vidal, D., Laguna, C., Diaz-Sanchez, S., Sanchez, S., Chicote, A., Florin, M. and Mateo, R., 
2014. Eutrophication and bacterial pathogens as risk factors for avian botulism outbreaks in 
wetlands receiving effluents from urban wastewater treatment plants. Applied and 
Environmental Microbiology 80, pp 4251-4259. 
Arias, M.V.B. and Carrilho, C., 2012. Antimicrobial resistance in animals and in human being. There 
is reason for concern? Semina-Ciencias Agrarias 33, pp 775-790. 
Ariefdjohan, M.W., Savaiano, D.A. and Nakatsu, C.H., 2010. Comparison of DNA extraction kits for 
PCR-DGGE analysis of human intestinal microbial communities from fecal specimens. 
Nutrition Journal 9, pp 23-28. 
Armstrong, E.S., Kostrub, C.F., Cass, R.T., Moser, H.E., Serio, A.W. and Miller, G.H., 2012. 
Aminoglycosides. In: Dougherty, T.J., Pucci, M.J. (Eds.), Antibiotic Discovery and 
Developments. Springer Boston, US, pp 229-269. 
Arné, P., Marc, D., Brée, A., Schouler, C. and Dho-Moulin, M., 2000. Increased tracheal colonization 
in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli 
MT78 with a fimH deletion. Avian Diseases 44, pp 343-355. 
 Page | 197  
 
Arp, L.H. and Jensen, A.E., 1980. Piliation, hemagglutination, motility, and generation time of 
Escherichia coli that are virulent or avirulent for turkeys. Avian Diseases 24, pp 153-161. 
Arsenault, J., Letellier, A., Quessy, S., Normand, V. and Boulianne, M., 2007. Prevalence and risk 
factors for Salmonella spp. and Campylobacter spp. caecal colonization in broiler chicken and 
turkey flocks slaughtered in Quebec, Canada. Preventive Veterinary Medicine 81, pp 250-
264. 
Ask, B., van der Waaij, E.H., van Eck, J.H., van Arendonk, J.A. and Stegeman, J.A., 2006. Defining 
susceptibility of broiler chicks to colibacillosis. Avian Pathology 35, pp 147-153. 
Aslam, M., Diarra, M.S., Service, C. and Rempel, H., 2009. Antimicrobial resistance genes in 
Escherichia coli isolates recovered from a commercial beef processing plant. Journal of Food 
Protection 72, pp 1089-1093. 
Australian Chicken Meat Federation, 2014. Industry Facts and Figures. [Available from 
http://www.chicken.org.au/page.php?id=4]; Accessed 15th September 2016. 
Australian Commission on Safety and Quality in Health Care, 2013 Australian One Health 
Antimicrobial Resistance Colloquium Background Paper July [Available from 
https://www.safetyandquality.gov.au/wp-content/uploads/2013/07/Briefing-paper-for-One-
Health-AMR-Colloquium-participants-Final-Jul-2013.pdf]; Accessed 25 November 2016. 
Australian Pesticides and Veterinary Medicines Authority (APVMA), 2015. Public Chemical 
Registration Information System Search (PubCRIS), [Available from 
https://portal.apvma.gov.au/pubcris]; Accessed May 2016. 
Australian Veterinary Association, 2017. Veterinary use of antibiotics highly important to human 
health, [Available from 
http://www.ava.com.au/sites/default/files/AVA_website/pdfs/Veterinary%20use%20of%20a
ntibiotics%20critical%20to%20human%20health.pdf]; Accessed July 2017. 
Awad, A., Arafat, N. and Elhadidy, M., 2016. Genetic elements associated with antimicrobial 
resistance among avian pathogenic Escherichia coli. Annals of Clinical Microbiology and 
Antimicrobials 15, pp 1-8. 
Babai, R., Blum-Oehler, G., Stern, B.E., Hacker, J. and Ron, E.Z., 1997. Virulence patterns from 
septicemic Escherichia coli O78 strains. FEMS Microbiology Letters 149, pp 99-105. 
 Page | 198  
 
Babic, M., Hujer, A.M. and Bonomo, R.A., 2006. What's new in antibiotic resistance? Focus on beta-
lactamases. Drug Resistance Update 9, pp 142-156. 
Badruzzaman, A., Noor, M., Mamun, M., Husna, A. and Islam, K., 2015. Prevalence of diseases in 
commercial chickens at Sylhet division of Bangladesh. International Clinical Pathology 
Journal 1, pp 1-5. 
Barnard, T.G., Robertson, C.A., Jagals, P. and Potgieter, N., 2011. A rapid and low-cost DNA 
extraction method for isolating Escherichia coli DNA from animal stools. African Journal of 
Biotechnology 10, pp 1485-1490. 
Baron, E.J., 2011. Conventional versus molecular methods for pathogen detection and the role of 
clinical microbiology in infection control. Journal of Clinical Microbiology 49, pp S43. 
Barros, A.J. and Hirakata, V.N., 2003. Alternatives for logical regression in cross-sectional studies: 
an empirical comparison of models that directly estimatet the prevalence ratio. BMC Medical 
Research Methodology 3, pp 1-13. 
Barros, M.R., da Silveira, W.D., de Araujo, J.M., Costa, E.P., Oliveira, A.A.D., Santos, A., Silva, 
V.A.S. and Mota, R.A., 2012. Antimicrobial resistance and plasmidial profile of Escherichia 
coli strain isolated from broilers and commercial layers in the state of Pernambuco, Brazil. 
Pesquisa Veterinaria Brasileira 32, pp 405-410. 
Barton, M. and Wilkins, J. 2001. Antibiotic resistance in bacteria isolated from poultry. A report for 
the Rural Industries. Research and Development Corporation. RIRDC Publication No 01/105, 
Project No USA-9A. 
Barton, M.D., Pratt, R. and Hart, W.S., 2003. Antibiotic resistance in animals. Communicable 
Diseases Intelligence 27, pp 121-126. 
Bass, L., C.A. , Liebert, M.D., Lee, A.O., Summers, D.G., White, S.G., Thayer, S. and Maurer, J.J., 
1999. Incidence and characterization of integrons, genetic elements mediating multiple-drug 
resistance in avian Escherichia coli. Antimicrobial Agents and Chemotherapy 43, pp 2925-
2929. 
Bauchart, P., Germon, P., Bree, A., Oswald, E., Hacker, J. and Dobrindt, U., 2010. Pathogenomic 
comparison of human extraintestinal and avian pathogenic Escherichia coli search for factors 
involved in host specificity or zoonotic potential. Microbial Pathogenesis 49, pp 105-115. 
 Page | 199  
 
Belanger, L., Garenaux, A., Harel, J., Boulianne, M., Nadeau, E. and Dozois, C.M., 2011. Escherichia 
coli from animal reservoirs as a potential source of human extraintestinal pathogenic E. coli. 
FEMS Immunology and Medical Microbiology 62, pp 1-10. 
Berg, R.D., 1996. The indigenous gastrointestinal microflora. Trends in Microbiology 4, pp 430-435. 
Bergstrom, C.T., Lipsitch, M. and Levin, B.R., 2000. Natural selection, infectious transfer and the 
existence conditions for bacterial plasmids. Genetics 155, pp 1505-1519. 
Bertran, K., Lee, D.H., Balzli, C., Pantin-Jackwood, M.J., Spackman, E. and Swayne, D.E., 2016. 
Age is not a determinant factor in susceptibility of broilers to H5N2 clade 2.3.4.4 high 
pathogenicity avian influenza virus. Veterinary Research 47, pp 116-127. 
Bindereif, A. and Neilands, J.B., 1985. Aerobactin genes in clinical isolates of Escherichia coli. 
Journal of Bacteriology 161, pp 727-735. 
Bingen, E., Picard, B., Brahimi, N., Mathy, S., Desjardins, P., Elion, J. and Denamur, E., 1998. 
Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests 
horizontal gene transfer from a predominant pool of highly virulent B2 group strains. Journal 
of Infectious Diseases 177, pp 642-650. 
Binns, M.M., Davies, D.L. and Hardy, K.G., 1979. Cloned fragments of the plasmid ColV,I-K94 
specifying virulence and serum resistance. Nature 279, pp 778-781. 
Blanco, J.E., Blanco, M., Mora, A. and Blanco, J., 1997. Production of toxins (enterotoxins, 
verotoxins, and necrotoxins) and colicins by Escherichia coli strains isolated from septicemic 
and healthy chickens: relationship with in vivo pathogenicity. Journal of Clinical 
Microbiology 35, pp 2953-2957. 
Blessmann, J., Buss, H., Nu, P.A., Dinh, B.T., Ngo, Q.T., Van, A.L., Alla, M.D., Jackson, T.F., 
Ravdin, J.I. and Tannich, E., 2002. Real-time PCR for detection and differentiation of 
Entamoeba histolytica and Entamoeba dispar in fecal samples. Journal of Clinical 
Microbiology 40, pp 4413-4417. 
Blyton, M.D., Pi, H., Vangchhia, B., Abraham, S., Trott, D.J., Johnson, J.R. and Gordon, D.M., 2015. 
Genetic structure and antimicrobial resistance of Escherichia coli and cryptic clades in birds 
with diverse human associations. Applied and Environmental Microbiology 81, pp 5123-
5133. 
 Page | 200  
 
Boerlin, P. and Reid-Smith, R.J., 2008. Antimicrobial resistance: its emergence and transmission. 
Animal Health Research Reviews 9, pp 115-126. 
Boerlin, P. and White, D., 2013. Antimicrobial resistance and its epidemiology. In: Giguere, S., 
Prescott, J., Dowling, P. (Ed.) Antimicrobial Therapy in Veterinary Medicine. John Wiley and 
Sons, Hoboken, New Jersey, USA, pp 21-40. 
Borjesson, S., Egervarn, M., Lindblad, M. and Englund, S., 2013. Frequent occurrence of extended-
spectrum beta-lactamase- and transferable AmpC beta-lactamase-producing Escherichia coli 
on domestic chicken meat in Sweden. Applied and Environmental Microbiology 79, pp 2463-
2466. 
Borjesson, S., Ny, S., Egervarn, M., Bergstrom, J., Rosengren, A., Englund, S., Lofmark, S. and 
Byfors, S., 2016. Limited dissemination of extended-spectrum β-lactamase– and plasmid-
encoded AmpC–producing Escherichia coli from food and farm animals, Sweden. Emerging 
Infectious Diseases 22, pp 634-640. 
Bortolaia, V., Guardabassi, L., Trevisani, M., Bisgaard, M., Venturi, L. and Bojesen, A., 2010. High 
diversity of extended-spectrum β-lactamases in Escherichia coli isolates from Italian broiler 
flocks. Antimicrobial Agents and Chemotherapy 54, pp 1623-1626. 
Bradford, P.A., 2001. Extended-spectrum β-lactamases in the 21st century: Characterization, 
epidemiology, and detection of this important resistance threat. Clinical Microbiology 
Reviews 14, pp 933-951. 
Braga, J.F.V., Chanteloup, N.K., Trotereau, A., Baucheron, S., Guabiraba, R., Ecco, R. and Schouler, 
C., 2016. Diversity of Escherichia coli strains involved in vertebral osteomyelitis and arthritis 
in broilers in Brazil. BMC Veterinary Research 12, pp 1-12. 
Bragg, R., Jansen, A., Coetzee, M., van der Westhuizen, W. and Boucher, C., 2014. Bacterial 
resistance to quaternary ammonium compounds (QAC) disinfectants. Advances in 
Experimental Medicine and Biology 808, pp 1-13. 
Brinas, L., Moreno, M.A., Zarazaga, M., Porrero, C., Saenz, Y., Garcia, M., Dominguez, L. and 
Torres, C., 2003. Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia 
coli fecal-sample isolates from healthy chickens. Antimicrobial Agents and Chemotherapy  
47, pp 2056-2058. 
 Page | 201  
 
Bush, K., 2010. Bench-to-bedside review: The role of β-lactamases in antibiotic-resistant Gram-
negative infections. Critical Care 14, pp 1-8. 
Bush, K., 2012. Antimicrobial agents targeting bacterial cell walls and cell membranes. Revue 
Scientifique et Technique 31, pp 43-56. 
Bush, K., Jacoby, G.A. and Medeiros, A.A., 1995. A functional classification scheme for beta-
lactamases and its correlation with molecular structure. Antimicrobial Agents and 
Chemotherapy 39, pp 1211-1233. 
Cambau, E. and Guillard, T., 2012. Antimicrobials that affect the synthesis and conformation of 
nucleic acids. Revue Scientifique et Technique 31, pp 65-87. 
Campos, T.A.d., Lago, J.C., Nakazato, G., Stehling, E.G., Brocchi, M., Castro, A.F.P.d. and Silveira, 
W.D.d., 2008. Occurrence of virulence-related sequences and phylogenetic analysis of 
commensal and pathogenic avian Escherichia coli strains (APEC). Pesquisa Veterinária 
Brasileira 28, pp 533-540. 
Canton, R., Gonzalez-Alba, J.M. and Galan, J.C., 2012. CTX-M enzymes: origin and diffusion. 
Frontiers in Microbiology 3, pp 110-129. 
Carattoli, A., 2001. Importance of integrons in the diffusion of resistance. Veterinary Research 32, 
pp 243-259. 
Carattoli, A., 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrobial Agents and 
Chemotherapy 53, pp 2227-2238. 
Carattoli, A., 2011. Plasmids in Gram negatives: Molecular typing of resistance plasmids. 
International Journal of Medical Microbiology 301, pp 654-658. 
Carattoli, A., 2013. Plasmids and the spread of resistance. International Journal of Medical 
Microbiology 303, pp 298-304. 
Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K.L. and Threlfall, E.J., 2005. Identification 
of plasmids by PCR-based replicon typing. Journal of Microbiological Methods 63, pp 219-
228. 
Carattoli, A., Tosini, F., Giles, W.P., Rupp, M.E., Hinrichs, S.H., Angulo, F.J., Barrett, T.J. and Fey, 
P.D., 2002. Characterization of plasmids carrying CMY-2 from expanded-spectrum 
 Page | 202  
 
cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 
1998. Antimicrobial Agents and Chemotherapy 46, pp 1269-1272. 
Cascales, E., Buchanan, S.K., Duche, D., Kleanthous, C., Lloubes, R., Postle, K., Riley, M., Slatin, 
S. and Cavard, D., 2007. Colicin biology. Microbiology and Molecular Biology Reviews  71, 
pp 158-229. 
Castellanos, L.R., Donado-Godoy, P., Leon, M., Clavijo, V., Arevalo, A., Bernal, J.F., Timmerman, 
A.J., Mevius, D.J., Wagenaar, J.A. and Hordijk, J., 2017. High heterogeneity of Escherichia 
coli sequence types harbouring ESBL/AmpC genes on IncI1 plasmids in the Colombian 
poultry chain. PLoS One 12, pp e0170777. 
Castillo, J.R., 2013. Tetracyclines. In: Giguere, S., Prescott, J., Dowling, P. (Ed.) Antimicrobial 
Therapy in Veterinary Medicine. Wiley and Sons, Inc., Hoboken, New Jersey, USA, pp 257-
268. 
Cavero, D., Schmutz, M., Philipp, H.C. and Preisinger, R., 2009. Breeding to reduce susceptibility to 
Escherichia coli in layers. Poultry Science 88, pp 2063-2068. 
Cavicchio, L., Dotto, G., Giacomelli, M., Giovanardi, D., Grilli, G., Franciosini, M.P., Trocino, A. 
and Piccirillo, A., 2015. Class 1 and class 2 integrons in avian pathogenic Escherichia coli 
from poultry in Italy. Poultry Science 94, pp 1202-1208. 
Caza, M., Lepine, F., Milot, S. and Dozois, C.M., 2008. Specific roles of the iroBCDEN genes in 
virulence of an avian pathogenic Escherichia coli O78 strain and in production of 
salmochelins. Infection and Immunity 76, pp 3539-3549. 
Chaffer, M., Heller, E.D. and Schwartsburd, B., 1999. Relationship between resistance to 
complement, virulence and outer membrane protein patterns in pathogenic Escherichia coli 
O2 isolates. Veterianry Microbiology 64, pp 323-332. 
Chah, K.F., Agbo, I.C., Eze, D.C., Somalo, S., Estepa, V. and Torres, C., 2010. Antimicrobial 
resistance, integrons and plasmid replicon typing in multiresistant clinical Escherichia coli 
strains from Enugu State, Nigeria. Journal of Basic Microbiology 50 Suppl 1, pp S18-24. 
Chambers, P.A., Duggan, P.S., Forbes, J.M. and Heritage, J., 2001. A rapid, reliable method for the 
extraction from avian faeces of total bacterial DNA to be used as a template for the detection 
of antibiotic resistance genes. The Journal of Antimicrobial Chemotherapy 47, pp 241-243. 
 Page | 203  
 
Chantziaras, I., Boyen, F., Callens, B. and Dewulf, J., 2014. Correlation between veterinary 
antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven 
countries. The Journal of Antimicrobial Chemotherapy 69, pp 827-834. 
Chaudhuri, R.R. and Henderson, I.R., 2012. The evolution of the Escherichia coli phylogeny. 
Infection Genetics and Evolution 12, pp 214-226. 
Chen, J. and Griffiths, M.W., 1998. PCR differentiation of Escherichia coli from other Gram-negative 
bacteria using primers derived from the nucleotide sequences flanking the gene encoding the 
universal stress protein. Letters in Applied Microbiology 27, pp 369-371. 
Chen, Y.T., Lauderdale, T.L., Liao, T.L., Shiau, Y.R., Shu, H.Y., Wu, K.M., Yan, J.J., Su, I.J. and 
Tsai, S.F., 2007. Sequencing and comparative genomic analysis of pK29, a 269-kilobase 
conjugative plasmid encoding CMY-8 and CTX-M-3 β-lactamases in Klebsiella pneumoniae. 
Antimicrobial Agents and Chemotherapy 51, pp 3004-3007. 
Cheng, A.C., Turnidge, J., Collignon, P., Looke, D., Barton, M. and Gottlieb, T., 2012. Control of 
fluoroquinolone resistance through successful regulation, Australia. Emerging Infectious 
Diseases 18, pp 1453-1460. 
Cherif, T., Saidani, M., Decre, D., Boutiba-Ben Boubaker, I. and Arlet, G., 2015. Cooccurrence of 
multiple AmpC β-lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus 
mirabilis in Tunisia. Antimicrobial Agents and Chemotherapy 60, pp 44-51. 
Cherifi, A., Contrepois, M., Picard, B., Goullet, P., Orskov, I., Orskov, F. and De Rycke, J., 1991. 
Clonal relationships among Escherichia coli serogroup 06 isolates from human and animal 
infections. FEMS Microbiology Letters 64, pp 225-230. 
Cheville, N.F. and Arp, L.H., 1978. Comparative pathologic findings of Escherichia coli infection in 
birds. Journal of the American Veterinary Medical Association 173, pp 584-591. 
Chinivasagam, H.N., Tran, T., Maddock, L., Gale, A. and Blackall, P.J., 2009. Mechanically 
ventilated broiler sheds: a possible source of aerosolized Salmonella, Campylobacter, and 
Escherichia coli. Applied and Environmental Microbiology 75, pp 7417-7425. 
Cho, S.H., Lim, Y.S. and Kang, Y.H., 2012. Comparison of antimicrobial resistance in Escherichia 
coli strains isolated from healthy poultry and swine farm workers using antibiotics in Korea. 
Osong Public Health and Research Perspectives 3, pp 151-155. 
 Page | 204  
 
Choi, M.J., Lim, S.K., Nam, H.M., Kim, A.R., Jung, S.C. and Kim, M.N., 2011. Apramycin and 
gentamicin resistances in indicator and clinical Escherichia coli isolates from farm animals in 
Korea. Foodborne Pathogens and Disease 8, pp 119-123. 
Circella, E., Pennelli, D., Tagliabue, S. and Camarda, A., 2012. Virulence-associated genes in avian 
pathogenic Escherichia coli from laying hens in Apulia, Southern Italy. British Poultry 
Science 53, pp 465-470. 
Clermont, O., Bonacorsi, S. and Bingen, E., 2000. Rapid and simple determination of the Escherichia 
coli phylogenetic group. Applied and Environmental Microbiology 66, pp 4555-4558. 
Clermont, O., Christenson, J.K., Denamur, E. and Gordon, D.M., 2013. The Clermont Escherichia 
coli phylo-typing method revisited: improvement of specificity and detection of new phylo-
groups. Environmental Microbiology Reports 5, pp 58-65.  
Clinical Laboratory Standards Institute (CLSI), 2013. Performance Standards for Antimicrobial Disk 
and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 
Fourth Edition. CLSI Document VET01-A4. Clinical and Laboratory Standards Institute, 
Wayne, Pennsylvania, USA.  
Clinical Laboratory Standards Institute (CLSI), 2015a. Performance Standards for Antimicrobial 
Disk and dilution susceptibility tests for bacteria isolated from animals; Third Edition. CLSI 
supplement VET01S. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 
USA.  
Clinical Laboratory Standards Institute (CLSI), 2015b. Performance Standards for Antimicrobial 
Susceptibility Testing; Twenty-Fifth Informational Supplement. CLSI document M100-S25. 
Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA. 
Cloud, S.S., Rosenberger, J.K., Fries, P.A., Wilson, R.A. and Odor, E.M., 1985. In vitro and in vivo 
characterization of avian Escherichia coli I. Serotypes, metabolic activity, and antibiotic 
sensitivity. Avian Diseases 29, pp 1084-1093. 
Cogliani, C., Goossens, H. and Greko, C., 2011. Restricting antimicrobial use in food animals: 
Lessons from Europe. Microbe 6, pp 274-279. 
Coleman, B.L., Salvadori, M.I., McGeer, A.J., Sibley, K.A., Neumann, N.F., Bondy, S.J., Gutmanis, 
I.A., McEwen, S.A., Lavoie, M., Strong, D., Johnson, I., Jamieson, F.B. and Louie, M., 2012. 
 Page | 205  
 
The role of drinking water in the transmission of antimicrobial-resistant E. coli. Epidemiology 
and Infection 140, pp 633-642. 
Collingwood, C., Kemmett, K., Williams, N. and Wigley, P., 2014. Is the concept of avian pathogenic 
Escherichia coli as a single pathotype fundamentally flawed? Frontiers in Veterinary Science  
1, pp 1-5. 
Collinson, S.K., Doig, P.C., Doran, J.L., Clouthier, S., Trust, T.J. and Kay, W.W., 1993. Thin, 
aggregative fimbriae mediate binding of Salmonella enteritidis to fibronectin. Journal of 
Bacteriology 175, pp 12-18. 
Cordoni, G., Woodward, M.J., Wu, H., Alanazi, M., Wallis, T. and La Ragione, R.M., 2016. 
Comparative genomics of European avian pathogenic E. coli (APEC). BMC Genomics 17, pp 
1-21. 
Cordova, J., Shiloh, R., Gilman, R.H., Sheen, P., Martin, L., Arenas, F., Caviedes, L., Kawai, V., 
Soto, G., Williams, D.L., Zimic, M., Escombe, A.R. and Evans, C.A., 2010. Evaluation of 
molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis 
in stool specimens from patients with pulmonary tuberculosis. Journal of Clinical 
Microbiology 48, pp 1820-1826. 
Cortes, P., Blanc, V., Mora, A., Dahbi, G., Blanco, J.E., Blanco, M., Lopez, C., Andreu, A., Navarro, 
F., Alonso, M.P., Bou, G., Blanco, J. and Llagostera, M., 2010. Isolation and characterization 
of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig 
farms in Spain. Applied and Environmental Microbiology 76, pp 2799-2805. 
Couturier, M., Bergquist, P., Bex, F. and Maas, W., 1988. Identification and classification of bacterial 
plasmids. Microbiology Review 52, pp 375-395. 
Craig, M., Lambert, S., Jourdan, S., Tenconi, E., Colson, S., Maciejewska, M., Ongena, M., Martin, 
J.F., van Wezel, G. and Rigali, S., 2012. Unsuspected control of siderophore production by 
N-acetylglucosamine in streptomycetes. Environmental Microbiology Reports  4, pp 512-521. 
Cremet, L., Caroff, N., Dauvergne, S., Reynaud, A., Lepelletier, D. and Corvec, S., 2011. Prevalence 
of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical 
isolates over a 1-year period in a French hospital. Pathologie-Biologie 59, pp 151-156. 
Crosa, J.H., 1989. Genetics and molecular biology of siderophore-mediated iron transport in bacteria. 
Microbiological Reviews 53, pp 517-530. 
 Page | 206  
 
Cunha, M.P.V., Saidenberg, A.B., Moreno, A.M., Ferreira, A.J.P., Vieira, M.A.M., Gomes, T.A.T. 
and Knobl, T., 2017. Pandemic extra-intestinal pathogenic Escherichia coli (ExPEC) clonal 
group O6-B2-ST73 as a cause of avian colibacillosis in Brazil. PLoS One 12, pp e0178970. 
da Costa, P.M., Bica, A., Vaz-Pires, P. and Bernardo, F., 2010. Changes in antimicrobial resistance 
among faecal enterococci isolated from growing broilers prophylactically medicated with 
three commercial antimicrobials. Preventive Veterinary Medicine 93, pp 71-76. 
da Costa, P.M., Loureiro, L. and Matos, A.J., 2013. Transfer of multidrug-resistant bacteria between 
intermingled ecological niches: the interface between humans, animals and the environment. 
International Journal of Environmental Research and Public Health 10, pp 278-294. 
da Rocha, A., da Silva, A.B., de Brito, B.G., Moraes, H.L.D., Pontes, A.P., Ce, M.C., do Nascimento, 
V.P. and Salle, C.T.P., 2002. Virulence factors of avian pathogenic Escherichia coli isolated 
from broilers from the South of Brazil. Avian Diseases 46, pp 749-753. 
Da Silva, G.J. and Mendonca, N., 2012. Association between antimicrobial resistance and virulence 
in Escherichia coli. Virulence 3, pp 18-28. 
Dahms, C., Hubner, N.O., Kossow, A., Mellmann, A., Dittmann, K. and Kramer, A., 2015. 
Occurrence of ESBL-producing Escherichia coli in livestock and farm workers in 
Mecklenburg-Western Pomerania, Germany. PLoS One 10, pp e0143326. 
Danzeisen, J.L., Wannemuehler, Y., Nolan, L.K. and Johnson, T.J., 2013. Comparison of multilocus 
sequence analysis and virulence genotyping of Escherichia coli from live birds, retail poultry 
meat, and human extraintestinal infection. Avian Diseases 57, pp 104-108. 
Darrell, W.T., Thomas, G.H. and Richard, K.G., 2014. Integrated farm management to prevent 
Salmonella Enteritidis contamination of eggs. The Journal of Applied Poultry Research 23, 
pp 353–365. 
Davies, J., 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science  264, 
pp 375-382. 
Day, M.J., Rodriguez, I., van Essen-Zandbergen, A., Dierikx, C., Kadlec, K., Schink, A.K., Wu, G., 
Chattaway, M.A., DoNascimento, V., Wain, J., Helmuth, R., Guerra, B., Schwarz, S., 
Threlfall, J., Woodward, M.J., Coldham, N., Mevius, D. and Woodford, N., 2016. Diversity 
of STs, plasmids and ESBL genes among Escherichia coli from humans, animals and food in 
 Page | 207  
 
Germany, the Netherlands and the UK. The Journal of Antimicrobal Chemotherapy 71, pp 
1178-1182. 
De Carli, S., Ikuta, N., Lehmann, F.K., da Silveira, V.P., de Melo Predebon, G., Fonseca, A.S. and 
Lunge, V.R., 2015. Virulence gene content in Escherichia coli isolates from poultry flocks 
with clinical signs of colibacillosis in Brazil. Poultry Science 94, pp 2635-2640. 
de Jong, A., Thomas, V., Simjee, S., Godinho, K., Schiessl, B., Klein, U., Butty, P., Valle, M., Marion, 
H. and Shryock, T.R., 2012. Pan-European monitoring of susceptibility to human-use 
antimicrobial agents in enteric bacteria isolated from healthy food-producing animals. The 
Journal of Antimicrobial Chemotherapy 67, pp 638-651. 
de Lorenzo, V. and Neilands, J.B., 1986. Characterization of iucA and iucC genes of the aerobactin 
system of plasmid ColV-K30 in Escherichia coli. Journal of Bacteriology 167, pp 350-355. 
de Oliveira, A.L., Rocha, D.A., Finkler, F., de Moraes, L.B., Barbieri, N.L., Pavanelo, D.B., Winkler, 
C., Grassotti, T.T., de Brito, K.C., de Brito, B.G. and Horn, F., 2015. Prevalence of ColV 
plasmid-linked genes and in vivo pathogenicity of avian strains of Escherichia coli. Foodborne 
Pathogens and Disease 12, pp 679-685. 
de Pace, F., Nakazato, G., Pacheco, A., de Paiva, J.B., Sperandio, V. and da Silveira, W.D., 2010. 
The type VI secretion system plays a role in type 1 fimbria expression and pathogenesis of an 
avian pathogenic Escherichia coli strain. Infection and Immunity 78, pp 4990-4998. 
DebRoy, C., Roberts, E. and Fratamico, P.M., 2011. Detection of O antigens in Escherichia coli. 
Animal Health Research Reviews 12, pp 169-185. 
Delicato, E.R., de Brito, B.G., Gaziri, L.C.J. and Vidotto, M.C., 2003. Virulence-associated genes in 
Escherichia coli isolates from poultry with colibacillosis. Veterinary Microbiology 94, pp 97-
103. 
Deng, Y., Bao, X., Ji, L., Chen, L., Liu, J., Miao, J., Chen, D., Bian, H., Li, Y. and Yu, G., 2015. 
Resistance integrons: class 1, 2 and 3 integrons. Annals of Clinical Microbiology and 
Antimicrobials 14, pp 1-11. 
Deshpande, L.M., Jones, R.N., Fritsche, T.R. and Sader, H.S., 2006. Occurrence of plasmidic AmpC 
type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY 
Antimicrobial Surveillance Program (North America, 2004). International Journal of 
Antimicrobial Agents 28, pp 578-581. 
 Page | 208  
 
Department of Agriculture, Fisheries and Forestry (DAFF), 2007. Pilot surveillance program for 
antimicrobial resistance in bacteria of animal origin, Australian Government Department of 
Agriculture, Fisheries and Forestry, Canberra. [Available from: 
http://www.agriculture.gov.au/animal/health/amr/antimicrobial-resistance-bacteria-animal-
origin]; Accessed May 2015. 
Desloire, S., Valiente Moro, C., Chauve, C. and Zenner, L., 2006. Comparison of four methods of 
extracting DNA from D. gallinae Veterinary Research 37, pp 725-732. 
Dhanashree, B. and Shrikara, P.M., 2012 Molecular typing of enteropathogenic Escherichia coli from 
diarrheagenic stool samples. Journal of Clinical and Diagnostic Research 6, pp 400-404. 
Dheilly, A., Bouder, A., Le Devendec, L., Hellard, G. and Kempf, I., 2011. Clinical and microbial 
efficacy of antimicrobial treatments of experimental avian colibacillosis. Veterinary 
Microbiology 149, pp 422-429. 
Dheilly, A., Le Devendec, L., Mourand, G., Jouy, E. and Kempf, I., 2013. Antimicrobial resistance 
selection in avian pathogenic E. coli during treatment. Veterinary Microbiology 166, pp 655-
658. 
Dhillon, A.S. and Jack, O.K., 1996. Two outbreaks of colibacillosis in commercial caged layers. 
Avian Diseases 40, pp 742-746. 
Dho-Moulin, M. and Fairbrother, J.M., 1999. Avian pathogenic Escherichia coli (APEC). Veterinary 
Research 30, pp 299-316. 
Dho, M. and Lafont, J.P., 1984. Adhesive properties and iron uptake ability in Escherichia coli lethal 
and nonlethal for chicks. Avian Diseases 28, pp 1016-1025. 
Diab, A.M. and Al-urk, I.M., 2011. ERIC and RAPD PCR-based DNA fingerprinting techniques 
application for microbial source tracking (MST) at Al-Madinah Al-Munwwarah, KSA. 
Journal of Taibah University for Science 5, pp 31-38. 
Diarra, M.S., Silversides, F.G., Diarrassouba, F., Pritchard, J., Masson, L., Brousseau, R., Bonnet, 
C., Delaquis, P., Bach, S., Skura, B.J. and Topp, E., 2007. Impact of feed supplementation 
with antimicrobial agents on growth performance of broiler chickens, Clostridium perfringens 
and Enterococcus counts, and antibiotic resistance phenotypes and distribution of 
antimicrobial resistance determinants in Escherichia coli isolates. Applied and Environmental 
Microbiology 73, pp 6566-6576. 
 Page | 209  
 
Dias da Silveira, W., Ferreira, A., Brocchi, M., Maria de Hollanda, L., Pestana de Castro, A.F.,  
Tatsumi Yamada, A. and Lancellotti, M., 2002. Biological characteristics and pathogenicity 
of avian Escherichia coli strains. Vetrinary Microbiology 85, pp 47-53. 
Dierikx, C., van Essen-Zandbergen, A., Veldman, K., Smith, H. and Mevius, D., 2010. Increased 
detection of extended spectrum beta-lactamase producing Salmonella enterica and 
Escherichia coli isolates from poultry. Veterinary Microbiology 145, pp 273-278. 
Dissanayake, D.R., Octavia, S. and Lan, R., 2014. Population structure and virulence content of avian 
pathogenic Escherichia coli isolated from outbreaks in Sri Lanka. Veterinary Microbiology 
168, pp 403-412. 
Dobrindt, U., 2005. (Patho-)Genomics of Escherichia coli. International Journal of Medical 
Microbiology 295, pp 357-371. 
Dohoo, I., Martin, S.W. and Stryhn, H., 2009. Veterinary Epidemiologic Research In: Dohoo, I., 
Martin, W., Stryhn, H. (Eds.), VER, Incorporated, Charlottetown, Prince Edward Island, 
Canada. 
Dolejska, M., Villa, L., Hasman, H., Hansen, L. and Carattoli, A., 2013. Characterization of IncN 
plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli and Salmonella from animals, 
the environment and humans. The Journal of Antimicrobial Chemotherapy 68, pp 333-342. 
Domingues, S., da Silva, G.J. and Nielsen, K.M., 2012. Integrons: Vehicles and pathways for 
horizontal dissemination in bacteria. Mobile Genetic Elements 2, pp 211-223. 
Dou, X., Gong, J., Han, X., Xu, M., Shen, H., Zhang, D., Zhuang, L., Liu, J. and Zou, J., 2016. 
Characterization of avian pathogenic Escherichia coli isolated in Eastern China. Gene 576, 
pp 244-248. 
Dowling, P., 2013. Chlorampehicol, thiamphenicol and florfenicol. In: Giguère, S., Prescott, J.F., 
Dowling, P. (Eds.) Antimicrobial Therapy in Veterinary Medicine. John Wiley and Sons Inc, 
Hoboken, New Jersey, USA, pp 269-277. 
Doyle, M.P., Loneragan, G.H., Scott, H.M. and Singer, R.S., 2013. Antimicrobial resistance: 
challenges and perspectives. Comprehensive Reviews in Food Science and Food Safety 12, 
pp 234-248. 
 Page | 210  
 
Dozois, C.M., Chanteloup, N., Dhomoulin, M., Bree, A., Desautels, C. and Fairbrother, J.M., 1994. 
Bacterial colonization and in vivo expression of F1 (type 1) fimbrial antigens in chickens 
experimentally infected with pathogenic Escherichia coli. Avian Diseases 38, pp 231-239. 
Dozois, C.M., Daigle, F. and Curtiss, R., 2003. Identification of pathogen-specific and conserved 
genes expressed in vivo by an avian pathogenic Escherichia coli strain. Proceedings of the 
National Academy of Sciences of the United States of America 100, pp 247-252. 
Dozois, C.M., Dho-Moulin, M., Bree, A., Fairbrother, J.M., Desautels, C. and Curtiss, R., 3rd, 2000. 
Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and 
localization and analysis of the tsh genetic region. Infection and Immunity 68, pp 4145-4154. 
Dozois, C.M., Fairbrother, J.M., Harel, J. and Bosse, M., 1992. pap-and pil-related DNA sequences 
and other virulence determinants associated with Escherichia coli isolated from septicemic 
chickens and turkeys. Infection and Immunity 60, pp 2648-2656. 
Dozois, C.M., Pourbakhsh, S.A. and Fairbrother, J.M., 1995. Expression of p-fimbriae and type-1 
(F1) fimbriae in pathogenic Escherichia coli from poultry. Veterinary Microbiology 45, pp 
297-309. 
Dragana, L., Maja, V., Dalibor, T., Marko, P. and Dubravka, M., 2016. Tetracycline resistance in 
Escherichia coli isolates from poultry. Arhiv Veterinarske Medicine 9, pp 61-81. 
Drews, S.J., Poutanen, S.M., Mazzulli, T., McGeer, A.J., Sarabia, A., Pong-Porter, S., Rzayev, Y., 
Willey, B., Green, K. and Low, D.E., 2005. Decreased prevalence of virulence factors among 
ciprofloxacin-resistant uropathogenic Escherichia coli isolates. Journal of Clinical 
Microbiology 43, pp 4218-4220. 
Dziva, F. and Stevens, M.P., 2008. Colibacillosis in poultry: unravelling the molecular basis of 
virulence of avian pathogenic Escherichia coli in their natural hosts. Avian Pathology 37, pp 
355-366. 
East, I.J., 2007. Adoption of biosecurity practices in the Australian poultry industries. Australian 
Veterinary Journal 85, pp 107-112. 
ECDC, 2012. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European 
Antimicrobial Resistance Surveillance Network (EARS-Net). European Centre for Disease 
Prevention and Control (ECDC), Stockholm.  
 Page | 211  
 
EFSA European Food Safety Authority, 2015. EU summary report on antimicrobial resistance and 
indicator bacteria from humans, animals and food in 2013. EFSA Journal 13, pp 4036-4012. 
Eftekharian, S., Ghorbanpoor, M., Seyfi Abad Shapouri, M.R., Ghanbarpour, R., Jafari, R.J. and 
Amani, A., 2016. Frequency of selected virulence-associated genes in intestinal and extra-
intestinal Escherichia coli isolates from chicken. Iranian Journal of Veterinary Medicine 10, 
pp 91-96. 
El-Shazly, D.A., Nasef, S.A., Mahmoud, F.F. and Jonas, D., 2017. Expanded spectrum β-lactamase 
producing Escherichia coli isolated from chickens with colibacillosis in Egypt. Poultry 
Science 96, pp 2375-2384. 
El Houadfi, M., Fellahi, S., Nassik, S., Guerin, J.L. and Ducatez, M.F., 2016. First outbreaks and 
phylogenetic analyses of avian influenza H9N2 viruses isolated from poultry flocks in 
Morocco. Virology Journal 13, pp 140-147. 
Eliopoulos, G.M. and Huovinen, P., 2001. Resistance to trimethoprim-sulfamethoxazole. Clinical 
Infectious Diseases 32, pp 1608-1614. 
Elmberg, J., Berg, C., Lerner, H., Waldenstrom, J. and Hessel, R., 2017. Potential disease 
transmission from wild geese and swans to livestock, poultry and humans: a review of the 
scientific literature from a one health perspective. Infection Ecology and Epidemiology 7, pp 
1300450-1300421. 
Emery, D.A., Nagaraja, K.V., Shaw, D.P., Newman, J.A. and White, D.G., 1992. Virulence factors 
of Escherichia coli associated with colisepticemia in chickens and turkeys. Avian Diseases  
36, pp 504-511. 
Escherich, T., 1988. The intestinal bacteria of the neonate and breast-fed infant 1884. Reviews of 
Infectious Diseases 10, pp 1220-1225. 
Ewers, C., Antao, E.M., Diehl, I., Philipp, H.C. and Wieler, L.H., 2009. Intestine and environment of 
the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic 
potential. Applied and Environmental Microbiology 75, pp 184-192. 
Ewers, C., Bethe, A., Semmler, T., Guenther, S. and Wieler, L.H., 2012. Extended-spectrum β-
lactamase-producing and AmpC-producing Escherichia coli from livestock and companion 
animals, and their putative impact on public health: a global perspective. Clinical 
Microbiology and Infection 18, pp 646-655. 
 Page | 212  
 
Ewers, C., Grobbel, M., Stamm, I., Kopp, P.A., Diehl, I., Semmler, T., Fruth, A., Beutlich, J., Guerra, 
B., Wieler, L.H. and Guenther, S., 2010. Emergence of human pandemic O25:H4-ST131 
CTX-M-15 extended-spectrum-β-lactamase-producing Escherichia coli among companion 
animals. The Journal of Antimicrobial Chemotherapy 65, pp 651-660. 
Ewers, C., Janssen, T., Kiessling, S., Philipp, H.C. and Wieler, L.H., 2004. Molecular epidemiology 
of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. 
Veterinary Microbiology 104, pp 91-101. 
Ewers, C., Janssen, T., Kiessling, S., Philipp, H.C. and Wieler, L.H., 2005. Rapid detection of 
virulence-associated genes in avian pathogenic Escherichia coli by multiplex polymerase 
chain reaction. Avian Diseases 49, pp 269-273. 
Ewers, C., Janssen, T. and Wieler, L.H., 2003. Avian pathogenic Escherichia coli (APEC). Berliner 
und Münchener Tierärztliche Wochenschrift 116, pp 381-395. 
Ewers, C., Li, G.W., Wilking, H., Kiessling, S., Alt, K., Antao, E.M., Laturnus, C., Diehl, I., Glodde, 
S., Homeier, T., Bohnke, U., Steinruck, H., Philipp, H.C. and Wieler, L.H., 2007. Avian 
pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: How closely 
related are they? International Journal of Medical Microbiology 297, pp 163-176. 
Eyigor, A. and Carli, K.T., 2003. Rapid detection of Salmonella from poultry by real-time polymerase 
chain reaction with fluorescent hybridization probes. Avian Diseases 47, pp 380-386. 
Fagan, P.K., Hornitzky, M.A., Bettelheim, K.A. and Djordjevic, S.P., 1999. Detection of shiga-like 
toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) 
hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR. Applied and Environmental 
Microbiology 65, pp 868-872. 
Fallavena, L.C., Moraes, H.L., Salle, C.T., Silva, A.B., Vargas, R.S., Nascimento, V.P. and Canal, 
C.W., 2000. Diagnosis of skin lesions in condemned or downgraded broiler carcasses - a 
microscopic and macroscopic study. Avian Pathology 29, pp 557-562. 
Fantinatti, F., Silveira, W.D. and Castro, A.F.P., 1994. Characteristics associated with pathogenicity 
of avian septicemic Escherichia coli strains. Veterinary Microbiology 41, pp 75-86. 
FAO/WHO/OIE, 2008. Joint FAO/OIE/WHO Expert Meeting on Critically Important 
Antimicrobials. Report of a meeting held in FAO, Rome, Italy,November 2007, [Available 
from 
 Page | 213  
 
http://www.who.int/foodborne_disease/resources/Report%20joint%20CIA%20Meeting.pdf]
; Accessed May 2014. 
Fernandes, M.R., McCulloch, J.A., Vianello, M.A., Moura, Q., Perez-Chaparro, P.J., Esposito, F., 
Sartori, L., Dropa, M., Matte, M.H., Lira, D.P., Mamizuka, E.M. and Lincopan, N., 2016. 
First report of the globally disseminated IncX4 plasmid carrying the mcr-1 gene in a colistin-
resistant Escherichia coli sequence type 101 isolate from a human infection in Brazil. 
Antimicrobial Agents and Chemotherapy 60, pp 6415-6417. 
Fernandez-Alarcon, C., Singer, R.S. and Johnson, T.J., 2011. Comparative genomics of multidrug 
resistance-encoding IncA/C plasmids from commensal and pathogenic Escherichia coli from 
multiple animal sources. PLoS One 6, pp e23415. 
Fernandez-Romero, N., Romero-Gomez, M.P., Gomez-Gil, M.R. and Mingorance, J., 2011. 
Epidemic population structure of extraintestinal pathogenic Escherichia coli determined by 
single nucleotide polymorphism pyrosequencing. Journal of Molecular Epidemiology and 
Evolutionary Genetics in Infectious Diseases 11, pp 1655-1663. 
Fischer, J., Rodriguez, I., Baumann, B., Guiral, E., Beutin, L., Schroeter, A., Kaesbohrer, A., Pfeifer, 
Y., Helmuth, R. and Guerra, B., 2014. blaCTX-M-15-carrying Escherichia coli and Salmonella 
isolates from livestock and food in Germany. The Journal of Antimicrobial Chemotherapy 69, 
pp 2951-2958. 
Fogarty, L.R., Haack, S.K., Wolcott, M.J. and Whitman, R.L., 2003. Abundance and characteristics 
of the recreational water quality indicator bacteria Escherichia coli and enterococci in gull 
faeces. Journal of Applied Microbiology 94, pp 865-878. 
Folorunso, O.R., Kayode, S. and Onibon, V.O., 2014. Poultry farm hygiene: microbiological quality 
assessment of drinking water used in layer chickens managed under the battery cage and deep 
litter systems at three poultry farms in South Western Nigeria. Pakistan Journal of Biological 
Sciences 17, pp 74-79. 
Foster, G., Evans, J., Knight, H.I., Smith, A.W., Gunn, G.J., Allison, L.J., Synge, B.A. and Pennycott, 
T.W., 2006. Analysis of feces samples collected from a wild-bird garden feeding station in 
Scotland for the presence of verocytotoxin-producing Escherichia coli O157. Applied and 
Environmental Microbiology 72, pp 2265-2267. 
 Page | 214  
 
Franz, E., Delaquis, P., Morabito, S., Beutin, L., Gobius, K., Rasko, D.A., Bono, J., French, N., Osek, 
J., Lindstedt, B.A., Muniesa, M., Manning, S., LeJeune, J., Callaway, T., Beatson, S., 
Eppinger, M., Dallman, T., Forbes, K.J., Aarts, H., Pearl, D.L., Gannon, V.P., Laing, C.R. 
and Strachan, N.J., 2014. Exploiting the explosion of information associated with whole 
genome sequencing to tackle Shiga toxin-producing Escherichia coli (STEC) in global food 
production systems. International Jounal of Food Microbiology 187, pp 57-72. 
Fratamico, P.M., DebRoy, C., Liu, Y., Needleman, D.S., Baranzoni, G.M. and Feng, P., 2016a. 
Advances in molecular serotyping and subtyping of Escherichia coli. Frontiers in 
Microbiology 7, pp 644-653. 
Fratamico, P.M., DebRoy, C. and Needleman, D.S., 2016b. Editorial: emerging approaches for 
typing, detection, characterization, and traceback of Escherichia coli. Frontiers in 
Microbiology 7, pp 2089-2025. 
Gao, Q., Wang, X., Xu, H., Xu, Y., Ling, J., Zhang, D., Gao, S. and Liu, X., 2012. Roles of iron 
acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin 
and aerobactin contribute more to virulence than heme in a chicken infection model. BMC 
Microbiology 12, pp 143-112. 
Garcia-Fernandez, A., Chiaretto, G., Bertini, A., Villa, L., Fortini, D., Ricci, A. and Carattoli, A., 
2008. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases 
in Escherichia coli and Salmonella of human and animal origin. Journal of Antimicrobial 
Chemotherapy 61, pp 1229-1233. 
Garofalo, C., Vignaroli, C., Zandri, G., Aquilanti, L., Bordoni, D., Osimani, A., Clementi, F. and 
Biavasco, F., 2007. Direct detection of antibiotic resistance genes in specimens of chicken 
and pork meat. International Journal of Food Microbiology 113, pp 75-83. 
Gibson, F.I. and Magrath, D.I., 1969. The isolation and characterization of a hydroxamic acid 
(aerobactin) formed by Aerobacter aerogenes 62-1. Biochim Biophys Acta 152, pp 175-184. 
Gibson, J.S., Cobbold, R.N., Heisig, P., Sidjabat, H.E., Kyaw-Tanner, M.T. and Trott, D.J., 2010. 
Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance 
determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections 
in companion animals. Veterinary Microbiology 143, pp 329-336. 
 Page | 215  
 
Giguère, S., 2006. Antimicrobial Drug Action and Interaction: An Introduction. In: Giguère, S., 
Prescott, J.F., Dowling, P.M. (Eds.) Antimicrobial Therapy in Veterinary Medicine. 
Blackwell Publishing Professional, Ames, USA, pp 3-9. 
Gillings, M. and Holley, M., 1997. Repetitive element PCR fingerprinting (rep-PCR) using 
enterobacterial repetitive intergenic consensus (ERIC) primers is not necessarily directed at 
ERIC elements. Letters in Applied Microbiology 25, pp 17-21. 
Ginns, C.A., Browning, G.F., Benham, M.L. and Whithear, K.G., 1998. Development and application 
of an aerosol challenge method for reproduction of avian colibacillosis. Avian Pathology 27, 
pp 505-511. 
Gioffre, A., Meichtri, L., Zumarraga, M., Rodriguez, R. and Cataldi, A., 2004. Evaluation of a 
QIAamp DNA stool purification kit for shiga-toxigenic Escherichia coli detection in bovine 
fecal swabs by PCR. Revista Argentina de Microbiologia 36, pp 1-5. 
Giufre, M., Graziani, C., Accogli, M., Luzzi, I., Busani, L., Cerquetti, M. and Escherichia coli Study 
Group, 2012. Escherichia coli of human and avian origin: detection of clonal groups 
associated with fluoroquinolone and multidrug resistance in Italy. Journal of Antimicrobial 
Chemotherapy 67, pp 860-867. 
Goldberg, C.S., Turner, C.R., Deiner, K., Klymus, K.E., Thomsen, P.F., Murphy, M.A., Spear, S.F., 
McKee, A., Oyler-McCance, S.J., Cornman, R.S., Laramie, M.B., Mahon, A.R., Lance, R.F., 
Pilliod, D.S., Strickler, K.M., Waits, L.P., Fremier, A.K., Takahara, T., Herder, J.E. and 
Taberlet, P., 2016. Critical considerations for the application of environmental DNA methods 
to detect aquatic species. Methods in Ecology and Evolution 7, pp 1299–1307. 
Goluszko, P., Moseley, S.L., Truong, L.D., Kaul, A., Williford, J.R., Selvarangan, R., Nowicki, S. 
and Nowicki, B., 1997. Development of experimental model of chronic pyelonephritis with 
Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented 
tubulointerstitial nephritis. The Journal of Clinical Investigation 99, pp 1662-1672. 
Gomis, S.M., Goodhope, R., Kumor, L., Caddy, N., Riddell, C., Potter, A.A. and Allan, B.J., 1997. 
Isolation of Escherichia coli from cellulitis and other lesions of the same bird in broilers at 
slaughter. Canadian Veterinary Journal 38, pp 159-162. 
Gonzalez-Zorn, B. and Escudero, J.A., 2012. Ecology of antimicrobial resistance: humans, animals, 
food and environment. International Microbiology 15, pp 101-109. 
 Page | 216  
 
Gororo, E. and Kashangura, T., 2016. Broiler production in an urban and peri-urban area of 
Zimbabwe. Development Southern Africa 33, pp 99-112. 
Gottlieb, T. and Nimmo, G.R., 2011. Antibiotic resistance is an emerging threat to public health: an 
urgent call to action at the Antimicrobial Resistance Summit 2011. The Medical Journal of 
Australia 194, pp 281-283. 
Gouvêa, R., Santos, F.d., Aquino, M.d. and Pereira, VL.de.A., 2015. Fluoroquinolones in industrial 
poultry production, bacterial resistance and food residues:a review. Brazilian Journal of 
Poultry Science 17, pp 1-10. 
Graham, J.P., Leibler, J.H., Price, L.B., Otte, J.M., Pfeiffer, D.U., Tiensin, T. and Silbergeld, E.K., 
2008. The animal-human interface and infectious disease in industrial food animal production: 
rethinking biosecurity and biocontainment. Public Health Reports 123, pp 282-299. 
Gridley, M.F., 1957. Manual of Histologic and Special Staining Technics, In: Armed Forces Institute 
of Pathology (Ed.) Blakiston Division, McGraw-Hill McGraw-Hill Book Company Inc., New 
York, USA. 
Gross, W.B., 1957. Pathological changes of an Escherichia coli infection in chickens and turkeys. 
American Journal of Veterinary Research 18, pp 724-730. 
Gross, W.B., 1990. Factors affecting the development of respiratory-disease complex in chickens. 
Avian Diseases 34, pp 607-610. 
Gross, W.B. and Siegel, P.B., 1997. Why some get sick? Journal of Applied Poultry Research 6, pp 
453-460. 
Guabiraba, R. and Schouler, C., 2015. Avian colibacillosis: still many black holes. FEMS 
Microbiology Letters 362, pp 23-30. 
Guardabassi, L., 2006. Modes of antimicrobial action and mechanisms of bacterial resistance. In: 
Aarestrup, F.M. (Ed.) Antimicrobial Resistance in Bacteria of Animal Origin. ASM Press, 
Washington, D.C, pp 1-18. 
Guardabassi, L. and Kruse, H., 2008. Principles of prudent and rational use of antimicrobials in 
animals. In: Guardabassi, L., Jensen, L.B., Kruse, H. (Eds.) Guide to Antimicrobial Use in 
Animals Blackwell Publishing Ltd, Oxford, UK, pp 1-12. 
 Page | 217  
 
Guastalli, E.A.L., Guastalli, B.H.L., Soares, N.M., Leite, D.S., Ikuno, A.A., Maluta, R.P., Cardozo, 
M.V., Beraldo, L.G., Borges, C.A. and Avila, F.A., 2013. Virulence characteristics of 
Escherichia coli isolates obtained from commercial one-week-old layer chicks with diarrhea. 
African Journal of Microbiology Research 7, pp 5306-5313. 
Guenther, S., Ewers, C. and Wieler, L.H., 2011. Extended-spectrum beta-lactamase producing E. coli 
in wildlife, yet another form of environmental pollution? Frontiers in Microbiology 2, pp 246-
254. 
Guenther, S., Grobbel, M., Beutlich, J., Guerra, B., Ulrich, R. and Wieler, L., 2010. Detection of 
pandemic B2-O25-ST131 Escherichia coli harbouring the CTX-M-9 extended-spectrum β-
lactamase type in a feral urban brown rat (Rattus norvegicus). Journal of Antimicrobial 
Chemotherapy 65, pp 255-267. 
Guerin, M.T., Martin, W., Reiersen, J., Berke, O., McEwen, S.A., Bisaillon, J.R. and Lowman, R., 
2007. A farm-level study of risk factors associated with the colonization of broiler flocks with 
Campylobacter spp. in Iceland, 2001-2004. Acta Veterinaria Scandinavica 49, pp 18-27. 
Guo, S., Wakeham, D., Brouwers, H.J., Cobbold, R.N., Abraham, S., Mollinger, J.L., Johnson, J.R., 
Chapman, T.A., Gordon, D.M., Barrs, V.R. and Trott, D.J., 2015. Human-associated 
fluoroquinolone-resistant Escherichia coli clonal lineages, including ST354, isolated from 
canine feces and extraintestinal infections in Australia. Microbes and Infection 17, pp 266-
274. 
Gyles, C.L. and Fairbrother, J.M., 2010. Escherichia coli. In: Gyles, C.L., Prescott, J F., Songer, G., 
Thoen, C.O., Glenn,T., Charles, O P. (Eds.) Pathogenesis of Bacterial Infections in Animals. 
Wiley-Blackwell, Oxford, UK, pp 267-308. 
Halova, D., Papousek, I., Jamborova, I., Masarikova, M., Cizek, A., Janecko, N., Oravcova, V., 
Zurek, L., Clark, A.B., Townsend, A., Ellis, J.C. and Literak, I., 2014. Plasmid-mediated 
quinolone resistance genes in Enterobacteriaceae from American crows: high prevalence of 
bacteria with variable qnrB genes. Antimicrobial Agents and Chemotherapy 58, pp 1257-
1258. 
Hammerum, A.M. and Heuer, O.E., 2009. Human health hazards from antimicrobial-resistant 
Escherichia coli of animal origin. Clinical Infectious Diseases 48, pp 916-921. 
 Page | 218  
 
Hammerum, A.M., Jakobsen, L., Olsen, S.S. and Agerso, Y., 2012. Characterization of CTX-M-14- 
and CTX-M-15-producing Escherichia coli of porcine origin. The Journal of Antimicrobial 
Chemotherapy 67, pp 2047-2049. 
Hanson, N.D., Moland, E.S., Hossain, A., Neville, S.A., Gosbell, I.B. and Thomson, K.S., 2002. 
Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and 
OXA-30 β-Lactamases. The Journal of Antimicrobial Chemotherapy 49, pp 1011-1014. 
Hanson, N.D., Thomson, K.S., Moland, E.S., Sanders, C.C., Berthold, G. and Penn, R.G., 1999. 
Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs 
and a plasmid-mediated AmpC. The Journal of Antimicrobial Chemotherapy 44, pp 377-380. 
Hantke, K., Nicholson, G., Rabsch, W. and Winkelmann, G., 2003. Salmochelins, siderophores of  
Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer 
membrane receptor IroN. Proceedings of the National Academy of Sciences of the United 
States of America 100, pp 3677-3682. 
Harbottle, H., Thakur, S., Zhao, S. and White, D.G., 2006. Genetics of antimicrobial resistance. 
Animal Biotechnology 17, pp 111-124. 
Harrell, F.E., 2001. Regression Modeling Strategies With Applications to Linear Models, Logistic 
Regression, and Survival Analysis, In: Springer Link Content, P. (Ed.). New York, USA. 
Hart, M.L., Meyer, A., Johnson, P.J. and Ericsson, A.C., 2015. Comparative evaluation of DNA 
extraction methods from feces of multiple host species for downstream next-generation 
sequencing. PLoS One 10, pp e0143334. 
Hasan, B., Faruque, R., Drobni, M., Waldenstrom, J., Sadique, A., Ahmed, K.U., Islam, Z., Parvez, 
M.B.H., Olsen, B. and Alam, M., 2011. High prevalence of antibiotic resistance in pathogenic 
Escherichia coli from large- and small-scale poultry farms in Bangladesh. Avian Diseases 55, 
pp 689-692. 
Hasman, H., Mevius, D., Veldman, K., Olesen, I. and Aarestrup, F.M., 2005. β-lactamases among 
extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products 
and human patients in the Netherlands. Journal of Antimicrobial Chemotherapy 56, pp 115-
121. 
 Page | 219  
 
Hassan, M.K., Afify, M.A. and Aly, M.M., 2004. Genetic resistance of Egyptian chickens to 
infectious bursal disease and Newcastle disease. Tropical Animal Health and Production 36, 
pp 1-9. 
Hawkey, P.M. and Jones, A.M., 2009. The changing epidemiology of resistance. Journal of 
Antimicrobial Chemotherapy 64, pp 3-10. 
Hayes, F., 2003. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle 
arrest. Science 301, pp 1496-1499. 
Heinemann, I.U., Jahn, M. and Jahn, D., 2008. The biochemistry of heme biosynthesis. Archives of 
Biochemistry and Biophysics 474, pp 238-251. 
Henderson, G., Cox, F., Kittelmann, S., Miri, V.H., Zethof, M., Noel, S.J., Waghorn, G.C. and 
Janssen, P.H., 2013. Effect of DNA extraction methods and sampling techniques on the 
apparent structure of cow and sheep rumen microbial communities. PloS One 8, pp e74787. 
Henry, I., Reichardt, J., Denis, M. and Cardinale, E., 2011. Prevalence and risk factors for 
Campylobacter spp. in chicken broiler flocks in Reunion Island (Indian Ocean). Preventive 
Veterinary Medicine 100, pp 64-70. 
Hernandez, A., Sanchez, M.B. and Martinez, J.L., 2011. Quinolone resistance: much more than 
predicted. Frontiers in Microbiology 2, pp 1-6. 
Hiki, M., Usui, M., Akiyama, T., Kawanishi, M., Tsuyuki, M., Imamura, S., Sekiguchi, H., Kojima, 
A. and Asai, T., 2014. Phylogenetic grouping, epidemiological typing, analysis of virulence 
genes, and antimicrobial susceptibility of Escherichia coli isolated from healthy broilers in 
Japan. Irish Veterinary Journal 67, pp 14-15. 
Hill, C.A. and Gutierrez, J.A., 2003. A method for extraction and analysis of high quality genomic 
DNA from ixodid ticks. Medical and Veterinary Entomology 17, pp 224-227. 
Hollenbeck, B.L. and Rice, L.B., 2012. Intrinsic and acquired resistance mechanisms in 
Enterococcus. Virulence 3, pp 421-433. 
Hommais, F., Pereira, S., Acquaviva, C., Escobar-Paramo, P. and Denamur, E., 2005. Single-
nucleotide polymorphism phylotyping of Escherichia coli. Applied and Environmental 
Microbiology 71, pp 4784-4792. 
 Page | 220  
 
Horcajada, J.P., Soto, S., Gajewski, A., Smithson, A., Jimenez de Anta, M.T., Mensa, J., Vila, J. and 
Johnson, J.R., 2005. Quinolone-resistant uropathogenic Escherichia coli strains from 
phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. 
Journal of Clinical Microbiology 43, pp 2962-2964. 
Hordijk, J., Wagenaar, J.A., van de Giessen, A., Dierikx, C., van Essen-Zandbergen, A., Veldman, 
K., Kant, A. and Mevius, D., 2013. Increasing prevalence and diversity of ESBL/AmpC-type 
β-Lactamase genes in Escherichia coli isolated from veal calves from 1997 to 2010. The 
Journal of Antimicrobial Chemotherapy 68, pp 1970-1973. 
Horn, F., Ribeiro Correa, A.M., Barbieri, N.L., Glodde, S., Weyrauch, K.D., Kaspers, B., Driemeier, 
D., Ewers, C. and Wieler, L.H., 2012. Infections with avian pathogenic and fecal Escherichia 
coli strains display similar lung histopathology and macrophage apoptosis. PloS One 7, pp 
e0041031. 
Horne, S.M., Pfaff-McDonough, S.J., Giddings, C.W. and Nolan, L.K., 2000. Cloning and 
sequencing of the iss gene from a virulent avian Escherichia coli. Avian Diseases 44, pp 179-
184. 
Hosmer, D.W., 2013. Applied logistic regression, In: Lemeshow, S., Sturdivant, R.X. (Eds.) John 
Wiley and Sons, Inc., Hoboken, New Jersey, USA. 
Huang, S.Y., Dai, L., Xia, L.N., Du, X.D., Qi, Y.H., Liu, H.B., Wu, C.M. and Shen, J.Z., 2009. 
Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken 
Escherichia coli isolates from 2001 to 2007. Foodborne Pathogens and Disease 6, pp 1203-
1209. 
Hulton, C.S.J., Higgins, C.F. and Sharp, P.M., 1991. ERIC sequences: a novel family of repetitive 
elements in the genomes of Escherichia coli, Salmonella Typhimurium and other 
Enterobacteria. Molecular Microbiology 5, pp 825-834. 
Hussein, A.H., Ghanem, I.A., Eid, A.A., Ali, M.A., Sherwood, J.S., Li, G., Nolan, L.K. and Logue, 
C.M., 2013. Molecular and phenotypic characterization of Escherichia coli isolated from 
broiler chicken flocks in Egypt. Avian Diseases 57, pp 602-611. 
Iguchi, A., Iyoda, S., Seto, K., Morita-Ishihara, T., Scheutz, F. and Ohnishi, M., 2015. Escherichia 
coli O-genotyping PCR: a comprehensive and practical platform for molecular O 
serogrouping. Journal of Clinical Microbiology 53, pp 2427-2432. 
 Page | 221  
 
Ishmael, F.T. and Stellato, C., 2008. Principles and applications of polymerase chain reaction: basic 
science for the practicing physician. Annals of Allergy, Asthma and Immunology 101, pp 
437-443. 
Jacobson, S.H., Ostenson, C.G., Tullus, K. and Brauner, A., 1992. Serum resistance in Escherichia 
coli strains causing acute pyelonephritis and bacteraemia. Acta Pathologica, Microbiologica 
and Immunologica Scandinavica 100, pp 147-153. 
Jacoby, G.A., 2005. Mechanisms of resistance to quinolones. Clinical Infectious Diseases : An 
Official Publication of the Infectious Diseases Society of America 41 Suppl 2, pp 120-126. 
Jacoby, G.A., 2009. AmpC β-Lactamase. Clinical Microbiology Reviews 22, pp 161-182. 
Jacoby, G.A., Strahilevitz, J. and Hooper, D.C., 2014. Plasmid-mediated quinolone resistance. 
Microbiology Spectrum 2, pp 1-24. 
Jakob, H.P., Morgenstern, R., Albicker, P. and Hoop, R.K., 1998. Reasons for condemnation of 
slaughtered broilers from two large Swiss producers. Schweizer Archiv für Tierheilkunde 
140, pp 60-64. 
Jakobsen, L., Kurbasic, A., Skjot-Rasmussen, L., Ejrnaes, K., Porsbo, L.J., Pedersen, K., Jensen, L.B., 
Emborg, H.D., Agerso, Y., Olsen, K.E., Aarestrup, F.M., Frimodt-Moller, N. and Hammerum, 
A.M., 2010. Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and 
pigs share phylogroups and antimicrobial resistance with community-dwelling humans and 
patients with urinary tract infection. Foodborne Pathogens and Disease 7, pp 537-547. 
Jakobsen, L., Sandvang, D., Jensen, V.F., Seyfarth, A.M., Frimodt-Moller, N. and Hammerum, A.M., 
2007. Gentamicin susceptibility in Escherichia coli related to the genetic background: 
problems with breakpoints. Clinical Microbiology and Infection 13, pp 830-832. 
Janssen, T., Schwarz, C., Preikschat, P., Voss, M., Philipp, H.C. and Wieler, L.H., 2001. Virulence -
associated genes in avian pathogenic Escherichia coli (APEC) isolated from internal organs 
of poultry having died from colibacillosis. International Journal of Medical Microbiology 291, 
pp 371-378. 
Jaureguy, F., Landraud, L., Passet, V., Diancourt, L., Frapy, E., Guigon, G., Carbonnelle, E., 
Lortholary, O., Clermont, O., Denamur, E., Picard, B., Nassif, X. and Brisse, S., 2008. 
Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC 
Genomics 9, pp 560-566. 
 Page | 222  
 
Jeffrey, J.S., Chin, R.P. and Singer, R.S., 1999. Assessing cellulitis pathogenicity of Escherichia coli 
isolates in broiler chickens assessed by an in vivo inoculation model. Avian Diseases 43, pp 
491-496. 
Jeffrey, J.S., Nolan, L.K., Tonooka, K.H., Wolfe, S., Giddings, C.W., Horne, S.M., Foley, S.L., 
Lynne, A.M., Ebert, J.O., Elijah, L.M., Bjorklund, G., Pfaff-McDonough, S.J. and Singer, 
R.S., 2002. Virulence factors of Escherichia coli from cellulitis or colisepticemia lesions in 
chickens. Avian Diseases 46, pp 48-52. 
Jensen, V.F., Jakobsen, L., Emborg, H.D., Seyfarth, A.M. and Hammerum, A.M., 2006. Correlation 
between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-
resistant Escherichia coli. The Journal of Antimicrobial Chemotherapy 58, pp 101-107. 
Jeong, Y.W., Kim, T.E., Kim, J.H. and Kwon, H.J., 2012. Pathotyping avian pathogenic Escherichia 
coli strains in Korea. Journal of Veterinary Science 13, pp 145-152. 
Jiang, H.X., Lu, D.H., Chen, Z.L., Wang, X.M., Chen, J.R., Liu, Y.H., Liao, X.P., Liu, J.H. and Zeng, 
Z.L., 2011. High prevalence and widespread distribution of multi-resistant Escherichia coli 
isolates in pigs and poultry in China. Veterinary Journal  187, pp 99-103. 
Jin, W., Zheng, Z., Zhang, Y., Qin, A., Shao, H. and Liu, Y., 2008. Distribution of virulence-
associated genes of avian pathogenic Escherichia coli isolates in China. Agricultural Sciences 
in China 7, pp 1511-1515. 
Johnson, J.R., Delavari, P., Kuskowski, M. and Stell, A.L., 2001. Phylogenetic distribution of 
extraintestinal virulence-associated traits in Escherichia coli. The Journal of Infectious 
Diseases 183, pp 78-88. 
Johnson, J.R., Johnston, B., Clabots, C.R., Kuskowski, M.A., Roberts, E. and C., D., 2008a. Virulence 
genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from 
humans, dogs, and cats. Journal of Clinical Microbiology 46, pp 417-422. 
Johnson, J.R., Kuskowski, M.A., Owens, K., Gajewski, A. and Winokur, P.L., 2003. Phylogenetic 
origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended -
spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and 
humans. The Journal of Infectious Diseases 188, pp 759-768. 
Johnson, J.R., McCabe, J.S., White, D.G., Johnston, B., Kuskowski, M.A. and McDermott, P., 2009. 
Molecular analysis of Escherichia coli from retail meats (2002-2004) from the United States 
 Page | 223  
 
National Antimicrobial Resistance Monitoring System. Clinical Infectious Diseases  49, pp 
195-201. 
Johnson, J.R. and Russo, T.A., 2002. Extraintestinal pathogenic Escherichia coli: "the other bad E. 
coli". The Journal of Laboratory and Clinical Medicine 139, pp 155-162. 
Johnson, J.R. and Stell, A.L., 2000. Extended virulence genotypes of Escherichia coli strains from 
patients with urosepsis in relation to phylogeny and host compromise. Journal of Infectious 
Diseases 181, pp 261-272. 
Johnson, J.R., Stell, A.L., O'Bryan, T.T., Kuskowski, M., Nowicki, B., Johnson, C., Maslow, J.N., 
Kaul, A., Kavle, J. and Prats, G., 2002a. Global molecular epidemiology of the O15:K52:H1 
extraintestinal pathogenic Escherichia coli clonal group: Evidence of distribution beyond 
Europe. Journal of Clinical Microbiology 40, pp 1913-1923. 
Johnson, T.J., Giddings, C.W., Horne, S.M., Gibbs, P.S., Wooley, R.E., Skyberg, J., Olah, P., 
Kercher, R., Sherwood, J.S., Foley, S.L. and Nolan, L.K., 2002b. Location of increased serum 
survival gene and selected virulence traits on a conjugative R plasmid in an avian Escherichia 
coli isolate. Avian Diseases 46, pp 342-352. 
Johnson, T.J., Johnson, S.J. and Nolan, L.K., 2006. Complete DNA sequence of a ColBM plasmid 
from avian pathogenic Escherichia coli suggests that it evolved from closely related ColV 
virulence plasmids. Journal of Bacteriology 188, pp 5975-5983. 
Johnson, T.J., Jordan, D., Kariyawasam, S., Stell, A.L., Bell, N.P., Wannemuehler, Y.M., Fernandez-
Alarcon, C., Li, G.W., Tivendale, K.A., Logue, C.M. and Nolan, L.K., 2010. Sequence 
analysis and characterization of a transferable hybrid plasmid encoding multidrug resistance 
and enabling zoonotic potential for extraintestinal Escherichia coli. Infection and Immunity 
78, pp 1931-1942. 
Johnson, T.J., Logue, C.M., Johnson, J.R., Kuskowski, M.A., Sherwood, J.S., Barnes, H.J., DebRoy, 
C., Wannemuehler, Y.M., Obata-Yasuoka, M., Spanjaard, L. and Nolan, L.K., 2012. 
Associations between multidrug resistance, plasmid content, and virulence potential among 
extraintestinal pathogenic and commensal Escherichia coli from humans and poultry. 
Foodborne Pathogens and Disease 9, pp 37-46. 
Johnson, T.J. and Nolan, L.K., 2009. Pathogenomics of the virulence plasmids of Escherichia coli. 
Microbiology and Molecular Biology Reviews 73, pp 750-774. 
 Page | 224  
 
Johnson, T.J., Siek, K.E., Johnson, S.J. and Nolan, L.K., 2005. DNA sequence and comparative 
genomics of pAPEC-O2-R, an avian pathogenic Escherichia coli transmissible R plasmid. 
Antimicrobial Agents and Chemotherapy 49, pp 4681-4688. 
Johnson, T.J., Wannemuehler, Y., Doetkott, C., Johnson, S.J., Rosenberger, S.C. and Nolan, L.K., 
2008b. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for 
use as a rapid diagnostic tool. Journal of Clinical Microbiology 46, pp 3987-3996. 
Johnson, T.J., Wannemuehler, Y., Johnson, S.J., Stell, A.L., Doetkott, C., Johnson, J.R., Kim, K.S., 
Spanjaard, L. and Nolan, L.K., 2008c. Comparison of extraintestinal pathogenic Escherichia 
coli strains from human and avian sources reveals a mixed subset representing potential 
zoonotic pathogens. Applied and Environmental Microbiology 74, pp 7043-7050. 
Johnson, T.J., Wannemuehler, Y.M., Johnson, S.J., Logue, C.M., White, D.G., Doetkott, C. and 
Nolan, L.K., 2007. Plasmid replicon typing of commensal and pathogenic Escherichia coli 
isolates. Applied and Environmental Microbiology 73, pp 1976-1983. 
Joint Expert Advisory Committee on Antibiotic Resistance (JETACAR), 1999. The use of antibiotics 
in food-producing animals: Antibiotic-resistant bacteria in animals and humans [Report], 
[Available from http://www.health.gov.au/internet/main/publishing.nsf/content/health-pubs-
jetacar-cnt.htm /]; Accessed February 2014. 
Jonas, D., Spitzmuller, B., Weist, K., Ruden, H. and Daschner, F.D., 2003. Comparison of PCR-based 
methods for typing Escherichia coli. Clinical Microbiology and Infection 9, pp 823-831. 
Jones-Dias, D., Manageiro, V., Sampaio, D.A., Vieira, L. and Canica, M., 2015. Draft genome 
sequence of a pathogenic O86:H25 sequence type 57 Escherichia coli strain isolated from 
poultry and carrying 12 acquired antibiotic resistance genes. Genome Announcements  3, pp 
e01107. 
Kabir, S.M.L., 2010. Avian colibacillosis and salmonellosis: A closer look at epidemiology, 
pathogenesis, diagnosis, control and public health concerns. International Journal of 
Environmental Research and Public Health 7, pp 89-114. 
Kaesbohrer, A., Schroeter, A., Tenhagen, B.A., Alt, K., Guerra, B. and Appel, B., 2012. Emerging 
antimicrobial resistance in commensal Escherichia coli with public health relevance. 
Zoonoses and Public Health 59 pp 158-165. 
 Page | 225  
 
Kafshdouzan, K., Salehi, T.Z., Nayeri, B., Madadgar, O., Yamasaki, S. and Hinenoya, A., 2013. 
Distribution of virulence associated genes in isolated Escherichia coli from avian 
colibacillosis. Iranian Journal of Veterinary Medicine 7, pp 1-6. 
Kamada, N., Chen, G.Y., Inohara, N. and Nunez, G., 2013. Control of pathogens and pathobionts by 
the gut microbiota. Nature Immunology 14, pp 685-690. 
Kaper, J.B., Nataro, J.P. and Mobley, H.L.T., 2004. Pathogenic Escherichia coli. Nature Reviews 
Microbiology 2, pp 123-140. 
Karch, H., Schubert, S., Zhang, D., Zhang, W., Schmidt, H., Olschlager, T. and Hacker, J., 1999. A 
genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-
producing Escherichia coli clonal lineages. Infection and Immunity 67, pp 5994-6001. 
Kariyawasam, S., Johnson, T.J., Debroy, C. and Nolan, L.K., 2006a. Occurrence of pathogenicity 
island IAPEC-O1 genes among Escherichia coli implicated in avian colibacillosis. Avian 
Diseases 50, pp 405-410. 
Kariyawasam, S., Johnson, T.J. and Nolan, L.K., 2006b. The pap operon of avian pathogenic 
Escherichia coli strain O1:K1 is located on a novel pathogenicity island. Infection and 
Immunity 74, pp 744-749. 
Kariyawasam, S. and Nolan, L.K., 2009. Pap mutant of avian pathogenic Escherichia coli O1, an 
O1:K1:H7 strain, is attenuated in vivo. Avian Diseases 53, pp 255-260. 
Kawamura-Sato, K., Yoshida, R., Shibayama, K. and Ohta, M., 2010. Virulence genes, quinolone 
and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia 
coli strains isolated in Japan. Japanese Journal of Infectious Diseases 63J, pp 113-115. 
Keawcharoen, J., van Riel, D., van Amerongen, G., Bestebroer, T., Beyer, W.E., van Lavieren, R., 
Osterhaus, A.D., Fouchier, R.A. and Kuiken, T., 2008. Wild ducks as long-distance vectors 
of highly pathogenic avian influenza virus (H5N1). Emerging Infectious Diseases 14, pp 600-
607. 
Kemmett, K., Humphrey, T., Rushton, S., Close, A., Wigley, P. and Williams, N.J., 2013. A 
longitudinal study simultaneously exploring the carriage of APEC virulence associated genes 
and the molecular epidemiology of faecal and systemic E. coli in commercial broiler chickens. 
PLoS One 8, pp e67749. 
 Page | 226  
 
Kemmett, K., Williams, N.J., Chaloner, G., Humphrey, S., Wigley, P. and Humphrey, T., 2014. The 
contribution of systemic Escherichia coli infection to the early mortalities of commercial 
broiler chickens. Avian Pathology 43, pp 37-42. 
Kern, W.V., Steinke, P., Schumacher, A., Schuster, S., von Baum, H. and Bohnert, J.A., 2006. Effect 
of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial 
drug susceptibility in clinical isolates of Escherichia coli. The Journal of Antimicrobial 
Chemotherapy 57, pp 339-343. 
Kim, J., Bae, I.K., Jeong, S.H., Chang, C.L., Lee, C.H. and Lee, K., 2011. Characterization of IncF 
plasmids carrying the blaCTXM-14 gene in clinical isolates of Escherichia coli from Korea. The 
Journal of Antimicrobial Chemotherapy 66, pp 1263-1268. 
Kim, T.E., Jeong, Y.W., Cho, S.H., Kim, S.J. and Kwon, H.J., 2007. Chronological study of antibiotic 
resistances and their relevant genes in Korean avian pathogenic Escherichia coli isolates. 
Journal of Clinical Microbiology 45, pp 3309-3315. 
Kluytmans, J.A., Overdevest, I.T., Willemsen, I., Kluytmans-van den Bergh, M.F., van der Zwaluw, 
K., Heck, M., Rijnsburger, M., Vandenbroucke-Grauls, C.M., Savelkoul, P.H., Johnston, 
B.D., Gordon, D. and Johnson, J.R., 2013. Extended-spectrum β-Lactamases-producing 
Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, 
resistance genes, and virulence factors. Clinical Infectious Diseases  56, pp 478-487. 
Kmeť, V. and KmeŤová, M., 2010. High level of quinolone resistance in Escherichia coli from 
healthy chicken broilers. Folia Microbiology 55, pp 79-82. 
Kmeť, V., KmeŤová, M., Drugdova, Z. and Stanko, M., 2013. Virulence and antibiotic resistance of 
Escherichia coli isolated from rooks. Annals of Agricultural and Environmental Medicine 20, 
pp 273-275. 
Knöbl, T., Gomes, T.A.T., Vieira, M.A.M., Bottino, J.A. and Ferreira, A.J.P., 2004. Detection of pap, 
sfa and fim adhesin-encoding operons in avian pathogenic Escherichia coli. International 
Journal of Applied Research Veterinary Medicine 2, pp 135-141. 
Knobl, T., Moreno, A.M., Paixao, R., Gomes, T.A., Vieira, M.A., da Silva Leite, D., Blanco, J.E. and 
Ferreira, A.J., 2012. Prevalence of avian pathogenic Escherichia coli (APEC) clone harboring 
sfa gene in Brazil. Scientific World Journal 2012, pp 437-342. 
 Page | 227  
 
Kobayashi, R.K., Aquino, I., Ferreira, A.L. and Vidotto, M., 2011. ECOR phylogenetic analysis and 
virulence genotyping of avian pathogenic Escherichia coli strains and Escherichia coli 
isolates from commercial chicken carcasses in Southern Brazil. Foodborne Pathogen Diseases  
8, pp 631-634. 
Koebnik, R., Baumler, A.J., Heesemann, J., Braun, V. and Hantke, K., 1993. The TonB protein of 
Yersinia enterocolitica and its interactions with TonB-box proteins. Molecular and General 
Genetics 237, pp 152-160. 
Kohler, C.D. and Dobrindt, U., 2011. What defines extraintestinal pathogenic Escherichia coli? 
International Journal of Medical Microbiology 301, pp 642-647. 
Kools, S.A., Moltmann, J.F. and Knacker, T., 2008. Estimating the use of veterinary medicines in the 
European union. Regulatory Toxicology and Pharmacology 50, pp 59-65. 
Kwon, S-G., Cha, S-Y., Choi, E-J., Kim, B., Song, H-J. and Jang, H-K., 2008. Epidemiological 
prevalence of avian pathogenic Escherichia coli differentiated by multiplex PCR from 
commercial chickens and hatchery in Korea. Journal of Bacteriology and Virology 38, pp 
179-188. 
La Ragione, R.M., Cooley, W.A. and Woodward, M.J., 2000. The role of fimbriae and flagella in the 
adherence of avian strains of Escherichia coli O78 : K80 to tissue culture cells and tracheal 
and gut explants. Journal of Medical Microbiology 49, pp 327-338. 
La Ragione, R.M. and Woodward, M.J., 2002. Virulence factors of Escherichia coli serotypes 
associated with avian colisepticaemia. Research in Veterinary Science  73, pp 27-35. 
Lacher, D.W., Gangiredla, J., Jackson, S.A., Elkins, C.A. and Feng, P.C., 2014. Novel microarray 
design for molecular serotyping of shiga toxin- producing Escherichia coli strains isolated 
from fresh produce. Applied and Environmental Microbiology 80, pp 4677-4682. 
Lafont, J.P., Dho, M., Dhauteville, H.M., Bree, A. and Sansonetti, P.J., 1987. Presence and expression 
of aerobactin genes in virulent avian strains of Escherichia coli. Infection and Immunity 55, 
pp 193-197. 
Lalioui, L. and Le Bouguenec, C., 2001. afa-8 Gene cluster is carried by a pathogenicity island 
inserted into the tRNAPhe of human and bovine pathogenic Escherichia coli isolates. Infection 
and Immunity 69, pp 937-948. 
 Page | 228  
 
Lambert, T., 2012. Antibiotics that affect the ribosome. Revue Scientifique et Technique  31, pp 57-
64. 
Landers, T.F., Cohen, B., Wittum, T.E. and Larson, E.L., 2012. A review of antibiotic use in food 
animals: perspective, policy, and potential. Public Health Reports 127, pp 4-22. 
Landis, J.R. and Kochi, G.G., 1977a. The measurement of observer agreement for categorical data. 
Biometrics 33, pp 159–174. 
Landis, J.R. and Kochi, G.G., 1977b. A one-way components of variance model for categorical data. 
Biometrics 33, pp 671–679. 
Landman, W.J., Buter, G.J., Dijkman, R. and van Eck, J.H., 2014. Molecular typing of avian 
pathogenic Escherichia coli colonies originating from outbreaks of E. coli peritonitis 
syndrome in chicken flocks. Avian Pathology 43, pp 345-356. 
Landman, W.J.M. and Cornelissen, R.A., 2006. Virulence factors of Escherichia coli, with emphasis 
on avian pathogenic isolates. Tijdschrift Voor Diergeneeskunde 131, pp 822-830. 
Langdon, A., Crook, N. and Dantas, G., 2016. The effects of antibiotics on the microbiome 
throughout development and alternative approaches for therapeutic modulation. Genome 
Medicine 8, pp 39-12. 
Larsen, M.V., Cosentino, S., Rasmussen, S., Friis, C., Hasman, H., Marvig, R.L., Jelsbak, L., 
Sicheritz-Ponten, T. and Ussery, D.W., 2012. Multilocus sequence typing of total-genome-
sequenced bacteria. Journal of Clinical Microbiology 50, pp 1355-1361. 
Latham, R.H. and Stamm, W.E., 1984. Role of fimbriated Escherichia coli in urinary tract infections 
in adult women: correlation with localization studies. The Journal of Infectious Diseases  149, 
pp 835-840. 
Laube, H., Friese, A., von Salviati, C., Guerra, B. and Rosler, U., 2014. Transmission of 
ESBL/AmpC-producing Escherichia coli from broiler chicken farms to surrounding areas. 
Veterinary Microbiology 172, pp 3-4. 
Lavakhamseh, H., Mohajeri, P., Rouhi, S., Shakib, P., Ramazanzadeh, R., Rasani, A. and Mansouri, 
M., 2016. Multidrug-resistant Escherichia coli strains isolated from patients are associated 
with Class 1 and 2 Integrons. Chemotherapy 61, pp 72-76. 
 Page | 229  
 
Law, J.W., Ab Mutalib, N.S., Chan, K.G. and Lee, L.H., 2014. Rapid methods for the detection of 
foodborne bacterial pathogens: principles, applications, advantages and limitations. Frontiers 
in Microbiology 5, pp 770-779. 
Lee, C.H., Su, L.H., Li, C.C., Chien, C.C., Tang, Y.F. and Liu, J.W., 2010. Microbiologic and clinical 
implications of bacteremia due to extended-spectrum-β-Lactamases-producing Klebsiella 
pneumoniae with or without plasmid-mediated AmpC β-Lactamases DHA-1. Antimicrobial 
Agents and Chemotherapy 54, pp 5395-5398. 
Leimbach, A., Hacker, J. and Dobrindt, U., 2013. E. coli as an all-rounder: the thin line between 
commensalism and pathogenicity. Current Topics in Microbiology and Immunology 358, pp 
3-32. 
Leitner, G. and Heller, E.D., 1992. Colonization of Escherichia coli in young turkeys and chickens. 
Avian Diseases 36, pp 211-220. 
Leverstein-van Hall, M.A., Dierikx, C.M., Cohen Stuart, J., Voets, G.M., van den Munckhof, M.P., 
van Essen-Zandbergen, A., Platteel, T., Fluit, A.C., van de Sande-Bruinsma, N., Scharinga, 
J., Bonten, M.J. and Mevius, D.J., 2011. Dutch patients, retail chicken meat and poultry share 
the same ESBL genes, plasmids and strains. Clinical Microbiology and Infection 17, pp 873-
880. 
Lévesque, B.t., Brousseau, P., Bernier, F., Dewailly, É. and Joly, J., 2000. Study of the bacterial 
content of ring-billed gull droppings in relation to recreational water quality. Water Research 
34, pp 1089-1096. 
Li, X.Z., Mehrotra, M., Ghimire, S. and Adewoye, L., 2007. β-lactam resistance and β-Lactamases 
in bacteria of animal origin. Veterinary Microbiology 121, pp 197-214. 
Lima-Filho, J.V., Martins, L.V., Nascimento, D.C.d.O., Ventura, R.F., Batista, J.E.C., Silva, A.F.B., 
Ralph, M.T., Vaz, R.V., Rabello, C.B.-V., Silva, I.d.M.M.d. and Evêncio-Neto, J., 2013. 
Zoonotic potential of multidrug-resistant extraintestinal pathogenic Escherichia coli obtained 
from healthy poultry carcasses in Salvador, Brazil. Brazilian Journal of Infectious Diseases  
17, pp 54-61. 
Ling, J., Pan, H., Gao, Q., Xiong, L., Zhou, Y., Zhang, D., Gao, S. and Liu, X., 2013. Aerobactin 
synthesis genes iucA and iucC contribute to the pathogenicity of avian pathogenic Escherichia 
coli O2 strain E058. PLoS One 8, pp e57794. 
 Page | 230  
 
Linggood, M.A., Roberts, M., Ford, S., Parry, S.H. and Williams, P.H., 1987. Incidence of the 
aerobactin iron uptake system among Escherichia coli isolates from infections of farm 
animals. Journal of General Microbiology 133, pp 835-842. 
Linton, A.H. and Hinton, M.H., 1988. Enterobacteriaceae associated with animals in health and 
disease. Society for Applied Bacteriology Symposium Series 17, pp 71-85. 
Literak, I., Dolejska, M., Janoszowska, D., Hrusakova, J., Meissner, W., Rzyska, H., Bzoma, S. and 
Cizek, A., 2010. Antibiotic-resistant Escherichia coli bacteria, including strains with genes 
encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea 
coast of Poland. Applied and Environmental Microbiology 76, pp 8126-8134. 
Liu, B.T., Liao, X.P., Yang, S.S., Wang, X.M., Li, L.L., Sun, J., Yang, Y.R., Fang, L.X., Li, L., Zhao, 
D.H. and Liu, Y.H., 2012. Detection of mutations in the gyrA and parC genes in Escherichia 
coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-
producing animals. Journal of Medical Microbiology 61, pp 1591-1599. 
Liu, B.T., Yang, Q.E., Li, L., Sun, J., Liao, X.P., Fang, L.X., Yang, S.S., Deng, H. and Liu, Y.H., 
2013. Dissemination and characterization of plasmids carrying oqxAB-blaCTX-M genes in 
Escherichia coli isolates from food-producing animals. PLoS One 8, pp e73947. 
Livermore, D.M., 1995. β-Lactamases in laboratory and clinical resistance. Clinical Microbiology 
Reviews 8, pp 557-584. 
Lleo, M.M., Bonato, B., Tafi, M.C., Signoretto, C., Pruzzo, C. and Canepari, P., 2005. Molecular vs 
culture methods for the detection of bacterial faecal indicators in groundwater for human use. 
Letters in Applied Microbiology 40, pp 289-294. 
Logue, C.M., Wannemuehler, Y., Nicholson, B.A., Doetkott, C., Barbieri, N.L. and Nolan, L.K., 
2017. Comparative analysis of phylogenetic assignment of human and avian ExPEC and fecal 
commensal Escherichia coli using the (previous and revised) clermont phylogenetic typing 
methods and its impact on avian pathogenic Escherichia coli (APEC) classification. Frontiers 
in Microbiology 8, pp 1-11. 
Lohren, U., Ricci, A. and Cummings, T.S., 2009. Guidelines for antimicrobial use in poultry. In: 
Guardabassi, L., Jensen, L., Kruse, H. (Eds.) Guide to Antimicrobial Use in Animals. 
Blackwell Publishing, Oxford, UK, pp 126-142. 
 Page | 231  
 
Lu, J., Idris, U., Harmon, B., Hofacre, C., Maurer, J.J. and Lee, M.D., 2003. Diversity and succession 
of the intestinal bacterial community of the maturing broiler chicken. Applied and 
Environmental Microbiology 69, pp 6816-6824. 
Lwinger, K., Fisher, C., Jeroch, H., Sauveur, B., Tiller, H. and Whitehead, C., 2016. A brief history 
of poultry nutrition over the last hundred years. World's Poultry Science Journal  72, pp 701-
720. 
Lymberopoulos, M.H., Houle, S., Daigle, F., Leveille, S., Bree, A., Moulin-Schouleur, M., Johnson, 
J.R. and Dozois, C.M., 2006. Characterization of Stg fimbriae from an avian pathogenic 
Escherichia coli O78:K80 strain and assessment of their contribution to colonization of the 
chicken respiratory tract. Journal of Bacteriology 188, pp 6449-6459. 
Lynne, A.M., Kariyawasam, S., Wannemuehler, Y., Johnson, T.J., Johnson, S.J., Sinha, A.S., Lynne, 
D.K., Moon, H.W., Jordan, D.M., Logue, C.M., Foley, S.L. and Nolan, L.K., 2012. 
Recombinant Iss as a potential vaccine for avian colibacillosis. Avian Diseases  56, pp 192-
199. 
Lynne, A.M., Skyberg, J.A., Logue, C.M. and Nolan, L.K., 2007. Detection of Iss and Bor on the 
surface of Escherichia coli. Veterinary Microbiology 102, pp 660-666. 
Maamar, E., Hammami, S., Alonso, C.A., Dakhli, N., Abbassi, M.S., Ferjani, S., Hamzaoui, Z., 
Saidani, M., Torres, C. and Boutiba-Ben Boubaker, I., 2016. High prevalence of extended-
spectrum and plasmidic AmpC beta-lactamase-producing Escherichia coli from poultry in 
Tunisia. International Journal of Food Microbiology 231, pp 69-75. 
Machado, E., Coque, T.M., Canton, R., Sousa, J.C. and Peixe, L., 2008. Antibiotic resistance 
integrons and extended-spectrum β-lactamases among Enterobacteriaceae isolates recovered 
from chickens and swine in Portugal. The Journal of Antimicrobial Chemotherapy 62, pp 296-
302. 
Magnet, S. and Blanchard, J.S., 2005. Molecular insights into aminoglycoside action and resistance. 
Chemical Reviews 105, pp 477-498. 
Maiden, M.C., Bygraves, J.A., Feil, E., Morelli, G., Russell, J.E., Urwin, R., Zhang, Q., Zhou, J., 
Zurth, K., Caugant, D.A., Feavers, I.M., Achtman, M. and Spratt, B.G., 1998. Multilocus 
sequence typing: a portable approach to the identification of clones within populations of 
 Page | 232  
 
pathogenic microorganisms. Proceedings of the National Academy of Sciences of the United 
States of America 95, pp 3140-3145. 
Mainil, J., 2013. Escherichia coli virulence factors. Veterinary Immunology and Immunopathology 
152, pp 2-12. 
Maluta, R.P., Logue, C.M., Casas, M.R., Meng, T., Guastalli, E.A., Rojas, T.C., Montelli, A.C., 
Sadatsune, T., de Carvalho Ramos, M., Nolan, L.K. and da Silveira, W.D., 2014. Overlapped 
sequence types (STs) and serogroups of avian pathogenic (APEC) and human extra-intestinal 
pathogenic (ExPEC) Escherichia coli isolated in Brazil. PLoS One 9, pp e105016. 
Manges, A.R. and Johnson, J.R., 2012. Food-borne origins of Escherichia coli causing extraintestinal 
infections. Clinical Infectious Diseases 55, pp 712-719. 
Marathe, N., Regina, V., Walujkar, S., Charan, S., Moore, E. and Larsson, D., 2013. A treatment plant 
receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi -
drug resistant integron-bearing bacteria. PLoS One 8, pp e77310. 
Marc, D., Arne, P., Bree, A. and Dho-Moulin, M., 1998. Colonization ability and pathogenic 
properties of a fim(-) mutant of an avian strain of Escherichia coli. Research in Microbiology 
149, pp 473-485. 
Marshall, B.M. and Levy, S.B., 2011. Food animals and antimicrobials: impacts on human health. 
Clinical Microbiology Reviews 24, pp 718-733. 
Martinez-Martinez, L., Pascual, A. and Jacoby, G.A., 1998. Quinolone resistance from a transferable 
plasmid. Lancet 351, pp 797-799. 
Martinez-Medina, M., Mora, A., Blanco, M., Lopez, C., Alonso, M.P., Bonacorsi, S., Nicolas-
Chanoine, M.H., Darfeuille-Michaud, A., Garcia-Gil, J. and Blanco, J., 2009. Similarity and 
divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli 
strains. Journal of Clinical Microbiology 47, pp 3968-3979. 
Martinez, M., Blondeau, J., Cerniglia, C.E., Fink-Gremmels, J., Guenther, S., Hunter, R.P., Li, X.Z., 
Papich, M., Silley, P., Soback, S., Toutain, P.L. and Zhang, Q., 2014. Workshop report: The 
2012 Antimicrobial Agents in Veterinary Medicine: exploring the consequences of 
antimicrobial drug use: a 3-D approach. Journal of Veterinary Pharmacology and 
Therapeutics 37, pp 1-16. 
 Page | 233  
 
Martineza, M., McDermott, P. and Walker, R., 2006. Pharmacology of the fluoroquinolones: A 
perspective for the use in domestic animals. The Veterinary Journal  172, pp 10-28. 
Maryam, A.R., 2016. Molecular typing of uropathogenic E. coli strains by the ERIC-PCR method. 
Electronic Physician 8, pp 2291-2296. 
Mascaretti, O.A., 2003. Antibiotics and synthetic antibacterial agents. In: Mascaretti, O.A. (Ed.) 
Bacteria versus Antibacterial Agents an Integrated Approach. ASM Press, Washington DC, 
pp 97-105. 
Mata, C., Miro, E., Alvarado, A., Garcillan-Barcia, M.P., Toleman, M., Walsh, T.R., de la Cruz, F. 
and Navarro, F., 2012. Plasmid typing and genetic context of AmpC β-lactamases in 
Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish 
hospital 1999-2007. The Journal of Antimicrobial Chemotherapy 67, pp 115-122. 
Matagne, A.J., Lamotte-Brasseur, J. and Frere, J.M., 1998. Catalytic properties of class A beta-
lactamases: efficiency and diversity. Biochemical Journal 330, pp 581-598. 
Mataseje, L.F., Baudry, P.J., Zhanel, G.G., Morck, D.W., Read, R.R., Louie, M. and Mulvey, M.R., 
2010. Comparison of CMY-2 plasmids isolated from human, animal, and environmental 
Escherichia coli and Salmonella spp. from Canada. Diagnostic Microbiology and Infectious 
Disease 67, pp 387-391. 
Maturana, V.G., De Pace, F., Carlos, C., Pires, M.M., De Campos, T.A. and Nakazato, G., 2011. 
Subpathotypes of avian pathogenic Escherichia coli (APEC) exist as defined by their 
syndromes and virulence traits. Open Microbiology Journal 5, pp 55-64. 
Maurer, J.J., Brown, T.P., Steffens, W.L. and Thayer, S.G., 1998. The occurrence of ambient 
temperature-regulated adhesions, curli and the temperature-sensitive hemagglutinin Tsh 
among avian Escherichia coli. Avian Diseases 42, pp 106-118. 
Mbanga, J. and Nyararai, Y.O., 2015. Virulence gene profiles of avian pathogenic Escherichia coli 
isolated from chickens with colibacillosis in Bulawayo, Zimbabwe. The Onderstepoort 
Journal of Veterinary Research 82, pp 840-850. 
McOrist, A.L., Jackson, M. and Bird, A.R., 2002. A comparison of five methods for extraction of 
bacterial DNA from human faecal samples. Journal of Microbiological Methods  50, pp 131-
139. 
 Page | 234  
 
McPeake, S.J., Smyth, J.A. and Ball, H.J., 2005. Characterisation of avian pathogenic Escherichia 
coli (APEC) associated with colisepticaemia compared to faecal isolates from healthy birds. 
Veterinary Microbiology 110, pp 245-253. 
Meacham, K.J., Zhang, L., Foxman, B., Bauer, R.J. and Marrs, C.F., 2003. Evaluation of genotyping 
large numbers of Escherichia coli isolates by enterobacterial repetitive intergenic consensus -
PCR. Journal of Clinical Microbiology 41, pp 5224-5226. 
Mellata, M., 2013. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic 
risks and antibiotic resistance trends. Foodborne Pathogens and Disease 10, pp 916-932. 
Mellata, M., Dho-Moulin, M., Dozois, C.M., Curtiss, R., 3rd, Brown, P.K., Arne, P., Bree, A., 
Desautels, C. and Fairbrother, J.M., 2003. Role of virulence factors in resistance of avian 
pathogenic Escherichia coli to serum and in pathogenicity. Infection and Immunity 71, pp 
536-576. 
Mellata, M., Maddux, J.T., Nam, T., Thomson, N., Hauser, H., Stevens, M.P., Mukhopadhyay, S., 
Sarker, S., Crabbe, A., Nickerson, C.A., Santander, J. and Curtiss, R., 2012. New insights into 
the bacterial fitness-associated mechanisms revealed by the characterization of large plasmids 
of an avian pathogenic E. coli. PloS One 7, pp e29481. 
Meyer, D.H., Mintz, K.P. and Fives-Taylor, P.M., 1997. Models of invasion of enteric and 
periodontal pathogens into epithelial cells: a comparative analysis. Critical Reviews in Oral 
Biology and Medicine 8, pp 389-409. 
Meyer, E., Schwab, F., Schroeren-Boersch, B. and Gastmeier, P., 2010. Dramatic increase of third-
generation cephalosporin-resistant E. coli in German intensive care units: secular trends in 
antibiotic drug use and bacterial resistance, 2001 to 2008. Critical Care 14, pp 113-222. 
Miajlovic, H. and Smith, S.G., 2014. Bacterial self-defence: how Escherichia coli evades serum 
killing. FEMS Microbiology Letters 354, pp 1-9. 
Miller, D.N., Bryant, J.E., Madsen, E.L. and Ghiorse, W.C., 1999. Evaluation and optimization of 
DNA extraction and purification procedures for soil and sediment samples. Applied and 
Environmental Microbiology 65, pp 4715-4724. 
Mohammad, K., 2010. Population structure of gut Escherichia coli and its role in development of 
extra-intestinal infections. Iranian Journal of Microbiology 2, pp 59–72. 
 Page | 235  
 
Mokady, D., Gophna, U. and Ron, E.Z., 2005. Virulence factors of septicemic Escherichia coli 
strains. International Journal of Medical Microbiology 295, pp 455-462. 
Mol, O. and Oudega, B., 1996. Molecular and structural aspects of fimbriae biosynthesis and 
assembly in Escherichia coli. FEMS Microbiology Reviews 19, pp 25-52. 
Monroy, M.A., Knobl, T., Bottino, J.A., Ferreira, C.S. and Ferreira, A.J., 2005. Virulence 
characteristics of Escherichia coli isolates obtained from broiler breeders with salpingitis. 
Comparative Immunology, Microbiology and Infectious Diseases 28, pp 1-15. 
Monteiro, L., Bonnemaison, D., Vekris, A., Petry, K.G., Bonnet, J., Vidal, R., Cabrita, J. and 
Megraud, F., 1997. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori 
model. Journal of Clinical Microbiology 35, pp 995-998. 
Moodley, A. and Guardabassi, L., 2009. Transmission of IncN plasmids carrying blaCTX-M-1 between 
commensal Escherichia coli in pigs and farm workers. Antimicrobial Agents and 
Chemotherapy 53, pp 1709-1711. 
Moon, H.W., 1990. Colonization factor antigens of enterotoxigenic Escherichia coli in animals. 
Current Topics in Microbiology and Immunology 151, pp 147-165. 
Mora, A., Blanco, M., Lopez, C., Mamani, R., Blanco, J.E., Alonso, M.P., Garcia-Garrote, F., Dahbi, 
G., Herrera, A., Fernandez, A., Fernandez, B., Agulla, A., Bou, G. and Blanco, J., 2011. 
Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-
ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing 
Escherichia coli clinical isolates in Galicia, Northwest Spain. International Journal of 
Antimicrobial Agents 37, pp 16-21. 
Mora, A., Viso, S., Lopez, C., Alonso, M.P., Garcia-Garrote, F., Dabhi, G., Mamani, R., Herrera, A., 
Marzoa, J., Blanco, M., Blanco, J.E., Moulin-Schouleur, M., Schouler, C. and Blanco, J., 
2013. Poultry as reservoir for extraintestinal pathogenic Escherichia coli O45:K1:H7-B2-
ST95 in humans. Veterinary Microbiology 167, pp 506-512. 
Moran, R.A., Anantham, S., Pinyon, J.L. and Hall, R.M., 2015. Plasmids in antibiotic susceptible and 
antibiotic resistant commensal Escherichia coli from healthy Australian adults. Plasmid 80, 
pp 24-31. 
Moreno, E., Prats, G., Sabate, M., Perez, T., Johnson, J.R. and Andreu, A., 2006. Quinolone, 
fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence 
 Page | 236  
 
determinants and phylogenetic background among uropathogenic Escherichia coli. The 
Journal of Antimicrobial Chemotherapy 57, pp 204-211. 
Morley, P.S., Apley, M.D., Besser, T.E., Burney, D.P., Fedorka-Cray, P.J., Papich, M.G., Traub-
Dargatz, J.L. and Weese, J.S., 2005. Antimicrobial drug use in veterinary medicine. Journal 
of Veterinary Medical Science 19, pp 617-629. 
Morris, J.G. and Potter, M., 1997. Emergence of new pathogens as a function of changes in host 
susceptibility. Emerging Infectious Diseases 3, pp 435-441. 
Moudgal, V. and Kaatz, G.W., 2009. Fluoroquinolone resistance in bacteria. In: Mayers, D.L. (Ed.) 
Antimicrobial Drug Resistance. Humana Press Inc., Totowa, NJ, USA, pp 195-205. 
Moulin-Schouleur, M., Reperant, M., Laurent, S., Bree, A., Mignon-Grasteau, S., Germon, P., 
Rasschaert, D. and Schouler, C., 2007. Extraintestinal pathogenic Escherichia coli strains of 
avian and human origin: Link between phylogenetic relationships and common virulence 
patterns. Journal of Clinical Microbiology 45, pp 3366-3376. 
Moulin-Schouleur, M., Schouler, C., Tailliez, P., Kao, M.-R., Bree, A., Germon, P., Oswald, E., 
Mainil, J., Blanco, M. and Blanco, J., 2006. Common virulence factors and genetic 
relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin. 
Journal of Clinical Microbiology 44, pp 3484-3492. 
Mulder and Nan, D., 2011. Crossroads for Growth. The International Poultry Sector Towards 2020. 
Rabobank. Utrecht. The Netherlands. 
Murase, K., Martin, P., Porcheron, G., Houle, S., Helloin, E., Penary, M., Nougayrede, J.P., Dozois, 
C.M., Hayashi, T. and Oswald, E., 2016. HlyF produced by extraintestinal pathogenic 
Escherichia coli is a virulence factor that regulates outer membrane vesicle biogenesis. The 
Journal of Infectious Diseases 213, pp 856-865. 
Musa, H.H., He, S.F., Wu, S.L., Zhu, C.H., Liu, Z.H., Zhang, Z.N., Raj, V.S., Gu, R.X. and Zhu, 
G.Q., 2009. Genetic engineering of avian pathogenic E. coli to study the functions of FimH 
adhesin. Indian Journal of Experimental Biology 47, pp 916-920. 
Nakazato, G., de Campos, T.A., Stehling, E.G., Brocchi, M. and da Silveira, W.D., 2009. Virulence 
factors of avian pathogenic Escherichia coli (APEC). Pesquisa Veterinaria Brasileira 29, pp 
479-486. 
 Page | 237  
 
Nather, G., Alter, T., Martin, A. and Ellerbroek, L., 2009. Analysis of risk factors for  Campylobacter 
species infection in broiler flocks. Poultry Science 88, pp 1299-1305. 
National Center for Biotechnology Information (NCBI), Beta-lactamase data resources, [Available 
from https://www.ncbi.nlm.nih.gov/pathogens/beta-lactamase-data-resources/]; Accessed 
September 2017. 
Naveh, M.W., Zusman, T., Skutelsky, E. and Ron, E.Z., 1984. Adherence pili in avian strains of 
Escherichia coli: effect on pathogenicity. Avian Diseases 28, pp 651-661. 
Ndi, O. and Barton, M., 2012. Antibiotic Resistance in Animals—The Australian Perspective. In: 
Keen, P., Montforts, M. (Eds.) Antimicrobial Resistance in the Environment. John Wiley and 
Sons, Inc., Hoboken, New Jersey, USA, pp 265-290. 
Nechvatal, J.M., Ram, J.L., Basson, M.D., Namprachan, P., Niec, S.R., Badsha, K.Z., Matherly, L.H., 
Majumdar, A.P. and Kato, I., 2008. Fecal collection, ambient preservation, and DNA 
extraction for PCR amplification of bacterial and human markers from human feces. Journal 
of Microbiological Methods 72, pp 124-132. 
Nelson, M.L. and Levy, S.B., 2011. The history of the tetracyclines. Annals of the New York 
Academy of Sciences 1241, pp 17-32. 
Neu, H.C., 1992. The crisis in antibiotic-resistance. Science 257, pp 1064-1073. 
Newell, D.G., Elvers, K.T., Dopfer, D., Hansson, I., Jones, P., James, S., Gittins, J., Stern, N.J., 
Davies, R., Connerton, I., Pearson, D., Salvat, G. and Allen, V.M., 2011. Biosecurity-based 
interventions and strategies to reduce Campylobacter spp. on poultry farms. Applied and 
Environmental Microbiology 77, pp 8605-8614. 
Ngeleka, M., Brereton, L., Brown, G. and Fairbrother, J.M., 2002. Pathotypes of avian Escherichia 
coli as related to tsh-, pap-, pil-, and iuc-DNA sequences, and antibiotic sensitivity of isolates 
from internal tissues and the cloacae of broilers. Avian Diseases 46, pp 143-152. 
Ngeleka, M., Kwaga, J.K., White, D.G., Whittam, T.S., Riddell, C., Goodhope, R., Potter, A.A. and 
Allan, B., 1996. Escherichia coli cellulitis in broiler chickens: clonal relationships among 
strains and analysis of virulence-associated factors of isolates from diseased birds. Infection 
and Immunity 64, pp 3118-3126. 
Nicklas, J.A. and Buel, E., 2003. Quantification of DNA in forensic samples. Analytical and 
Bioanalytical Chemistry 376, pp 1160-1167. 
 Page | 238  
 
Nilsson, O., Borjesson, S., Landen, A. and Bengtsson, B., 2014. Vertical transmission of Escherichia 
coli carrying plasmid-mediated AmpC (pAmpC) through the broiler production pyramid. The 
Journal of Antimicrobial Chemotherapy 69, pp 1497-1500. 
Nogrady, N., Paszti, J., Piko, H. and Nagy, B., 2006. Class 1 integrons and their conjugal transfer 
with and without virulence-associated genes in extra-intestinal and intestinal Escherichia coli 
of poultry. Avian Pathology 35, pp 349-321. 
Nolan, L., K., Barnes, H., Jean Pirre, V., Abdul-Aziz, T. and Louge, C.M., 2013. Colibacillosis. In: 
Swayne, D., E. (Eds.) Diseases of Poultry. John Wiley and Sons, Ames, Iowa, pp 751-785. 
Nolan, L.K., Giddings, C.W., Horne, S.M., Doetkott, C., Gibbs, P.S., Wooley, R.E. and Foley, S.L., 
2002. Complement resistance, as determined by viable count and flow cytometric methods, 
and its association with the presence of iss and the virulence of avian Escherichia coli. Avian 
Diseases 46, pp 386-392. 
Nolan, L.K., Horne, S.M., Giddings, C.W., Foley, S.L., Johnson, T.J., Lynne, A.M. and Skyberg, J., 
2003. Resistance to serum complement, iss, and virulence of avian Escherichia coli. 
Veterinary Research Communications 27, pp 101-110. 
NORM/NORM-VET, 2007. Usage of antimicrobial agents and occurrence of antimicrobial resistance 
in Norway, [Available from http://www.vetinst.no/eng/Research/Publications/Norm-Norm-
Vet-Report/The-Norm-Norm-Vet-Report-2006]; Accessed June 2015. 
Norton, R.A., Bilgili, S.F. and McMurtrey, B.C., 1997. A reproducible model for the induction of 
avian cellulitis in broiler chickens. Avian Diseases 41, pp 422-428. 
Norton, R.A., Macklin, K.S. and McMurtrey, B.L., 2000. The association of various isolates of 
Escherichia coli from the United States with induced cellulitis and colibacillosis in young 
broiler chickens. Avian Pathology 29, pp 571-574. 
Novick, R.P., 1987. Plasmid incompatibility. Microbiological Reviews 51, pp 381-395. 
O'Hara, A.M. and Shanahan, F., 2006. The gut flora as a forgotten organ. EMBO Reports 7, pp 688-
693. 
Obeng, A.S., Rickard, H., Ndi, O., Sexton, M. and Barton, M., 2012. Antibiotic resistance, 
phylogenetic grouping and virulence potential of Escherichia coli isolated from the faeces of 
intensively farmed and free range poultry. Veterinary Microbiology 154, pp 305-315. 
 Page | 239  
 
Obeng, A.S., Rickard, H., Ndi, O., Sexton, M. and Barton, M., 2014. Prevalence of antimicrobial 
resistance in Enterococci and Escherichia coli in meat chicken flocks during a production 
cycle and egg layer pullets during rearing. International Journal of Poultry Science 13, pp 489-
503. 
Oh J.Y., Kwon Y.K., Tamang M.D., Jang H.K., Jeong O.M., Lee H.S., Kang M.S. , 2016. Plasmid-
mediated quinolone resistance in Escherichia coli isolates from wild birds and chickens in 
South Korea. Microbial Drug Resistance 22, pp 69-79. 
Oh, J.Y., Kang, J.M., Song, E.A., Kim, J.Y., Shin, E.G., Kim, M.J., Kwon, J.H. and Kwon, Y.K., 
2011. Characterization of Escherichia coli isolates from laying hens with colibacillosis on 2 
commercial egg-producing farms in Korea. Poultry Science 90, pp 1948-1954. 
Ojer-Usoz, E., Gonzalez, D., Vitas, A.I., Leiva, J., Garcia-Jalon, I., Febles-Casquero, A. and Escolano 
Mde, L., 2013. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae 
in meat products sold in Navarra, Spain. Meat Science 93, pp 316-321. 
Olsen, A., Jonsson, A. and Normark, S., 1989. Fibronectin binding mediated by a novel class of 
surface organelles on Escherichia coli. Nature 338, pp 652-655. 
Olsen, R.H., Christensen, H. and Bisgaard, M., 2012. Comparative genomics of multiple plasmids 
from APEC associated with clonal outbreaks demonstrates major similarities and identifies 
several potential vaccine-targets. Veterinary Microbiology 158, pp 384-393. 
Orskov, F. and Orskov, I., 1992. Escherichia coli serotyping and disease in man and animals. 
Canadian Journal of Microbiology 38, pp 699-704. 
Osinska, A., Harnisz, M. and Korzeniewska, E., 2016. Prevalence of plasmid-mediated multidrug 
resistance determinants in fluoroquinolone-resistant bacteria isolated from sewage and 
surface water. Environmental Science and Pollution Research International  23, pp 10818-
10831. 
Oulas, A., Pavloudi, C., Polymenakou, P., Pavlopoulos, G.A., Papanikolaou, N., Kotoulas, G., 
Arvanitidis, C. and Iliopoulos, I., 2015. Metagenomics: tools and insights for analyzing next-
generation sequencing data derived from biodiversity studies. Bioinformatics and Biology 
Insights 9, pp 75-88. 
 Page | 240  
 
Oves-Costales, D., Kadi, N. and Challis, G.L., 2009. The long-overlooked enzymology of a 
nonribosomal peptide synthetase-independent pathway for virulence-conferring siderophore 
biosynthesis. Chem Commun 21, pp 6530-6541. 
Oz, T., Guvenek, A., Yildiz, S., Karaboga, E., Tamer, Y.T., Mumcuyan, N., Ozan, V.B., Senturk, 
G.H., Cokol, M., Yeh, P. and Toprak, E., 2014. Strength of selection pressure is an important 
parameter contributing to the complexity of antibiotic resistance evolution. Molecular 
Biology and Evolution 31, pp 2387-2401. 
Ozawa, M., Harada, K., Kojima, A., Asai, T. and Sameshima, T., 2008. Antimicrobial susceptibilities, 
serogroups, and molecular characterization of avian pathogenic Escherichia coli isolates in 
Japan. Avian Diseases 52, pp 392-397. 
Pacholewicz, E., Liakopoulos, A., Swart, A., Gortemaker, B., Dierikx, C., Havelaar, A. and Schmitt, 
H., 2015. Reduction of extended-spectrum-β-lactamase- and AmpC-β-lactamase-producing 
Escherichia coli through processing in two broiler chicken slaughterhouses. International 
Journal of Food Microbiology 215, pp 57-63. 
Packey, C.D. and Sartor, R.B., 2009. Commensal bacteria, traditional and opportunistic pathogens, 
dysbiosis and bacterial killing in inflammatory bowel diseases. Current Opinion in Infectious 
Diseases 22, pp 292-301. 
Paixao, A.C., Ferreira, A.C., Fontes, M., Themudo, P., Albuquerque, T., Soares, M.C., Fevereiro, M., 
Martins, L. and Correa de Sa, M.I., 2016. Detection of virulence-associated genes in 
pathogenic and commensal avian Escherichia coli isolates. Poultry Science 95, pp 1646–
1652. 
Pallen, M. J. (2016). Microbial bioinformatics 2020. Microbial Biotechnology. 9, pp. 681–  
686. 
Pan, D. and Yu, Z., 2014. Intestinal microbiome of poultry and its interaction with host and diet. Gut 
Microbes 5, pp 108-119. 
Pandey, P.K., Kass, P.H., Soupir, M.L., Biswas, S. and Singh, V.P., 2014. Contamination of water 
resources by pathogenic bacteria. AMB Express 4, pp 51-12. 
Parreira, V.R., Arns, C.W. and Yano, T., 1998. Virulence factors of avian Escherichia coli associated 
with swollen head syndrome. Avian Patholgy 27, pp 148-154. 
 Page | 241  
 
Parreira, V.R. and Gyles, C.L., 2003. A novel pathogenicity island integrated adjacent to the thrW 
tRNA gene of avian pathogenic Escherichia coli encodes a vacuolating autotransporter toxin. 
Infection and Immunity 71, pp 5087-5096. 
Partridge, S.R., 2011. Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS 
Microbiology Reviews 35, pp 820-855. 
Pelludat, C., Rakin, A., Jacobi, C.A., Schubert, S. and Heesemann, J., 1998. The yersiniabactin 
biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent 
regulation. Journal of Bacteriology 180, pp 538-546. 
Penz, A. and Bruno, D. 2011. Challenges facing the global poultry industry until 2020. In: 
Proceedings of 22nd Annual Australian Poultry Science Symposium, Sydney, New South 
Wales. pp 49-55. 
Perez-Perez, F.J. and Hanson, N.D., 2002. Detection of plasmid-mediated AmpC β-lactamase genes 
in clinical isolates by using multiplex PCR. Journal of Clinical Microbiology 40, pp 2153-
2162. 
Perry, J.A., Westman, E.L. and Wright, G.D., 2014. The antibiotic resistome: what's new? Current 
Opinion in Microbiology 21, pp 45-50. 
Pfaff-McDonough, S.J., Horne, S.M., Giddings, C.W., Ebert, J.O., Doetkott, C., Smith, M.H. and 
Nolan, L.K., 2000. Complement resistance-related traits among Escherichia coli isolates from 
apparently healthy birds and birds with colibacillosis. Avian Diseases 44, pp 23-33. 
Philippon, A., Arlet, G. and Jacoby, G.A., 2002. Plasmid-determined AmpC-type β-lactamases. 
Antimicrobial Agents and Chemotherapy 46, pp 1-11. 
Pires-dos-Santos, T., Bisgaard, M. and Christensen, H., 2013. Genetic diversity and virulence profiles 
of Escherichia coli causing salpingitis and peritonitis in broiler breeders. Veterinary 
Microbiology 162, pp 873-880. 
Pitout, J.D., 2012. Extraintestinal pathogenic Escherichia coli: a combination of virulence with 
antibiotic resistance. Frontiers in Microbiology 3, pp 1-9. 
Platell, J.L., Cobbold, R.N., Johnson, J.R., Heisig, A., Heisig, P., Clabots, C., Kuskowski, M.A. and 
Trott, D.J., 2011. Commonality among fluoroquinolone-resistant sequence type ST131 
extraintestinal Escherichia coli isolates from humans and companion animals in Australia. 
Antimicrobial Agents and Chemotherapy 55, pp 3782-3787. 
 Page | 242  
 
Poole, K., 2000. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. 
Antimicrob Agents and Chemotherapy 44, pp 2233-2241. 
Pourbakhsh, S.A., Dho-Moulin, M., Brée, A., Desaultels, C., Doize, B.M. and Fairbrother, J.M., 
1997. Localization of the in vivo expression of P and F1 fimbriae in chickens experimentally 
inoculated with pathogenic Escherichia coli. Microbial Pathology 22, pp 331-341. 
Prescott, J.F., 2013. Sulfonamides, diaminopyrimidines and their combinations. In: Giguère, S., 
Prescott, J.F., Dowling, P.M. (Eds.) Antimicrobial Therapy in Veterinary Medicine. John 
Wiley and Sons, Inc, Hoboken, New Jersey, USA, pp 279-294. 
Provence, D.L. and Curtiss, R., 1994. Isolation and characterization of a gene involved in 
hemagglutination by an avian pathogenic Escherichia coli strain. Infection and Immunity 62, 
pp 1369-1380. 
Qabajah, M., Awwad, E. and Ashhab, Y., 2014. Molecular characterisation of Escherichia coli from 
dead broiler chickens with signs of colibacillosis and ready-to-market chicken meat in the 
West Bank. British Poultry Science 55, pp 442-451. 
Quinn, P.J., Markey, B.K., Bryan, K., Leonard, F.C., Fitz-Patrick, E.S., Fanning, S. and Hartigan, 
P.J., 2011. Veterinary Microbiology and Microbial Disease. Wiley-Blackwell, Chichester, 
UK.  
Radhouani, H., Silva, N., Poeta, P., Torres, C., Correia, S. and Igrejas, G., 2014. Potential impact of 
antimicrobial resistance in wildlife, environment and human health. Frontiers in Microbiology 
5, pp 1-23. 
Ramirez, R.M., Almanza, Y., Gonzalez, R., Garcia, S. and Heredia, N., 2009. Avian pathogenic 
Escherichia coli bind fibronectin and laminin. Veterinary Research Communications 33, pp 
379-386. 
Ranjbar, R., Tabatabaee, A., Behzadi, P. and Kheiri, R., 2017. Enterobacterial repetitive intergenic 
consensus polymerase chain reaction (ERIC-PCR) genotyping of Escherichia coli strains 
isolated from different animal stool specimens. Iranian Journal of Pathology 12, pp 25-34. 
Rankin, D.J., Rocha, E.P. and Brown, S.P., 2011. What traits are carried on mobile genetic elements, 
and why? Heredity 106, pp 1-10. 
Rao, J.N.K. and Cott, A.J.S., 1984. On chi-squared tests for multiway contingency tables with cell 
proportions estimated from survey data. Annals of Statistics 12, pp 46–60. 
 Page | 243  
 
Rao, J.N.K. and Scott, A.J., 1981. The analysis of categorical data from complex surveys: chi-squared 
tests for goodness of fit and independence in two-way tables. Journal of the American 
Statistical Association 76, pp 221-230. 
Rapp, D., 2010. DNA extraction from bovine faeces: current status and future trends. Journal of 
Applied Microbiology 108, pp 1485-1493. 
Rashid, M.H., Xue, C., Islam, M.R., Islam, M.T. and Cao, Y., 2013. A longitudinal study on the 
incidence of mortality of infectious diseases of commercial layer birds in Bangladesh. 
Preventive Veterinary Medicine 109, pp 354-358. 
Rasmussen, M.M., Opintan, J.A., Frimodt-Moller, N. and Styrishave, B., 2015. β-lactamase 
producing Escherichia coli isolates in imported and locally produced chicken meat from 
Ghana. PLoS One 10, pp e0139706. 
Ratledge, C. and Dover, L.G., 2000. Iron metabolism in pathogenic bacteria. Annual Review of 
Microbiology 54, pp 881-941. 
Rayamajhi, N., Jung, B.Y., Cha, S.B., Shin, M.K., Kim, A., Kang, M.S., Lee, K.M. and Yoo, H.S., 
2010. Antibiotic resistance patterns and detection of blaDHA-1 in Salmonella species isolates 
from chicken farms in South Korea. Applied and Environmental Microbiology 76, pp 4760-
4764. 
Rayamajhi, N., Kang, S.G., Lee, D.Y., Kang, M.L., Lee, S.I., Park, K.Y., Lee, H.S. and Yoo, H.S., 
2008. Characterization of TEM-, SHV- and AmpC-type β-lactamases from cephalosporin-
resistant Enterobacteriaceae isolated from swine. International Journal of Food Microbiology 
124, pp 183-187. 
Raymond, K.N., Dertz, E.A. and Kim, S.S., 2003. Enterobactin: an archetype for microbial iron 
transport. Proceedings of the National Academy of Sciences of the United States of America  
100, pp 3584-3588. 
Reid, S.D., Herbelin, C.J., Bumbaugh, A.C., Selander, R.K. and Whittam, T.S., 2000. Parallel 
evolution of virulence in pathogenic Escherichia coli. Nature 406, pp 64-67. 
Roberts, M.C., 2012. Acquired tetracycline resistance genes. In: Dougherty, T.J., Pucci, M.J. (Eds.) 
Antibiotic Discovery and Development. Springer, US, Boston, pp 543-568. 
Robicsek, A., Jacoby, G.A. and Hooper, D.C., 2006a. The worldwide emergence of plasmid-mediated 
quinolone resistance. The Lancet. Infectious Diseases 6, pp 629-640. 
 Page | 244  
 
Robicsek, A., Strahilevitz, J., Jacoby, G.A., Macielag, M., Abbanat, D., Park, C.H., Bush, K. and 
Hooper, D.C., 2006b. Fluoroquinolone-modifying enzyme: a new adaptation of a common 
aminoglycoside acetyltransferase. Nature Medicine 12, pp 83-88. 
Rocha, A.C.G.P., Rocha, S.L.S., Lima-Rosa, C.A.V., Souza, G.F., Moraes, H.L.S., Salle, F.O., 
Moraes, L.B. and Salle, C.T.P., 2008. Genes associated with pathogenicity of avian 
Escherichia coli (APEC) isolated from respiratory cases of poultry. Pesquisa Veterinaria 
Brasileira 28, pp 183-186. 
Rodrigues, C., Machado, E., Peixe, L. and Novais, A., 2013. IncI1/ST3 and IncN/ST1 plasmids drive 
the spread of blaTEM-52 and blaCTX-M-1/-32 in diverse Escherichia coli clones from different 
piggeries. The Journal of Antimicrobial Chemotherapy 68, pp 2245-2248. 
Rodriguez-Martinez, J.M., Velasco, C., Pascual, A., Garcia, I. and Martinez-Martinez, L., 2006. 
Correlation of quinolone resistance levels and differences in basal and quinolone-induced 
expression from three qnrA-containing plasmids. Clinical Microbiology and Infection 12, pp 
440-445. 
Rodriguez-Rojas, A., Rodriguez-Beltran, J., Couce, A. and Blazquez, J., 2013. Antibiotics and 
antibiotic resistance: A bitter fight against evolution. International Journal of Medical 
Microbiology 303, pp 293-297. 
Rodriguez-Siek, K.E., Giddings, C.W., Doetkott, C., Johnson, T.J. and Nolan, L.K., 2005a. 
Characterizing the APEC pathotype. Veterinary Research 36, pp 241-256. 
Rogers, B.A., Ingram, P.R., Runnegar, N., Pitman, M.C., Freeman, J.T., Athan, E., Havers, S.M., 
Sidjabat, H.E., Jones, M., Gunning, E., De Almeida, M., Styles, K. and Paterson, D.L., 2014. 
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins 
in low-prevalence countries. Antimicrobial Agents and Chemotheropy 58, pp 2126-2134. 
Rouault, T.A. and Tong, W.H., 2008. Iron-sulfur cluster biogenesis and human disease. Trends in 
Genetics 24, pp 398-407. 
Ruiz, J., 2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation 
and DNA gyrase protection. The Journal of Antimicrobial Chemotherapy 51, pp 1109-1117. 
Ruiz, J., Pons, M.J. and Gomes, C., 2012. Transferable mechanisms of quinolone resistance. 
International Journal of Antimicrobial Agents 40, pp 196-203. 
 Page | 245  
 
Russo, T.A. and Johnson, J.R., 2000. Proposal for a new inclusive designation for extraintestinal 
pathogenic isolates of Escherichia coli: ExPEC. Journal of Infectious Diseases 181, pp 1753-
1754. 
Russo, T.A. and Johnson, J.R., 2003. Medical and economic impact of extraintestinal infections due 
to Escherichia coli: focus on an increasingly important endemic problem. Microbes and 
Infection 5, pp 449-456. 
Russo, T.A. and Johnson, J.R., 2009. Extraintestinal Pathogenic Escherichia coli. In: Barret, A.D.T., 
Stanberry, L.R. (Eds.) Vaccines for Biodefence and Emerging and Neclected Diseases 
Elsevier Ltd., London, pp 939-961. 
Sabate, M., Prats, G., Moreno, E., Balleste, E., Blanch, A.R. and Andreu, A., 2008. Virulence and 
antimicrobial resistance profiles among Escherichia coli strains isolated from human and 
animal wastewater. Research in Microbiology 159, pp 288-293. 
Sabri, M., Caza, M., Proulx, J., Lymberopoulos, M.H., Bree, A., Moulin-Schouleur, M., Curtiss, R. 
and Dozois, C.M., 2008. Contribution of the SitABCD, MntH, and FeoB metal transporters 
to the virulence of avian pathogenic Escherichia coli O78 strain χ7122. Infection and 
Immunity 76, pp 601-611. 
Sabri, M., Leveille, S. and Dozois, C.M., 2006. A SitABCD homologue from an avian pathogenic 
Escherichia coli strain mediates transport of iron and manganese and resistance to hydrogen 
peroxide. Microbiology 152, pp 745-758. 
Saenz, Y., Zarazaga, M., Brinas, L., Lantero, M., Ruiz-Larrea, F. and Torres, C., 2001. Antibiotic 
resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain. 
International Journal of Antimicrobial Agents 18, pp 353-358. 
Sahl, J.W., Matalka, M.N. and Rasko, D.A., 2012. Phylomark, a tool to identify conserved 
phylogenetic markers from whole-genome alignments. Applied and Environmental 
Microbiology 78, pp 4884-4892. 
Saidy, L.N., Mohamed, R.A. and Abouelenien, F., 2015. Assessment of variable drinking water 
sources used in Egypt on broiler health and welfare. Veterinary World 8, pp 855-864. 
Sakamoto, K., Hayashi, A., Sakamoto, A., Kiga, D., Nakayama, H., Soma, A., Kobayashi, T., 
Kitabatake, M., Takio, K., Saito, K., Shirouzu, M., Hirao, I. and Yokoyama, S., 2002. Site-
 Page | 246  
 
specific incorporation of an unnatural amino acid into proteins in mammalian cells. Nucleic 
Acids Research 30, pp 4692-4699. 
Sams, R. 1994. Florfenicol: chemistry and metabolism of a novel broad spectrum antibiotic. In: 
Proceedings of the XVIII World Buiatrics Congress, Bologna, Italy, 13-17. 
Santos, M.M., Alcântara, A.C., Perecmanis, S., Campos, A. and Santana, A.P., 2014. Antimicrobial 
resistance of bacterial strains isolated from avian cellulitis. Revista Brasileira de Ciência 
Avícola 16, pp 13-18. 
Sawma-Aouad, G., Hashwa, F. and Tokajian, S., 2009. Antimicrobial resistance in relation to 
virulence determinants and phylogenetic background among uropathogenic Escherichia coli 
in Lebanon. Journal of Chemotherapy 21, pp 153-158. 
Scanes, C.G., 2007. The global importance of poultry. Poultry Science 86, pp 1057-1058. 
Schaufler, K., Bethe, A., Lubke-Becker, A., Ewers, C., Kohn, B., Wieler, L.H. and Guenther, S., 
2015. Putative connection between zoonotic multiresistant extended-spectrum beta-lactamase 
(ESBL)-producing Escherichia coli in dog feces from a veterinary campus and clinical 
isolates from dogs. Infection Ecology and Epidemiology 5, pp 25334-25344. 
Scheutz, F., Cheasty, T., Woodward, D. and Smith, H.R., 2004. Designation of O174 and O175 to 
temporary O groups OX3 and OX7, and six new E. coli O groups that include Verocytotoxin-
producing E. coli (VTEC): O176, O177, O178, O179, O180 and O181. Acta Pathologica, 
Microbiologica and Immunologica Scandinavica 112, pp 569-584. 
Schouler, C., Schaeffer, B., Bree, A., Mora, A., Dahbi, G., Biet, F., Oswald, E., Mainil, J., Blanco, J. 
and Moulin-Schouleur, M., 2012. Diagnostic strategy for identifying avian pathogenic 
Escherichia coli based on four patterns of virulence genes. Journal of Clinical Microbiology 
50, pp 1673-1678. 
Schubert, S., Rakin, A., Karch, H., Carniel, E. and Heesemann, J., 1998. Prevalence of the "high-
pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic 
to humans. Infection and Immunity 66, pp 480-485. 
Schultsz, C. and Geerlings, S., 2012. Plasmid-mediated resistance in Enterobacteriaceae: changing 
landscape and implications for therapy. Drugs 72, pp 1-16. 
 Page | 247  
 
Schwaber, M.J., Navon-Venezia, S., Schwartz, D. and Carmeli, Y., 2005. High levels of antimicrobial 
coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. 
Antimicrobial Agents and Chemotherapy 49, pp 2137-2139. 
Schwarz, S. and Chaslus-Dancla, E., 2001. Use of antimicrobials in veterinary medicine and 
mechanisms of resistance. Veterinary Research 32, pp 201-225. 
Schwarz, S., Kehrenberg, C., Doublet, B. and Cloeckaert, A., 2004. Molecular basis of bacterial 
resistance to chloramphenicol and florfenicol. FEMS Microbiology Reviews  28, pp 519-542. 
Searle, L.J., Meric, G., Porcelli, I., Sheppard, S.K. and Lucchini, S., 2015. Variation in siderophore 
biosynthetic gene distribution and production across environmental and faecal populations of  
Escherichia coli. PLoS One 10, pp e0117906. 
Seiffert, S.N., Hilty, M., Perreten, V. and Endimiani, A., 2013. Extended-spectrum cephalosporin-
resistant Gram-negative organisms in livestock: An emerging problem for human health? 
Drug Resistance Updates 16, pp 22-45. 
Sello, J.K., 2012. Mining the antibiotic resistome. Chemistry and Biology 19, pp 1220-1221. 
Seni, J., Falgenhauer, L., Simeo, N., Mirambo, M.M., Imirzalioglu, C., Matee, M., Rweyemamu, M., 
Chakraborty, T. and Mshana, S.E., 2016. Multiple ESBL-producing Escherichia coli 
sequence types carrying quinolone and aminoglycoside resistance genes circulating in 
companion and domestic farm animals in Mwanza, Tanzania, harbor commonly occurring 
plasmids. Frontiers in Microbiology 7, pp 142-148. 
Šeol, B., Matanović, K., Mekić, S. and Starešina, V., 2011. In vitro activity of cefovecin, extended-
spectrum cephalosporin, against 284 clinical isolates collected from cats and dogs in Croatia. 
Veterinarski Arhiv 81, pp 91-97. 
Servin, A.L., 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clinical 
Microbiology Reviews 18, pp 264-292. 
Shaban, R.Z., Simon, G.I., Trott, D.J., Turnidge, J. and Jordan, D., 2014. Surveillance and reporting 
of antimicrobial resistance and antibiotic usage in animals and agriculture in Australia, Report 
to the Department of Agriculture, Griffith University, and University of Adelaide, Australia. 
Department of Agriculture, Canberra, Australia, [Available from 
http://www.agriculture.gov.au/SiteCollectionDocuments/animal-plant/animal-
health/amria.pdf]; Accessed March 2015. 
 Page | 248  
 
Shah, A.A., Hasan, F., Ahmed, S. and Hameed, A., 2004. Characteristics, epidemiology and clinical 
importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-
lactamases. Research in Microbiology 155, pp 409-421. 
Sharma, S., Kaur, N., Malhotra, S., Madan, P., Ahmad, W. and Hans, C., 2016. Serotyping and 
antimicrobial susceptibility pattern of Escherichia coli isolates from urinary tract infections 
in pediatric population in a tertiary care hospital. Journal of Pathogens  2016, pp 4-10. 
Sharples, G.J. and Lloyd, R.G., 1990. A novel repeated sequence located in the intergenic regions of 
bacterial chromosomes. Nucleic Acids Resarch 18, pp 6503-6508. 
Sheikholvaezin, A., Blomberg, F., Öhrmalm, C., Sjösten, A., Blomberg, J., 2011. Rational 
recombinant XMRV antigen preparation and bead coupling for multiplex serology in a 
suspension array. Protein Expression and Purification 80, pp 176-184. 
Shen, L., Kohlbrenner, W., Weigl, D. and Baranowski, J., 1989. Mechanism of quinolone inhibition 
of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme- DNA complexes. 
Journal of Biological Chemistry 264, pp 2973-2978. 
Shobrak, M.Y. and Abo-Amer, A.E., 2014. Role of wild birds as carriers of multi-drug resistant 
Escherichia coli and Escherichia vulneris. Brazilian Journal of Microbiology 45, pp 1199-
1209. 
Sidjabat, H.E., Hanson, N.D., Smith-Moland, E., Bell, J.M., Gibson, J.S., Filippich, L.J. and Trott, 
D.J., 2007. Identification of plasmid-mediated extended-spectrum and AmpC β-lactamases in 
Enterobacter spp. isolated from dogs. Journal of Medical Microbiology 56, pp 426-434. 
Sjolund, M., Bonnedahl, J., Hernandez, J., Bengtsson, S., Cederbrant, G., Pinhassi, J., Kahlmeter, G. 
and Olsen, B., 2008. Dissemination of multidrug-resistant bacteria into the Arctic. Emerging 
Infectious Diseases 14, pp 70-72. 
Sköld, O., 2010. Sulfonamides and trimethoprim. Expert Review of Anti-infective Therapy 8, pp 1-
6. 
Skov, T., Deddens, J., Petersen, M. and Endahl, L., 1998. Prevalence proportion ratios: estimation 
and hypothesis testing. International Journal of Epidemiology 27, pp 91-95. 
Skyberg, J.A., Horne, S.M., Giddings, C.W., Wooley, R.E., Gibbs, P.S. and Nolan, L.K., 2003. 
Characterizing avian Escherichia coli isolates with multiplex polymerase chain reaction. 
Avian Diseases 47, pp 1441-1448. 
 Page | 249  
 
Skyberg, J.A., Johnson, T.J., Johnson, J.R., Clabots, C., Logue, C.A. and Nolan, L.K., 2006. 
Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate 
enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine 
kidney. Infection and Immunity 74, pp 6287-6292. 
Skyberg, J.A., Johnson, T.J. and Nolan, L.K., 2008. Mutational and transcriptional analyses of an 
avian pathogenic Escherichia coli CoIV plasmid. Microbiology 8, pp 10-18. 
Smith, S.G., Wang, J., Fanning, S. and McMahon, B.J., 2014. Antimicrobial resistant bacteria in wild 
mammals and birds: a coincidence or cause for concern? Irish Veterinary Journal  67, pp 8-14. 
Sola-Gines, M., Cameron-Veas, K., Badiola, I., Dolz, R., Majo, N., Dahbi, G., Viso, S., Mora, A., 
Blanco, J., Piedra-Carrasco, N., Gonzalez-Lopez, J.J. and Migura-Garcia, L., 2015. Diversity 
of multi-drug resistant avian pathogenic Escherichia coli (APEC) causing outbreaks of 
colibacillosis in broilers during 2012 in Spain. PLoS One 10, pp e0143191. 
Sorsa, L.J., Dufke, S., Heesemann, J. and Schubert, S., 2003. Characterization of an iroBCDEN gene 
cluster on a transmissible plasmid of uropathogenic Escherichia coli: evidence for horizontal 
transfer of a chromosomal virulence factor. Infection and Immunity 71, pp 3285-3293. 
Sosa, A.D.J., 2009. Antimicrobial Resistance in Developing Countries. In: Aníbal, D.J., SosaDenis, 
K., Bya rugaba, C.F., Amábile, C., Po-Ren, H., Samuel, K., Iruka, N.O. (Eds.) Springer New 
York, NY, USA. 
Stacy, A.K., Mitchell, N.M., Maddux, J.T., De la Cruz, M.A., Duran, L., Giron, J.A., Curtiss, R., 3 rd 
and Mellata, M., 2014. Evaluation of the prevalence and production of Escherichia coli 
common pilus among avian pathogenic E. coli and its role in virulence. PLoS One 9, pp 
e86565. 
Stathopoulos, C., Provence, D.L. and Curtiss, R., 3rd, 1999. Characterization of the avian pathogenic 
Escherichia coli hemagglutinin Tsh, a member of the immunoglobulin A protease-type family 
of autotransporters. Infection and Immunity 67, pp 772-781. 
Stedt, J., Bonnedahl, J., Hernandez, J., McMahon, B.J., Hasan, B., Olsen, B., Drobni, M. and 
Waldenstrom, J., 2014. Antibiotic resistance patterns in Escherichia coli from gulls in nine 
European countries. Infection Ecology and Epidemiology 4, pp 10-20. 
 Page | 250  
 
Stehling, E.G., Yano, T., Brocchi, M. and da Silveira, W.D., 2003. Characterization of a plasmid-
encoded adhesin of an avian pathogenic Escherichia coli (APEC) strain isolated from a case 
of swollen head syndrome (SHS). Veterinary Microbiology 95, pp 111-120. 
Stokholm, N., Permin, A., Bisgaard, M. and Christensen, J., 2010. Causes of mortality in commercial 
organic layers in Denmark. Avian Diseases 54, pp 1241-1250. 
Stordeur, P., Brée, A.M., J. and Moulin-Schouleur, M., 2004. Pathogenicity of pap-negative avian 
Escherichia coli isolated from septicaemic lesions. Microbes Infection 6, pp 637-645. 
Stordeur, P. and Mainil, J., 2002. Colibacillosis in poultry. Annales De Medecine Veterinaire  146, pp 
11-18. 
Svara, F. and Rankin, D.J., 2011. The evolution of plasmid-carried antibiotic resistance. BMC 
Evolutionary Biology 11, pp 130-120. 
Swedish Veterinary Antimicrobial Resistance Monitoring (SVARM), 2007. [Available from 
http://www.sva.se/upload/pdf/Tj%C3%A4nster%20och%20produkter/Trycksaker/svarm200
6.pdf]; Accessed August 2016. 
Szmolka, A., Fortini, D., Villa, L., Carattoli, A., Anjum, M.F. and Nagy, B., 2011. First report on 
IncN plasmid-mediated quinolone resistance gene qnrS1 in porcine Escherichia coli in 
Europe. Microbial Drug Resistance 17, pp 567-573. 
Szmolka, A., Lestar, B., Paszti, J., Fekete, P. and Nagy, B., 2015. Conjugative IncF and IncI1 
plasmids with tet(A) and class 1 integron conferring multidrug resistance in F18(+) porcine 
enterotoxigenic E. coli. Acta Veterinaria Hungarica 63, pp 425-443. 
Szmolka, A. and Nagy, B., 2013. Multidrug resistant commensal Escherichia coli in animals and its 
impact for public health. Frontiers in Microbiology 4, pp 258-256. 
Tadesse, D.A., Zhao, S., Tong, E., Ayers, S., Singh, A., Bartholomew, M.J. and McDermott, P.F., 
2012. Antimicrobial drug resistance in Escherichia coli from humans and food animals, 
United States, 1950-2002. Emerging Infectious Diseases 18, pp 741-749. 
Tagg, K.A., Ginn, A.N., Jiang, X., Ellem, J., Partridge, S.R. and Iredell, J.R., 2015. Distribution of 
acquired AmpC β-lactamase genes in Sydney, Australia. Diagnostic Microbiology and 
Infectious Disease 83, pp 56-58. 
 Page | 251  
 
Talebiyan, R., Kheradmand, M., Khamesipour, F. and Rabiee-Faradonbeh, M., 2014. Multiple 
antimicrobial resistance of Escherichia coli isolated from chickens in Iran. Veterinary 
Medicine International 20, pp 1-4. 
Taneja, N., Singh, G., Singh, M., Madhup, S., Pahil, S. and Sharma, M., 2012. High occurrence of 
blaCMY-1 AmpC lactamase producing Escherichia coli in cases of complicated urinary tract 
infection (UTI) from a tertiary health care centre in North India. The Indian Journal of Medical 
Research 136, pp 289-291. 
Tchesnokova, V., Billig, M., Chattopadhyay, S., Linardopoulou, E., Aprikian, P., Roberts, P.L., 
Skrivankova, V., Johnston, B., Gileva, A., Igusheva, I., Toland, A., Riddell, K., Rogers, P., 
Qin, X., Butler-Wu, S., Cookson, B.T., Fang, F.C., Kahl, B., Price, L.B., Weissman, S.J., 
Limaye, A., Scholes, D., Johnson, J.R. and Sokurenko, E.V., 2013. Predictive diagnostics for 
Escherichia coli infections based on the clonal association of antimicrobial resistance and 
clinical outcome. Journal of Clinical Microbiology 51, pp 2991-2999. 
Thaker, M., Spanogiannopoulos, P. and Wright, G.D., 2010. The tetracycline resistome. Cellular and 
Molecular Life Sciences 67, pp 419-431. 
The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP), 
2014. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from 
food animals, food and humans in Denmark, [Available from www.danmap.org/]; Accessed 
February 2016. 
Thomas, C.M. and Nielsen, K.M., 2005. Mechanisms of, and barriers to, horizontal gene transfer 
between bacteria. Nature Reviews Microbiology 3, pp 711-721. 
Thomas, M. S., & Wigneshweraraj, S. (2014). Regulation of virulence gene expression. Virulence, 
5(8), 832–834. 
Thornton, P.K., 2010. Livestock production: recent trends, future prospects. Philosophical 
Transactions of the Royal Society of London, Series B, Biological Sciences 365, pp 2853-
2867. 
Tivendale, K.A., Allen, J.L. and Browning, G.F., 2009. Plasmid-borne virulence-associated genes 
have a conserved organization in virulent strains of avian pathogenic Escherichia coli. Journal 
of Clinical Microbiology 47, pp 2513-2519. 
 Page | 252  
 
Tivendale, K.A., Allen, J.L., Ginns, C.A., Crabb, B.S. and Browning, G.F., 2004. Association of iss 
and iucA but not tsh, with plasmid-mediated virulence of avian pathogenic Escherichia coli. 
Infection and Immunity 72, pp 6554-6560. 
Tivendale, K.A., Logue, C.M., Kariyawasam, S., Jordan, D., Hussein, A., Li, G.W., Wannemuehler, 
Y. and Nolan, L.K., 2010. Avian-pathogenic Escherichia coli strains are similar to neonatal 
meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. 
Infection and Immunity 78, pp 3412-3419. 
Toma, C., Espinosa, E.M., Song, T.Y., Miliwebsky, E., Chinen, I., Iyoda, S., Iwanaga, M. and Rivas, 
M., 2004. Distribution of putative adhesins in different seropathotypes of Shiga toxin-
producing Escherichia coli. Journal of Clinical Microbiology 42, pp 4937-4946. 
Toth, I., Herault, F., Beutin, L. and Oswald, E., 2003. Production of cytolethal distending toxins by 
pathogenic Escherichia coli strains isolated from human and animal sources: establishment 
of the existence of a new cdt variant (Type IV). Journal of Clinical Microbiology 41, pp 4285-
4291. 
Trott, D., 2013. β-lactam resistance in Gram-negative pathogens isolated from animals. Applied and 
Environmental Microbiology 19, pp 239-249. 
Twisk, J.W.R., 2013. Applied Longitudinal Data Analysis for Epidemiology: a Practical Guide. 
Department of Epidemiology and Biostatistics, Medical Centre and the Department of Health 
Sciences of the Vrije Universteit, Cambridge University Press, Amsterdam. 
Ugorski, M. and Chmielewski, R., 2000. REP and ERIC repetitive DNA sequences in bacteria-
diagnostic significance. Postepy Higieny Medycyny Doswiadczalnej 54, pp 3-15. 
Valvano, M.A. and Crosa, J.H., 1988. Molecular cloning, expression, and regulation in Escherichia 
coli K-12 of a chromosome-mediated aerobactin iron transport system from a human invasive 
isolate of E. coli K1. Journal of Bacteriology 170, pp 5529-5538. 
Van Bambeke, F., Michot, J.M., Van Eldere, J. and Tulkens, P.M., 2005. Quinolones in 2005: an 
update. Clinical Microbiology and Infection 11, pp 256-280. 
van den Bogaard, A.E., London, N., Driessen, C. and Stobberingh, E.E., 2001. Antibiotic resistance 
of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers. Journal of 
Antimicrobial Chemotherapy 47, pp 763-771. 
 Page | 253  
 
van Essen-Zandbergen, A., Smith, H., Veldman, K. and Mevius, D., 2007. Occurrence and 
characteristics of class 1, 2 and 3 integrons in Escherichia coli, Salmonella and 
Campylobacter spp. in the Netherlands. Journal of Antimicrobial Chemotherapy 59, pp 746-
750. 
Vandekerchove, D., De Herdt, P., Laevens, H. and Pasmans, F., 2004a. Risk factors associated with 
colibacillosis outbreaks in caged layer flocks. Avian Pathology 33, pp 337-342. 
Vandekerchove, D., Herdt, P.D., Laevens, H., Butaye, P., Meulemans, G. and Pasmans, F., 2004b. 
Significance of interactions between Escherichia coli and respiratory pathogens in layer hen 
flocks suffering from colibacillosis-associated mortality. Avian Pathology 33, pp 298-302. 
Vandekerchove, D., Vandemaele, F., Adriaensen, C., Zaleska, A., Hernalsteens, J.P., De Baets, L., 
Butaye, P., Van Immerseel, F., Wattiau, P., Laevens, H., Mast, J., Goddeeris, B. and Pasmans, 
F., 2005. Virulence-associated traits in avian Escherichia coli: Comparison between isolates 
from colibacillosis-affected and clinically healthy layer flocks. Veterinary Microbiology 108, 
pp 75-87. 
Vandeplas, S., Dubois Dauphin, R., Beckers, Y., Thonart, P. and Thewis, A., 2010. Salmonella in 
chicken: current and developing strategies to reduce contamination at farm level. Journal of 
Food Protection 73, pp 774-785. 
Vangchhia, B., Abraham, S., Bell, J.M., Collignon, P., Gibson, J.S., Ingram, P.R., Johnson, J.R., 
Kennedy, K., Trott, D.J., Turnidge, J.D. and Gordon, D.M., 2016. Phylogenetic diversity, 
antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in 
Australia. Microbiology 162, pp 1904-1912. 
Velhner, M. and Milanov, D., 2015. Resistance to tetracycline in Escherichia coli and Staphylococcus 
aureus: brief overview on mechanisms of resistance and epidemiology. Archives of 
Veterinary Medicine 8, pp 27-36. 
Verraes, C., Van Boxstael, S., Van Meervenne, E., Van Coillie, E., Butaye, P., Catry, B., de 
Schaetzen, M.A., Van Huffel, X., Imberechts, H., Dierick, K., Daube, G., Saegerman, C., De 
Block, J., Dewulf, J. and Herman, L., 2013. Antimicrobial resistance in the food chain: a 
review. International Journal of Environmental Research and Public Health 10, pp 2643-2669. 
 Page | 254  
 
Versalovic, J., Koeuth, T. and Lupski, J.R., 1991. Distribution of repetitive DNA-sequences in 
eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Research 19, 
pp 6823-6831. 
Verweij, J.J., Blange, R.A., Templeton, K., Schinkel, J., Brienen, E.A., van Rooyen, M.A., van 
Lieshout, L. and Polderman, A.M., 2004. Simultaneous detection of Entamoeba histolytica, 
Giardia lamblia, and Cryptosporidium parvum in feacal samples by using multiplex real-time 
PCR. Journal of Clinical Microbiology 42, pp 1220-1223. 
Verweij, J.J., Ten Hove, R., Brienen, E.A. and van Lieshout, L., 2007. Multiplex detection of 
Enterocytozoon bieneusi and Encephalitozoon spp. in feacal samples using real-time PCR. 
Diagnostic Microbiology and Infectious Disease 57, pp 163-167. 
Vidotto, M.C., Gaziri, L.C.J. and Delicato, E.R., 2004. Virulence-associated genes in Escherichia 
coli isolates from poultry with colibacillosis: correction. Veterinary Microbiology 102, pp 95-
96. 
Vidotto, M.C., Muller, E.E., Defreitas, J.C., Alfieri, A.A., Guimaraes, I.G. and Santos, D.S., 1990. 
Virulence factors of avian Escherichia coli. Avian Diseases 34, pp 531-538. 
Vidotto, M.C., Navarro, H.R. and Gaziri, L.C.J., 1997. Adherence pili of pathogenic strains of avian 
Escherichia coli. Veterinary Microbiology 59, pp 79-87. 
Vieira, A.R., Collignon, P., Aarestrup, F.M., McEwen, S.A., Hendriksen, R.S., Hald, T. and Wegener, 
H.C., 2011. Association between antimicrobial resistance in Escherichia coli isolates from 
food animals and blood stream isolates from humans in Europe: an ecological study. 
Foodborne Pathogens and Disease 8, pp 1295-1301. 
Vignaroli, C., Luna, G.M., Rinaldi, C., Di Cesare, A., Danovaro, R. and Biavasco, F., 2012. New 
sequence types and multidrug resistance among pathogenic Escherichia coli isolates from 
coastal marine sediments. Applied and Environmental Microbiology 78, pp 3916-3922. 
Vila, J., Simon, K., Ruiz, J., Horcajada, J.P., Velasco, M., Barranco, M., Moreno, A. and Mensa, J., 
2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent? The Journal of 
Infectious Diseases 186, pp 1039-1042. 
Wales, A.D. and Davies, R.H., 2015. Co-selection of resistance to antibiotics, biocides and heavy 
metals, and its relevance to foodborne pathogens. Antibiotics 4, pp 567-604. 
 Page | 255  
 
Walsh, C. and Fanning, S., 2008. Antimicrobial resistance in foodborne pathogens- a cause for 
concern? Current Drug Targets 9, pp 808-815. 
Wang, H., McEntire, J.C., Zhang, L., Li, X. and Doyle, M., 2012. The transfer of antibiotic resistance 
from food to humans: facts, implications and future directions. Revue Scientifique et 
Technique 31, pp 249-260. 
Wang, J., Ma, Z.B., Zeng, Z.L., Yang, X.W., Huang, Y. and Liu, J.H., 2017. The role of wildlife 
(wild birds) in the global transmission of antimicrobial resistance genes. Zoological Research 
38, pp 55-80. 
Wang, J., Stephan, R., Karczmarczyk, M., Yan, Q., Hachler, H. and Fanning, S., 2013a. Molecular 
characterization of blaESBL-harboring conjugative plasmids identified in multidrug resistant 
Escherichia coli isolated from food-producing animals and healthy humans. Frontiers in 
Microbiology 4, pp 188-113. 
Wang, X.-M., Liao, X.-P., Zhang, W.-J., Jiang, H.-X., Sun, J., Zhang, M.-J., He, X.-F., Lao, D.-X. 
and Liu, Y.-H., 2010. Prevalence of serogroups, virulence genotypes, antimicrobial resistance, 
and phylogenetic background of avian pathogenic Escherichia coli in South of China. 
Foodborne Pathogens and Disease, pp 1099-1106. 
Wang, X., Wei, L., Wang, B., Zhang, R., Liu, C., Bi, D., Chen, H. and Tan, C., 2016. Complete 
genome sequence and characterization of avian pathogenic Escherichia coli field isolate 
ACN001. Standards in Genomic Sciences 11, pp 13-20. 
Wang, Y., Jiang, Z., Jin, Z., Tan, H. and Xu, B., 2013b. Risk factors for infectious diseases in 
backyard poultry farms in the Poyang Lake area, China. PLoS One 8, pp e67366. 
Warner, P.J., Williams, P.H., Bindereif, A. and Neilands, J.B., 1981. ColV plasmid-specific 
aerobactin synthesis by invasive strains of Escherichia coli. Infection and Immunity 33, pp 
540-545. 
Wasyl, D., Hasman, H., Cavaco, L.M. and Aarestrup, F.M., 2012. Prevalence and characterization of 
cephalosporin resistance in nonpathogenic Escherichia coli from food-producing animals 
slaughtered in Poland. Microbial Drug Resistance 18, pp 79-82. 
Wasyl, D., Hoszowski, A., Zajac, M. and Szulowski, K., 2013. Antimicrobial resistance in 
commensal Escherichia coli isolated from animals at slaughter. Frontiers in Microbiology 4, 
pp 221-228. 
 Page | 256  
 
Waters, V.L., 1999. Conjugative transfer in the dissemination of beta-lactam and aminoglycoside 
resistance. Frontiers in Bioscience 4, pp 433-456. 
Watkins, S., 2008. Water identifying and correcting challenges. Avian Advice 10, pp 10-15. 
Weissman, S.J., Johnson, J.R., Tchesnokova, V., Billig, M., Dykhuizen, D., Riddell, K., Rogers, P., 
Qin, X., Butler-Wu, S., Cookson, B.T., Fang, F.C., Scholes, D., Chattopadhyay, S. and 
Sokurenko, E., 2012. High-resolution two-locus clonal typing of extraintestinal pathogenic 
Escherichia coli. Applied and Environmental Microbiology 78, pp 1353-1360. 
Whiley, H., van den Akker, B., Giglio, S. and Bentham, R., 2013. The role of environmental 
reservoirs in human campylobacteriosis. International Journal of Environmental Research and 
Public Health 10, pp 5886-5907. 
Whiteman, C.E., Bickford, A.A. and Barnes, H.J., 1979. Avian Disease Manual, In: Barnes, H.J., 
American Association of Avian Pathologists (Eds.) Texas A and M University College 
Station, Texas, USA. 
Whitford, M.F., Forster, R.J., Beard, C.E., Gong, J. and Teather, R.M., 1998. Phylogenetic analysis 
of rumen bacteria by comparative sequence analysis of cloned 16S rRNA genes. Anaerobe  4, 
pp 153-163. 
Williams, P.H. and Warner, P.J., 1980. ColV plasmid-mediated, colicin V-independent iron uptake 
system of invasive strains of Escherichia coli. Infection and Immunity 29, pp 411-416. 
Wilson, I.G., 1997. Inhibition and facilitation of nucleic acid amplification. Applied and 
Environmental Microbiology 63, pp 3741-3751. 
Wilson, L.A. and Sharp, P.M., 2006. Enterobacterial repetitive intergenic consensus (ERIC) 
sequences in Escherichia coli: Evolution and implications for ERIC-PCR. Molecular Biology 
and Evolution 23, pp 1156-1168. 
Windhorst, H.W., 2006. Changes in poultry production and trade worldwide. Worlds Poultry Science 
Journal 62, pp 585-602. 
Wirth, T., Falush, D., Lan, R.T., Colles, F., Mensa, P., Wieler, L.H., Karch, H., Reeves, P.R., Maiden, 
M.C.J., Ochman, H. and Achtman, M., 2006. Sex and virulence in Escherichia coli: an 
evolutionary perspective. Molecular Microbiology 60, pp 1136-1151. 
 Page | 257  
 
Wohlsen, T.D., 2011. Comparative evaluation of chromogenic agar CM1046 and mFC agar for 
detection of E. coli and thermotolerant coliform bacteria from water samples. Letters in 
Applied Microbiology 53, pp 155-160. 
Won, G.Y., Moon, B.M., Oh, I.G., Matsuda, K., Chaudhari, A.A., Hur, J., Eo, S.K., Yu, I.J., Lee, 
Y.J., Lee, Y.S., Kim, B.S. and Lee, J.H., 2009. Profiles of virulence-associated genes of avian 
pathogenic Escherichia coli isolates from chickens with colibacillosis. Journal of Poultry 
Science 46, pp 260-266. 
Woodford, N., Reddy, S., Fagan, E.J., Hill, R.L., Hopkins, K.L., Kaufmann, M.E., Kistler, J., 
Palepou, M.F., Pike, R., Ward, M.E., Cheesbrough, J. and Livermore, D.M., 2007. Wide 
geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and 
Klebsiella spp. in the UK and Ireland. The Journal of Antimicrobial Chemotherapy 59, pp 
102-105. 
Wooldridge, K.G. and Williams, P.H., 1993. Iron uptake mechanisms of pathogenic bacteria. FEMS 
Microbiology Reviews 12, pp 325-348. 
Wooley, R.E., Spears, K.R., Brown, J., Nolan, L.K. and Fletcher, O.J., 1992. Relationship of 
complement resistance and selected virulence factors in pathogenic avian Escherichia coli. 
Avian Diseases 36, pp 679-684. 
World Health Organization (WHO), 2016. Critically important antimicrobials for human medicine: 
categorization for the development of risk management strategies to contain antimicrobial 
resistance due to non-human antimicrobial use: report of the second WHO Expert Meeting, 
Copenhagen, 29–31 May 2007, [Available from 
http://www.who.int/foodborne_disease/resistance/]; Accessed February 2016. 
Wozniak, R.A.F. and Waldor, M.K., 2010. Integrative and conjugative elements: mosaic mobile 
genetic elements enabling dynamic lateral gene flow. Nature Reviews Microbiology 8, pp 
552-563. 
Wray, C. and Woodward, M.J., 1994. Laboratory diagnosis of Escherichia coli infections. In: Gyles, 
C.L. (Ed.) Escherichia coli in Domestic Animals and Humans. CAB International, 
Wallingford, UK, pp 595-628. 
Wright, G.D., 2010. Q&A: Antibiotic resistance: where does it come from and what can we do about 
it? BMC Biology 8, pp 123-129. 
 Page | 258  
 
Xiong, L., Ling, J., Gao, Q., Zhou, Y., Li, T., Gao, S. and Liu, X., 2012. Construction of iucB and 
iucBiutA mutants of avian pathogenic Escherichia coli and evaluation of their pathogenicity. 
Veterinary Microbiology 159, pp 420-431. 
Yaguchi, K., Ogitani, T., Osawa, R., Kawano, M., Kokumai, N., Kaneshige, T., Noro, T., Masubuchi, 
K. and Shimizu, Y., 2007. Virulence factors of avian pathogenic Escherichia coli strains 
isolated from chickens with colisepticemia in Japan. Avian Diseases  51, pp 656-662. 
Yan, J.J., Hsueh, P.R., Lu, J.J., Chang, F.Y., Shyr, J.M., Wan, J.H., Liu, Y.C., Chuang, Y.C., Yang, 
Y.C., Tsao, S.M., Wu, H.H., Wang, L.S., Lin, T.P., Wu, H.M., Chen, H.M. and Wu, J.J., 2006. 
Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical 
isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. 
Antimicrobial Agents and Chemotherapy 50, pp 1861-1864. 
Yang, H., Chen, S., White, D.G., Zhao, S., McDermott, P., Walker, R. and Meng, J., 2004. 
Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased 
chickens and swine in China. Journal of Clinical Microbiology 42, pp 3483-3492. 
Yang, H.Y., Nam, Y.S. and Lee, H.J., 2014. Prevalence of plasmid-mediated quinolone resistance 
genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae 
isolated from blood cultures in Korea. The Canadian Journal of Infectious Diseases and 
Medical Microbiology 25, pp 163-169. 
Yang, J.L., Wang, M.S., Cheng, A.C., Pan, K.C., Li, C.F. and Deng, S.X., 2008. A simple and rapid 
method for extracting bacterial DNA from intestinal microflora for ERIC-PCR detection. 
World Journal of Gastroenterology 14, pp 2872-2876. 
Yao, J., D.C. and Moellering, R.C., 2007. Antibacterial agents. In: Murray, E.J., Baron, J.J., 
Orgensen, H., Landry, M.L., Pfaller, M.A. (Eds.) Manual of Clinical Microbiology. ASM 
Press, Washington DC, pp 1077-1113. 
Yassin, A., Gong, J., Kelly, P., Lu, G. and Guardabassi, L., 2017. Antimicrobial resistance in clinical 
Escherichia coli isolates from poultry and livestock, China. PLoS One 12, pp e0185326. 
Yerushalmi, Z., Smorodinsky, N.I., Naveh, M.W. and Ron, E.Z., 1990. Adherence pili of avian strains 
of Escherichia coli O78. Infection and Immunity 58, pp 1129-1131. 
Yu, Z. and Morrison, M., 2004. Improved extraction of PCR-quality community DNA from digesta 
and fecal samples. BioTechniques 36, pp 808-812. 
 Page | 259  
 
Yunis, A.A., 1988. Chloramphenicol: relation of structure to activity and toxicity. Annual Review of 
Pharmacology and Toxicology 28, pp 83-100. 
Zanella, A., Alborali, G.L., Bardotti, M., Candotti, P., Guadagnini, P.F., Martino, P.A. and Stonfer, 
M., 2000. Severe Escherichia coli O111 septicaemia and polyserositis in hens at the start of 
lay. Avian Pathology 29, pp 311-317. 
Zarubica, T., Baker, M.R., Wright, H.T. and Rife, J.P., 2011. The aminoglycoside resistance 
methyltransferases from the ArmA/Rmt family operate late in the 30S ribosomal biogenesis 
pathway. RNA 17, pp 346-355. 
Zhang, B.W., Li, M., Ma, L.C. and Wei, F.W., 2006. A widely applicable protocol for DNA isolation 
from fecal samples. Biochemical Genetics 44, pp 503-512. 
Zhang, P., Shen, Z., Zhang, C., Song, L., Wang, B., Shang, J., Yue, X., Qu, Z., Li, X., Wu, L., Zheng, 
Y., Aditya, A., Wang, Y., Xu, S. and Wu, C., 2017. Surveillance of antimicrobial resistance 
among Escherichia coli from chicken and swine, China, 2008-2015. Veterinary Microbiology 
203, pp 49-55. 
Zhao, L., Gao, S., Huan, H., Xu, X., Zhu, X., Yang, W., Gao, Q. and Liu, X., 2009. Comparison of 
virulence factors and expression of specific genes between uropathogenic Escherichia coli 
and avian pathogenic E. coli in a murine urinary tract infection model and a chicken challenge 
model. Microbiology 155, pp 1634-1644. 
Zhao, R., Shi, J., Shen, Y., Li, Y., Han, Q., Zhang, X., Gu, G. and Xu, J., 2015. Phylogenetic 
distribution of virulence genes among ESBL-producing uropathogenic Escherichia coli 
isolated from long-term hospitalized patients. Journal of Clinical and Diagnostic Research 9, 
pp 1-4. 
Zhao, S., Maurer, J.J., Hubert, S., De Villena, J.F., McDermott, P.F., Meng, J., Ayers, S., English, L. 
and White, D.G., 2005. Antimicrobial susceptibility and molecular characterization of avian 
pathogenic Escherichia coli isolates. Veterinary Microbiology 107, pp 215-224. 
Zhao, X., Lin, C.W., Wang, J. and Oh, D.H., 2014. Advances in rapid detection methods for 
foodborne pathogens. Journal of Microbiology and Biotechnology 24, pp 297-312. 
Zhu Ge, X., Jiang, J., Pan, Z., Hu, L., Wang, S., Wang, H., Leung, F.C., Dai, J. and Fan, H., 2014. 
Comparative genomic analysis shows that avian pathogenic Escherichia coli isolate IMT5155 
 Page | 260  
 
(O2:K1:H5; ST complex 95, ST140) shares close relationship with ST95 APEC O1:K1 and 
human ExPEC O18:K1 strains. PLoS One 9, pp e112048. 
Zhu, M., Valdebenito, M., Winkelmann, G. and Hantke, K., 2005. Functions of the siderophore 
esterases IroD and IroE in iron-salmochelin utilization. Microbiology 151, pp 2363-2372. 
 
 
 
 
Page | 261  
 
List of Appendices 
Appendices to Chapter 4 
Supplementary Table 1: Questionnaire for the cross-sectional study to identify risk factors 
associated with avian pathogenic E. coli on commercial broiler chicken farms in South East 
Queensland. 
 
(Section one) 
Details from slaughterhouse visit and farm list (To be completed by the researcher)  
1. Date of field investigation:  __/__/____  
2. Date of slaughterhouse visit:   __/__/____  
3. Name of poultry slaughterhouse:  _____________________  
4. Name of farm:   _____________________ 
5. Farm code: ____________________ 
6. City:   ____________________ 
7.  Farm location saved on the GPS?       Yes               No 
a) If yes, farm GPS location saved as: __________________________________ 
8. Elevation: _______metres; Longitude: ______________; Latitude: ________ 
9. Phone No: ____________________ 
10. Fax No.:  _____________________ 
11. Email:   ___________________________ 
12. Website: ___________________________ 
Section Two 
Farm details  
 (To be completed by the farmers/managers) 
1. Date: __/__/____ 
2. Surname:   ____________First name:    __________   
3. Your role on the farm: Owner / Manager / Both 
4. Email: __________________________________ 
5. Farm address:                                                                            Post code: 
____________________ 
6. How chickens are currently housed (tick all boxes that might apply)? 
Separate age groups housed on the farm at the same time 
Same age groups housed on the farm at the same time  
Other (please specify) ________________________________________ 
7. Where does the chickens’ drinking water currently come from (tick all boxes that might apply)?  
Local water utility  
Well on the property 
 River 
Other (please specify):____________________________________  
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a) Is there any treatment of water currently conducted before it is given to the chickens? 
                               Yes □                No □  
If yes, how is the water treated?  
 
8. Are there currently any vehicle tyre disinfection facilities on the farm? 
        Yes □                No □ 
9. If yes, how often are vehicle tyres disinfected by ‘workers /visitors’ when entering the farm? 
 Always Usually Sometimes Rarely Never Unknown 
Farm 
worker 
□ □ □ □ □ □ 
Visitors □ □ □ □ □ □ 
 
10. Please specify who currently conducts the spreading service for litter used on the farm?  
 Always Usually Sometimes Rarely Never Unknown 
Farm worker □ □ □ □ □ □ 
Other, please 
specify  
 
 
□ □ □ □ □ □ 
 
11. Which of these methods are currently used to clean the farm (tick all the boxes that applies)? 
 At the 
removal of 
birds to the 
abattoir of 
each flock 
At the 
removal of 
birds to the 
abattoir of 
every 
second                
flock 
At the 
removal of 
birds to the 
abattoir of  
every 
third flock 
At the 
removal of 
birds to the 
abattoir of 
every 
fourth  
flock 
Other, 
please 
specify 
frequency  
Litter removal  □ □ □ □ □ 
Sweeping without water □ □ □ □ □ 
Pressure hose + mild 
detergent 
□ □ □ □ □ 
Sanitization of the 
shed(s) 
□ □ □ □ □ 
Washing the walls □ □ □ □ □ 
Other (please, specify) 
 
 
 
 
 
□ □ □ □ □ 
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12. Are there other farm animal (either backyard or commercial) currently kept within 500 m to this 
farm?  
             Yes □                No □                If No, go to next question    
 If Yes,   
Type of farm animal Number of animals (if 
known) 
Distance to this farm 
   
   
   
   
   
 
13. Number of chicken sheds currently on the farm: __________ 
14. What were the maximum numbers of birds per shed within the last 12 months? 
____________________ 
15. What were the minimum numbers of birds per shed within the last 12 months? 
____________________ 
16. What were the average numbers of birds per shed within the last 12 months?  
____________________ 
17. Did the mortality vary between the shed(s) within the last 12 months? 
         Yes □                No □  
If yes, 
a) What was the highest mortality rate per shed within the last 12 months? 
____________________ 
b) What was the lowest mortality rate per shed within the last 12 months? 
____________________ 
c) What was the average mortality rate per shed within the last 12 months? 
____________________ 
 
18. If you answered yes for Question 17, why do you think there were differences in the mortality 
rate between sheds? 
 
 
19. Total number of birds supplied to the farm from the hatchery in the last year (2013):  
__________________ 
20. Total number of birds send to slaughter in the last year (2013): _____________________ 
21. Please specify the type of workers currently working on the farm (for example a) manger or b) 
causal farm worker c) other, (please specify). A worker is a person who works on the farm on 
daily basis or has contact with the chickens on the farm on a regular basis). 
Type of 
worker 
Average 
number of 
days/week 
Type of work Does the farm worker 
own or come into 
contact with other 
Specify the animal 
type and frequency of 
contact with animals 
(daily, weekly, 
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working on 
the farm 
animals (pets, or 
livestock) regularly? 
monthly, specify other 
frequency) 
   Yes □     No□       
Unknown□ 
 
 
   Yes □     No□       
Unknown□ 
 
 
   Yes □     No□       
Unknown□ 
 
 
   Yes □     No□       
Unknown□ 
 
 
   Yes □     No□       
Unknown□ 
 
 
   Yes □     No□       
Unknown□ 
 
 
Section Three 
Farm ------- shed number……………  
Farm details (To be completed by the farmers/managers) 
22. Please specify any visitors that visited the farm during the period the sampled flock was present 
on the farm. 
Visitors Average 
frequency of 
visits (daily/ 
Weekly/monthly, 
as required etc.) 
Reasons 
for 
visit(s) 
Did the visitor own or 
was into contact with 
other animals (pets, 
poultry or livestock) 
regularly? 
Specify the animal 
type and frequency of 
contact with these 
animals (daily, 
weekly, monthly, 
specify other 
frequency) 
Repairer   Yes □     No□       
Unknown□  
Cleaner   Yes □     No□       
Unknown□  
Management 
advisor 
  Yes □     No□       
Unknown□ 
Veterinarian    Yes □     No□       
Unknown□  
Researcher   Yes □     No□       
Unknown□  
Collector of 
chickens  
   Yes □     No□       
Unknown□ 
 
23. Have you noticed the presence of any of the following animals inside or within 300 m distance 
to the outside of the shed during the period the sampled flock was present on the farm?  
Type of animals Inside the shed Outside the shed (within 300 m 
distance) 
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Number of 
individuals 
Average frequency 
seen 
(daily/weekly/monthly, 
specify other 
frequency) 
Number of 
individuals 
Average frequency 
seen 
(daily/weekly/monthly, 
specify other 
frequency) 
Rats/mice     
Wild birds 
(specify) 
    
Amphibians or 
reptiles 
    
Domestic dogs     
Domestic cats     
Domestic 
ruminants 
(cow/sheep) 
    
Other domestic 
animals (specify) 
1. 
2. 
    
Stray/feral animal 
(specify) 
1. 
2. 
    
     
Kangaroos     
Possums     
Other (please 
specify) 
1. 
2. 
3. 
 
 
    
 
24. Did farm workers or visitors use footbaths when entering the poultry sheds where the sampled 
flock was housed? 
 Always Usually Sometimes Rarely Never Unknown 
Farm 
worker 
□ □ □ □ □ □ 
Visitors □ □ □ □ □ □ 
 
a) If footbaths were used, what disinfectant was used in these foot baths specified above? 
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25. Did farm workers or visitors use overalls supplied by the farm when having contact with the 
chickens of the sampled flock?  
 Always Usually Sometimes Rarely Never Unknown 
Farm 
worker 
□ □ □ □ □ □ 
Visitors □ □ □ □ □ □ 
 
26. Is there any shower facility located on the farm? 
Yes □                           No □ 
27. Did farm workers or visitors use the shower facility located on the farm before entering the 
sheds where the sampled flock was kept? 
 Always Usually Sometimes Rarely Never Unknown 
Farm 
worker 
□ □ □ □ □ □ 
Visitors □ □ □ □ □ □ 
 
28. Did farm workers or visitors use hand sanitiser before entering the shed or before handling the 
chickens from the sampled flock? 
 Always Usually Sometimes Rarely Never Unknown 
Farm 
worker 
□ □ □ □ □ □ 
Visitors □ □ □ □ □ □ 
 
a) If yes, can you please specify the type of sanitiser used? 
 ___________________________________________________ 
 
29. What is the approximate distance in metres between the car park and poultry shed where the 
sampled flock was kept? _________________________________  
 
 
30. Did farm workers or visitors disinfect equipment (ladder, fixing tools, etc.) before entering the 
shed of the sampled flock? 
 Always Usually Sometimes Rarely Never Unknown 
Farm 
worker 
□ □ □ □ □ □ 
Visitors □ □ □ □ □ □ 
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b) If so, what disinfectant was used? 
___________________________________________________ 
31. How often was the following equipment cleaned in the shed where the sampled flock was kept? 
 Always Usually Sometimes Rarely Never Unknown 
Pan feeder  □ □ □ □ □ □ 
Water 
lines 
□ □ □ □ □ □ 
 
 
32. How frequently was litter changed where the sampled flock was kept? 
At the 
removal of 
birds to the 
abattoir of 
each flock 
At the removal of 
birds to the 
abattoir of every 
second                
flock 
At the removal of 
birds to the 
abattoir of  every 
third flock 
At the removal 
of birds to the 
abattoir of every 
fourth  flock 
Other, specify 
frequency  
□ □ □ □ □ 
 
33. Was the shed where the sampled flock was kept, cleaned after the litter removal? 
Yes □                           No □ 
34. Was insecticide used in the shed where the sampled flock was kept, after cleaning the shed? 
            Yes □                           No □ 
 
a) If so, what type of insecticide was used? 
___________________________________________________ 
 
35. How many birds died in the shed where the sampled flock was kept? 
Week number number of deaths  
1  
2  
3  
4  
5  
6  
7  
8  
9  
10  
11  
12  
 
36. How frequently were dead birds removed from the shed(s) during the duration the sampled 
flock was kept in these sheds?  
 Page | 268  
 
More than twice 
a day 
Twice a day Once a day Every other 
day 
Other, specify 
frequency  
□ □ □ □ □ 
 
37. What was the peak density per kilogram per square metres for the shed where the sampled flock 
was kept? 
  
 
38. In which week did you reach peak density in the shed(s) where the sampled flock was kept? 
 
 
39. Can you describe the ammonia odour in the shed where the sampled flock were kept at peak 
density?  
No odour Slightly  annoying 
(faint) 
Annoying 
(distinct) 
Very annoying  
(strong ) 
Extremely  
annoying 
(very strong) 
□ □ □ □ □ 
 
40. Can you describe the ammonia odour in the shed of the sampled flock before slaughtering?  
No odour Slightly  annoying 
(faint) 
Annoying 
(distinct) 
Very annoying  
(strong ) 
Extremely  
annoying 
(very strong) 
□ □ □ □ □ 
 
41. What type of ventilation was used in the shed where the sampled flock was kept, please describe 
in detail? 
 
         
         
 
 
 
42. Were transport vehicles (for transport of chickens to the slaughterhouse) allowed to enter the 
farm during the sampling period? 
Yes □                No □                
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a) If yes, did the transport vehicles have chickens on them when they arrived at the farm? 
Yes □                No □               Sometimes□       
 
Section Five 
Farm ------- shed number…………..  
 Farm Management Details (To be completed by the farmers/managers) 
43. Were there any second grade eggs ‘dirty eggs’ used for the sampled flock? 
Yes □                No □ 
44. How many second grade eggs ‘dirty eggs’ were used for the sampled flock? 
 
 
45. What was the weekly weight of the sampled flock? 
 
Week number Average weight for the sampled flock  
1  
2  
3  
4  
5  
6  
7  
8  
9  
10  
11  
12  
 
46. Was there any stress-full events occurring during the period when the sampled flock was present 
on the farm? 
Yes □                No □ 
If yes, Please provide details  
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Section Six 
Farm ------- shed number………….. 
47.  Has E. coli been diagnosed on this farm within the last 12 months? 
Yes □                No □  
Clinical signs 
observed 
Diagnostic test 
method(s) 
used  
Date 
(estimate) 
Number of death associated with E. coli  
infection 
  __/__/__  
  __/__/__  
 
48.  Has E. coli diagnosed on this farm in the sampled flock? 
Yes □                No □  
If yes, please provide details below. 
Clinical signs 
observed 
Diagnostic test 
method(s) used  
Date 
(estimate) 
Number of death associated with the E. 
coli infection 
  _/__/__  
  _/__/__  
 
49. Have any respiratory diseases other than E. coli been diagnosed on this farm within the last 12 
months? 
                        Yes □                No □  
If yes, please provide details below. 
Disease 
Diagnostic test 
method(s) used 
Date 
(estimate) 
Symptoms of the disease observed  
  __/__/__  
  __/__/__  
 
50. Have any respiratory diseases other than E. coli been diagnosed on this farm in the sampled 
flock? 
Yes □                No □  
If yes, please provide details below. 
Disease 
Diagnostic test 
method(s) used 
Date 
(estimate) 
Symptoms of the disease observed 
  __/__/__  
  __/__/__  
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51. Have any antimicrobial treatments been used on this farm within the last 12 months? 
Yes □                No □ 
If yes, please provide details below. 
Type of 
antimicrobial used  
Date 
(estimate) 
Details (use for what problem, administration procedure 
etc.) 
 __/__/__  
 __/__/__  
 
52. Where any antimicrobial treatments used on this farm in the sampled flock? 
Yes □                No □ 
If yes, please provide details below. 
Type of 
antimicrobial used  
Date 
(estimate) 
Details (use for what problem, administration procedure 
etc.) 
 __/__/__  
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Appendices to Chapters 5 
Supplementary Table 2: Number (N), prevalence and association of the five avian pathogenic E. coli related virulence genes among clinical E. 
coli (n = 50) and faecal E. coli isolates (n = 187) cultured from Australian broiler chickens. 
Antimicrobial drug 
Clinical E. coli  Faecal E. coli  
iroN 
N (%) 
ompT 
N (%) 
iss 
N (%) 
hlyF 
N (%) 
iutA 
N (%) 
Total 
Number 
iroN 
N (%) 
ompT 
N (%) 
iss 
N (%) 
hlyF 
N (%) 
iutA 
N (%) 
Total 
Number 
Ampicillin 10 (71)+ 12 (86)  12 (86) 12 (86) 12 (86) 14 23 (39) 33 (56) 27 (46) 34 (58) 37 (58) 59 
Amoxicillin/clavulanic acid 1 (50) 1 (50) 1 (50) 1 (50) 1 (50) 2 4 (50) 7 (88) 4 (50) 7 (88) 3 (38) 8 
Ticarcillin/clavulanic acid 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 1 (50) 1 (50) 1 (50) 1 (50) 2 (100) 2 
Cephalothin 2 (67) 2 (67) 2 (67) 2 (67) 2 (67) 3 24 (51)+ 27 (57) 24 (51) 25 (53) 21 (45)+ 47 
Cefoxitin 1 (50) 1 (50) 1 (50) 1 (50) 1 (50) 2 0 0 0 0 0 0 
Cefovecin 1 (50) 1 (50) 1 (50) 1 (50) 1 (50) 2 0 0 0 0 0 0 
Ciprofloxacin 0 0 0 0 0 2 0 0 3 (38) 1 (13) 5 (75) 7 
Chloramphenicol 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 0 0 0 2 (100) 2 (100) 2 
Apramycin 4 (100 4 (100 4 (100 4 (100) 4 (100) 4 0 0 0 0 1 (100) 1 
Gentamicin 4 (67)+ 4 (67)+ 4 (67)+ 4 (67)+ 4 (67)+ 6 0 0 2 (40) 0 3 (60) 5 
Streptomycin 10 (83) 10 (83) 10 (83) 10 (83) 10 (83) 12 16 (39) 19 (46) 19 (46) 19 (46) 20 (49) 41 
Spectinomycin 2 (50) 2 (50) 2 (50) 2 (50) 2 (50) 4 0 0 0 0 0 0 
Neomycin 3 (75) 3 (75) 3 (75) 3 (75) 3 (75) 4 3 (75) 3 (75) 3 (75) 3 (75) 3 (75) 4 
Sulfamethoxazole/trimethoprim 19 (86) 20 (91) 20 (91) 20 (91) 20 (91) 22 33 (44) 45 (60) 40 (53)+ 47 (63) 44 (59) 75 
Tetracycline 23 (85) 25 (93) 25 (93) 25 (93) 25 (93) 27 24 (46) 32 (62) 27 (52) 32 (62) 32 (62) 52 
+ Indicates a positive association between traits (p <0.05). 
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Supplementary Table 3: Number (N), prevalence and association of phylogenetic groups among antimicrobial resistant avian clinical E. coli (n 
= 50) and faecal E. coli (n = 187) isolates from commercial broiler chickens in Australia. 
Phylogenetic Group  
Antimicrobial drug 
A B1 B2 C D E E_clade 1 F 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
CEC 
N (%) 
FEC 
N (%) 
Ampicillin 9 (64) 8 (14) 0 6 (10) 3 (21) 1 (2) 2 (14) 18 (31) 0 8 (14) 0 3 (5) 0 2 (3) 0 13(22) 
Amoxicillin/clavulanic acid 2 (100) 2 (25) 0 0 0 0 0 1 (13) 0 2 (25) 0 1 (13) 0 0 0 2 (25) 
Ticarcillin/clavulanic acid 1 (100) 0 0 0 0 0 0 0 0 1 (50) 0 0 0 0 0 1 (50) 
Cephalothin 2 (67) 10 (21) 0 4 (9) 0 1 (2) 1 (33) 13 (28) 0 5 (11) 0 2 (4) 0 0 0 
12 
(26) 
Cefoxitin 2 (100) 0 0 0 0 0 0 0  0 0 0 0 0 0 0 
Cefovecin 2 (100) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Ciprofloxacin 2 (100) 0 0 2 (26) 0 0 0 0 0 0 0 0 0 0 0) 5 (71)+ 
Chloramphenicol 1 (100) 0 0 0 0 0 0 2 (100) 0 0 0 0 0 0 0 0 
Gentamicin 3 (50) 1 (20) 0 1 (20) 2 (33) 0 1 (17) 0 0 0 0 0 0 0 0 3 (60) 
Streptomycin 2 (50) 5 (12) 0 6 (15) 1 (25) 1 (2) 1 (25) 
12 
(29) 
0 6 (15) 0 2 (5) 0 0 0 8 (20) 
Neomycin 4 (100) 1 (25) 0 1 (25) 0 0 0 0 0 1 (25) 0 0 0 0 0 0 
Spectinomycin 1 (25) 0 0 0 2 (50) 0 1 (25) 0 0 0 0 0 0 0 0 0 
Apramycin 3 (75) 0 0 0 1 (25) 0 0 0 0 0 0 0 0 0 0 
1 
(100) 
Sulfamethoxazole/ 
trimethoprim 
12 (55) 
12 
(16) 
0 6 (8) 
5 
(23)+ 
5 (7) 3 (14) 
24 
(32) 
0 
10 
(13) 
0 2 (3) 0 2 (3) 2 (9) 
13 
(17) 
Tetracycline 14 (52) 
11 
(21) 
0 5 (10) 3 (11) 1 (2) 6 (22) 
16 
(31) 
0 5 (10) 0 1 (2) 0 2 (4) 4 (15) 
11 
(21) 
+ Indicates a positive association between traits (P <0.05). 
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Animals ethic approval I 
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Animals ethics approval II  
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Human ethic approval  
